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ABSTRACT
The SlOO-family protein p l l  (S100A10) is involved in a variety o f physiological 
processes, including channel trafficking and angiogenesis. In this thesis, we used 
genetic approaches to investigate the functional roles o f p l l .  p l l  modulates the 
plasma membrane trafficking o f the sensory neuron-specific voltage-gated Na" channel 
Na\T.8 and numerous other proteins. Since N av i.8 performs a specialised function in 
the detection o f noxious stimuli (nociception), we investigated the role o f p l l  in 
peripheral pain pathways. We used the C tq-IoxP  system to delete pi 1 exclusively from 
nociceptive neurons, allowing the examination o f this aspect o f p l l  function without 
confounding effects from roles of p l l  in other tissues, p ll-n u ll neurons showed 
deficits in the functional expression o f N av i.8. Noxious coding in wide-dynamic range 
neurons in the dorsal horn was compromised in p ll-n u ll animals. Acute mechanical 
pain behaviour was attenuated, but no deficits in inflammatory pain were observed. 
Reduced neuropathic pain behaviour was apparent in nociceptor-specific pi 1-null 
mice. While certain effects o f p l l  deletion can be explained by reduced N ayl.8 
trafficking. N ayl.8  is not required for neuropathic pain, p l l  therefore acts through 
both Nay 1.8-dependent and alternative mechanisms to control nociceptive thresholds. 
This suggests it is a potential therapeutic target.
Given the importance o f pi 1-dependent modulation o f N ayl.8. we investigated the 
p ll-b ind ing  site on the Nayl.8 N-terminus. In vitro fluorescence resonance energy 
transfer (FRET) assays were used to examine this interaction. In contrast to previous 
studies, we found the interaction to be complex, involving two distinct binding sites 
and an autoinhibitory domain. The pi 1-Nayl.8 interaction is therefore not well-suited 
to small molecule-based inhibition.
pi 1 has been reported to play an important role in processes required for angiogenesis. 
In assays o f angiogenesis-dependent tumour growth, global p l l  deletion resulted in 
increased tumour volume and altered vascular morphology. This may have 
implications for novel anti-cancer therapies targeting p l l .
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1 INTRODUCTION
This thesis examines the role of the SI 00 protein pi 1 in pain pathways, in particular through its 
interaction with the voltage-gated sodium channel N av 1.8. The introduction will give an 
overview of pi 1 and the SI 00 proteins, followed by a discussion of the clinical aspects o f pain 
and the physiological process o f  nociception. This will be followed by an introduction to 
voltage-gated sodium channels, focusing on Nav 1.8 and others expressed in damage-sensing 
neurons.
1.1 T he S100 Pro tein s
The S I 00 proteins are small (10-12kDa). acidic proteins, found exclusively in vertebrates 
(Schafer and Heizmann. 1996a). and are members of the EF-hand superfamily. EF-hand 
proteins are defined by the presence o f between 2 and 12 helix-turn-helix structural motifs, 
each consisting o f two u-helices separated bv a short loop region o f around 12 amino acids. 
The EF-hand motif is usually capable o f  binding a Ca2 ion. via aspartate and glutamate side 
chains (Marsden et al.. 1990). which causes a conformational change. This allows functional 
regulation o f  SI 00 proteins by changes in intracellular Ca" concentration.
The S I00 family contains over 25 distinct isoforms with 25-65% amino acid identity, the genes 
for which are clustered at chromosome locus 1 q 2 1 in humans (chromosome 3 in the mouse) 
(Schafer and Heizmann, 1996b). They are characterised by two consecutive EF-hands (N- 
terminal unconventional with low Ca2 affinity. C-terminal canonical, with high affinity for 
Ca2 (Donato, 1986a)) connected by a flexible linker region (the "hinge"), and flanked by 
conserved hydrophobic residues with N- and C-terminal extensions. The sequences o f the 
linker and the C-terminal extension are the most variable regions, and are often involved in 
target binding (Donato, 2001;Kligman and Hilt, 1988). Structurally, the S I 00 proteins are 
similar to calmodulin, although they do not share its ubiquitous expression. Instead, they are 
expressed in certain ceil types at varying levels, often changing in response to environmental 
factors. Members o f  the S I00 family are under complex transcriptional control (Chen and 
Barraclough. 1996;e.g. Cohn et al., 2001).
With the exception o f  calbindin (which functions as a Ca2 buffer), S I 00 proteins exist as non-
covalent homo- and hetero-dimers, related by a 2-fold axis o f  rotation. This dimerisation is
important for functional activity (Donato, 2003), and may be dynamic (Santamaria-Kisiel et al.,
2006). The binding o f  Ca" to S I 00 proteins causes a conformational change in structure,
resulting in a 40% alteration in the position o f the 3rd a-helix, which exposes a broad
14
hydrophobic surface (e.g. Dempsey et al., 2003). This is proposed to allow the interaction o f 
S100 proteins with their target proteins under conditions o f high Ca' concentration. One 
member o f the family. S100A10 (p l l ) .  has a mutation in each EF loop, rendering it Ca' - 
independent and resulting in a permanently-active conformation (Gerke and Weber. 
1985b:Rety et al.. 1999).
The S I00 proteins generally act via effector molecules, such as ion channels, enzymes, or 
components of the cytoskeleton. For the Ca2 -dependent S I00 proteins, this provides a 
mechanism for the regulation o f cellular function by changes in Ca' levels. Yeast two-hybrid 
screens have played a large part in the identification of target proteins to which SI 00 members 
bind, although this method has limited biological relevance and interactions must therefore be 
confirmed by other methods. For example, the low Ca' levels in yeast (~200nM) (Halachmi 
and Eilam. 1993) would prevent the detection of many Ca2 -dependent interactions. 
Additionally, proteins forced to co-localise in the nucleus (by the addition o f nuclear 
localisation signals) may not come into contact in a physiological setting. In vivo 
colocalisation studies have been o f  use in recent years, supplemented by immunoprecipitation 
assays to demonstrate a physical interaction.
1.1.1 S100-target interactions
The dissociation constant (Kd) for the Ca" dependence o f most S I00 proteins is around 10- 
50nM (Donato. 1986b), meaning that the majority will assume the active conformation during 
an intracellular Ca' spike (~lpM ). This provides a mechanism for the control o f  interactions 
by intracellular Ca2 levels. Some interactions, however, are Ca2 -independent, and 
presumably regulated by alternative mechanisms. Over 90 proteins to which S I 00 proteins 
may bind have been identified (including tubulin, glial fibrillary acidic protein and F-actin), 
although in vivo confirmation o f  binding has only been performed for a subset o f  these.
Whilst all S I 00 proteins act by binding to other proteins, the effects o f  S I 00 binding on these 
proteins are diverse. Effects on oligomerisation, steric inhibition o f  kinase-mediated 
phosphorylation (e.g. Yu and Fraser. 2001). retention o f proteins in the ER (e.g. Renigunta et 
al.. 2006), masking o f  ER retention signals to allow subsequent trafficking (e.g. Girard et al.,
2002), interactions with the cytoskeleton (e.g. Yamasaki et al., 2001), regulation o f  ion channel 
activity, regulation o f  enzyme activity (e.g. Duda et al., 1996) and acting as co-receptors for 
enzyme-substrate interactions (e.g. Kwon et al., 2005a) have all been described. Additionally, 
secreted S I 00 proteins have been shown to act in a cytokine-like manner through the receptor 
for advanced glycosylation end products (RAGE).
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1.2 P l l  (S100A 10)
pi 1 (SIOOAIO, calpactin light-chain, annexin 2 light-chain) is an 1 lkDa member o f  the SI 00 
protein family, consisting o f 96 amino acids (Mus musculus. Homo sapiens). The SIOOAIO 
gene, highly conserved among vertebrates, is located in the S I 00 cluster o f  genes, on 
chromosome 1 q 2 1 in the human, and chromosome 3 in the mouse, pi 1 is unique among the 
S I00 proteins in being insensitive to Ca2 . due to mutations in both EF hands resulting in a 
permanently active ("Ca2 on") conformation (Gerke and Weber. 1985a;Rety et al.. 1999).
pi 1 was first identified through its association with annexin 2 (described in detail later), when 
its similarity to other S I 00 proteins was described (Gerke and Weber. 1985c). pi 1 exists as a 
heterotetramer with annexin 2. in which state the majority of its functions are performed (for 
review, see Gerke and Moss. 2002). The nucleotide and amino acid sequences o f pi 1 are well- 
conserved between species (determined using GenBank sequences), showing a degree of 
homology with other S I00 proteins (Saris et al.. 1987b). It is expressed widely, in organs 
including kidney, intestine and lung (high levels), thymus, brain and spleen (intermediate 
levels) and liver, heart and testis (low levels) (Saris et al.. 1987a). Additionally, more recent 
reports have shown p l l  mRNA to be present at high levels in dorsal root ganglion (DRG) 
neurons, including small-diameter putative nociceptors (>98% of Nav l .8-positive cells also 
expressed pi 1 transcript) (Okuse et al., 2002).
pi 1 is constitutively expressed in many cell types, and has a promoter sequence which does not 
contain a TATA box and is GC-rich, similar to other "housekeeping" genes (Bird. 1986;Harder 
et al., 1992). Despite this, more recent studies have revealed that pi 1 expression is inducible 
(Huang et al., 2003a), and is modulated by a variety o f factors. Importantly, Okuse et al.
(2002) described a large increase in pi 1 mRNA levels in rat DRG neurons following treatment 
with nerve growth factor (NGF), which is known to reduce pain thresholds in animal models, 
pi 1 mRNA and protein production were found to be induced by dexamethasone (Yao et al., 
1999b), a glucocorticoid with anti-inflammatory properties, in contrast with the putative pro- 
inflammatory role o f  pi 1 via NGF. Transforming growth factor-a also increased pi 1 protein 
levels (Akiba et al., 2000b), as did epidermal growth factor, possibly via receptor tyrosine 
kinase stimulation o f  p38 MAP kinase leading to transcriptional activation (Huang et al., 2002). 
Pawliczak et al. (2001) reported an increase in p l l  expression in human bronchial epithelial 
cells in response to nitric oxide donors, which was found to be mediated by cGMP and protein 
kinase G, acting on an AP-1 site in the pi 1 promoter. Finally, interferon-y, the antiviral, anti­
tumour and immunoregulatory cytokine, was shown to induce pi 1 gene and protein expression 
via the STAT1 protein, which binds to the pi 1 promoter (Huang et al., 2003b). Interestingly, 
this paper also reported that reduced pi 1 expression resulted in enhanced interferon-y release,
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suggesting a counter-regulatory (negative feedback) role for interferon-y-stimulated pi 1 
expression. The tricyclic antidepressant imipramine has recently been reported to increase 
transcript pi 1 levels: this effect was specific to the forebrain and did not occur in other brain 
areas (Svenningsson et al., 2006). Progesterone also appears to upregulate pi 1 expression 
(Zhang and Wu. 2007). The regulation o f pi 1 expression by intercellular signalling molecules 
is thus complex.
In addition to transcriptional control o f  p l l  expression, post-translation mechanisms for 
regulation have also been described. Expression of the binding partner o f  p l l ,  annexin 2. 
upregulates cellular levels o f  pi 1. In this case, there is no increase in pi 1 transcript levels, but 
the half-life o f  pi 1 protein is increased more than 6-fold in the presence o f  annexin 2 (Puisieux 
et al., 1996). The presence o f a stable p l l  protein therefore appears to require annexin 2, 
suggesting that pi 1 may always act in the form o f  the annexin 2 heterotetramer. It has also 
been reported that retinoic acid reduces pi 1 protein levels by a post-translational mechanism 
(Gladwin et al.. 2000). although more precise details o f  this effect are lacking. Finally, 
covalent modification o f pi 1 by transglutaminases has been reported, at both the N- and C- 
terminal regions o f the protein (Ruse et al., 2001). This may be a general mechanism for the 
regulation o f pi 1 function.
The complex regulation o f pi 1 by growth factors, and by inflammatory mediators such as nitric 
oxide and IFN-y, suggests that pi 1 performs a variety o f roles in different tissues. Changes in 
pi 1 levels have been reported in a variety o f  disease states, although the aetiological 
involvement o f  pi 1 is not always clear. Alterations in pi 1 levels have been observed in several 
forms o f  cancer, including increased levels in renal cell carcinoma (Domoto et al., 2006a) and 
anaplastic large cell lymphoma (Rust et al., 2005a). In contrast, a substantial reduction in pi 1 
protein appears to be an essential early stage in the development o f  prostate cancer, probably 
caused by a gene methylation-mediated decrease in annexin 2 expression (Chetcuti et al., 
2001b). pi 1 increases have also been reported in irritable bowel syndrome (Camilleri et al.,
2007), alcoholic hepatitis (Seth et al., 2003). nerve injury' (De et al., 1991) and animal models 
o f  multiple sclerosis (Craner et al., 2003a). A decrease in pi 1 levels was recently described in 
the anterior cingulated cortex of patients suffering from unipolar major depression disorder, 
with a causal link proposed via the 5-HTtR receptor (Svenningsson et al., 2006).
1.2.1 p i 1-protein in teractions and physiological roles
pi 1 interacts with many proteins and is involved in a wide variety o f physiological processes, 
including membrane protein trafficking and angiogenesis. A selection o f protein interactions
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and roles of p ll are discussed here. For a recent review, see Svenningsson and Greengard 
(2007).
1.2.1.1 Annexin 2
p ll exists as a heterotetramer with annexin 2. Although monomeric annexin 2 has been 
reported, it is not clear whether pi 1 exists in the cell independently of annexin 2; molar ratios 
and the rapid degradation of pi 1 in the absence of annexin 2 would suggest that the majority of 
pi 1 protein exists in the heterotetrameric form. Annexin 2 is a Ca2"- and phospholipid-binding 
protein with several N-terminal splice variants (Upton and Moss, 1994), which is translocated 
to the plasma membrane upon binding to pl l ,  the control of which is effected by a 
phosphorylation switch on annexin 2 (Deora et al., 2004). The crystal structure of the annexin- 
2-pl 1 heterotetramer and p ll alone was described by Rety et al. (1999), with a predicted 
structure based on this proposed in a subsequent paper (Sopkova-de Oliveira et al., 2000). This 
is illustrated in Figure 1.1. The interaction is non-covalent, with each annexin 2 peptide 
forming hydrophobic interactions with both pi 1 monomers. Helices III and IV of pi 1 bind to 
the N-terminus of annexin 2 with high-affinity (Kube et al., 1992). N-terminal acetylation of 
annexin 2 is essential for its high-affinity interaction with pl l .
b
Figure 1.1 The com plex o f  p l l  and the annexin 2 N-terminal peptide, a: Crystal structure, pi 1 is 
shown in blue and yellow, the annexin 2 N-terminal peptide in green. Taken from Rety et al. (1999). b: 
Predicted pi 1-annexin 2 heterotetramer model, pi 1 dimer is shown in black and white, annexin 2 N- 
terminal peptides in dark grey. Taken from Sopkova-de Oliveira et al. (2000).
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Many functions o f annexin 2 require its presence at the cell surface. The trafficking o f annexin 
2 to the cell surface was shown to be pi 1-dependent, under the control o f  a phosphorylation 
switch on annexin 2 (Deora et al., 2004).
The pll-annexin  2 heterotetramer is involved in several processes, one o f  the most 
fundamental o f  which is the organisation of membrane microdomains. These microdomains 
are regions o f membrane with a particular composition, often rich in cholesterol and related 
lipids, and sometimes referred to as "lipid rafts". Membrane microdomains are thought to be 
important for the organisation o f  signalling pathways and molecular trafficking, through 
colocalisation o f  membrane proteins. Menke et al. (2005) described the lateral organisation of 
the annexin 2-pl 1 heterotetramer in artificial membranes and its influence on the lateral 
organisation o f membrane lipids. The annexin 2-pl 1 heterotetramer was found to be capable of 
inducing lipid segregation and therefore likely to affect the presence o f membrane 
microdomains. In a similar vein, Gokhale et al. (2005) reported the induction o f  membrane 
microdomain formation by the annexin 2-pl 1 heterotetramer, via an effect on the regulation of 
Ptdlns(4, 5)P2 (a phospholipid component o f  the plasma membrane) clustering. Annexin 2 was 
recently shown to interact directly with both polymerised and monomeric actin, which was 
found to have an essential role in maintaining the plasticity o f  the dynamic-membrane 
associated actin cytoskeleton (Hayes et al., 2006a). The annexin 2-pl 1 heterotetramer is also 
capable o f  F-actin bundling (Ikebuchi and Waisman, 1990), membrane-cytoskeleton linkage, 
perhaps via an interaction with actin (Gerke and Weber, 1984), collagen (Wirl and Schwartz- 
Albiez, 1990) or tenascin-C (Chung and Erickson, 1994), membrane trafficking and 
endocytosis (Zobiack et al., 2003). Annexin 2 is required for actin polymerisation-dependent 
vesicle locomotion, demonstrated by the effects o f  dominant-negative annexin 2 constructs on 
the process o f  macropinocytic rocketing (Merrifield et al., 2001) and thought to be through 
annexin 2 control o f  actin polymerisation at the actin-pinosome interface. In addition to these 
functions, it is likely that the majority o f  the roles of pi 1 are in fact performed by the p 11 - 
annexin 2 heterotetramer. These functions will be discussed in the subsequent sections 
according to target protein.
1.2.1.2 Nav1.8
The voltage-gated sodium channel Nav 1.8 is expressed exclusively in a subset o f  sensory 
neurons, over 85% of which are involved in the detection o f noxious stimuli (nociception) 
(Akopian et al., 1996;Djouhri et al., 2003a), and plays a specialised role in pain pathways 
(Akopian et al., 1999). Current densities o f  Nav 1.8 expressed in heterologous systems are 
substantially below endogenous levels in DRG (England, 1998), with channels displaying
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properties different from those in DRG neurons (FitzGerald et al., 1999). Microinjection of 
Nav 1.8 cDNA into the nuclei o f  superior cervical ganglion (SCG) or Nav l.8-null mutant DRG 
neurons, however, produces sodium currents with similar properties and magnitude to wild- 
tvpe DRG neurons (England, 1998), implying that these cells contain additional factors 
required for endogenous levels o f  Nav 1.8 functional expression. With this in mind. Okuse et 
al. (2002) used the yeast two-hybrid system to search for proteins interacting with the 
intracellular domains o f Nav 1.8. p l l  was among the proteins identified (Malik-Hall et al..
2003), and was found to increase functional plasma membrane expression o f N a v 1.8, measured 
by both electrophysiological and immunological methods (Dekker et al.. 2005:0kuse et al.,
2002). This effect was shown to be mediated by an interaction between the N-terminus o f 
Nav 1.8 (proposed to be residues 74-103) and residues 33-78 o f pi 1. corresponding to helix III. 
The region 74-103 o f N av l.8 has a characteristic cluster o f  acidic and basic amino acids 
divided by a putative |3-strand, which is well-conserved in other species, including mouse 
(Poon et al., 2004). Two domains with low homology to other sodium channels have been 
identified (residues 87-90 and 98-102), which may play a role in binding to pi 1. Other than 
these regions, however, a fairly high degree o f  homology w ith other VGSCs is seen.
The involvement o f  annexin 2 in the N av 1 -8-p 11 interaction has not been investigated. 2 
models for the annexin 2-pll complex, a heterotetramer and a heterooctamer, have been 
proposed (Lewit-Bentley et al.. 2000). In both cases, the putative binding domains for N av 1.8 
are the most peripheral and exposed (Poon et al., 2004). Since annexin 2 is present in higher 
quantities in the cell than pi 1 (SE Moss, personal communication), it is likely that annexin 2
forms part o f  the p 11 -Nav 1.8 complex.
The pi 1-Nav l .8 interaction is discussed further in Chapter 3.
1.2.1.3 5-H T1B
pi 1 was recently shown to bind to the serotonin receptor 5-HT|B. again through a yeast two- 
hybrid screen (Svenningsson et al., 2006). 5-HT|B is a G-protein-coupled receptor, coupled to 
the inhibitory subunit G, (which inhibits adenylate cyclase, reducing levels of cyclic AMP), p70 
S6 kinase and the mitogen-activated protein kinase ERK-2 (Pullarkat et al., 1998), and plays a 
central role in the regulation o f serotonin (5-HT) neurotransmission. Roles have been 
suggested for the 5-HTIB receptor in the pathophysiology o f obsessive compulsive disorder, 
drug addiction, depression, anxiety, aggression and sleep disorders (Gingrich and Hen,
2001;Moret and Briley, 2000b;Saudou et al., 1994). They act as autoreceptors on 5-HT-
containing neurons originating from the raphe nuclei, and as heteroreceptors on other neurons
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that do not contain 5-HT (Maroteaux et al.. 1992;Moret and Briley, 2000a). pi 1 and 5-H T |B 
(but not related receptors) were found to coimmunoprecipitate and colocalise at the cell surface 
in the brain, and trafficking o f 5-HT]B in COS-7 cells was enhanced by p l l .  pi  1-null mice 
showed reduced 5-HTtB functional expression and a depression-like phenotype, while mice 
overexpressing pi 1 acted as though they had been treated with antidepressants. Cortical slices 
from pi 1-null mice displayed characteristics distinct to those of wild-type controls: application 
o f 5-HT depressed the amplitude o f field excitatory post-synaptic potentials in wild-type mice 
only. Consistent with a negative regulation o f 5-HT metabolism by 5-HT1B receptors, pi 1-null 
mice displayed increased levels o f 5-HT metabolism. Interestingly, this study described an 
upregulation o f pi 1 mRNA in the cortices o f  mice treated with the antidepressants imipramine 
and tranylcypromine, and with electroconvulsive therapy, p l l  mRNA and protein were 
downregulated in the anterior cingulated cortex in patients suffering from unipolar major 
depressive disorder. Taken together, these observations support a mechanistic role for pi 1 in 
the pathophysiology and treatment o f  depression. This study concluded that 5-HT|B receptor 
function is modulated by pi 1. and that this process may be important in neuronal networks that 
are dysregulated in depression-like states (Svenningsson et al., 2006).
1.2.1.4 A SlC la
pi 1 interacts with the acid-sensing ion channel A S lC la  (Donier et al.. 2005). A S lC la  is a 
voltage-independent, proton-gated ion channel permeable to Na and Ca2 , primarily expressed 
in the brain and dorsal root ganglia (particularly small-diameter nociceptors). In dorsal root 
ganglion neurons, A S lC la  detects acidification o f the extracellular fluid, which can be caused 
by inflammation, ischaemia and other painful conditions (Voillev. 2004b), and is involved in 
mechanosensation in neurons innervating the viscera (Page et al., 2004b). In the brain, A S lC la  
carries the main proton-gated current, and has been shown to be important in synaptic plasticity 
and fear conditioning (Wemmie et al., 2002;Wemmie et al., 2003:Wemmie et al., 2004). Ca2 
overload via A S lC la  activation also appears to be responsible for the majority o f  ischaemic 
damage during stroke, following channel activation by ischaemia-induced acidification (Immke 
and McCleskey, 2001). Interestingly, pharmacological block o f A S lC la  has been shown to be 
effective in limiting ischaemic damage to the brain (Xiong et al., 2004).
Using a yeast two-hybrid assay, Donier et al. (2005) found that pi 1 binds to the N-terminal 
domain o f  ASlCla, but not to other ASICs. Both membrane-associated immunoreactivity and 
A SlCla  peak currents were increased by around 2-fold when p l l  was co-expressed with 
A SlC la  in CHO cells, compared to expression o f A S lC la  alone. No kinetic or pH-dependence 
changes in ASIC la-mediated currents were observed, implying that pi 1 acts by increasing cell
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surface levels o f  ASlCla , probably by a trafficking action. The precise residues required for 
the A S lC la -p l l  interaction have yet to be determined; the N-terminus o f  ASlCla , however, 
does not share sequences with the binding domains identified on other proteins that interact 
with pl l ,  suggesting a distinct mode o f interaction.
1.2.1.5 TASK-1
TASK-1 (TWIK-related acid-sensitive K channel-1) is a two-pore-domain K channel, 
considered to be the prototype o f background K channels that set the resting potential and 
regulate action potential duration, slope and frequency in excitable cells (Duprat et al.. 1997). 
TASK-1 channels are highly regulated by pH. losing most of their activity below pH 6.9. and 
are inhibited by a variety o f hormones and neurotransmitters via phospholipase C activity 
(Czirjak et al.. 2000;Millar et al.. 2000a;Talley et al.. 2000b). This can result in substantial 
changes in resting potential and thus cellular excitability (Millar et al.. 2000c). TASK-1 is 
expressed in a wide range of tissues, including brain and other nervous tissue (Lesage and 
Lazdunski. 2000). It has been shown to play important roles in the regulation o f  sleep (Meuth 
et al.. 2003). chemoreception in respiratory neurons (Bayliss et al., 2001), initiation of neuronal 
apoptosis (Tauritzen et al.. 2003). excitatory post-synaptic potentials (Millar et al.. 
2000b;Talley et al., 2000a) and ion transport in the kidney (Hebert et al., 2005).
Two groups have reported the interaction o f  TASK-1 and pl l .  describing different binding 
sites and modes o f  action. Girard et al. (2002) found that pi 1 binds to a consensus sequence, 
Ser-Ser-Val (SSV), at the extreme C-terminus o f  TA SK-1, and that binding is abolished upon 
deletion o f  these residues. The association o f  p l l  and TASK-1 masks an endoplasmic 
reticulum retention signal, Lys-Arg-Arg (KRR), on TASK-1. This sequence normally prevents 
trafficking to the plasma membrane, but upon pi 1 binding this restriction is removed, allowing 
functional TASK-1 expression at the cell surface. Electrophvsiological and immunological 
measurement o f  TASK-1 indicated an increase in membrane levels in the presence o f  p l l ,  
which was inhibited by a competing C-terminal peptide. More recently, however, Renigunta et 
al. (2006) published conflicting data, reporting that pi 1 reduces functional expression o f 
TASK-1 by providing an endoplasmic retention signal. In this study, the C-terminal SSV 
sequence was not required for interaction with p l l .  and a helical 40 amino acid domain 120-80 
residues proximal to the C-terminus was found to be responsible for the interaction. Binding o f 
pi I to TASK-1 was reported to retard surface expression due to the presence o f  a di-lysine 
endoplasmic retention signal at the p l l  C-terminus, with supporting electrophysiological and 
immunological data. Disruption o f the interaction increased surface expression o f T A SK -1, as 
did removal o f  the di-lysine motif o f  pi 1, consistent with this hypothesis.
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The contradictions between these studies have yet to be resolved. Renigunta et al. (2006) 
suggest that the observation that C-terminal truncation o f TASK-1 reduces whole-cell currents 
(Girard et al.. 2002) may be explained by the disruption o f another interaction, between TASK- 
1 and a 14-3-3 family protein, which is known to recognise the RRSSV motif (Rajan et al.. 
2002b). No explanations were offered, or apparent, for other contradictions. It may be that 
differences in expression systems are responsible, or that pi 1 does in fact act in 2 alternate 
ways upon TASK-1.
Renigunta et al. (2006) observe that TASK-1 binds to the same or overlapping regions o f pi 1 
as annexin 2. It therefore appears that TASK-1 trafficking/retention is not mediated by the 
anne.xin 2-pl 1 heterotetramer. but by p l l  alone. It is possible that a pi 1-TA SK -1 
heterotetramer is formed, but this hypothesis has yet to be tested. Although p l l  has been 
reported to be very unstable in the absence o f annexin 2 (Puisieux et al.. 1996). it is possible 
that interaction with TASK-1 is capable o f  preventing pi 1 degradation.
1.2.1.6 TRPV5/6
TRPV5 and TRPV6 are epithelial Ca2 channels, belonging to the transient receptor potential 
(TRP) superfamily. They mediate the rate-limiting influx step in active Ca' reabsorption in 
the kidney, proximal intestine and placenta (Hoenderop et al.. 2001c;Hoenderop et al.. 2002). 
Their activity is regulated by a Ca2 -dependent feedback mechanism (Nilius et al.. 2002). and 
by reinsertion o f  channels from an intracellular pool (Nilius et al., 2001). They contain 
conserved motifs for regulatory activities including protein kinase C phosphorylation, ankyrin 
repeats and PDZ domains (Hoenderop et al., 200 Id).
Both TRPV5 and TRPV6 were shown to interact with pi 1, via the C-terminal tail sequence 
VATTV between amino acids 598 and 603 on TRPV5 and corresponding residues on TRPV6 
(van de Graaf et al., 2003). This is similar to the SSV sequence proposed to be the TASK-1 
p l l  interaction site (Girard et al., 2002). TRPV5 interacts with the p ll-annexin  2
heterotetramer, since annexin 2 was able to be co-immunoprecipitated with TRPV5 in the 
presence (but not absence) o f  pi 1. p l l  binding to TRPV5 and TRPV6 was shown to be critical 
for channel activity, assessed by whole-cell patch-clamp analysis in HEK293 cells. This was 
ascribed to the requirement o f  pi 1 for TRPV5/6 trafficking, visualised immunocytochemically 
(van de Graaf et al., 2003). No reports o f  TRPV5 and TRPV6 expression in dorsal root ganglia 
exist, meaning that a role in the peripheral nervous system is unlikely.
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1.2.1.7 Tissue plasminogen activator
Plasmin is a serine protease, the key function o f which is the degradation o f fibrin, (a major 
component o f  blood thrombi and clots). Other significant functions include collagenase 
activation and the degradation o f  other circulating proteins. Extracellular matrix proteolysis by 
plasmin (and other proteases) is required for the invasiveness o f  cancer cells and for 
angiogenesis. which in turn is necessary for tumour growth. Plasmin is synthesised as a 
precursor, plasminogen, and released in this form into the circulation. Plasminogen is 
expressed by a variety o f  cells types, with the majority of production coming from the liver. 
The conversion o f  plasminogen to plasmin is performed by another serine protease, tissue 
plasminogen activator (tPA). at the surface of endothelial cells.
pi 1 is expressed as a heterotetramer with annexin 2 on the surface of endothelial (Kassam et 
al.. 1998b) and tumour (Yeatman et al.. 1993b) cells. It was shown to stimulate the activation 
o f  plasminogen via a tPA-dependent process, increasing the catalytic activity 20-90 fold 
(Kassam et al.. 1998e;Kassam et al., 1998a). The C-terminal penultimate and ultimate lysine 
residues o f pi 1 (helix IV) were shown to participate in this stimulation, since their cleavage by 
basic carboxypeptidases resulted in a loss o f tPA-stimulatory ability (Fogg et al.. 2002). 
Although early studies focused on annexin 2 as the plasminogen/tPA receptor. Macleod et al.
(2003) used surface plasmon resonance on an immobilised lipid bilayer to demonstrate that 
p l l ,  but not annexin 2, binds directly to plasminogen and tPA via the C-terminal lysine 
residues. This interaction results in the colocalisation o f plasminogen and tPA, providing a 
mechanism for the increased catalytic activity observed in the presence o f  pi 1. The binding o f 
tPA and plasmin to pi 1 also protects against inhibition by physiological inhibitors. PAI-1 and 
alpha2-antiplasmin, respectively (Kwon et al., 2005a). Deletion o f annexin 2, however, was 
found to result in impaired fibrinolysis and reduced neoangiogenesis in vivo (Ling et al., 2004), 
appearing to contradict this localisation o f the tPA binding site. This can be explained, 
however, by the observation that annexin 2 is required for post-translational stability o f  p l l .  
with rapid degradation occurring in its absence (Puisieux et al., 1996). p l l  levels are thus 
likely to be very' low in the annexin 2-null mouse.
A degree o f  regulation occurs in the stimulation o f plasminogen activation by pi 1. Thrombin, 
a protease involved in fibrin production, induces endothelial cell-surface expression o f  the 
annexin 2-pl 1 heterotetramer, with the ultimate effect o f  increasing fibrinolysis (Peterson et al.,
2003). In a curious twist, Kwon et al. (2002) reported that the annexin 2-pl 1 heterotetramer 
acts as a plasmin reductase via the cysteine residues 61 and 82 on pl l .  This results in plasmin 
autoproteolysis and the release o f A(61), an anti-angiogenic protein, opposing the plasmin-
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generating, pro-angiogenic role o f  pl l .  The annexin 2-pl I heterotetramer also inhibits 
plasmin-dependent fibrinolysis, prov iding a further layer o f  regulation (Choi et al., 1998a).
The role o f p l l  in plasmin generation and thus extracellular matrix degradation and 
angiogenesis has led to its investigation in several cancers. In many cases, changes in p l l  
expression have been linked to tumourigenesis. For example, pi 1 expression in renal cell 
carcinoma was reported to be upregulated (Domoto et al.. 2006b) with a similar result in 
anaplastic large cell lymphoma (Rust et al., 2005b). In contrast, a substantial reduction in pi 1 
protein appears to be an essential early stage in the development o f  prostate cancer, probably 
caused by a gene methylation-mediated decrease in annexin 2 expression (Chetcuti et al., 
2001a). RNA interference-mediated silencing of pi 1 was shown to attenuate the invasiveness 
o f  colorectal cancer cells, via a reduction in plasmin generation and thus extracellular matrix 
degradation (Zhang et al.. 2004). Finally, regulation o f fibrosarcoma cell invasiveness by pl l ,  
via extracellular plasmin production, was reported (Choi et al., 2003).
The involvement o f  the annexin 2-pl 1 heterotetramer in angiogenic processes, following the 
identification o f annexin 2 as a tPA activator (Ffajjar et al., 1994), led to the investigation o f  the 
effects o f  annexin 2 deletion on angiogenesis in the mouse. Ling et al. (2004) described 
increased fibrin deposition, reduced clearance o f  arterial thrombi and deficiencies in endothelial 
cell surface plasmin generation. Endothelial cell migration and invasion through in vitro 
fibrin/collagen lattices and in in vivo Matrigel assays was markedly reduced, as was 
neovascularisation o f  oxygen-primed neonatal retina. The paper concluded that annexin 2- 
bound endothelial cell surface plamin acts both intra- and extravascularly to promote 
neoangiogenesis. The relevance of these findings to tumour growth was shown in a recent 
report describing contributions o f  annexin 2 to tumour invasion and progression in breast 
cancer (Sharma et al., 2006a). An antibody against annexin 2 was found to inhibit lung 
carcinoma growth via reduced plasminogen activation, suggesting that annexin 2 may be a 
target for angiostatin, and demonstrating the therapeutic potential o f  work on this system 
(Sharma et al., 2006b).
tPA is also capable o f  converting pro-BDNF (brain-derived neurotrophic factor) to its active 
form, BDNF (Pang et al., 2004c). This activity appears to be essential for long-term 
hippocampal plasticity and long-term potentiation, required for long-term memory (Pang et al., 
2004b). It is not clear if pi 1 is involved in this tPA-dependent activation, but it appears likely.
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1.2.1.8 BAD
BAD (Bcl-\L/Bcl-2-Associated Death Promoter) is a member o f  the Bcl-2 family o f apoptosis- 
regulating proteins. It promotes apoptosis via pathways leading to changes in mitochondrial 
membrane permeability, and is believed to act in a manner different to other Bcl-2 family 
members, due to the lack o f an otherwise conserved C-terminal transmembrane domain (Hsu et 
al.. 1997b). pi 1 was reported to bind preferentially to the underphosphorylated form o f  BAD, 
in contrast to the 14-3-3 proteins, which bind upon phosphorylation (Hsu et al.. 1997e). In the 
same study, the expression o f p l l  in CHO cells was found to suppress BAD expression- 
induced apoptosis, without affecting BAD levels. Expression of pi 1 is therefore anti-apoptotic, 
in agreement with the interesting observation that pi 1 expression is increased following 
transformation induced by viral oncogenes (Ozaki and Sakiyama. 1993). Nerve growth factor 
(NGF) is required for the survival o f  a subset o f  sensory neurons, pi 1. which is upregulated by 
NGF, can substitute for NGF in this function. The mechanism o f  action o f NGF on cell 
survival is thus thought to be via pll-mediated inhibition of apoptosis (Masiakowski and 
Shooter. 1990).
1.2.1.9 AHNAK
AHNAK (non-acronymic) was first identified as a gene undergoing transcriptional repression 
in cell lines derived from human neuroblastoma and certain other tumours (Shtivelman et al.. 
1992). It is also downregulated by transforming (oncogenic) forms o f  the small G-protein RAS 
in fibroblasts (Zuber et al., 2000). AHNAK is an exceptionally large protein o f around 
700kDa, encoded by an intronless gene (Kudoh et al.. 1995; Shtivelman and Bishop, 1993b). 
Its exact biological function is unknown, although its abundance increases dramatically upon 
cell differentiation (Shtivelman and Bishop, 1993a), and several interacting proteins have been 
identified. AHNAK associates with cardiac F-tvpe Ca2 channels at the plasma membrane, 
transmitting information from (3-adrenoreceptors via protein kinase A (Haase et al., 1999), and 
has been proposed to play a role in the maintenance and functional organisation o f the 
subsarcolemmal cytoarchitecture by providing a link between F-type channels and the actin 
cytoskeleton (Hohaus et al., 2002). AHNAK is also localised to the plasma membrane in a 
variety o f  other cell types, the process o f  which appears to be regulated by Ca2 signalling 
(Borgonovo et al., 2002). Benaud et al. (2004) demonstrated that AHNAK interacts with actin 
and the annexin 2-pl 1 heterotetramer at the plasma membrane, which is required for AHNAK 
plasma membrane localisation, pi 1 was found to mediate the interaction between annexin 2 
and the C-terminal regulatory domain o f AHNAK. They reported that downregulation o f 
AHNAK affects the cell membrane cytoarchitecture o f  cells, preventing actin cytoskeleton 
reorganisation and providing a molecular mechanism for the observed membrane organisation
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effect o f  annexin 2 (Babiychuk et al., 2002;Gerke and Moss. 2002). Although pi 1 contains the 
residues that bind to AHNAK, neither pi 1 nor annexin 2 are capable o f AHNAK interaction 
alone: annexin 2 interaction with pi 1 is required for high-affinity binding o f pi 1 to AHNAK 
(De et al.. 2006a). The C-terminal domain o f AHNAK involved in pi 1 binding was defined as 
a 20 amino-acid sequence, which did not show homology to any other proteins outside the 
AHNAK family. This paper also reported that the localisation of the annexin 2-pl l  
heterotetramer at the plasma membrane was controlled by cellular signalling, in agreement with 
previous observations.
The functional significance o f the interaction between AHNAK and the annexin 2-pl 1 
heterotetramer appears to be through organisation o f the cell membrane cytoarchitecture. 
through interactions with actin and perhaps other entities. The role of annexin 2 in membrane 
organisation has been well documented, and is likely to be important in a range o f 
physiological processes, including channel clustering and endo/exocytosis.
1.2.1.10 Phospholipase A2
Phospholipase A; (PLA2) represents a group of enzy mes that catalyse the hydrolysis o f  an ester 
bond in phospholipids, generating lipid products which can serve as intracellular 2nd 
messengers or can be metabolised to inflammatory mediators. In particular, the release o f 
arachadonic acid (AA) from cellular membranes, which can then be converted to pro- 
inflammatory leukotrienes, protaglandins and other eicosanoids, is a central process in 
inflammation. Cytosolic PLA2 (cPLA2) is a large 85kDa protein and is regulated at both 
transcriptional and post-translational levels by cytokines and other pro-inflammatory factors 
(see references within Wu et al.. 1997d). Wu et al. (1997c) used a yeast two-hybrid screen to 
identify p l l  as a protein interacting with the C-terminal domain o f cPLA2, confirming the 
interaction by co-immunoprecipitation from a human epithelial cell line. In vitro , p l l  was 
shown to inhibit cPLA2 activity, while pi 1 antisense increased PLA2 activity in the epithelial 
cell line. The inhibition o f cPLA2 by pi 1 was found to be independent o f  annexin 2, although 
annexin 2 does produce a small additive inhibition o f cPLA2 (Wu et al., 1997b).
The inhibitory effect o f  p l l  on cPLA2 provides a mechanism for the control o f  pro- 
inflammatory molecule levels. Akiba et al. (2000a) found that transforming growth factor-a 
was able to stimulate prostaglandin generation under the control o f  pi 1, while another group 
reported that the anti-inflammatory compound dexamethasone reduced arachidonate release by 
inducing pi 1 expression, thus inhibiting cPLA2 activity (Yao et al., 1999a). Epidermal growth 
factor induced pi 1 expression and thus downregulated AA release in human epithelial cells
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(Huang et al., 2002). The opposite effect was observed upon application o f retinoic acid, which 
reduced pi 1 protein levels by a post-translational mechanism and thus increased cPLA2 
activity (Gladwin et al.. 2000).
In addition to the anti-inflammatory role o f  p l l  suggested by these findings, the interaction 
between pi 1 and cPLA2 was reported to control AA release as a function o f  epithelial cell 
confluence (Bailleux et al.. 2004b). This study found that intercellular contacts between kidney 
cells directly control cPLA2 activity through alterations in the stoichiometry o f the pi l-cPLA2 
interaction. The regulation o f cPLA2 activity by p l l  thus plays a role in multiple processes, 
and contributes to the control of inflammatory mediator release induced by intercellular 
signalling molecules.
1.2.1.11 Cathepsin B
For tumour cell invasion and metastasis, limited degradation o f the extracellular matrix is 
required to facilitate invasion, angiogenesis and other processes. The lysosomal cysteine 
protease cathepsin B is one o f the proteases involved in this degradation. Cathepsin B is 
capable of degrading extracellular matrix proteins laminin, fibrin and collagen IV at the neutral 
or acidic pH often found in sites of tumour growth (Buck et al., 1992;Lah et al., 1989). It has 
been observed that its activity, secretion and membrane association are increased in malignant 
tumours, in particular at their invasive edges, and that this correlates with a poor prognosis 
(Campo et al., 1994;Emmert-Buck et al., 1994;Frosch et al.. 1999;Rempel et al., 1994). 
Cathepsin B can also activate other proteolytic enzymes, including urokinase-type plasminogen 
activator, allowing actions on cellular signalling pathways (Kobayashi et al., 1991).
Mai et al. (2000) found that p l l  interacts with cathepsin B both in vitro and in vivo. A 
complex consisting o f  the annexin 2-pl 1 heterotetramer and cathepsin B was reported, the 
formation o f  which appeared to result in the activation o f procathepsin B. p l l  and cathepsin B 
were found to colocalise on the cell surface, suggesting a role for p l l  in cathepsin B 
trafficking. Upregulation o f annexin 2 on the surface o f tumour cells (Yeatman et al., 1993a) 
implies that this may result in increased cathepsin B activity, leading to matrix degradation and 
increased tumour invasiveness.
1.2.1.12 PCTAIRE-1
PCTAIRE-1 (name deriving from residues in a conserved region) is a protein kinase with 
similarities to the cyclin-dependent kinase family. It is ubiquitously expressed and present at
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high levels in neuronal cells, including the brain. The function o f  PCTAIRE-1 has yet to be 
defined, although roles have been proposed in Ca~ -dependent exocytosis (Liu et al.. 2006) and 
neurite outgrowth (Graeser et al.. 2002). Yeast two-hybrid screen discovered an interaction 
between PCTAIRE-1 and p l l .  confirmed using pure recombinant proteins (Sladeczek et al.,
1997). This interaction was later shown to occur in vivo, in rodent brain, and was found to 
require the presence o f both the N- and C-terminal domains (but not the catalytic core domain) 
o f  PCTAIRE-1 (Ee et al.. 1998). The functional significance o f this interaction is currently 
unclear.
1.2.2 Importance of p l l  in cellular function
The interactions o f pi 1 with target proteins are remarkable in both diversity and physiological 
relevance. Proteins from many different families, with a variety o f distinct functions are bound 
by p l l .  often resulting in a change in physiological activity. Many are trafficked to the plasma 
membrane, while others are inhibited or activated. The distinct binding sites o f  each o f these 
proteins (where defined) suggest the possibility o f  multiple simultaneous interactions between 
pi 1 and other proteins. Combined with the ability o f  pi 1 to organise membrane microdomains, 
this advocates a model where pi 1 regulates cellular function by the formation o f defined areas 
o f  plasma membrane, populated by controlled groups o f membrane proteins, pi 1 thus appears 
to be an important regulatory molecule for the control o f  cellular function, perhaps with a more 
general role in the control of membrane trafficking and organisation.
29
1.3 Pain and  N o c iception
This thesis examines the role o f  pi 1 in pain pathways in the peripheral nervous system. The 
following section provides an introduction to the process o f  pain sensation, from detection o f 
noxious stimuli to the processing and interpretation o f these signals in the brain.
Pain is defined as "an unpleasant sensory and emotional experience associated with actual or 
potential tissue damage or described in terms o f such damage" (International Association for 
the Study o f  Pain: www.iasp-pain.org). This is distinct from nociception, the detection o f 
noxious (tissue-damaging) stimuli, in that it involves cognitive and emotional (affective) 
components requiring higher-level cortical processing. As such, pain can occur in disease 
states in the absence of nociception, while nociception does not necessarily result in pain. In 
the majority o f  circumstances, however, pain results from nociception, arising from the 
application o f  a noxious stimulus.
Nociception has an intrinsic physiological value in promoting withdrawal from tissue- 
damaging stimuli, through spinal reflex pathways in response to afferent input. Higher-level 
processing, however, allows the association o f negative affective responses with the 
circumstances surrounding the noxious stimulus, resulting in aversion and subsequent 
behavioural modification to avoid these circumstances and thus further injury. Under 
conditions o f inflammation, pain thresholds are lowered by both peripheral and central 
neuronal plasticity, resulting in hyperalgesia (increased pain in response to a noxious stimulus) 
or allodynia (pain caused by a normally innocuous stimulus). This increased sensitivity has 
survival value in promoting the protection o f  injured tissues, allowing healing to occur. Under 
conditions o f  chronic inflammation, however, the reduction in pain thresholds may outlive its 
usefulness. Additionally, pain can result from nerve damage, for example from mechanical 
trauma, HIV infection, diabetic neuropathy or certain drugs. This pain, described as 
neuropathic in origin, is generally spontaneous or allodynic in nature, in the absence o f  
nociception, and as such confers no survival value. Instead, chronic inflammatory and 
neuropathic pain often cause significant emotional distress and result in reduced quality o f  life.
Pain is an important clinical problem, and is one o f the most common reasons for seeking 
medical attention. A large-scale study by the World Health Organisation found that 22% of 
adult primary care patients reported persistent pain, resulting in increased likelihood of 
psychological disorders (including depression), poor health perception, and interference with 
work (Gureje et al., 1998). Whilst acute pain can be treated effectively with a range of 
pharmacological agents, including volatile anaesthetics, opioids and ketamine, chronic
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inflammatory and neuropathic pain states are frequently refractory to analgesics. Inflammatory 
pain is often treated with anti-inflammatory compounds in an attempt to reduce the cause of 
hyperalgesia. In particular, non-steroidal anti-inflammatory drugs (NSAIDs), which inhibit the 
enzyme cyclo-oxygenase, are often efficacious in the treatment o f  inflammatory pain. 
Neuropathic pain, however, is more complex. Different patients may respond to differing 
pharmacological agents, often leading to an iterative (trial and error) approach to treatment. In 
many cases, effective treatment is achieved using drugs with primary indications for other 
conditions, such as gabapentin (an anticonvulsant) and tricyclic antidepressants (e.g. 
amitriptyline), although the mechanisms by which these suppress neuropathic pain are still 
under investigation. Cancer-related pain, present in 30-45% of cancer patients on diagnosis 
and rising to 65-90% with advanced disease, is thought to be a combination o f inflammatory 
and neuropathic pain. Damage to invaded tissues causes the release o f  inflammatory 
mediators, while direct mechanical pressure on sensory nerves can occur upon tumour growth. 
Certain cytotoxic drugs used to treat cancer can also cause nerve damage and thus neuropathic 
pain. Treatment is with a combination of pharmacological agents, non-pharmacological 
interventions (e.g. surgery) and psychological therapy. A significant proportion o f patients 
suffering from chronic or neuropathic pain, however, do not obtain complete relief (Sindrup 
and Jensen. 1999). For example, 10-20% of cancer patients do not experience adequate pain 
control free from side effects (Meuser et al., 2001). In all areas o f  pain, treatment is often 
accompanied by adverse side effects, including gastrointestinal irritation by NSAIDs and 
central effects, such as drowsiness and dependence, from opioids. There is therefore a need for 
novel therapeutic approaches to the treatment o f pain. O f  particular interest are agents acting 
on the peripheral nervous system, allowing the elimination o f centrally-mediated side effects. 
This possibility has been used to promote the study o f nociception with a view to identifying 
novel therapeutic targets.
1.4 N o c ic e ptio n  and  DRG prim ary  afferent  neur o n s
The interaction between pi 1 and Nav 1.8, which is one o f  the main topics o f  this thesis, occurs 
in a subset o f  primary afferent neurons involved in the detection o f  noxious stimuli. This 
section discusses the physiology and histology o f these cells, and the mechanisms by which 
they transduce and transmit information from noxious stimuli.
The primary afferent neurons o f  the somatosensory nervous system convey sensory information 
from their peripheral termini to the spinal cord. The cell bodies o f  sensory neurons innervating 
the limbs and trunk are contained within the dorsal root ganglia (DRG), while for orofacial 
structures the trigeminal ganglia perform this role.
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Multiple subtypes o f  sensory neuron are contained within the DRG. These neurons are often 
classified according to anatomical features, most notably diameter, termination site and degree 
o f  myelination, and functional characteristics, including conduction velocity and the modality 
o f  stimuli to which they respond. Additionally, grouping based on neurotrophin dependence or 
gene expression (including membrane proteins, neurotransmitters and transcription factors) has 
proven useful in defining subgroups o f  sensory neurons. While it is often assumed that neurons 
within a functional group display identical anatomical and physiological characteristics and 
gene expression profiles, new levels of complexity continue to be described. Only the broadest 
categories, therefore, are fully characterised at present. These are discussed below; also see 
Wood (2000) and Julius & Basbaum (2001a). Figure 1.2 illustrates the distinct types o f  
nociceptor currently identified.
Peptidergic C-fibre
Unmyelinated, 
peripherin, trkA, 
BDNF, CGRP, SP, 
TRPV1
A5-fibre
Myelinated, NF200, 
trkA, trkC, BDNF, 
CGRP, TRPV1
SK IN
Non-peptidergic C- 
fibre
Unm yelinated, 
peripherin, Ret, 
IB4, P2X3, TRPV1
Ap-fibre (non­
nociceptive)
NS
Lamina I
NS
Lamina II
NS
Lamina III
Lamina IV
W DR
Lamina V
S P IN A L  C O R D
Figure 1.2 D iagram  illustrating nociceptor subtypes. Subsets of primary afferent neurons express 
different genes and terminate in different laminae of the spinal cord dorsal hom. Nociceptor-specific 
(NS) and wide dynamic range (WDR) neurons project from the spinal cord to higher structures. BDNF: 
bain derived neurotrophic factor; CGRP: calcitonin gene-related peptide; SP: substance P. Note that this 
diagram is extremely simplified, and for clarity omits dendritic connections from projection neurons.
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1.4.1 Anatomical and functional classification of DRG neurons
One of the primary criteria used to categorise primary afferent neurons is conduction velocity 
(Perl, 1992). Aa-fibres conduct at >30m.sec’1. Ap at lOoOm.sec"1. A8 at 1.2-10m.sec"1, and C- 
fibres at <1.2m.sec"1 (approximate for mouse/rat). These differences in conduction velocities 
are due to a combination o f axon diameter and the degree o f myelination present, with larger 
diameter and more heavily myelinated axons conducting faster than smaller, unmyelinated 
axons. Aa and Ap-fibres are thus heavily myelinated, large diameter neurons. A8-fibres are 
thinly myelinated and o f intermediate diameter, while C-fibres are small diameter and 
unmyelinated. A and C-fibres can be distinguished histologically by staining with Nissl 
substance: cell bodies o f  A-fibres appear as large, light cells, whereas those of C-fibres appear 
small and dark (Lawson. 1979). Immunochemical discrimination is also possible using 
antibodies to the 200kDa neurofilament subunit N200, present in A-fibres (Lawson et al., 
1984). and peripherin. an intermediate neurofilament expressed only in C-fibres and often used 
to identify small, nociceptive neurons (Goldstein et al., 1991).
Interestingly, a large number of functional characteristics can be correlated to conduction 
velocity. The majority o f  Ap-fibres detect innocuous stimuli, particularly light touch. They 
also include proprioceptive neurons, and innervate skin, muscles and joints. A small proportion 
o f  Ap-fibres. however, appear to transduce noxious stimuli (Djouhri et al., 1998a;Lawson,
2002). demonstrating that anatomical classification can not be viewed as an absolute guide to 
functional properties. Ap-fibres generally detect a single stimulus modality, and display 
adaptation in response to a repeated stimulus. Fibres detecting noxious stimuli (nociceptors), in 
contrast, are often polymodal, and show sensitisation in response to repeated noxious stimuli, 
an essential requirement for effective protection against further tissue injury. A5-fibres respond 
to noxious mechanical stimuli, and can be subdivided according to responsiveness to intense 
thermal stimulation or the effect of tissue damage on thresholds (Treede et al., 1998). Two 
distinct categories are evident: type I fibres are responsive to heat, mechanical and chemical 
stimuli, with a conduction velocity close to that o f  Ap-fibres. They show an increasing 
response to intense heat, and sensitise to burn and chemical injury (Wall and Melzack, 1999). 
Type II A8-fibres are generally mechanically insensitive, responding to thermal and chemical 
stimuli only, with a reduced conduction velocity compared to type I fibres. They show an 
adapting response to intense heat, and are not sensitised to heat injury (Wall and Melzack, 
1999). C-fibres are generally polymodal nociceptors, responding to both noxious thermal and 
mechanical stimuli, and to chemical stimuli associated with tissue damage, such as acid and 
ATP. Around 10% of C-fibres, however, convey only innocuous thermal information (Hunt 
and Mantyh, 2001a). Itch is also thought to be C-fibre-mediated, although the subgroups 
responsible have yet to be identified. The presence o f  “silent” nociceptors, which do not
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appear to possess a natural stimulus but become active only when sensitised by tissue injury, 
has also been revealed (Michaelis et al., 1996). Both A and C-fibre silent nociceptors have 
been identified following peripheral inflammation (Xu et al., 2000).
Action potential characteristics vary between classes o f DRG neuron. Two classes o f action 
potential are evident: narrow (when displayed as voltage over time), tetrodotoxin (TTX)- 
sensitive. and broad/inflected potentials containing a TTX-resistant component. These 
differences can be ascribed to the differential expression of TTX-resistant voltage-gated 
sodium channels (VGSCs). and to the involvement o f  high-threshold voltage-gated calcium 
channels (Blair and Bean. 2002). A robust correlation between action potential shape and fibre 
type exists, with all C-fibres displaying broad action potentials. The shape o f A-flbre action 
potentials appears to be dependent on receptive properties: low threshold mechanosensitive 
neurons have narrow action potentials, while those with high thresholds have an inflected 
action potential (Ritter and Mendell, 1992). It is interesting to note that all nociceptive fibres 
have long-duration afterhyperpolarisations (AHPs), in contrast to the short AHPs o f  non­
nociceptive A and C-fibres (Djouhri et al., 1998b).
1.4.2 Differential gene expression in distinct populations of nociceptors
Several distinct populations o f nociceptors can be defined based on gene expression profile. A 
number o f  genes are used to classify nociceptors in this way. most commonly growth factor 
receptors, neurotransmitters, ion channels and transcription factors.
In early stages o f  development, cells destined to become nociceptive neurons express the high- 
affinity nerve growth factor tyrosine kinase receptor TrkA, and require nerve growth factor 
(NGF) for survival. NGF null-mutant mice are born lacking almost all small-diameter sensory7 
neurons, and are accordingly profoundly hypoalgesic (Crowley et al., 1994). Postnatally, 
however, a proportion o f C-fibres lose dependence on NGF, with a concurrent downregulation 
o f TrkA expression (Molliver and Snider, 1997). These cells express the tyrosine kinase 
receptor RET, and become dependent on glial cell line-derived neurotrophic factor (GDNF, the 
endogenous ligand o f  RET) (Molliver et al., 1997). GDNF-sensitive C-fibres express cell 
surface glycoconjugates that bind the lectin IB4, the enzy me fluoride-resistant acid phosphatase 
(FRAP) and are non-peptidergic: that is, they do not synthesise neuropeptides such as 
calcitonin gene-related peptide (CGRP). Additionally, the ATP-gated receptor P2X3 is 
expressed almost exclusively in IB4-positive neurons in rats (Burgard et al.. 1999). The subset 
o f  C-fibres retaining NGF sensitivity, accounting for around 40% o f  total DRG cells, 
constitutively synthesise the neuropeptides CGRP and substance P, but do not bind IB4.
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Although quantitative functional differences have been shown between these groups (Stucky 
and Lew in, 1999) w ith respect to heat sensitivity, TTX-resistant currents and action potential 
duration, distinct functional roles have yet to be determined. IB4-negative neurons were also 
found to express a transient proton-gated current (taken to be indicative o f acid-sensing ion 
channel (ASIC) expression), absent in IB4-positive cells, with a quantitative difference in 
capsaicin sensitivity (Dirajlal et al., 2003). It is not yet clear if these groups perforin distinct 
roles in chronic inflammatory or neuropathic pain states.
1.4.3 Transduction of noxious stimuli
To convey information regarding a noxious stimulus to the brain, primary afferent neurons 
must convert the original stimulus modality into an electrical signal, a process know as 
transduction. This signal, the generator potential, produces a local depolarisation o f  the plasma 
membrane, which with sufficient magnitude will initiate an action potential. Nociceptors are 
capable o f detecting thermal, mechanical or chemical stimulus modalities, with many being 
polymodal. Each stimulus modality is transduced by a distinct mechanism, although not all are 
well understood. In general, transduction is performed by ion channels gated by the stimulus 
modality in question. This is rapid, usually in the millisecond timescale. to allow an 
appropriate behavioural response to be made before major tissue damage occurs.
1.4.3.1 Transduction of noxious mechanical stimuli
Many painful clinical conditions involve mechanically-induced pain, often occurring as a result 
o f  a normally innocuous stimulus (allodynia). Neuronal mechanosensory channels mediate the 
sensations o f  hearing, light touch and noxious mechanical stimulation. Mechanotransduction in 
hair cells o f  the inner ear, required for hearing, has been studied extensively, and may inform 
the search for the noxious mechanosensor. Corey et al. (2004a) found that siRNA to the 
transient receptor potential (TRP) channel TRPA1 diminished hair cell transduction currents, 
making this channel a promising candidate for the hair cell mechanotransducer. This 
hypothesis, however, was questioned by the findings o f two independent studies, both o f  which 
reported that TRPA1 knockout mice displayed no deficits in a number o f  measures o f  auditory 
detection (Bautista et al., 2006c;Kwan et al., 2006d). These mice, however, expressed a 
truncated transcript o f  TRPA1 due to the deletion strategy used, although one study inserted an 
endoplasmic reticulum (ER) retention signal to prevent cell surface expression in the event o f  
the expression o f  a truncated protein (Kwan et al., 2006e). A more likely explanation for the 
discrepancy, however, is an off-target effect of the siRNA used by Corey et al. (2004b). The 
identity o f  the hair cell mechanotransducer has therefore yet to be determined.
35
Both polymodal C-fibre nociceptors and a subset o f  A8-fibres respond to noxious (but not 
innocuous) mechanical stimuli. Neurons from the superior cervical ganglion, however, are not 
mechanosensitive, providing a useful control when searching for the noxious mechanosensor: a 
key requirement is its differential expression between these cell types. Since mechano- 
nociceptors terminate in free nerve endings, and neuromas and cultured DRG neurons are 
mechanosensitive. specialised organs appear unnecessary for noxious mechanotransduction. 
Channels from several families have been proposed as the mechanotransducer for noxious 
stimuli, including the ASIC and TRP families. While mechanically-gated channels are 
abundant, this may not always be o f physiological relevance, since channels gated by 
mechanical stimuli at the single-channel level often exist in mechanically insensitive cells 
(Morris and Horn, 1991), or have an established physiological function (e.g. NMDA receptors 
(Paoletti and Ascher. 1994)). In these cases, it is possible that non-physiological membrane 
deformation favours an open channel conformation, generating a mechanosensitive artefact. 
Likewise, proteins clearly identified to play a role in mechanosensation may not function as 
mechanically-gated ion channels (e.g. Wetzel et al.. 2007b), suggesting that 
mechanotransduction may require a multi-protein complex.
The proteins required for noxious mechanosensation in mammals have yet to be identified, 
despite the provision o f many leads from the study o f  C.elegans and Drosophila. Mammalian 
ASICs belong to the same family as the ENaC ion channel subunits MEC-4. MEC-6 and MEC- 
10, which are required for light touch sensation in C.elegans (Ernstrom and Chalfie. 2002). 
ASIC2 (Garcia-Anoveros et al., 2001;Price et al., 2000a) and ASIC3 (Price et al., 2001b) are 
detectable by immunological methods in mechanosensory structures, consistent with a role in 
mechanosensation. Null-mutant mice for ASIC2, assessed using the skin-nerve preparation, 
were found to have normal responses to supra-threshold mechanical stimulation o f  Ad and C- 
fibres, but a decreased firing rate of A(3-fibres (Price et al., 2000b), suggesting a role for AS1C2 
in light touch sensation, but not noxious mechanosensation. In ASIC3-null mice, however. Ad 
mechano-nociceptors displayed a reduction in firing to supra-threshold stimuli, along with a 
small increase in mechanical threshold (Price et al., 2001c). although no change in C-fibre 
mechanical response was observed. Behaviourally, ASIC3 knockout mice have been assessed 
in 2 independent studies (Chen et al., 2002d;Price et al., 2001a). While neither group found an 
effect on acute mechanical withdrawal thresholds, measured using von Frey hairs, Chen et al. 
(2002c) observed reduced responses to high-intensity noxious stimuli, regardless o f  modality. 
This suggests that rather than a direct role in mechanotransduction, ASIC3 is involved in the 
modulation of moderate- to high-intensity pain sensation. Using mechanical stimulation o f the 
neuronal cell body as a model o f  sensory terminal mechanosensation, Drew et al. (2004) 
demonstrated that mechanotrasduction in DRG neurons from ASIC2 and ASIC3 null-mutants
36
comparable to wild-type. It therefore seems likely that AS1C2 and ASIC3 are not noxious 
mechanotransducers. A recently-identified blocker o f mechanically activated currents in DRG 
neurons was found to have no effect on ASIC-mediated currents (Drew and Wood, 2007b).
It has been proposed that the noxious mechanosensor may be a member o f  the TRP family o f 
ion channels, since currents mediated by these channels share properties with mechanically- 
activated currents in DRG neurons. Both are inhibited by micromolar concentrations o f 
gadolinium and ruthenium red. are attenuated by extracellular Ca~ , and have non-selective 
cation permeability (Drew et al.. 2002;Watanabe et al.. 2002a). TRPV4 shows a degree of 
homology to a mechanically-gated channel expressed in C.elegans (Liedtke and Friedman,
2003). and is gated by hypotonicity (Liedtke et al., 2000a). suggesting that it may play a part in 
mechanosensation. Subsequent work, however, found that TRPV4 is an unlikely candidate for 
the noxious mechanosensor. due to the lack o f effect of pressure on channel gating (Strotmann 
et al.. 2000b), and the slow time course o f hypotonicity-induced activation (Liedtke et al., 
2000b;Strotmann et al., 2000a). Xu et al. (Xu et al., 2003) later performed work strongly 
implying that gating o f TRPV4 by hypotonicity is via an indirect mechanism, involving the 
tyrosine phosphorylation of the channel by an Src kinase. TRPV4 nul 1-mutants displayed 
impaired but not absent pressure sensation, assessed by Randal 1-Selitto assay, but no change in 
von Frey withdrawal thresholds (Suzuki et al., 2003). This study also reported the expression 
o f  TRPV4 in only 11% of DRG neurons. It remains unclear whether TRPV4 can be activated 
directly by mechanical stimuli, but at present it does not appear to be a strong candidate for the 
noxious mechanosensor.
TRPA1 is another candidate for the noxious mechanosensor in DRG neurons. It is expressed at 
free nerve endings by small neurons of the DRG, as well as those o f the trigeminal root ganglia, 
and displays behaviours expected of nociceptive transducers, including block by ruthenium red 
and calcium sensitivity. Inactivation does not appear to occur in depolarised cells, consistent 
w ith the non-desensitising nature of mechanical pain (Nagata et al., 2005). TRPA1 null-mutant 
mice were found to have an increased von Frey withdrawal threshold, and a reduced response 
to supra-threshold stimulation compared to control animals (Kwan et al., 2006b). A gene 
dosage effect was also suggested by the intermediate phenotype o f  heterozygotes. TRPA1, 
however, is expressed in C but not A8-fibres (Kobayashi et al.. 2005), despite the pricking pain 
induced on A8-fibre stimulation. It therefore appears that, while TRPA1 may contribute to or 
even be responsible for noxious mechanotransduction in C-fibres, another high-threshold 
mechanotransducer fulfils this function in AS-fibres.
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While direct mechanotransduction by a mechanicallv-gated ion channel remains the most likely 
mechanism for the detection o f noxious mechanical stimuli, various accessory proteins required 
for this process have been identified. Wetzel et al. (2007a) found that stomatin-like protein 3 
(SLP3). a mammalian mec-2 (a gene involved in mechanosensation in C.elegans) homologue 
expressed in sensory neurons, appears to be an essential subunit o f  a mammalian 
mechanotransducer. Using the skin-nerve preparation, they found a substantial reduction in the 
number o f A(3 and A5-fibres responding to mechanical stimuli, but no change in C-fibre 
mechanoreceptive properties.
Drew et al. (2007a) recently identified FM1-43. a fluorescent dye used to label cell membranes, 
as a permeant blocker o f  mechanically-activated currents in DRG neurons. Intraplantar FM1- 
43 was shown to increase noxious mechanical withdrawal thresholds, assessed by both von 
Frey filaments and Randall-Selitto test. As mentioned previously, this dye does not affect 
currents mediated by ASICs. F M 1-43 may prove to be a useful tool for the identification o f  the 
noxious mechanotransducer.
It is possible that the transduction o f  noxious mechanical stimuli is mediated indirectly, by a 
chemical process. Mechanical pressure would cause the release o f a diffusible chemical 
messenger, which then acts (intra-or extracellular) on chemically-gated ion channels. In the 
bladder, stretch promotes the release of ATP from epithelial cells, activating P2X3 receptors on 
primary sensory neurons. P2X3 null mice show reduced urination as a result o f  this (Cockayne 
et al.. 2000b). In particular, recent work suggests a role for keratinocytes in noxious 
mechanotransduction (Lumpkin and Caterina. 2007). Due to the time delay inherent in indirect 
signalling, however, it is likely that normal noxious mechanotransduction occurs via a direct 
mechanism.
1.4.3.2 Transduction of noxious thermal stimuli
Both noxious heat and noxious cold are detected by primary afferent nociceptors. In culture, 
around 45% o f  small to medium diameter neurons display heat-evoked currents with a 
threshold o f  43°C. while 5-10% respond to heat with a threshold o f 52°C (Nagy and Rang, 
1999); (Caterina et al., 2000b). Noxious cold (4°C) activates only 10-15% of C-fibres, but a 
greater proportion o f nociceptors appear to be activated by temperatures < 0°C (Simone and 
Kajander, 1997a).
Noxious thermal stimuli are transduced by members o f the TRP channel family, labelled the 
“thermoTRPs”. TRPV1 (VR1) is expressed at free nerve endings o f  nociceptive neurons
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(Tominaga et al., 1998b), and is activated by the vanilloid capsaicin and by extracellular 
acidification (Caterina et al., 1997a). It confers sensitivity to heat when expressed in 
heterologous systems, and is expressed almost exclusively in small-diameter sensory neurons 
(Caterina et al., 1997b). mostly C-fibres. The thermal activation threshold for this channel is 
around 43°C, similar to that observed in a subset of nociceptors, and single channel currents 
can be evoked by heat, demonstrating direct thermal gating (Tominaga et al., 1998a). 
Interestingly, heat-activated currents are inhibited by the TRPV1 antagonists ruthenium red and 
capsazepine, and nearly all heat-sensitive neurons are capsaicin-sensitive (Nagy and Rang,
1999). These factors strongly suggest that TRPV1 is a transducer o f noxious heat in DRG 
neurons. Simultaneous publications from two groups reported the phenotype o f  TRPV1 -null 
mice, both showing deficits in thermosensation (Caterina et al., 2000a;Davis et al., 2000b). 
Caterina et al. (20000 reported that TRPVl-null mice had reduced responses to acute thermal 
stimuli above 50°C, but not at lower temperatures. In contrast. Davis et al. (2000a) found no 
significant differences acute thermal nociception, although a trend to reduced sensitivity was 
observed (p=0.053). and comment was made by the authors that the mixed strain background 
may have masked a difference. Both groups found that TRPV1 DRG neurons did not show 
currents activated by heat o f 43-50°C, and Caterina et al. (2000c) described changes in heat 
sensitivity in C-fibres, using the skin nerve preparation, and in spinal neurons, recording at the 
dorsal horn, at 41-43°C. This corresponds to the threshold at which TRPV1 is activated, 
implying a direct link between the lack of TRPV1 and these deficits. The confinement o f  
behavioural deficits to temperatures above 50°C, however, require a more complex 
explanation, which may involve a limited and specific role for T R PV 1-positive neurons in 
behavioural responses to noxious heat. Differences between behavioural studies and those 
using isolated neurons may be due to a lack o f expression o f other heat-sensitive channels in 
dissociated cells, or could suggest the involvement o f non-neuronal cells in the detection of 
noxious heat.
A key observation from these studies is the continued ability to detect noxious heat in T R PV l- 
null animals, implying that other mechanisms for the transduction o f  noxious thermal stimuli 
exist. Caterina et al. (1999b) used an in silica screen to identify sequences related to TRPV1. 
The majority o f  sequences detected corresponded to TRPV2, named vanilloid receptor-like 
protein 1 (VRL-1) at the time o f the study. TRPV2 was studied in HEK293 cells and Xenopus 
oocytes, and was found to be insensitive to capsaicin and protons. Thermal stimuli sufficient to 
cause pain (43°C) did not activate the channel, but the channel was found to be gated by high 
temperatures, with a threshold o f  around 52°C, and inhibited by ruthenium red. TRPV2 is not 
expressed in IB4-positive or substance P-positive neurons (i.e. C-fibres), but is confined to 
myelinated medium to large diameter DRG neurons, a proportion o f  which express CGRP
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(Caterina et al.. 1999a) and correspond to a subpopulation of A5 neurons (McCarthy and 
Lawson. 1997). This subpopulation displays properties consistent with the high thermal 
threshold Type 1 AS neurons (Wall and Melzack. 1999). In culture, a subset o f  medium 
diameter, capsaicin-sensitive DRG neurons were found to express a high threshold, heat- 
activated current, correlated with TRPV2 and a lack of TRPV1 expression (Ahluwalia et al.,
2002). Caterina et al. (2000e) also reported similar currents in DRG cultures from TRPVl-null 
mutant mice. These data strongly suggest that TRPV2 is responsible for the thermal sensitivity 
of high threshold. Type 1 AS neurons. The generation and analysis of TRPV2-null mice will 
provide a definitive test o f  this hy pothesis.
Woodbury et al. (2004) reported that nociceptors lacking TRPV1 and TRPV2 in the mouse 
have normal heat responses, indicating that other channels are important in the transduction of 
noxious heat. The detection o f  noxious heat is thus performed by more than one transducer. 
TRPV3 and TRPV4 are also thermally gated (Smith et al., 2002b;Watanabe et al., 2002b;Xu et 
al., 2002). but do not appear to mediate heat-activated currents in the DRG. TRPV channels, 
however, can form heteromultimers: for example, TRPV1 and TRPV3 heteromultimerise in 
heterologous systems and colocalise in small DRG neurons (Smith et al., 2002a). This means 
that the transduction o f  thermal stimuli o f  different intensities may be mediated by a variety o f 
TRPV channel combinations. The differential expression patterns o f various TRPs in 
subpopulations o f  DRG neurons suggests a mechanism for intensity coding o f noxious thermal 
stimuli.
Noxious cold is also capable o f  producing the sensation o f  pain. Spontaneous pain with the 
sensation o f coldness is a common feature o f certain types o f neuropathic pain syndromes, and 
subpopulations o f both C and A8-fibres respond to noxious cold (Simone and Kajander, 
1997b). The cyclic terpene alcohol menthol, which occurs naturally in mint oils, produces a 
cooling sensation when applied to the skin. Like capsaicin, the topical application o f  small 
doses produces a mild analgesic effect. Higher doses cause burning, irritation and pain (Green, 
1992;Wasner et al., 2004). Since cold-sensitive fibres are directly activated or sensitised by 
menthol (Henzel and Zotterman, 1951), it has proven to be a useful tool in the search for 
transducers o f  noxious cold. Several theoretical mechanisms have been proposed for the 
transduction o f cold stimuli, including direct action at a cold-gated channel, modulation o f 
channel properties, or inhibition o f protein function.
Reid and Flonta (2001c) first described an ionic current activated by cooling in DRG neurons. 
Using Ca" imaging to identify cold-responsive neurons (around 7% o f  DRG neurons), they 
compared eiectrophysiological properties to those of cold-insensitive cells. All cold-sensitive
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neurons expressed a cold-activated mixed cationic current, potentiated by menthol, insensitive 
to amiloride, and sensitive to changes in Ca' concentration. Menthol was shown to increase 
intracellular Ca2 concentration via stimulation of Ca2 entry, providing a mechanism for 
neuron activation. In a later paper, Reid et al. (2002) described properties o f cold-sensitive 
DRG neurons distinct form cold-insensitive nociceptors. Cold-sensitive nociceptors had 
shorter action potentials, smaller AHPs and more rapidly decaying Na currents. The majority 
o f  the cold/menthol-activated current was carried by Na ions, and was blocked by high 
concentrations o f  the TRPV1 antagonist capsazepine, although this is known to act at other 
channels at high concentration.
The molecular identity o f  a channel conferring cold sensitivity in DRG was identified by 
expression cloning, using Fura-2 Ca' imaging to identify cells responding to menthol 
(McKemy et al.. 2002a). A trigeminal ganglia (TG) cDNA library, chosen due to the high 
proportion o f cold-sensitive neurons compared to DRG. was expressed in HEK293 cells for 
screening. A single cDNA clone conferring cold sensitivity was identified, and termed C M R1. 
When expressed in Xenopus oocytes, electrophysiological analysis revealed currents elicited bv 
menthol and icilin (a super-cooling agent), but not by analogous compounds or capsaicin. In 
transfected HEK293 cells, menthol- and cold-evoked currents displayed properties similar to 
those observed in trigeminal neurons. CMR1 was found to have significant homology to 
certain members o f  the TRP channel family, most notably those of the TRPM class, and was 
found to be the rat orthologue of the human channel TRPM8. Transcripts for this protein were 
found in a subset o f  small-diameter sensory neurons in DRG and TG, similar to that expressing 
TRPV1, and representing C and possibly A5-fibres. Transcripts were not found in larger 
diameter neurons, but were more prevalent in TG than DRG, consistent with the greater 
proportion o f  cold-sensitive cells in this structure.
Peier et al. (2002) identified TRPM8 as a cold sensor at the same time as the work by McKemy 
et al. (2002b), using an alternative approach. A bioinformatic search based on TRP channel 
homology identified TRPM8, which was found to be expressed in a subset o f  small diameter 
sensory neurons, and not co-expressed with CGRP and TRPV 1. A cold- and menthol-activated 
current was produced upon expression in CHO cells, with similar properties to the cold- 
activated current in DRG. This approach was used by the same group to identify ANKTM1, a 
TRP-like channel expressed in nociceptors and activated by cold temperatures (Story et al.,
2003). ANKTM1 was shown to be expressed in a peptidergic population o f  nociceptors 
expressing TRPV1 (a distinct population from those expressing TRPM8). Expression in CHO 
cells identified a sensitivity to low temperatures (<17°C). resulting in Ca2 influx, sensitive to 
icilin but not menthol. A subpopulation o f DRG neurons was found to possess properties
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consistent with ANKTM1 expression. This channel was later shown to be responsible for 
currents evoked by pain-causing mustard oil (Jordt et al., 2004). ANKTM1 was later termed 
TRPA1. and found to be upregulated by nerve damage and inflammation, contributing to the 
cold hypersensitivity observed under neuropathic and inflammatory-' conditions (Obata et al.,
2005). Interestingly, this paper reported TRPA1 (but not TRPM8) upregulation by 
administration o f  NGF, via the p38 MAPK pathway.
Two independent studies analysed the effect o f  TRPA1 deletion from mice. Kwan et al. 
(2006c) found deficits in behavioural responses to noxious cold, assessed using cold plate (0°C) 
and acetone tests. This effect was found to be gender-dependent: a trend towards diminished 
sensitivity in TRPAl-null males was greater in female mice, adding an additional layer of 
complexity to the role o f TRPA1 in the detection o f noxious cold. Bautista et al. (2006b). 
however, found no difference from control in either cold plate or acetone tests, and further 
found no differences in electrophvsiological assays o f cold sensitivity in DRG neurons. These 
differences may arise from subtle differences in assay methodology: for example, Kwan et al. 
(2006a) recorded the number o f responses in a fixed period, whereas Bautista et al. (2006a) 
measured time to first response. Additionally, different constructs for TRPA1 deletion were 
used in each study. In both cases, a truncated fragment was expressed, but Kwan et al. (2006f) 
included an ER retention signal to retard fragment trafficking, as described previously in the 
discussion o f mechanotransduction. Since TRP channels are known to form heteromultimers. it 
is possible that truncated TRPA1 fragments could exert dominant-negative effects on a variety 
o f  other channels, confounding phenotypic analysis. Alternatively, difficulties in assessing 
cold-induced pain behaviour (for example, some mice shown no response to very' cold 
temperatures (Story' and Gereau, 2006)) may explain these discrepancies.
A recent paper from Zurborg et al. (2007) provides an explanation for the differences between 
cellular and whole-animal studies on the role o f  TRPA1 in cold sensing. They used a 
heterologous expression system to show that intracellular Ca2 activates TRPA1 via an EF-hand 
domain, and that it is increased intracellular Ca~ concentration during cooling that activates the 
channel, rather than gating by cold. This study used a logical series o f  experiments to 
demonstrate that this indirect, non-physiological mechanism is responsible for previous 
observations o f TRPA1 gating by cold. Responses to cold were seen in TRPA1-expressing 
cells but also in TRPA1 -negative neurons, with almost identical thresholds. Ca2 -insensitive 
TRPA1 mutants showed cold sensitivity comparable to controls animals. Ca2 -buffered whole 
cell patch-clamp experiments also found no activation o f TRPA1 channels by cold. The role o f 
TRPA1 as a noxious cold sensor is thus unclear.
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Several studies report populations o f cold-sensitive DRG neurons expressing neither TRPM8 
nor TRPA1. Munns et al. (2006) found that a third of cold-responsive DRG neurons did not 
respond to any TRP channel agonist, including menthol (TRPM8) and mustard oil (TRPA1). 
Another group reported a novel cold-sensitive DRG neuron subpopulation, sensitive to cold but 
with rapid adaptation, expressing neither TRPA1 nor TRPM8, and possibly corresponding to 
the rapidly-adapting cold sensors decribed in vivo (Babes et al., 2006). Bautista et al. (2006d) 
also observed two distinct populations o f cold-sensitive neurons in DRG culture, one 
responding to menthol but neither to mustard oil, suggesting the presence o f  an additional 
transduction mechanism for noxious cold in DRG neurons. Inhibition of K channels (Viana et 
al., 2002b) and o f  the N a '/K ' ATPase (Spray, 1986) have both been suggested as mechanisms 
for depolarisation in response to cold. Inhibition o f the Na /K ATPase by oubain elicited a 
depolarisation o f only 10-1 5% of that induced by cooling, and did not produce action potentials 
in DRG neurons (Reid and Flonta. 2001a), implying a secondary role in cold transduction. 
Cooling did, however, inhibit a background K current by 49-72% (32-20°C) that was found to 
be resistant to tetraethylammonium (TEA) and 4-aminopyridine (4-AP). This current was 
suggested to be carried by the two-pore domain channel TREK-1, although this was speculative 
(Reid and Flonta, 2001b). Subsequently, Viana et al. (2002a) found that cold-sensitive TG 
neurons differed from cold-insensitive by K current expression profile. In cold-sensitive 
neurons, cooling inhibited K leak channels, causing depolarisation and firing limited by the 
slower reduction o f  4 ,  a cationic inward current. In cold-insensitive neurons this inhibition 
also occurred, but did not cause depolarisation due to the presence o f  another K current, IKD. 
This current acts as an “excitability brake" in cold-insensitive neurons. 4-AP block o f  IKD 
induced cold-sensitivity in previously unresponsive neurons, leading to the suggestion that cold 
allodynia could be caused by changes in K channel distribution in sensory' nerve termini. For 
this mechanism o f  cold transduction to be physiologically relevant, the relative distributions o f 
the K channels observed here (in the soma) must be similar to that at the nerve termini, the site 
o f  cold transduction.
The transduction o f noxious cold stimuli thus appears to involve several ion channels, the 
relative contributions o f which have yet to be assessed. A more detailed characterisation o f 
cold-sensing DRG neurons and the roles of various channels, similar to that performed for the 
detection o f noxious heat, is likely to provide a more specific model for this process.
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1.4.3.3 Transduction of noxious chemical stimuli
Tissue damage and inflammation cause the release o f a variety o f  chemical mediators, the 
detection of which induces protection o f the affected body part from further trauma. 
Nociceptive nerve termini in the vicinity o f  tissue damage are exposed to these mediators, and 
are able to transduce this exposure into electrical activity. Certain chemicals are able to 
activate nociceptors directly, while others cause sensitisation to other stimulus modalities. 
Hvpoxia-induced alterations in extracellular fluid (ECF) composition, often occurring during 
exercise or compromised cardiac function, are also capable o f  causing nociceptor excitation.
Upon tissue damage, inflammation and hypoxia, the extracellular environment surrounding the 
nociceptor terminal is acidified. Extracellular pH may fall from 7.4 to around 6 under these 
conditions, due to release o f protons from lysed cells, degranulation of stimulated mast cells, 
and lactic acid formation where metabolism exceeds oxygen supply. These conditions, along 
with exposure to exogenous acid or iontophoresis o f  protons, evoke pain (Jones et al., 
2004;Voilley, 2004a). Upon application o f acid to a receptive field, around 40% of 
nociceptors, primarily mechanoheat polymodal C-fibres, display a sustained, non-desensitising 
action potential discharge (Steen et al., 1992;Steen et al., 1995).
Several cation channels expressed in DRG neurons are gated by protons, notably TRPV1 and 
the ASIC family. Most ASIC subtypes are expressed in DRG, with ASIC lb and ASIC3 
showing exclusive or preferential expression. Heterologous expression o f  most ASIC subtypes 
results in a rapidly-desensitising current in the physiological pH range, inconsistent with the 
sustained activity observed in nociceptors, or a biphasic, Na -selective sustained current 
activated by non-physiological pH drops (reviewed in Julius and Basbaum, 2001b). ASICs are 
known to form heteromultimers in vivo , with properties distinct from that o f  their component 
subunits (Benson et al., 2002;Xie et al., 2002). Co-expression o f  ASIC2b and ASIC3, a 
combination specific to sensory neurons, produces currents resembling native acid-evoked 
currents in DRG, with a sustained, non-selective cation permeable component (Lingueglia et 
al., 1997a). Additionally, while most ASIC-mediated currents are activated only on rapid 
changes o f  pH, currents mediated by ASIC3-containing channels can be activated by the 
gradual acidification more likely to occur in physiological conditions (Lingueglia et al., 1997b). 
Amiloride, the non-specific ASIC blocker, was found to reduce pain resulting from transdermal 
iontophoresis o f  protons in humans (Jones et al., 2004), and from abdominal acetic acid and 
intraplantar formalin in animal models (Ferreira et al., 1999). Although amiloride also affects 
other ion channels, the specific ASIC antagonist A -317567 displayed clear analgesic effects in 
an animal model o f  post-operative pain (Dube et al., 2005), in which the central role of 
decreasing pH in pain induction has been established (Woo et al., 2004). Studies on ASIC3-
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null mice produced conflicting results, showing electrophysiological (at pH 5 but not pH 4) but 
not behavioural deficits to acidic stimuli (Chen et al., 2002b:Price et al.. 2 0 0 Id). Mice 
expressing a dominant-negative form of AS1C3. intended to investigate the role o f  AS1C3 
heteromultimers. displayed a substantial reduction in ASIC-mediated proton-induced currents 
in DRG neurons, but increased behavioural sensitivity to mechanical and chemical (including 
acidic) stimuli (Mogil et al., 2005). It has been found that several ASICs are upregulated 
during inflammation (Voilley et al., 2001), although no proton-induced action potential 
generation was observed under these conditions. Overall, these data suggest an important but 
not exclusive role for ASICs in the detection o f protons by nociceptors.
TRPV1, the heat-sensitive capsaicin receptor expressed in DRG neurons, is also gated by 
protons. TRPV 1-mediated responses to capsaicin and heat are potentiated by protons in the 
physiological range (pH 6-8). while activation occurs at room temperature (and therefore by 
body temperature) at pH< 6 (Tominaga et al.. 1998c). It has been shown that protons produce 
this effect by direct interaction with TRPV1, via several negatively-charged residues in putative 
extracellular loops (Jordt et al., 2000). The responses of TRPV 1 to low pH are similar to 
currents observed in dissociated DRG neurons (Bevan and Yeats. 1991). suggesting that 
TRPV1 could be the transducer of low pH in DRG neurons. Additionally, acid sensitivity and 
TRPV1 expression (measured by capsaicin sensitivity) show a strong correlation (Bevan and 
Geppetti, 1994). DRG from TRPV 1-deficient mice show a marked reduction in sustained 
proton-evoked currents, supporting the role of TRPV 1 in acid-evoked nociception. Proton 
sensitivity is not abolished, however, implying a role for other pH-sensitive channels (Caterina 
et al., 2000d), perhaps including the ASICs.
Tissue damage often results in the release of ATP from necrotic cells, which is normally absent 
from the extracellular fluid. ATP is thus a specific indicator o f  cell damage, and can be 
detected by nociceptors. Receptors for ATP and related substances, known as “pur'nergic" 
receptors, are present on DRG neurons, in addition to many other cell types. Purinergic 
receptors fall into 2 groups, ligand-gated ion channels (ionotropic, P2X family) and G-protein- 
coupled (metabotropic) receptors (P2Y family). Expression o f P2X3, an ionotropic ATP 
receptor, is limited to putative nociceptors (Chen et al., 1995;Cook et al., 1997), suggesting a 
role in nociception. The P2X3-mediated current, however, is rapidly desensitising, inconsistent 
with nociceptor properties (Virginio et al., 1998). Coexpression o f P2X3 with P2X2 results in a 
slowly-adapting ATP-gated current similar to that observed in nociceptors, suggesting that the 
P2X2/P2X3 heteromultimer underlies this current (Lewis et al., 1995). DRG neurons from 
P2X2/P2X3 double knockout mice were found to be insensitive to exogenous ATP application 
and behavioural responses to intrapiantar formalin (which causes tissue damage) were reduced 
(Cockayne et al., 2005), consistent with this hypothesis. Certain data, resulting from analysis
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of a P2X;,-null mouse, suggest that homomultimeric P2X;, receptors are sufficient to account for 
ATP-induced nociception (Cockayne et al., 2000a). but this remains unclear. Likewise, the role 
o f  other P2X or P2Y receptors in ATP-induced pain has yet to be investigated.
Bradykinin (BK). a peptide inflammatory mediator involved in the induction o f hyperalgesia, is 
capable o f exciting nociceptors directly (Inoue and Ueda, 2000b). It acts primarily on the free 
nerve endings o f C-fibres (Ueda et al., 2000) to cause depolarisation and subsequent pain- 
related behaviour in naive animals (Inoue and Ueda, 2000a). BK acts through the receptor 
subtypes B, and B2. both G-protein coupled receptors linked to phospholipase C (PLC). 
Activation o f these receptors generates IP;, and DAG. DAG causes depolarisation o f  the nerve 
membrane by stimulation o f protein kinase C (PKC) (Burgess et al., 1989b). which 
phosphorylates a non-specific cation channel, causing increased opening and thus 
depolarisation (Wall and Melzack. 1999). BK activation of sensory neurons increases 
intracellular Ca2 via IP;, production and voltage-gated Ca' channel activation, with multiple 
effects on the neuron (Burgess et al., 1989a). In naive animals, these actions are likely to be 
mediated by the B: receptor, which is expressed constitutively by nociceptors, rather than B,. 
the expression of which is induced upon tissue damage.
The plant-derived compounds capsaicin, menthol and mustard oil are all capable o f  exciting 
nociceptors and causing pain. The molecules involved in transducing these stimuli have been 
discussed previously in this section. Other ligands acting on nociceptors include 5-HT 
(serotonin), histamine and noradrenaline.
1.4.4 Transmission of noxious stimuli
Following the transduction o f a noxious stimulus into a localised depolarisation at the distal 
nerve terminal, this signal must be transmitted to the spinal cord synapse. This is achieved by 
the generation o f an action potential, a self-propagating depolarisation along the length o f  the 
axon. The majority o f  the depolarising (inward cationic) current required for this action 
potential is carried by voltage-gated sodium channels (VGSCs), o f  which there are many 
subtypes with varying biophysical properties, expression profiles, and cellular localisation. The 
subtypes Nav l . l ,  1.2, 1.6, 1.7, 1.8 and 1.9 are expressed in the mature DRG, while N av 1.3 is 
expressed in the embryonic sensory nervous system. The expression o f  N av 1.8 and 1.9 is 
limited to a subset o f  neurons in the sensory nervous system, over 85% o f  which are putative 
nociceptors (Akopian et al., 1996;Djouhri et al., 2003a). VGSCs are discussed in more detail 
subsequently.
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Potassium channels are important regulators o f  neuronal excitability. Several K currents have 
been described in DRG, including delayed rectifiers (/K), which open in response to 
depolarisation, and IA currents, which activate rapidly in response to depolarisation, then 
inactivate (Gold et al., 1996). Depending on their opening characteristics, they can control the 
rate o f  repolarisation following an action potential, the membrane excitability, or the rate o f  
firing. Activation o f K channels in DRG neurons is controlled either by intracellular Ca" 
concentration (which rises following an action potential) or by membrane hvperpolarisation.
Voltage-activated calcium channels, activated by membrane depolarisation, also contribute to 
the action potential, in particular to the characteristic “hump” on the falling phase o f the C-fibre 
action potential. Ca" entry regulates excitability via the control of Ca" -gated ion channels, but 
also causes a variety o f  responses through intracellular signalling cascades. In particular, Ca" 
entry' is critical for presynaptic neurotransmitter release. At least 5 types of voltage-activated 
Ca" channel are expressed in sensory' neurons (L. N. P/Q, T and R), each having distinct 
effects on neuronal excitability (Wall and Melzack, 1999).
1.4.5 Inflammatory pain
Following inflammation, nociceptive thresholds are decreased. This sensitisation is mediated 
by changes to both peripheral and central components of pain sensation. Central sensitisation 
involves processes including long-term potentiation, which strengthens synapses, increases in 
descending facilitation and decreases in descending inhibition in the spinal cord, discussed 
briefly in subsequent sections. Peripheral sensitisation is a result o f  plastic changes in 
nociceptors, resulting in reduced thresholds either to all stimuli (i.e. an effect on transmission), 
or to a specific stimulus modality (an effect on transduction).
Tissue damage results in the release o f inflammatory mediators from recruited immune cells, 
particularly mast cells, and from proteolytic plasma cascades. Moreover, repeated nociceptor 
excitation results in the release o f pro-inflammatory compounds from their distal termini, a 
process known as neurogenic inflammation and resulting in local vasodilatation, plasma 
extravasation and mast cell degranulation. Inflammatory mediators released by these routes 
include NGF, cytokines (TNF-a, interleukin-1/6), histamine, prostagladins (particularly PGE2 
and bradykinin), 5-HT, protons, CGRP and substance P (released mainly from nociceptors), 
although this is not a comprehensive list. These mediators induce plastic changes in 
nociceptors, resulting in enhanced sensitivity to noxious (or previously innocuous) stimuli. 
Interestingly, a normally-unresponsive (“silent” ) class o f  nociceptors become active under
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conditions o f inflammation (Lewin and Mendell, 1994;Meyer et al., 1991), resulting in a 
greater spinal input for a given stimulus intensity.
A variety o f post-translational mechanisms contribute to peripheral sensitisation. In particular, 
ligand binding to G-protein-coupled receptors such as H| (histamine), coupled to Gs, results in 
the formation o f cyclic AMP. activating protein kinase A (PICA). This effect can be opposed 
by opiates and cannabinoids, the receptors for which couple to G, and therefore inhibit 
adenylate cyclase. Bradykinin binds to BK: Gq -coupled receptors which stimulate 
phospholipase C, activating PKC. Other ligands, such as NGF, bind to tyrosine kinase 
receptors which activate protein kinase C (PKC). PKA and PKC phosphorylate a variety of 
target proteins to induce sensitisation. Phosphory lation of Nav 1.8 by PKA or PKC causes a 
shift in the current-voltage relationship and possibly the voltage-dependence o f  activation 
(FitzGerald et al.. 1999;Gold et al., 1998;Vijavaragavan et al., 2004a). making the neurons 
more excitable to all stimulus modalities. Bradykinin induces PKC-s-mediated 
phosphory lation o f  TRPV1 and TRPV2. resulting in thermal but not mechanical hyperalgesia 
(Cesare et al., 1999;Cesare and McNaughton, 1996). Some inflammatory mediators act 
directly on ion channels, without the need for 2nd messenger pathways. For example, protons 
bind to the extracellular loops o f TRPV1, causing an increased channel sensitivity to heat or 
capsaicin (Tominaga et al., 1998e;Welch et al., 2000). In the presence o f  pH 6 or lower, even 
ambient body temperature can activate TRPV1 (Tominaga et al.. 1998d).
Changes in gene expression levels also contribute to peripheral sensitisation following 
inflammation. For example, NGF acts through the tyrosine kinase receptor TrkA to activate 
p38 MAPK pathways (Ganju et al., 1998), resulting in an increase in expression o f  TRPV1 and 
therefore thermal hyperalgesia (Ji et al., 2002). Actions of NGF through TrkA also result in 
increased expression o f  Nav 1.8, while GDNF causes upregulation o f  both N av 1.8 and N av 1.9 
(Fjell et al., 1999b;Fjell et al., 1999a). Many other transcriptional changes are induced by 
inflammatory mediators to effect peripheral sensitisation.
Voltage-gated sodium channels (VGSCs) are thought to play a significant role in the 
development o f  inflammatory hyperalgesia. Nav 1.8 was thought to be important in this 
process, due to its phosphorylation and transcriptional upregulation by inflammatory mediators, 
but deletion o f N av 1.8 from the mouse had only a small effect (although this was proposed to 
be due to compensatory upregulation o f other VGSCs) (Akopian et al., 1999). Nociceptor- 
specific deletion o f N a v 1.7, however, resulted in a substantial reduction in inflammatory pain, 
suggesting a major role for this channel in peripheral sensitisation (Nassar et al., 2004). 
Several human genetic conditions that result in spontaneous inflammatory-type pain
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(erythromelalgia) have been mapped to the Nav 1.7 gene, with gain-of-function mutations 
causing increased channel activity (Choi et al.. 2006b:Cummins et al.. 2004b;Dib-Hajj et al., 
2005a:Han et al.. 2006b;Han et al.. 2007:Harty et al., 2006a;Lampert et al.. 2006b:Sheets et al., 
2007a). A gain-of-function mutation in Nav 1.7, resulting in a reduction in fast inactivation and 
therefore a persistent Na current, was recently shown to be the cause o f paroxysmal extreme 
pain disorder, a genetic disorder resulting in spontaneous pain with some inflammatory 
character (Fertleman et al., 2006b). Surprisingly, loss-of-function mutations in this gene appear 
to result in complete insensitivity to pain, with no other neurological changes (Cox et al., 
2006a).
For a review o f  the mechanisms o f inflammatory pain, see Julius and Basbauni (2001 d ) or Kidd 
and Urban (2001). A diagram illustrating a selection of peripheral mechanisms o f 
inflammatory hyperalgesia is shown in Figure 1.3.
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Figure 1.3 Processes contributing to inflam m atory hyperalgesia in prim ary afferen t neurons.
Taken from Julius and Basbaum (2001c).
While a proportion o f  the processes involved in peripheral sensitisation by inflammation have 
been identified, it is likely that others remain to be discovered. It should be noted that many 
processes important to the development o f  inflammatory hyperalgesia occur at the level o f  the 
spinal cord or higher structures. Central nervous system changes important in hyperalgesia are 
currently the focus o f  investigation by many groups, and may provide novel therapeutic targets.
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1.4.6 Neuropathic pain
Spontaneous pain, pain from previously innocuous stimuli (allodynia) and increased pain from 
noxious stimuli (hyperalgesia) can all result from nerve damage. This damage can be a 
consequence o f  mechanical trauma, diabetes, HIV infection, cancer or many other conditions, 
and generally causes neuropathy (necrotic neuronal death, often described as Wallerian 
degeneration). It is generally believed that many of the changes required for the maintenance
of neuropathic pain occur at the level of the spinal cord. A particularly interesting example
described recently involves microglial-induced BDNF release, which causes decreased 
expression o f the CT channel KCC2. The resulting shift in CT gradient switches light touch- 
related GABA-ergic interneuron function from inhibitory to neutral or facilitatory, allowing 
light touch to cause pain (Coull et al., 2003c;Coull et al.. 2005a). Since the primary neuronal 
damage that triggers a neuropathic pain state occurs peripherally, however, changes in the 
properties o f  peripheral nerves must be responsible for the induction o f  neuropathic pain. 
Additionally, the fact that neuropathic pain develops gradually implies that changes in gene 
expression, rather than post-translational modifications, are responsible.
Following nerve damage, both injured and uninjured primary afferent neurons display 
abnormal and spontaneous activity' (the “afferent barrage”) (Han et al., 2000). This is likely to 
be the trigger for subsequent plastic changes in the spinal cord and brain. The first stage in the 
phenotypic changes causing abnormal activity in damaged primary afferents is the loss o f 
trophic support, in the form of NGF and GDNF (and related molecules), since growth factor 
retrograde transport from source (cells surrounding the distal terminal) to cell soma is 
prevented by the damage. The importance of this loss o f  support in the generation o f  
neuropathic pain is emphasised by the ability o f  GDNF exogenously applied to the soma to 
reverse this pain and the associated phenotypic changes (Bennett et al., 2000;Boucher et al., 
2000;Boucher and McMahon, 2001c). Aside from loss o f  trophic support, the block o f  axonal 
trafficking results in local accumulation of channel-carrying transport vesicles; for example, 
VGSCs have been shown to accumulate in painful neuroma endings and in patches o f  
demyelination in both animal models and human patients (Kretschmer et al., 2002b). The
degeneration o f  injured nerves results in the release o f  cell contents, many o f  which act
externally as inflammatory mediators, onto nearby uninjured neurons, either in the same or an 
adjacent nerve.
Axotomy, through loss o f trophic support but also other mechanisms, causes changes in DRG 
neuron gene expression profiles, upregulating or downregulating both transcript and protein. A 
recent report used microarray analysis to show that expression levels o f  hundreds o f  genes were 
altered after peripheral nerve injury (Costigan et al., 2002), illustrating the highly complex
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nature o f neuropathic pain. For example, substance P and CGRP are both downregulated 
following axotomy. Due to interest as potential drug targets, however, the majority o f  research 
has focused on changes in expression of ion channels, particularly voltage-gated sodium 
channels (VGSCs). Increased functional expression o f VGSCs would theoretically result in 
increased membrane excitability, possibly including spontaneous activity. N av 1.8 and N av 1.9 
were reported to be downregulated at the level o f  both transcript and protein (Decosterd et al., 
2002;Dib-Hajj et al.. 1996). while levels o f  the embryonic Nav 1.3 increase (Black et al.. 1999). 
A persistent Na conductance, carried by the channel Nax. is also upregulated. In adjacent 
uninjured fibres, however, an increase in Nav 1.8 functional expression, but not total protein, 
was observed, representing a redistribution of protein along the axon (Gold et al., 2003). A 
complete description o f VGSC changes following axotomy is given in a recent review by 
Devor (2006). Although observations o f changes in gene expression can inform the search for 
proteins contributing to neuropathic pain, the use of gene deletion technology in mouse lines 
provides a more definitive test of relevance. Nav 1.3 (Nassar et al., 2006), N av 1.7 (Nassar et 
al., 2005), N av 1.8 (Akopian et al., 1999) and Nav l .7/Nav l -8 (Nassar et al., 2005) conditional- 
null mutant mice showed no deficits in animal models of neuropathic pain. Interestingly, the 
ectopic discharges from damaged sensory neurons that are characteristic o f  neuropathic pain 
generation were found to be present in Nav 1.3 conditional-null mice, demonstrating that 
another mechanism is responsible for this element o f  the primary afferent barrage (Nassar et al.,
2006).
Aside from VGSCs, several other groups o f ion channels have been proposed to play a role in 
the primary afferent component o f  neuropathic pain, through a combination o f  theoretical 
mechanistic proposals and experimental observation. Voltage-gated Ca2 channels, particularly 
the accessory subunit Obb-l, are thought to play a role in neuropathic pain processes in the 
periphery. Interestingly, cbS-l is thought to be the target for gabapentin, often effective in 
treating neuropathic pain, and is upregulated following nerve injury (Luo et al., 2002). The 4  
pacemaker K current, carried by CNH, may also play a role in neuropathic pain (Chaplan et 
al., 2003b). This current is activated by hyperpolarisation, and regulates the rate at which 
repetitive firing can occur. An increase in channel activity is observed following nerve 
damage, resulting in pacemaker-driven spontaneous action potentials in the injured nerve 
(Chaplan et al., 2003a). K -carrying KCNQ channels are reported to play a key role in the 
control of nociceptor excitability, meaning that alterations in expression may induce 
neuropathic pain (Passmore et al., 2003).
Given the prevalence o f potential mechanisms for neuropathic pain, a unified theory for its 
origin remains elusive. While many changes reproducibly occur, dissecting those that are
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essential for neuropathic pain from those which do not play a significant role has proven to be a 
challenge. The use o f transgenic technologies, alongside the growing pharmacological 
repertoire isolated from previously undiscovered sources will prove valuable in defining the 
processes essential for neuropathic pain.
1.4.7 Central processing
Information about noxious stimuli from primary afferent nociceptors is transmitted to the brain 
via the dorsal horn o f  the spinal cord. The dorsal horn is divided anatomically into laminae, 
designated I-VI from outermost inwards. Peptidergic (NGF-dependent) C-fibres terminate in 
lamina I and the outer segment o f  lamina II, while non-peptidergic (GDNF-dependent) C-fibres 
synapse in the inner segment o f  lamina II. A5-fibres synapse primarily in lamina I (Wall and 
Melzack, 1999). In contrast. A(3-fibres innervate lamina V. In the dorsal horn, nociceptive 
neurons synapse with either nociceptor-specific (NS) or wide-dynamic-range (WDR) 
projection neurons, which carry information to higher structures. NS neurons respond only to 
high-intensity stimuli, while WDR neurons respond to both high- and low-intensitv stimulation 
with a graded output. In lamina I and II, the majority o f  projection neurons are nociceptor- 
specific, while lamina V contains primarily WDR neurons. In lamina V. WDR neurons 
synapse with A(3-fibres, but also receive input from C- and A5-fibre neurons via spinal 
interneurons.
Sensory neurons communicate with spinal neurons via a variety' o f  neurotransmitters. The 
main excitatory neurotransmitter released is glutamate, which activates post-synaptic ionotropic 
NMDA, AMPA and kainate receptors, as well as metabotropic (G-protein-coupled) glutamate 
receptors. A8-fibres and NGF-responsive C-fibres also release brain-derived neurotrophic 
factor (BDNF), which activates TrkB receptors. Substance P and calcitonin gene-related 
peptide (CGRP) are also released by this class of C-fibre, acting on post-synaptic NK1 and 
CGRP receptors respectively. Protons and ATP are also likely to play a role in synaptic 
transmission in the dorsal horn o f the spinal cord. While glutamate is released by relatively 
moderate activity, Substance P required more intense nociceptor activation, and BDNF is 
released following repetitive bursts o f C-fibre activity.
Higher centres can modulate dorsal horn activity through descending inhibition and descending 
facilitation. Here, neurons descending from the brainstem and other higher structures release 
neurotransmitters, particularly 5-HT and noradrenaline, which act both pre- and post- 
synaptically to enhance or inhibit transmission. These processes are though to be important in 
chronic pain states: for example, evidence exists showing enhanced serotonergic descending
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input following formalin-induced inflammation and peripheral nerve injury'. 5-HT released acts 
on primary afferent 5-HT\ excitatory ionotropic receptors, increasing neurotransmitter release 
from these neurons (Green et al., 2000; Suzuki et al., 2004). In contrast. a 2A adrenoreceptors 
mediate a large component o f  anti-nociceptive descending control. Pre-synaptic mechanisms 
o f descending control allow selective regulation o f nociceptive and non-nociceptive inputs, 
while post-synaptic actions do not discriminate between sources.
Excitatory and inhibitory' intemeurons in the dorsal horn allow a complex interplay between 
stimuli. Some pathway s o f  descending control act through interneurons, and primary afferent 
input to interneurons in one lamina o f the dorsal horn can influence the sy naptic activity o f  
connections in other laminae. The interconnectivity provided by dorsal horn interneurons 
allows fine control o f  somatosensory coding to ascending pathways, but makes the 
investigation o f nociceptive pathways complex. In addition to neuronal influences, non­
neuronal cells such as glia and microglia can modulate dorsal horn activity through the release 
o f  brain-derived neurotrophic factor (BDNF) and other substances.
Persistent activity in nociceptors can induce plastic changes in the dorsal horn. This central 
sensitisation plays an important role in inflammatory' hyperalgesia and neuropathic pain, and is 
characterised by increased synaptic efficiency, lowered thresholds o f activation and wider 
dorsal horn neuron receptive fields. In response to persistent low-frequency nociceptor 
activity, the phenomenon of wind-up can be observed. This consists o f  a summating dorsal 
horn response, with a constant afferent input generating increasing activity in dorsal horn 
neurons. Wind-up occurs rapidly (seconds) and does not persist beyond the duration o f  the 
stimulus. The primary mechanism behind this phenomenon is the removal o f  Mg2 block from 
the pore o f NMDA receptors, allowing increased Ca2 currents. This removal occurs due to 
repeated depolarisation displacing the Mg2* ion from the pore. A related phenomenon, long­
term potentiation (LTP), describes a lasting synaptic facilitation in response to repeated high- 
frequency nociceptor activity. This process involves the activation o f  metabotropic glutamate 
and NK1 receptors, activating 2nd messenger signalling pathways and resulting in the 
phosphorylation o f  NMDA and AMPA receptors. Increased Ca2 influx through NMDA 
receptors results in the activation of the transcription factor CREB (cAMP-response-element 
binding protein), which induces the transcription o f c-fos and other immediate-early genes that 
contribute to synaptic strengthening. Many other transcriptional changes occur following 
inflammation or nerve damage, contributing to the generation and maintenance o f  abnormal 
pain states. In addition to changes in neuronal properties, activation o f  microglia and other 
non-neuronal cells can influence synaptic strength and contribute to hyperalgesic and allodynic 
states.
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Information is conveyed to the brain from the spinal cord by many pathways, the most well- 
described o f which are the spinothalamic, spinoparabrachial and spinoreticular. On a very 
simple level, the spinothalamic tract originates in deeper layers o f  the dorsal horn, projecting 
through the thalamus to the primary somatosensory cortex (which generates the conscious 
perception o f pain) through the thalamocortical tract. The spinoparabrachial pathway projects 
from the most superficial layer o f  the dorsal horn to the periaqueductal grey, the hy pothalamus 
(emotion and vascular response) then amygdala (memory and emotion). The spinoreticular 
pathway ascends to the thalamus, then to a variety o f brain areas including the anterior 
cingulated gvrus (emotion), the amygdala and the hypothalamus. These pathways can be 
associated with distinct components o f pain. Pain is often described as having sensory 
(discriminative, e.g. thermal vs. mechanical) and affective (emotional, unpleasantness) 
dimensions, with secondary effects o f chronic pain such as anxiety and depression (Price,
2000). There is evidence to suggest that different ascending pathways mediate these distinct 
components o f pain sensation. The spinothalamic pathway is thought to be responsible for the 
sensory discriminative aspects o f  pain sensation. The spinoparabrachial and spinoreticular 
pathways, in contrast, project onto brain areas, including the hypothalamus and amygdala, that 
mediate the affective components o f  pain and control autonomic activity (e.g. Lumb and 
Lovick, 1993). as well as detecting pain intensity (Bernard et al., 1996). The spinoparabrachial 
pathway originating from lamina I appears to play a role in signalling pain intensity, with 
emotional/aversive and autonomic components, but not in discriminative activity (Bester et al., 
2000;Doyle and Hunt, 1999).
For a detailed review o f  higher pain pathways, see Mantyh and Hunt (2001b).
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1.5 V o l t a g e-gated  sodium  channels
The interaction between the voltage-gated sodium channel Nav 1.8 and pi 1 is examined in this 
thesis. The following section introduces the voltage-gated sodium channel family, and 
provides further information on Nav l .8.
The voltage-gated sodium channels (VGSCs) are responsible for the depolarising component o f  
the action potential, and are thus o f substantial interest in the study o f nociceptive mechanisms 
in primary afferent neurons. VGSCs consist of a pore-forming a-subunit, responsible for 
carrying Na' ions across the plasma membrane, and accessory (3-subunits ((31-4), which 
modulate channel properties. The a-subunits (260kDa) are a family o f 10 structurally-related 
transmembrane proteins, arising from evolutionary gene duplication events and 75% identical 
over transmembrane and extracellular domains (Catterall, 2000). Each a-subunit consists o f  4 
internally homologous domains, each containing 6 transmembrane a-helices. The Na - 
selective pore is formed by residues in the loop between segments S5 and S6. known as the P- 
loop. Exchange o f  residues DEKA in the inner pore to EEEE, their counterparts in calcium 
channels, resulted in a change from Na* to Ca' selectivity (Heinemann et al., 1992). Other 
mutations to these residues likewise produce alterations in ion selectivity (Schlief et al., 1996; 
Sun et al.. 1997). The general structure o f the VGSCs is shown in Figure 1.4.
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Figure 1.4 V oltage-gated  sodium  channel structure. The a subunit of the Nav1.2 channel is 
illustrated together with the (31 and (32 subunits; the extracellular domains of the (3-subunits are shown as 
immunoglobulin-like folds, which interact with the loops in the a-subunits as shown. Roman numerals 
indicate the domains of the a-subunit; segments 5 and 6 (shown in green) are the pore-lining segments 
and the S4 helices (yellow) make up the voltage sensors. Blue circles in the intracellular loops of 
domains III and IV indicate the inactivation gate IFM motif and its receptor (h, inactivation gate); P, 
phosphorylation sites (in red circles, sites for protein kinase A; in red diamonds, sites for protein kinase 
C); \|/, probable TV-linked glycosylation site. The circles in the re-entrant loops in each domain represent 
the amino acids that form the ion selectivity filter (the outer rings have the sequence EEDD and inner 
rings DEKA). Figure taken from Yu and Catterall (2003).
Voltage gating is mediated by the a-helical S4 transmembrane segments. Positively-charged
lysine or arginine residues occur at 3 amino acid intervals, producing a linear array o f  positive
charges as a result o f  the helical structure. Upon membrane depolarisation, this segment moves
across the membrane electrical field, causing the channel to open. This movement has been
detected directly using a combination o f  mutagenesis and covalent modification. Substitution
o f  cysteines for the positively-charged residues, followed by exposure to charged sulfhydryl
compounds, provides a system for the measurement o f  movement in response to membrane
potential. Experiments using this system demonstrated that 3 positively-charged residues from
this region became accessible to the extracellular region during channel gating (Yang et al.,
1996; Yang and Horn, 1995). Further evidence in support o f  the central role o f  these residues in
voltage gating is given by experiments showing that mutagenesis o f  these residues to neutral
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amino acids causes significant changes in the voltage dependence o f  activation (Kontis et al., 
1997;Stuhmer et al., 1989). The voltage sensor is trapped by (3-scorpion toxins, shifting 
voltage-dependence to more negative potentials and thus enhancing activation (Cestele et al.,
1998).
Following channel opening, inactivation occurs on a millisecond timescale, mediated by the 
residues IFM in the intracellular loop between domains 111 and IV. Initial experiments in the 
squid giant axon demonstrated the sensitivity of inactivation to intracellular protease perfusion, 
suggesting mediation by an intracellular gate and resulting in an internal ball and chain model 
(Armstrong, 1981b). Antibodies against the intracellular loop connecting domains III and IV, 
but not antibodies to other domains were shown to prevent fast inactivation (Vassilev et al., 
1989;Vassilev et al., 1988). Mutagenesis o f  this region identified the hydrophobic IFM triad as 
critical for fast inactivation (West et al., 1992). The voltage dependence o f inactivation comes 
from its coupling to the process o f  activation (Armstrong, 1981a). This link is uncoupled by a- 
scorpion toxins, which bind to the extracellular region o f the S4 segment in domain IV, 
preventing inactivation (Rogers et al., 1996).
The 10 VGSC a-subunits, Nav 1.1 -1.9 and Nax, show diversity o f  biophysical and 
pharmacological characteristics. Subtypes show differential expression and developmental 
regulation, and in some cases specialised functional roles. Nociceptive sensory neurons 
express a wide range o f  a-subunits. Several explanations have been proposed for this, all 
providing for control o f  neuronal properties under changing physiological conditions. The 
relative expression levels, topological relationships, differential phosphorylation and varied 
effects o f  phosphorylation, and differential trafficking o f subtypes all allow the control o f  
activation (and therefore pain) thresholds by external factors (Wood et al., 2004a).
1.5.1 P harm acology
Although pharmacological tools for the investigation o f VGSCs are rare, channels can be 
categorised according to their sensitivity to tetrodotoxin (TTX), a guanidinium compound 
isolated from the puffer fish Fugu. TTX is produced by several bacterial species, which 
colonise puffer fish in a mutualistic (symbiotic) manner, rendering them an undesirable target 
for predators. Several other species also use TTX for protection, while for the blue-ringed 
octopus it is a potent venom. The majority o f VGSCs are blocked by nanomolar 
concentrations o f  TTX and are defined as TTX-sensitive (TTX-S). Others are resistant to 
micromolar TTX and are therefore described as TTX-resistant (TTX-R). TTX binds to a 
hydrophobic/aromatic residue in the first P-loop of the ion selectivity pore o f VGSCs, which is
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mutated to serine (hydrophilic) in TTX-R channels (Noda et al., 1989;Satin et al., 1992). 
Channel sensitivities are summarised in Table 1.1: Nav 1.8 and 1.9 are resistant to TTX, N av 1.5 
is resistant to a lesser extent, and the other VGSCs are sensitive to nanomolar concentrations of 
TTX. Saxitoxin, produced by marine dinoflagellates. acts in a manner comparable to TTX. 
VGSCs are also blocked non-specifically by local anaesthetics such as lignocaine, some of 
which travel through the outer pore to bind to the inner pore, showing use-dependence as a 
result. Others cross the plasma membrane to act, and are therefore sensitive to small changes in 
extracellular pH. Unlike Ca2* or K channels, for which a range o f  specific blockers are 
available, few pharmacological tools exist that are specific to a particular VGSC subtype, 
meaning that VGSC research has been centred around molecular biological techniques rather 
than traditional pharmacology. Recently, however, a group identified two closely-related 
conotoxins (peptide toxins from marine cone shells), pO-conotoxin MrVIA and MrVlB. which 
selectively inhibit the TTX-R current carried by Nayl.8 (Ekberg et al., 2006). These should 
prove a useful experimental tool, in addition to having therapeutic potential (discussed later).
1.5.2 V G SC  properties and expression in sensory neurons
The properties and expression profiles of the VGSCs are summarised in Table 1.1. The TTX-S 
channels N av 1.1, 1.2, 1.3 and 1.6 are remarkably similar in sequence and biophysical properties 
(*Nav 1.4 and 1.5 are not expressed in neurons). Typically, the TTX-S channels are rapidly- 
activating and inactivating, with a threshold of activation of -25 to -40mV, whereas the TTX-R 
channels display slower kinetics (Wall and Melzack, 1999). Nav 1.8 activates and inactivates 
slowly, with a relatively high (depolarised) threshold o f activation (Akopian et al., 1996). The 
inactivation potential is similarly depolarised (half inactivation potential -30 to -40mV), 
meaning that channels are fully available at normal resting potentials. A faster rate o f  recovery 
from inactivation compared to TTX-S channels has also been observed (Wall and Melzack,
1999). The higher threshold and reduced inactivation time o f  this channel mean that it is suited 
to generating continuous action potential bursts in response to high-intensity stimuli. N av 1.9 
generates a persistent current, with kinetics that are too slow to contribute to the action 
potential. Its threshold o f activation, however, is such that it is likely to have a depolarising 
effect on the resting membrane potential (Dib-Hajj et al., 1998b;Ekberg and Adams, 2006). 
N av 1.9 is inactivated at resting/holding potentials o f >-60, allowing electrophysiological 
separation from currents mediated by Nav l .8 (Dib-Hajj et al., 1998a).
O f the VGSC a-subunits, six are expressed at high levels in sensory neurons. N av l . l ,  1.2, 1.3 
and 1.6 are highly expressed in brain and spinal cord in addition to sensory neurons (although 
N av 1.3 is expressed in the embryonic but not adult DRG under normal conditions), while
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Nav 1.7 is expressed in sensory neurons, sympathetic neurons and Schwann cells. The TTX-R 
channels N av 1.8 and N av 1.9, however, are unique in that their expression is restricted only to 
sensory neurons, and are not detectable in other cell types under normal conditions. N av 1.8 
expression is restricted to a precise subset o f  small- to medium-diameter sensory' neurons, over 
85% of which are likely to be nociceptors (Akopian et al., 1996;Djouhri et al., 2003a). Nav l .8 
expression has also been observed in cerebellar Purkinje cells under conditions o f experimental 
autoimmune encephalomyelitis or multiple sclerosis, with associated changes in neuronal firing 
characteristics (Black et al., 2000b), although the physiological relevance o f  this has yet to be 
described fully.
The subcellular localisation o f  VGSCs has also been examined to a limited extent. Toledo-Aral 
et al. (1997) found that N av 1.7 is targeted to the nerve terminals o f  cultured DRG neurons, 
rather than being concentrated along the axon or in the cell body. Likewise, Brock et al. 
(1998b) described the localisation o f TTX-R currents, probably attributable to N av 1.8, to the 
distal terminal o f  probable nociceptors in the cornea. In contrast, Nav 1.6 is localised at nodes 
o f  Ranvier in myelinated neurons (Caldwell et al., 2000), while Nav l . l ,  1.2 and 1.3 are likely 
to be mainly axonal. These observations suggest that different channels have distinct roles in 
the generation and propagation o f action potentials, with channels clustered at nerve termini 
controlling the sensitivity (or gain) o f transduction mechanisms. Nav 1.7 and Nav 1.8 are thus 
well-placed to regulate nociceptor sensitivity' in conditions such as inflammation.
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Primary
Name
Alternative
Names
Gene Distribution TTX Sensitivity
(IC50)
N av l.l Rat I SCN1A CNS, sensory neurons TTX-S (6nM)
N av 1.2 Rat II SCN2A CNS, sensory neurons TTX-S (12nM)
N av l .3 Rat III SCN3A CNS, embryonic sensory neurons TTX-S (4nM)
N av 1.4 SCN4A Skeletal muscle TTX-S (5nM)
N av l .5 HI SCN5A Cardiac muscle, immature & 
denervated skeletal muscle
TTX-R (1-2jj.M)
N av l.6 NaCh6 SC NX A CNS, sensory neurons, nodes o f 
Ranvier in CNS/PNS
TTX-S (InM )
N av l .7 PN1 SCN9A Sensory neurons, sympathetic 
neurons, Schwann cells
TTX-S (4nM)
N av 1.8 SNS/PN3 SCN10A Sensory neurons TTX-R (60pM)
Nav l.9 SNS2/NaN SC N U A Sensory neurons TTX-R (40pM)
N ax NaG SCN7A Lung, nerve TTX-S
T able 1.1 N a + ch an n el  a-subunits .  Adapted from Ekberg et al. (2006) and Wood et al. (2004b).
1.5.3 p -subun its
VGSC auxiliary (3-subunits are not required for channel activity, but modulate channel 
properties and interact with cytoskeletal and extracellular matrix proteins, stabilising channels 
in the plasma membrane. They consist of a single 22-36kDa transmembrane domain with an 
extracellular immunoglobulin-like region (Isom and Catterall, 1996). Four subtypes exist, 
denoted p M. pi and p2 were first identified due to their association with a-subunits, followed 
by functional investigation in heterologous expression systems (Isom et al., 1992). In contrast, 
p3 and p4 were identified by molecular cloning (Morgan et al., 2000;Yu et al., 2003). A splice 
variant o f  Pi (Pia) has also been described, expressed only during embryonic development and 
apparently resulting from an intron retention event (Kazen-Gillespie et al., 2000). All 
currently-known P-subunits are expressed in the peripheral nervous system, although 
expression in putative nociceptors may be somewhat more restricted, pi, p2 and p2, are all 
expressed in small- and medium-diameter DRG neurons, while p4 is expressed in large- but not 
small- or medium diameter primary afferents (Chahine et al., 2005). Investigation o f  the 
functional roles o f  P-subunits has been hindered by sensitivity to the particular heterologous 
expression system used (Isom, 2001), although considerable progress has been made despite 
this.
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O f particular interest is the role o f  VGSC P-subunits in neuropathic pain, where changes in 
functional expression and biophysical properties o f  VGSCs are observed. In rat models o f 
neuropathic pain, changes in expression levels o f  P-subunits have been reported in both DRG 
neurons and in the spinal cord. Following nerve damage, p, mRNA levels in the dorsal horn 
(laminae I-II) o f  the spinal cord were increased, while P2 expression was reduced in laminae I- 
IV (Blackburn-Munro and Fleetwood-Walker, 1999). The downregulation o f P: was proposed 
to disrupt interaction with tenascins, promoting axonal growth and projection o f  neurons into 
superficial laminae, with the possibility of new synaptic contact formation. A more recent 
study also reported an increase in p3 expression in the trigeminal ganglia in an orofacial 
neuropathic pain model (Eriksson et al., 2005), confirming previous reports o f  P3 but not pi or 
P2 upregulation in the DRG following nerve injury (Shah et al., 2000;Takahashi et al., 2003). 
It has been proposed that increased levels of p3 may contribute to the generation o f  ectopic 
activity in axotomised DRG neurons (Takahashi et al., 2003). Deletion o f P-subunits leads to a 
complex phenotype including seizures and epileptogenic activity (Chen et al., 2002a;Chen et 
al., 2004), precluding investigation o f pain sensation. The development o f  subtype- and tissue- 
specific null mutant mice may help to shed light on the contributions o f P-subunits to pain 
pathways.
For a comprehensive review of VGSC P-subunits, see Isom (2001).
1.5.4 N av 1.8
The trafficking o f  the VGSC Nav 1.8 by p l l  is one of the main topics o f  this thesis. This 
section provides additional background on this channel.
The TTX-R Na channel Nav 1.8 was first cloned in 1996 using a difference cloning method to 
identify genes expressed selectively in DRG neurons (Akopian et al., 1996;Sangameswaran et 
al., 1996). It was shown to mediate the TTX-R current first described by Matsuda et al. (1978), 
with an aromatic to hydrophilic amino acid alteration in the channel atrium conferring TTX- 
resistance (Akopian et al., 1996). The murine Nav 1.8 gene, SCNJ0A , was characterised soon 
after and shown to have 95.3% amino acid sequence homology with the rat gene. The gene is 
located on chromosome 9 and comprised of 27 exons, spanning approximately 90kb (Souslova 
et al., 1997). N av 1.8 carries a slowly-activating, slowly-inactivating current, with an activation 
threshold o f -40 to -30mV, relatively depolarised compared to TTX-S channels. Importantly, 
Nayl.8 is inactivated only at relatively depolarised potentials (—30mV), and reprimes rapidly 
from fast inactivation (Cummins and Waxman, 1997b;Elliott and Elliott, 1993), allowing
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neuronal excitability under conditions o f sustained depolarisation. This allows nociceptor 
activity to continue in the event o f  prolonged stimuli, with associated survival value.
The expression profile o f  N av 1.8 has been examined in detail by several groups, including 
correlation with electrophysiological properties o f  neurons. Under naive conditions, N av 1.8 
expression was found to be restricted to a subset o f  primary afferent neurons. It is expressed in 
at least 50% o f  unmyelinated (C-fibre) DRG neurons, in both NGF- and GDNF-responsive 
populations, and in a proportion o f medium-diameter A5-fibres. Expression has also been 
observed in a small proportion o f  large-diameter A|3 neurons, and in the trigeminal and nodose 
ganglia. O f the 10% o f  A-fibres expressing Nav 1.8, all are TrkA-positive, and many express 
the vanilloid-like receptor TRPV2 (Amaya et al.. 2000b). Djouhri et al. (2003a) recently 
examined the relationship between Nav 1.8 expression and neuronal properties. N av 1.8 
immunoreactivity was found to be present in 83% of C-fibres, 93% o f  A6-fibres. and 25% of 
Aa/p-fibres, a significantly higher proportion than previously observed. In addition, 88% o f  C- 
unresponsive neurons, representing a “silent" population o f nociceptors activated under 
conditions o f  inflammation, displayed Nav 1.8 immunoreactivity. Over 80% o f  nociceptive 
neurons, assessed by sensory receptive properties, were Nav l .8-positive. It can be deduced 
from this study and that o f  Akopian et al. (1996) that over 85% o f  N av l .8-expressing cells are 
nociceptors (Stirling et al., 2005). Nav1.8 expression levels are significantly higher in 
nociceptive than non-nociceptive neurons (Djouhri et al., 2003a). In addition to the cellular 
distribution o f N av 1.8, subcellular localisation has also been examined. Brock et al. (1998d) 
reported TTX-R currents located in the distal termini of nociceptors, suggesting that N av 1.8 
channels play an important role in action potential generation immediately following stimulus 
transduction.
The expression and functional properties of Nav 1.8 are altered under conditions o f 
inflammation and nerve damage (see section “Nav 1.8 in pain"). Expression o f N a v 1.8 has also 
been reported in cerebellar Purkinje cells during experimental autoimmune encephalomyelitis 
and human multiple sclerosis (Black et al., 2000a;Damarjian et al., 2004), in conjunction with 
an increase in pi 1/annexin 2 expression (Craner et al., 2003b). This dysregulated expression is 
though to contribute to the abnormal Purkinje cell activity observed in these conditions (Saab et 
al., 2004).
1.5.4.1 Modulators of Nayl.8 expression and properties
Properties o f  VGSCs are often investigated by expression o f the channel in heterologous 
expression systems, such as Xenopus oocytes, CHO, COS or HEK cells. Many channels 
require accessory P-subunits for native levels o f functional expression. Although the low
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functional expression o f  N av 1.8 is increased by co-expression with the (31 subunit 
(Vijayaragavan et al., 2004b), current densities in Xenopus oocytes, CHO, COS-7 and HEK- 
293 cell lines remains substantially below endogenous levels in DRG (England, 1998), with 
channels displaying properties different from those in DRG neurons (FitzGerald et al., 1999). 
Microinjection o f  N av 1.8 cDNA into the nuclei o f  SCG or Nav 1.8-null mutant DRG neurons, 
however, produces sodium currents with similar properties and magnitude to wild-type DRG 
neurons (England, 1998), implying that these cells contain additional factors required for 
endogenous levels o f  N av 1.8 functional expression. With this in mind. Okuse et al. (2002) 
used the yeast two-hybrid system to search for proteins interacting with the intracellular 
domains o f  N av 1.8. A range o f  proteins were identified, including p 11. Papin, PAF67, 
connexin, calmodulin, and (3-actin (Malik-Hall et al., 2003). The roles o f  several o f  these 
interactions have been investigated further, with interesting results, pi 1 increases plasma 
membrane expression o f N av 1.8 via an interaction with the N-terminal domain, increasing 
surface immunoreactivity and TTX-R current density (Okuse et al., 2002;Poon et al., 2004). 
This interaction is described in more detail elsewhere in this thesis. Papin is a 300kDa protein 
containing 6 PDZ domains which binds to the intracellular loop between domains II and III o f  
N av 1.8. Nuclear injection o f  antisense vector to Papin into DRG neurons resulted in a 71% 
reduction in TTX-R current density, implying a role in functional expression (Shao et al., 
2005). PAF67 is a 67kDa protein associated with a subtype o f RNA polymerase I, and plays an 
important role in the initiation o f transcription. PAF67 bind to the C-terminal domain o f 
N av 1.8. Antisense downregulation o f PAF67 resulted in a 76% reduction in TTX-R current 
density, while overexpression in CHO cells promoted translocation o f  N av 1.8 to the plasma 
membrane, resulting in functional channel expression (Shao et al., 2005).
Calmodulin binds directly to ion channels by an IQ motif, present in the C-terminus o f  all 
VGSCs, in a Ca" -independent manner (Herzog et al., 2003b;Mori et al., 2000;Rhoads and 
Friedberg, 1997). The modulation o f VGSCs is isoform dependent; that is, disruption o f  
calmodulin binding has differing effects on each isoform (e.g. Herzog et al., 2003a;Young and 
Caldwell, 2005). Choi et al. (2006d) recently examined the effect o f  disruption o f  calmodulin 
binding to Nav 1.8 in DRG neurons. In the absence o f calmodulin binding, N av 1.8 current 
density was reduced by over 50%, possibly via endocytotic mechanisms, with voltage- 
dependence o f  activation and inactivation unchanged. Additionally, frequency-dependent 
inhibition was significantly enhanced, even at a relatively low frequency o f  0.1 Hz. The 
association o f  calmodulin with Nav l .8 can therefore enhance electrogenesis in DRG neurons.
Contactin, a glycosyl-phosphatidylinositol-anchored neuronal cell surface glycoprotein, was 
not identified in the Nav 1.8 yeast two-hybrid screen, but was shown by other methods to
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regulate Nav 1.8 functional expression. DRG neurons from contactin-null mice displayed a 
reduction in N av 1.8 (and N av 1.9) current density' of more than 2-fold, but this effect was 
limited to smal 1-diameter, IB4-positive cells, for reasons that have yet to be explained. Axonal 
Nav l .8 immunoreactivity was also reduced in the contactin-null mice. Contactin may therefore 
regulate N av 1.8 functional expression in a subtype o f nociceptive DRG neurons (Rush et al., 
2005a).
1.5.4.2 N ayl.8  in pain
The expression profile o f  N av 1.8 suggests a specialised role in nociceptive pathways, 
prompting the investigation o f Nav 1.8 function in a range o f pain models. Changes in 
expression have been observed in conditions in inflammation and nerve damage. During 
inflammation. NGF causes a modest increase in Nav 1.8 expression in A but not C-fibres (Fang 
et al., 2005;0kuse et al.. 1997). More striking is the PKA and PKC-mediated phosphorylation 
o f  N av 1.8 induced by inflammatory mediators such as PGE2, which increases TTX-R currents 
by shifting the current-voltage relationship and possibly the voltage-dependence o f  activation 
(FitzGerald et al., 1999;Gold et al., 1998;Vijayaragavan et al., 2004a). Several groups have 
investigated changes in N av 1.8 expression following various types o f  nerve injury, with a 
consensus downregulation being reported. Okuse et al. (1997) reported decreases o f  25-80% 
in Nav 1.8 transcript levels in various models of sensory' nerve damage (including diabetic 
neuropathy), while Cummins et al. (1997a) observed a substantial decrease in TTX-R currents 
in axotomised neurons. Following ischaemic injury to the trigeminal nerve in a model o f 
orofacial neuropathic pain, N av 1.8 transcript was downregulated (Eriksson et al., 2005), in 
agreement with observations in DRG. Redistribution o f Nav 1.8 from soma to axon, however, 
was observed in neuropathic conditions (Novakovic et al., 1998), and the channel was also 
found to accumulate in painful human neuroma (Kretschmer et al., 2002a), leaving the 
contribution o f  the channel to neuropathic pain unclear (although this has now been addressed 
by other methods).
Akopian et al. (1999) created a null-mutant mouse to investigate the role o f  N av 1.8 in pain 
pathways, reporting behavioural deficits in nociception in response to acute mechanical and 
thermal stimuli. Matthews et al. (Matthews et al., 2006) used electrophysiological recordings 
from the dorsal horn in these mice to show reduced noxious coding in response to mechanical 
but not thermal (apart from cold) stimuli. Inflammatory pain thresholds following carrageenan 
injection were unchanged by Nav1.8 deletion, although a reduction in pain compared to wild- 
type animals was observed when given in combination with a low dose o f lidocaine, proposed 
to unmask an effect obscured by compensatory changes in other VGSCs (Akopian et al., 1999).
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NGF-induced hyperalgesia was attenuated in the Nav l.8-null mouse (Kerr et al., 2001), in 
conjunction with a small NGF-induced increase in transcript (Okuse et al., 1997). PGE2- 
mediated phosphory lation can alter the properties o f  this channel as previously discussed. No 
differences in neuropathic pain were seen in the N av 1.8-null mouse (Kerr et al., 2001). It was 
speculated that compensatory upregulation o f N av 1.7 was masking the effect o f  N av 1.8 
deletion on neuropathic pain, but N av 1 -7/1.8 double knockout mice also displayed behaviour 
similar to wild-type in models of neuropathic pain (Nassar et al., 2005). Studies reporting a 
downregulation o f  N av 1.8 transcript or protein in response to nerve injury support these results 
(Eriksson et al.. 2005;0kuse et al., 1997). Treatment with antisense to Nav 1.8 mRNA, 
however, substantially reduced neuropathic pain, although this paper did not test selectivity 
over other VGSCs (Lai et al., 2002). Additionally, the conotoxin MrVIB, a selective blocker o f  
Nav 1.8 reduced allodynia resulting from both neuropathic and chronic inflammatory pain 
models (Ekberg et al.. 2006). The site o f  action o f this conotoxin is not clear, since in this case 
it was administered by intrathecal injection, raising doubts about access to primary afferent 
neurons. Finally, the presence of Nav 1.8 was shown to be required for spontaneous activity in 
damaged sensory neurons, a process which may be important in the generation o f neuropathic 
pain states (Roza et al., 2003). On balance, the data do not appear to support a role for N av l .8 
in neuropathic pain, although some data do suggest a limited function in this process. Laird et 
al. (2002) investigated the role of Nav 1.8 in visceral pain, reporting that Navl.8-null mice 
displayed reduced visceral pain and referred hyperalgesia. It is thus apparent from these 
studies that N av l-8 plays a specialised role in pain pathways, including acute, visceral and 
inflammatory pain.
1.5.5 V G SC s and nociception
A detailed discussion o f  the role o f VGSCs in pain pathways can be found in a recent review by 
Wood et al. (2004c). A brief overview is given here.
Small-diameter sensory neurons, representing putative nociceptors, express a sodium current 
consisting o f  several pharmacologically- and electrophysiologically distinct components. 
Correspondingly, several different VGSC transcripts are expressed, as described previously. 
Several VGSC subtypes have been shown to be important in nociception or in the development 
o f  inflammatory and neuropathic pain states, where changes in expression levels can alter 
neuronal properties.
N av 1.3 is normally absent from the adult peripheral nervous system, but is strongly induced by 
nerve damage (Hains et al., 2003;Waxman et al., 1994), while this can be reversed by
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exogenous GDNF. N av l .3 is rapidly repriming (Cummins et al., 2001) and therefore suited to 
a role in the generation o f  ectopic neuronal activity. A recent study by Nassar et al. (2006), 
however, found that in N av l .3 conditional (nociceptor-specific) null mice, the development and 
extent o f  neuropathic pain was unaltered, precluding a major role for this channel in 
neuropathic pain.
N av 1.7 is expressed predominantly in the peripheral nervous system, in both sensory and 
sympathetic neurons. Immunocytochemical studies support a strong association with 
nociceptors (Djouhri et al., 2003b), suggesting a role in nociception. Nociceptor-specific 
N av 1.7 knockout mice show substantial deficits in acute and inflammatory (but not 
neuropathic) pain (Nassar et al., 2004). The most compelling evidence, however, comes from 
human genetic studies. A range o f  heritable painful conditions in humans have been mapped to 
several different gain-of function mutations in Nav 1.7. The first group o f  mutations to be 
identified give rise to erthyromelalgia, an autosomal dominant neuropathy characterised by 
severe burning pain and redness in the extremities in response to mild thermal stimuli. Many 
different gain-of-function mutations have been associated with this condition, resulting in either 
hyperpolarising shifts in activation, depolarising shifts in inactivation, increased current 
amplitude in response to small depolarisations, and other changes in biophysical properties 
leading to increased neuronal excitability (Choi et al., 2006a;Cummins et al., 2004a;Dib-Hajj et 
al., 2005b;Han et al., 2006a;Han et al., 2007;Harty et al., 2006b;Lampert et al., 2006a;Sheets et 
al., 2007b). Another gain-of-function mutation in Nav 1.7, resulting in a reduction in fast 
inactivation and therefore a persistent Na* current, was recently shown to be the cause o f 
paroxysmal extreme pain disorder, a genetic disorder resulting in spontaneous pain with some 
inflammatory character (Fertleman et al., 2006a). Most recently, a heritable disorder resulting 
in the complete absence o f  nociception was mapped to 3 distinct nonsense mutations in SCN9A , 
the gene encoding N av l .7 (Cox et al., 2006b). Surprisingly, no other neurological deficits were 
described in this group, suggesting that Nav 1.7 may be a good therapeutic target for the 
treatment o f  pain.
N av 1.9 is expressed in unmyelinated DRG neurons (Amaya et al., 2000a;Dib-Hajj et al., 
1998c), although it is also present in some myelinated nociceptive neurons (Fang et al., 2002). 
Interestingly, it has been localised to nerve endings in the cornea (Black and Waxman, 2002). 
Together with its role in setting activation thresholds and regulating excitability (Baker et al., 
2003;Herzog et al., 2001b), and its upregulation by G-protein pathways (Baker et al., 2003), 
these data suggest a role in nociception. Two groups generated N av l.9-null mouse lines to 
investigate the effect on pain-related behaviour, both describing deficits in inflammatory but 
not acute or neuropathic pain behaviour. Priest et al. (2005) found deficits in thermal but not 
mechanical hyperalgesia following inflammation. Amaya et al. (2006b) reported a similar
67
effect upon administration o f  pro-inflammatory intraplantar complete Freund's adjuvant, but 
also described reduced or absent pain hypersensitivity elicited by intraplantar PGE2, 
bradykinin, IL-ip  and capsaicin, but not NGF. These results support the hypothesis that 
N av l .9 is an effector o f  the hypersensitivity produced by inflammatory mediators and therefore 
plays a key role in peripheral sensitisation (Amaya et al., 2006a).
1.6 Pr o jec t  O utline
Studies in heterologous expression systems have illustrated the role o f pi 1 in the functional 
expression o f  the VGSC Nav 1.8 at the plasma membrane. Given the analgesic phenotype o f 
the Nav l.8-null mouse line, the interaction between pi 1 and N av 1.8 would appear to be a 
potential target for the development o f novel therapeutic interventions for the treatment o f  pain. 
The significance o f  this interaction in pain sensation, however, has yet to be examined. This 
thesis aims to examine the importance of the pi 1-Nav 1.8 interaction in nociceptive pathways. 
This will be achieved by the generation and analysis of a nociceptor-specific pi 1-null mouse 
line.
Should the p 11 -Nav 1 -8 interaction prove to be a valid therapeutic target, a thorough 
understanding o f  the nature o f  the binding sites involved will aid intelligent drug design. This 
thesis will investigate the residues o f the Navl.8 N-terminus required for its interaction with 
pi 1, with a view to producing a model for the interaction.
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2 MATERIALS AND METHODS
2.1 M o l e c u l a r  B i o l o g y
2.1.1 A garose G el E lectrophoresis
Agarose gel electrophoresis was used to separate DNA/RNA fragments by length. Powdered 
agarose (Sigma) was added to IX TAE buffer (Tris-acetate-EDTA pH 8.3, Promega) to a final 
concentration o f  0.6-1.5% (w/v), depending on expected fragment length. After dissolution by 
heating, the solution was cooled to around 50°C using a water bath. Ethidium bromide (EtBr) 
(Mercury Reagents) was added to a final concentration o f 0.00005% (w/v). and the solution 
allowed to set in a casting tray (Fisherbrand). The gel was then placed into an electrophoresis 
tank and covered with IX TAE. Samples were mixed with 6X loading buffer and loaded into 
wells, along with an appropriate molecular weight marker. A potential difference o f 60-130mV 
was then applied across the gel until the loading buffer dye approached the end o f  the gel. The 
DNA/RNA was visualized using a UV transilluminator, which induces fluorescence in the EtBr 
intercalated in the nucleic acid minor groove. Images were taken using a camera attached to 
the transilluminator. Where the DNA was required for subsequent reactions, aluminium foil 
was used to limit UV-induced damage to the DNA.
2.1.2 R ecovery  o f  D N A  from  agarose gels
DNA fragments o f  the required size were cut from gels using a sterile scalpel blade. 
Stratagene’s Strataprep DNA Gel Extraction Kit was used according to instructions to isolate 
DNA.
2.1.3 T he P olym erase C hain R eaction
The polymerase chain reaction (PCR) allows the exponential amplification o f regions o f 
nucleic acid between two defined sites. It can be used for both constructive (amplification o f  a 
DNA fragment for cloning) and diagnostic purposes. PCR is dependent on the specific binding 
o f  primers to complementary regions o f a template, which is influenced by reaction conditions 
such as annealing temperature and MgCE concentration, the optimal levels o f  which differ 
according to primer sequence. Reaction conditions were therefore optimised for each set o f  
primers, to minimise non-specific priming whilst allowing efficient amplification o f  the target 
sequence.
As PCR is an amplification reaction, it is sensitive to contamination by other DNA 
sources. Sterile materials were therefore used where possible. Reactions were carried out in 
200pl PCR tubes, using the following mixture as a standard starting point:
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lOng template DNA, 400nM each primer, IX polymerase buffer (dependent on polymerase), 
0.5mM MgCE, 0.2mM dNTP and 1 unit KOD HiFi DNA polymerase (constructive PCR) or 2 
units Taq polymerase (diagnostic PCR), in deionised water (ddfFO). An example 
amplification protocol is given below:
Initial denaturing: 94°C, 1 min
Cycle: Denaturing 94°C, 30 secs
Annealing 60°C, 30 secs
Extension 72°C, 90 secs x 30-35
Final extension: 72°C, 1 min
Final temperature: 4°C, forever
Annealing temperatures used were typically 2-5°C below the melting temperature, T m. for the 
primer bound to its target sequence. On completion o f the PCR reaction, products were 
subjected to agarose gel electrophoresis before use in subsequent reactions.
2.1.4 A dd ition  o f  3 ’A O verhangs for TO PO -TA  C loning
For the TOPO-TA cloning reaction, it was necessary to produce fragments with a 3 'A overhang 
following amplification by KOD HiFi DNA polymerase. As KOD is a proofreading 
polymerase, it does not show 3 ‘-adenylation activity. A further reaction was used for this 
purpose: 0.4mM dATP and 5 units Taq DNA polymerase were added to the products o f  the 
initial PCR reaction, and incubated at 72°C for 10 mins.
2.1.5 T O P O -T A  C lon ing ®: Insertion o f D N A  Fragm ents into pC R II
TOPO-TA Cloning (Invitrogen) was used as a sub-cloning step, to insert DNA fragments 
produced by PCR into a high copy number vector for amplification. This system utilises 
Topoisomerase 1, covalently bound to the open vector, to insert fragments possessing a 3 ' A- 
overhang.
2.1.6 T ransform ation  o f C hem ically C om petent B acterial C ells
For general cloning purposes, One Shot ® TOP 10 E. coli cells (Invitrogen) were used. BI21 
cells (Invitrogen) were used for protein expression. Each cell type was transformed according 
to instructions, with appropriate selective agent present. Where the pCRII vector was used, 
40pl o f  40mg/ml X-gal was spread onto each plate to discriminate between insert-containing 
and empty vectors, and only white colonies used for further steps. Transformation efficiency 
was generally good.
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2.1.7 Screen ing B acteria l C lones by C olony PCR
Colony PCR was used to identify bacterial clones containing the required construct. This 
technique allowed the screening o f  clones before plasmid isolation by miniprep.
50pl o f  L-broth (Fisher) containing 0.01% (w/v) ampicillin (Sigma) was added to the required 
number o f  wells in a 96-well plate (Neptune). Individual bacterial colonies were then picked 
from an agar plate into separate wells, and the plate sealed. This was then incubated at 37°C, 
170 rpm for 1 hour in a shaking incubator (Gallenkamp). 2pl from each well was then used as 
template for a diagnostic PCR reaction.
2.1.8 Isolation  o f  P lasm id  D N A  by M ini- and M idiprep
The isolation o f  plasmid DNA that was to be sequenced was performed using Wizard Plus SV 
Miniprep and Wizard Plus Midiprep kits (Promega). All other minipreps were performed using 
the alkaline lysis method, as described by Sambrook et al. (1989).
2.1.9 R estriction  D igests
Digestion o f  DNA with restriction enzymes was used to remove inserts from plasmids during 
the cloning process. It was also used in addition to colony PCR as a diagnostic tool, prior to 
DNA sequencing. For both purposed, the cloning enzymes BamHl and Ndel were used. 
Digests were carried out in a volume of 20gl, containing lx  Buffer D, 0.5pl o f  each enzyme 
and 17pl DNA solution (from miniprep). The reaction was incubated at 37°C for around 1 
hour, then run on agarose gel.
2.1 .10 L igation  o f  F ragm ents into pET14b
The bacterial expression vector pET14b was used to express recombinant proteins. pET14b 
contains an N-terminal sequence coding for 6 x His, which was required for protein purification 
(described later), under the control o f  the bacteriophage T7 promoter. The vector was first 
opened using the restriction enzymes Ndel and BamHl, then treated with shrimp alkaline 
phosphatase (SAP) to prevent re-ligation o f the empty vector. The desired fragment was 
isolated from the cloning vector pCRII with the same enzymes, to produce cohesive ends. 
2.5pl o f  pET14b and 7.5j l i1 of the required insert were mixed in a 2ml Eppendorf tube, lx  
Quick Ligase Buffer (New England Biolabs) and lpl Quick Ligase (New England Biolabs) 
were added, and the mixture incubated for 15 mins at room temperature followed by storage on 
ice. TOP 10 cells were then transformed with 2pl o f product as described previously.
2.1.11 D N A  Sequencing
DNA sequencing was carried out from miniprep or midiprep by Lark Technologies. Both raw 
trace data and sequence were received, to allow evaluation o f errors in sequence. Primers
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based on the T7 and Sp6 promoters were used, depending on vector. Sequencing was started 
around 1 OObp from the section o f  interest to allow for errors in the initial stages o f the reaction.
2.1.12 Iso lation  o f  G enom ic D N A  from  T issue Sam ples
The isolation o f  genomic DNA from murine tissue samples was required for genotyping and 
the assessment o f  Cre activity. DNA was isolated from a small (<2mm) section o f  tail for 
genotyping, or from other tissues (most commonly DRG) for other applications. Tissue 
samples were digested for 1 hour - overnight in tail lysis buffer containing 0.01% Proteinase 
K, at 55°C. After digestion, samples were vortexed vigorously then centrifuged at 13,000 rpm 
for 2 mins in a benchtop microcentrifuge to remove debris. The supernatant was transferred to 
a fresh tube and the DNA precipitated with an equal volume o f  isopropanol. Following 
vigorous shaking, after which the DNA was visible, centrifugation (as before) was used to 
pellet the DNA. The supernatant was discarded, leaving the precipitate DNA. After 2 washes 
in 70% ethanol, the pellet was briefly dried then resuspended in 200pl TE buffer or ddPTO.
2.1.13 Southern  B lot
2.1.13.1 DNA Separation and Blotting
Around 10 fig o f  mouse genomic DNA was digested using a range o f  restriction enzymes and 
appropriate buffers. A total volume o f 50 pi was incubated for >16 h at either room 
temperature or 37°C depending on enzyme. Bands were separated by agarose gel 
electrophoresis, using 0.6-0.8% gels run at 15-30V overnight.
After digestion and separation o f  DNA, the gel was exposed to short wavelength UV 
light to fragment the DNA, ensuring complete transfer to the membrane. The DNA was 
denatured (1 h) (0.5 M NaOH, 1.5 M NaCl) followed by a rinse in distilled water, then 
neutralised (1 h) (1.0 M Tris-HCl, 1.5M NaCl) followed by another rinse in distilled water.
The DNA was then attached to a Hybond™+ Membrane (Amersham Pharmacia 
Biotech UK Ltd) by capillary transfer, as follows: a glass plate was placed on top o f  a tray 
filled with 10X SSPE (20X stock: 3M NaCl, 0.2M NaEEP04, 0.02M EDTA, pH 7.0). A large 
piece o f  filter paper was placed over the glass plate with the ends in the SSPE. The gel was 
then covered with a piece o f  Hybond™+ Membrane, and a further two layers o f  soaked filter 
paper were placed on top, followed by multiple layers o f  absorbent paper. This setup was left 
for >6h, after which the SSPE had carried the DNA to the membrane. The DNA was cross- 
linked (120,000 pJ) to the membrane using a Stratalinker® UV Crosslinker, Stratagene, US.
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2.1.13.2 Pre-Hybridization
The membrane was pre-hybridised (blocked) in a glass tube containing hybridization mix (6X 
SSPE. 5X Denhardt's reagent, lOOpg/ml yeast RNA and 0.5-1.0% SDS). The same volume of 
formamide was added and the membrane incubated at 42°C in a rotary PreHybaid oven for 6 
hours. This step reduces non-specific probe binding.
2.1.13.3 Probe Labelling and Hybridisation
For hybridisation, a 0.4-1.0 kb probe was prepared using PCR. After gel separation on 1.0% 
low melting point agarose gel, the DNA fragment was excised and 3 volumes o f water added. 
The probe was labelled with 2P using a Prime-it Random Labelling Kit (Stratagene), and 
purified using Qiagen's Nucleotide Purification Kit, before being denatured for 3 mins at 94°C, 
then snap-cooled on ice for another 1-3 min. The radioactive probe was then added to the 
hybridisation solution and incubated with the membrane at 42°C for 6 hours.
2.1.13.4 M embrane W ashing and Imaging
After hybridization, any excess probe was removed by washing the membrane in 2X SSPE, 
0.1% SDS for 15-30 min at 65°C followed by another wash using 0.2 X SSPE, 0.1% SDS for 
5-20 min. The washed membrane was exposed to Kodak film at -80°C for between 1 hr and 5 
days, and developed using standard methods.
2.1.14 R N A  E xtraction
DRG were removed from humanely-killed mice, working quickly on ice. RNA that was to be 
used for quantitative PCR was extracted immediately with Qiagen's RNeasy Mini Kit, to 
reduce genomic DNA contamination. RNA for other purposes was extracted as follows: DRG 
from one mouse were homogenised in 500pl TRIzol and incubated for 5 mins at room 
temperature. 0.1ml chloroform was added and tubes were shaken vigorously for 15s, incubated 
for 3 mins at room temperature, followed by centrifugation at 12,000 X g for 15 mins at 4°C. 
The colourless aqueous phase was taken, and the remainder discarded. RNA was precipitated 
with 0.25ml isopropanol for 10 mins at room temperature, with the addition o f  lpl glycogen to 
aid precipitation. Following centrifugation at 12,000 X g, 4°C for 10 mins, the supernatant was 
discarded and the pellet washed twice in 75% ethanol. The pellet was dried for 5 mins at room 
temperature, before being dissolved in 20pl RNase-free FTO. RNA quality was checked by 
agarose gel electrophoresis, looking for 2 distinct rRNA bands without excessive smearing 
(from degradation). Quantity and purity were assessed by spectrophotometry, reading A26o and 
A28o- RNA was stored at -80°C.
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2.1 .15 R everse T ran scrip tion  R eaction
cDNA was made from RNA using a Bio-Rad iScript kit, or with Invitrogen Superscript II, 
according to manufacturer's instructions. cDNA was stored at -20°C.
2.1 .16 Q u an tita tive  (R eal-T im e) PCR
qPCR primers were designed with Beacon Designer 5, using BLAST searches to ensure 
specificity. Primers were designed to give an amplicon of 80-150 bp, and to overlap an intron 
where possible, to reduce the effect of potential genomic DNA contamination. Primers were 
first examined by conventional PCR, to check for specificity. Only primers giving a single 
distinct band were used for qPCR. Reactions were performed in a volume o f  20pl, using Bio- 
Rad iQ SYBR Green Supermix. Primers were used at 200-400nM. Reaction mixtures were 
prepared on ice. and run using a Bio-Rad iCycler PCR machine. The following programme 
was used as a starting point:
Start:
Cycle (x 40):
Final denaturing:
Final annealing/extension: 
Melt curve (80 steps):
95°C, 3 mins 
95°C, 20s 
55°C, 30s 
95°C, 1 min 
55°c, 1 min 
55°C, 10s + 0.5°C/cycle
Primer efficiency was measured using a dilution series of cDNA. The efficiency, E, was 
calculated using the gradient o f  a graph of log (template) against threshold cycle, Ct. 
Efficiency is given by the formula: E = ]o(‘1,gradien,) - 1. Only primers with efficiencies o f  90- 
110% were used for RNA quantification.
The Pfaffl method (Pfaffl, 2001) was used for the relative quantification o f  cDNA 
levels. This equation takes into account the efficiency o f  a primer set when calculating relative 
changes in gene expression. Housekeeping primers for GAPDH and P-actin were used for 
normalisation o f  cDNA levels.
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2.2 Pr o t ein  B io lo g y
2.2.1 R ecom b in an t P rotein  E xpression
The expression o f  recombinant proteins in bacteria can in some cases affect bacterial growth or 
survival. In order to minimise these effects, a repression system was used to prevent protein 
expression until required. The expression plasmid, pETMb, contained the sequence for 
expression under the control o f  the bacteriophage T7 promoter. The B121 bacterial cells 
express the T7 phage polymerase under the control o f  the lac promoter, which is repressed by 
the plasmid pREP4. The addition o f  isopropyl-beta-D-thiogalactopyranoside (IPTG) removes 
this repression, allowing expression of T7 polymerase and therefore the recombinant protein. 
This system allows very low levels o f  expression “ leak’' in the absence o f  IPTG, but high levels 
o f  expression after IPTG addition, due to the strength o f the T7 promoter. To prevent 
degradation o f  the recombinant proteins, protease-deficient B121 cells were used for 
expression.
B121(DE3) cells were co-transformed with pET14b containing the N av l .8 1-120 or pi 1 
sequence, and pREP4, as described, and grown overnight at 37°C on LB agar plates containing 
0.01% (w/v) ampicillin and 0.002% (w/v) kanamycin. A colony from these plates was then 
used to inoculate 200ml L-broth containing 0.01% (w/v) ampicillin and 0.002% (w/v) 
kanamycin. This was grown overnight at 30°C, 170rpm, in an orbital shaker. The culture was 
then diluted to 4x 500ml L-broth (0.01% (w/v) ampicillin and 0.002% (w/v) kanamycin) in 2- 
litre barbed flasks, to ensure sufficient aeration, and grown for 2 hours at 30°C. IPTG was 
added to lOpM final concentration, and the cultures grown for a further 4 hours. The cells were 
harvested by centrifugation at 3,800 rpm (Kendro Heraeus Multifuge) for around 40 mins, then 
stored overnight at -80°C.
2.2.2 P u rification  o f  R ecom binant Proteins
Following the expression o f recombinant proteins, purification was achieved using the His-Tag 
-  Ni-NTA (nickel-nitrilotriacetic acid) system. This system uses NTA-chelated Ni2" ions 
attached to agarose resin to bind a 6 x His sequence at the N- or C-terminal end o f  a peptide, 
allowing its isolation from cellular lysate. Once the recombinant protein has been isolated from 
the lysate, it can be released by either a reduction in pH or the addition o f  imidazole as a 
competitor.
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2.2.2.1 Purification o f N ayl.8  1-120 (Wild-type & Mutant)
It was found that the protein “N av 1.8 1-120’' and related proteins were confined to inclusion 
bodies after bacterial expression, due to low cytoplasmic solubility. The extraction and 
purification o f  these proteins therefore required denaturing methodologies to be used. 
Extraction was possible using 8M urea and 2mM (3-mercaptoethanol.
The frozen bacterial cell pellets were thawed in Buffer B + 2mM (3-mercaptoethanol 
(used to prevent protein aggregation). 20ml per 2 litre culture was used to resuspend. The 
mixture was homogenized in a dounce homogenizer (Wheaton, 15ml) using at least 20 up and 
down strokes (tight pestle), then incubated on a roller incubator for 15 mins at room 
temperature. This was followed by centrifugation at 10,000 X g for 30 mins. after which the 
supernatant was taken.
2ml Ni-NTA agarose beads (Novagen), equivalent to 1ml bead volume, were washed 
with buffer B and added to the supernatant. This was incubated on a roller incubator for 1 hour 
at room temperature. The beads were centrifuged at 3,800 rpm for 10 mins and the supernatant 
discarded. The beads were washed with 2x 50ml Buffer C + 2mM (3-mercaptoethanol, then 
loaded into a column cartridge (Evergreen Scientific). After the liquid had run out, the beads 
were washed with a further 10ml Buffer C + 2mM (3-mercaptoethanol. The protein was then 
eluted with 3mi Buffer E + 2mM (3-mercaptoethanol.
2.2.2.2 Buffer exchange
For use in FRET interaction assays, it was necessary' to transfer recombinant N av 1.8 1-120 
from the 8M urea buffer to the physiological buffer PBS. The 3ml eluate from the purification 
protocol was concentrated using a Centricon YM-3000 centrifugal concentrator (Millipore). 
After washing the filter with water then Buffer B + 2mM (3-mercaptoethanol, the protein 
solution was added and concentrated to around 0.5ml (giving a concentration o f  around 
40mg/ml) by centrifugation at 4,000 X g. The concentrated protein was then added dropwise to 
4.5ml PBS + 2mM (3-mercaptoethanol. The resulting 5ml was taken over 2 PD10 columns 
(Amersham Biosciences) equilibrated in PBS + 2mM (3-mercaptoethanol, giving an eluate o f  2 
x 3.5ml, which was stored at 4°C.
2.2.2.3 Cy3 Labelling of N ayl.8 1-120
Following buffer exchange, 2.5 ml N av 1.8 1-120 was labelled using 1 vial o f  Cy3 fluorophore 
(PA23000, Amersham). 0.5ml o f the aliquot was added to 1 vial o f  Cy3 label, mixed, and 
returned to the remaining solution. Incubation was carried out at room temperature for 45
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mins. The labelled material was then taken over a PD10 column equilibrated in PBS + 2mM (3- 
mercaptoethanoh and 3.5ml eluate collected.
2.2.2.4 Isolation o f Pure p i 1
In contrast to recombinant N av 1.8 1-120, pi 1 was found to have a high cytoplasmic solubility. 
This allowed purification in its native state (i.e. in the physiological buffer PBS).
The frozen bacterial cell pellets were thawed in 20ml PBS + lOmM imidazole. 2mM (3- 
mercaptoethanol, the protease inhibitors leupeptin, benzamidine and PMSF, and DNase I. 
Lvsozyme was added to 0.05% (w/v) and Triton X-100 to 1% (w/v) final volume, followed by 
homogenization in a dounce homogenizer. At least 20 up and down strokes with the tight 
pestle were performed, followed by incubation at 4°C for 15 mins. The resulting mixture was 
then spun at 11,000 rpm for 30 mins. The supernatant was taken and incubated with 1ml bead 
volume Ni-NTA beads for 1 hour, with occasional shaking. The beads were then spun at 3,800 
rpm for 30 mins, and the supernatant discarded. The beads were washed sequentially with 
50ml PBS + 2mM (3-mercaptoethanol, 2x 50ml PBS + 20mM imidazole + 2mM (3- 
mercaptoethanol, and 2x 50ml PBS + 40mM imidazole + 2mM (3-mercaptoethanol. After 
loading into a column cartridge, a further wash o f 2x 5ml PBS + 40mM imidazole + 2mM (3- 
mercaptoethanol was performed. Two elutions were carried out using 10ml PBS + 250mM 
imidazole + 2mM (3-mercaptoethanol. The eluate was collected and stored at 4°C. Purity was 
assessed using SDS-PAGE, and concentration was measured as described.
2.2.2.5 Cy5 Labelling of p i 1
5mg o f  p l l  protein in 2.5ml was labelled with 1 vial o f  Cy5 fluorophore (PA25000, 
Amersham). Concentration o f p l l  was adjusted before labelling if necessary, using a 
centrifugal concentrator. 0.5ml pi 1 was added to the Cy5 vial, mixed, and returned to the pi 1 
solution. After incubation at room temperature for 30 mins, the labelled material was taken 
over a PD10 column equilibrated in PBS + 2mM (3-mercaptoethanol, and 3.5ml eluate 
collected.
2.2.3 M easurem ent o f  Protein  C oncentration
A variety o f methods have been described for the measurement o f  protein concentration in 
solution, each with particular considerations. Biochemical methods, such as the Bradford and 
Lowry assays, depend on the presence o f particular residues, particularly those with aromatic 
side chains, with which the reagent reacts to form coloured complexes. With complex mixtures
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o f proteins, such as whole-cell lysates, these methods work well, relying on an averaging effect 
to normalise aromatic residue variation between proteins. These methods, however, are 
unsuitable for comparing concentrations o f  pure proteins with different compositions. In this 
case, two proteins o f  equal concentration may appear to be o f different concentrations due to 
differening aromatic content. For solutions o f pure proteins, absorbance at 280nm ( A 28o) is a 
more accurate way o f  comparing concentration. For a known sequence, the extinction 
coefficient per unit concentration can be calculated using chemical models, allowing 
adjustment for sequence differences and thus permitting accurate comparisons between proteins 
o f  different composition.
2.2.3.1 Bradford Assay
The Bradford assay was used as a quick method to determine approximate protein 
concentration. 1ml Bradford reagent (Sigma) was added to protein in a volume o f  less than 
lOul in a plastic disposable cuvette. After 10 mins at room temperature, absorbance at 595nm 
was read. A standard curve (bovine serum albumin, Sigma) and appropriate blanks were used 
to convert absorbance to concentration.
2.2.3.2 Micro Lowry Assay (Peterson’s Modification)
The Lowry method was also used to measure protein concentration. 1ml o f  Lowry reagent 
(Sigma) was added to protein in less than lOul volume, in a plastic disposable cuvette. After 30 
mins incubation at room temperature, 0.5ml Folin & Ciocalteu's phenol reagent (Sigma) was 
added. After a further 30 mins absorbance was read at 595nm. A BSA standard was used.
2.2.3.3 M easurement of Protein Concentration by Absorbance at 280nm
Absorbance at 280nm was used to measure protein concentration. The extinction coefficient 
for each protein, based on primary structure, was determined using the program ProtParam 
from the ExPASy Proteomics Server (http://www.expasv.org/). The absorbance at 280nm of 
lml o f  protein was measured by spectrophotometer. The appropriate buffer was used as a 
blank. Absorbance was converted to concentration using the formula:
Concentration (M) =  Absorbance____________________ ,
Path Length (cm) x Extinction Coefficient (M '1 cm '1)
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2.2.3.4 BCA Method
The BCA method was performed according to manufacturers instructions.
2.2.4 M easu rem en t o f  p l l -  N av 1.8 1-120 Interaction  by F luorescence  
R esonance E nergy T ransfer (FR ET)
Experiments were carried out in black-bottomed 384 well plates (Fluorotrac 200). A total 
volume o f  50pl was used for each well. Cy-5 labelled pi 1 was added to all wells, followed by 
unlabelled competitor if required. Plates were spun at 300rpm for 1 min. then Cy5-labelled 
Nav 1.8 1-120 was added. Addition o f  labelled components was performed using a Matrix 
Impact 2 multichannel pipette. The plates were spun again before being analysed in an LJL 
Biosystems Analyst. Analysis was performed immediately, at 5 mins, and at 30 mins. Data 
were recorded using the program CriterionHost (Molecular Devices). For FRET recording, the 
wells were excited using light at 525nm, and fluorescence was recorded at 695nm. In each 
case, wells without labelled pi 1 or without labelled Nav 1.8 1-120 were included to quantify 
"bleed-though" (either excitation of pi 1-Cy5 by light at 525nm, or emission o f  light around 
695nm by excitation o f  Nav l .8-Cy3). When both were present in a well, the expected emission 
at 695nm would be the additive o f these measurements. Any 695nm fluorescence above this 
level was therefore taken to be FRET-dependent. FRET was therefore defined as total 
fluorescence at 695nm after subtraction o f bleed-through. Each concentration/condition was 
present in triplicate. The experimental approach is summarised below:
pi 1-Cy5 - + - +
N av 1.8-Cy3 - - + +
Function Background Bleed-through Bleed through FRET
2.2.5 A nalysis o f  FR E T  Protein  Interaction Studies
Data were downloaded from CriterionHost into Microsoft Excel, and converted into the 
required format. GraphPad Prism was then used for analysis. Interactions between 2 labelled 
proteins were fit to the One-Site Binding function, while data from competition assays were fit 
to the One-Site Competition function using non-linear regression. BMax, Kd and IC50 (denoted 
in Prism as ECso) were the main parameters o f interest. Comparisons were performed by 
Student’s /-test.
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2.2.6 SD S-P A G E
Denaturing SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) was used to separate 
proteins by molecular weight. SDS anions impart a uniform charge per unit mass (1.4:1) to the 
protein, negating the effects o f charged amino acids and allowing separation solely by size. 
Dithiothreitol (DTT) was used to reduce disulphide bonds, allowing proteins to adopt the 
required random coil configuration.
8-16% acrylamide gels were made in a Hoefer Mighty Small gel caster. Higher percentage gels 
were used to visualise larger proteins. Running gel was made as follows: for 10ml o f  16% gel. 
4ml 40% aery lamide/bisacryiamide mix was added to 0.15ml 20% SDS, 3.75ml 1M Tris (pH 
8.8). and 2.15ml ddH20 .  To polymerise the mixture, 0.01ml TEMED and 0.05ml 20% 
ammonium persulfate were added, and the mixture poured into the caster. A layer o f  butan-1- 
ol was used to prevent inhibition o f  polymerisation by atmospheric oxygen, and to provide a 
smooth transition between the running and stacking gels. Once the running gel had set, a layer 
o f  stacking gel was added. The stacking gel is more porous than the running gel, and causes 
the accumulation o f  the proteins in a very thin layer at the interface between the two gel layers. 
For 10ml stacking gel, the following components were mixed: 1.67ml 40% (v/v)
acr> lamide/bisacryiamide mix, 0.05ml 20% SDS, 1.25ml 1M Tris (pH 6.8), 7ml ddH20 ,  
0.01ml TEM ED and 0.05ml 20% ammonium persulfate.
The gels were then transferred to the electrophoresis apparatus (Hoefer Mighty Small 
Mini-Vertical Unit), and covered with running buffer. Samples were mixed with 4 x sample 
buffer (containing DTT) and incubated at 95°C for 3-5 mins. After brief centrifugation, 
samples were then loaded onto the gel using a Microliter #702 syringe. A constant current of 
35mA per gel was applied across the gel for around 1 hour.
2.2.7 C oom assie  B lue Staining
Coomassie Blue staining was used to visualise total protein content on SDS-PAGE gels. 
Immediately after electrophoresis, gels were transferred to a staining and fixing solution 
containing 0.1% Brilliant Blue R-250, 50% methanol, 10% acetic acid. After staining 
overnight, gels were de-stained in 50% methanol, 10% acetic acid.
2.2.8 W estern  B lotting
Western blotting was used to transfer proteins to a nitrocellulose membrane, allowing 
verification o f protein identity by antibody binding. Immediately after SDS-PAGE, gels were 
transferred to a nitrocellulose membrane (Hybond-C, Amersham Biosciences) in transfer buffer 
(25mM Tris-HCl pH 8.3, 192mM glycine, 0.1% SDS, 20% methanol) for lh at 100V. Semi-
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dry transfer was used for smaller proteins, but wet transfer used for larger proteins to increase 
transfer efficiency. The membrane was blocked with 5% non-fat milk in PBS-Tween (0.1%) 
for lh at room temperature and then incubated with primary antibody, diluted 1:200-1:1000 in 
blocking buffer, overnight at 4°C. The membrane was then washed 3 times with PBS-Tween 
and horseradish peroxidise-conjugated secondary antibody applied at 1:1000 in PBS-Tween for 
2h at room temperature. For anti-His-Tag Western blots, the Novagen protocol for His-Tag 
Monoclonal Antibody was followed. Bound secondary antibody was detected using ECL 
Detection reagent (Amersham Pharmacia Biotech), exposed to BioMax film (Kodak, Harrow, 
UK).
Quantification o f  western blots was performed using the programme ImageJ (National 
Institutes o f  Health, USA). Band pixel density was calculated and normalised according to 
reference gene bands, before comparison to control. The area o f  analysis was kept constant, 
and greater than band size, between test and control, to account for effects o f differences in 
band area. Blots were repeated several times for quantitative data.
2.2.9 I m m u n ocytoch em istry
DRG were excised and neurons cultured on poly-L-lysine and laminin-coated glass cover slips 
for 24-48 hours. Cells were fixed using 4% paraformaldehyde for 5 mins at room temperature, 
washed ( 3 x 5  mins) in PBS, then blocked and permeablised in PBS containing 0.1% Triton X- 
100 and 10% goat serum for 20 mins at room temperature. Cells were incubated with primary 
antibody diluted 1:100-1:1,000 in blocking solution for 2 hours, washed, then exposed to 
secondary' antibody (Alexa 488 or 595), diluted 1:100, for one hour. Following a final wash, 
cover slips were mounted on slides with Citifluor (Citifluor, Leicester, UK) to prevent 
bleaching. Images were obtained using a Zeiss confocal microscope.
2.2 .10 Im m un oh istoch em istry
DRG were excised from humanely-killed mice and rapidly frozen in OCT. 12 pm sections 
were cut by Cryostat and mounted on Superfrost Plus (positively-charged) slides. Following 
30-45 mins drying, the slides were fixed in 4% paraformaldehyde for 5mins on ice. Sections 
were washed and permeablised in PBS + 0.3% Triton X-100 (3 x 5 mins), then blocked in PBS 
+ 10% goat serum (or appropriate other species) for 1 hour at room temperature. Primary 
antibody was diluted in blocking buffer (1:200 -  1:1,000) and exposed to the sections for 2 
hours at room temperature, or overnight at 4°C. Slides were then washed ( 3 x 1 0  mins) in PBS, 
before addition o f  secondary antibody (Alexa Fluor 488 or 594) in blocking buffer and
81
incubation for 1-2 hours in the dark (room temperature). 3 x 5  mins washes reduced 
background before mounting with CitiFluor1M, which helps to prevent photo-bleaching o f  the 
fluorophore. Images were obtained using a fluorescence light microscope.
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2 .3  E l e c t r o p h y s io l o g y
2.3.1 W h ole-ce ll p atch -clam p  recordings
DRG neuron cultures were prepared from humanely-killed mice aged 4-8 weeks, as described 
previously (Stirling et al., 2005). Neurons were maintained in culture in the presence o f NGF 
(0.25pg.mr') for a maximum o f  48 hours. Whole-cell patch-clamp was performed in the 
absence o f  TTX, followed by the addition o f 250nM TTX by acute local superfusion.
Voltage-clamp recordings were made from single DRG neurons o f  < 25 pm diameter, 
using an Axopatch 200B amplifier controlled by PClamp 9 software (both Axon Instruments, 
Union City, CA). Neurons were voltage-clamped at -80mV, except when a noticeable N av l .9- 
mediated current was observed, where the cells were held at -60mV to inactivate this channel. 
Series resistance was compensated for at 70-70%, using a feedback lag o f  12ps. Currents were 
elicited by incremental (+10mV) depolarizing steps (50ms duration), preceded by a 
hyperpolarizing pulse to -lOOmV to remove any inactivation. Averages o f 3 sweeps were taken 
to form the current records, which were filtered at 5 KHz (8-pole Bessel). TTX-sensitive 
currents were obtained by digital subtraction o f the TTX-resistant current from total current. 
Current density estimates were made from stable, maximal current amplitudes. All currents 
included in the analysis displayed appropriate kinetics and voltage dependencies, 
corresponding to TTX-sensitive or -resistant Na~ channels. Current densities were compared 
using a Mann-Whitney rank sum test, since the current distributions failed normality testing.
Resting potential measurements were made in current-clamp mode. Voltage-clamp 
mode was used to patch the cell, holding at -70mV, then the amplifier configuration was 
switched. No current was injected, and the resting potential was read immediately. This 
minimised the effect o f  dialysis o f  pipette solution into the cell altering the ionic balance across 
the membrane. Voltage-clamp was then used to examine the sodium channels present in the 
cell, to allow grouping o f  cells by channel expression.
2.3.2 In  vivo  record ings from  dorsal horn neurons
Measurements o f  electrical inputs into wide dynamic range neurons in the spinal cord were 
carried out as described previously (Matthews et al., 2006), in urethane-anaesthetised mice. 
Single-unit extracellular recordings were made following electrical, mechanical or thermal 
stimulation o f  varying magnitude. A- and C-fibre-mediated responses were distinguished by 
latency relative to initial stimulus. Neuronal responses occurring after the C-fibre latency band 
o f  the neuron (250 -  800 ms) were classed as postdischarge, a result o f  repeated stimulation 
leading to wind-up neuronal hyperexcitability. The 'input' (non-potentiated response), and the
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'wind-up' (potentiated response, evident by increased neuronal excitability to repeated 
stimulation) were calculated. Input = (action potentials (50 - 800ms) evoked by first pulse at 3 
times C-fibre threshold) x total number o f  pulses (16). Wind-up = (total action potentials (90 - 
800ms) after 16 train stimulus at 3 time C-fibre threshold) -  Input. Data are presented as mean 
± S.E.M. Two-factor ANOVA with replication was used for statistical analysis and the level o f  
significance taken to be p<0.05.
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2 .4  A n im a l  B r e e d in g  &  B e h a v io u r a l  A n a l y s is
Animals were bred at University College London under conditions complying with United 
Kingdom Home Office guidelines. They were housed in filter cages, with a 12 hour light/dark 
cycle and were fed standard chow and water ad libitum.
All behavioural tests were approved under the United Kingdom Home Office Animals 
(Scientific Procedures) Act 1986. They were performed in a Home Office designated room at 
22±2°C. Experiments were performed on F5 or F6 animals o f at least 8 weeks o f  age. pi 1 
floxed (p l l- / - ) ,  NaV1.8 Cre heterozygote (+/-) animals were compared to Cre-negative 
littermate controls. Results for male and female animals were combined, unless a significant 
difference was found in testing. All experiments were performed blind by the same observer.
2.4.1 M otor F unction
The Rotarod test (Ugo Basile) was used to assess motor function. Animals were placed on the 
rod at a constant rate o f  20rpm. After one minute the rate of revolution was switched to a 
progressively increasing mode, reaching a maximum of 36rpm after 2 mins, until the animal 
fell. A cut-off time o f  5 mins was used. Each animal was tested 3 times, with at least 1 hour 
recovery between tests. The results for the two groups were compared using a Student's t-test.
2.4.2 M ech an ica l W ithdraw al Thresholds
Withdrawal thresholds to mechanical stimuli were measured using the Randall-Selitto 
apparatus and von Frey hairs.
2.4.2.1 Randall-Selitto
Each animal was placed in a restrainer (IITC) and left to settle for a few minutes until cessation 
of struggling. An analgesy meter (Ugo Basile) was used to apply an increasing force to the tail, 
at a point where the tail diameter was just greater than that o f  the probe. Three tests were 
performed per animal, each on a different section o f the tail. The force at which the animal 
attempted to withdraw the tail or struggle was recorded. The results for the two groups were 
compared using an unpaired 2-tailed Student’s /-test.
2.4.2.2 von Frey
Animals were acclimatised in individual chambers with a metal mesh floor for 1-2 hours, until 
exploratory activity had ceased. The up-down method, as described by Chaplan et al. (1994),
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was used to assess the 50% withdrawal threshold o f each mouse. This method has been shown 
to be more powerful and less labour-intensive than battery methods. Starting from hair 7 
(0.6g), hairs were applied until moderate bending occurred. If a response was elicited, the next 
test used a weaker hair, and vice-versa. 6 trials were performed on each mouse, with at least 10 
mins between applications. Results were analysed using an unpaired 2-tailed Student's /-test.
2.4.3 T h erm al T h resh o ld s
Withdrawal thresholds to thermal stimuli were measured using Hargreaves' apparatus and the 
hot plate.
2.4.3.1 H argreaves’ Apparatus
Animals were acclimatised to test chambers on a clean Plexiglass plate for at least 1 hour until 
exploratory activity had ceased. Beam intensity was set to give a latency to withdrawal o f  
around 10-15s. Paw withdrawal latency was measured on the left hindpaw, with 4 repeats per 
animal and at least 2 mins between tests. Results were compared using an unpaired 2-tailed 
Student's /- test.
2.4.3.2 Hot Plate
Animals were acclimatised to the hot plate (Ugo Basile) in it in groups o f 4-6 for 15 mins, with 
the plate at room temperature. Latency to hindpaw licking was measured at 50°C and 55°C. 
Each animal was tested once at each temperature, with tests separated by 24 hrs. Results were 
compared using an unpaired 2-tailed Student’s /- test.
2.4.4 In flam m atory  Pain M odels
2.4.4.1 Intraplantar Nerve Growth Factor
Baseline thermal withdrawal thresholds for the left hindpaw were measured for each animal 
using Hargreaves’ test. 50ng human-recombinant NGF in 5pl saline carrier (pH 7.0) was 
delivered subcutaneously to the plantar region of the left hindpaw using a Hamilton syringe 
with 27g needle. Hargreaves’ test was then repeated at intervals for the next 24 hours. Data 
were expressed for each mouse as relative change from baseline. These data were compared 
using 2-way repeated measures analysis o f variance.
2.4.4.2 Intraplantar Carrageenan
Baseline thermal withdrawal thresholds for the left hindpaw were measured for each animal 
using Hargreaves’ test. 20pl o f  2% carrageenan in saline was injected into the plantar region of
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the left hindpaw as before. Thermal withdrawal thresholds were then measured at hourly 
intervals. Data were expressed for each mouse as relative change from baseline, and were 
compared using 2-way repeated measures analysis o f  variance.
2.4.4.3 Intraplantar Formalin
Animals were acclimatised individually to an observation chamber for around 15 mins. until 
exploratory activity had ceased. 20pl o f  5% formalin (40% formaldehyde) in saline was 
injected subcutaneously into the plantar region of the left hindpaw. using a Hamilton syringe 
and 27g needle. The time spent engaged in nocifensive behaviour (licking or biting the injected 
paw ) was recorded in 5 minute sections over the next hour. The first phase o f response was 
defined as 0-10 mins post-injection, while the second phase referred to subsequent behaviour. 
Comparison was made using an unpaired 2-tailed Student's t test.
2.4.5 N europath ic Pain M odel
A modified version o f  the Chung method (Kim and Chung, 1992) was used to induce 
neuropathic pain in the mouse. First, baseline measurements of mechanical and thermal 
withdrawal thresholds (von Frey and Hargreaves') were performed on two consecutive days. 
Animals were then anaesthetised using halothane, and a midline incision made into the skin o f  
the back. The L5 transverse process was removed and the left L5 spinal nerve cut. This 
surgery7 was performed by Mohammed Nassar and Bjarke Abrahamsen. Mechanical and 
thermal withdrawal thresholds were then assessed at intervals, up to 25 days post-surgery. 
Thresholds were expressed as relative changes compared to pre-surgery baselines, at the level 
o f  the individual animal. Results were analysed using 2-way repeated measures analysis o f 
variance.
87
2 .5  A n g io g e n e sis  a ssa y s
2.5.1 T u m ou r cell grow th
Cell from the B16 murine melanoma line, derived from the C57BL/6 strain, were cultured in 
DMEM + 10% FCS. Cultures were passaged 1:10 before confluence, until sufficient numbers 
were obtained at 30% confluence. Cells were then trypsinised. washed and resuspended at a 
concentration o f 1.000,000 cells/200pl PBS.
2.5.2 M elanom a cell injection
1,000,000 cells, in 200pl PBS. were injected subcutaneously into the dorsal neck region of each 
mouse. After days, during which time the health o f  the animals was monitored carefully, the 
animals were humanely sacrificed and the tumours excised. Tumour volume was measured by 
multiplying the maximum length, breadth and depth measurements. Tumours were then fixed 
in 4% PFA overnight, before being subjected to histological analysis.
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3 MAPPING THE NAV1.8-P11 INTERACTION
3.1 In t ro d u c t io n
The intelligent design o f  pharmacological inhibitors o f the pi 1-Nav 1.8 interaction, which has 
been proposed as a therapeutic target, requires a detailed understanding o f the nature o f the 
domains involved in binding. This chapter explores the residues in the N av 1.8 N-terminus 
required for its interaction with pi 1 .
3.1.1 N a v 1 .8 -p l l  Interaction
Voltage-gated sodium channels (VGSCs) consist o f  primary, pore-forming a-subunits and 
auxiliary P-subunits. Whilst a-subunits are sufficient for voltage-gated channel activity. (3- 
subunits are required for cellular localisation, full levels of functional expression and certain 
aspects o f  channel kinetics (reviewed in Isom (2000)). Expression o f a-subunits alone in 
heterologous cell expression systems (including mammalian cell lines) often results in low- 
level functional expression, with altered voltage-dependence o f activation and inactivation 
(Isom, 2001). When co-expressed with P-subunits, however, the expression levels and kinetics 
o f  most VGSCs become closer to those o f the endogenous channels (Isom et al.. 1994;lsom et 
al.. 1995).
Although functional expression o f  Nav 1.8 in Xenopus oocytes is increased by co-expression 
with the pi subunit, (Vijayaragavan et al.. 2004b), current densities remain substantially below 
endogenous levels in DRG. The functional expression o f Nav 1.8 in CHO, COS-7 and HEK- 
293 cell lines is poor even in the presence o f P-subunits (England, 1998). with channels 
showing different properties from the endogenous current (FitzGerald et al., 1999). 
Microinjection o f  N av 1.8 cDNA into the nuclei of SCG or Nav 1.8-null mutant DRG neurons, 
however, produces sodium currents with similar properties and magnitude to wild-type DRG 
neurons (England, 1998). More recent studies have successfully expressed functional N av 1.8 
channels in neural cell lines (SH-SY5Y, ND7-23), with properties matching the endogenous 
current (Dekker et al., 2005;John et al.. 2004). These data imply that N av 1.8 requires the 
presence o f additional regulatory factors, present in DRG neurons, to achieve endogenous 
levels of functional expression.
Okuse et al. (2002) used the yeast two-hybrid system to search for proteins interacting with the 
intracellular domains o f Nav 1.8. O f the 28 positive clones identified, five were found to code 
for the SI 00 protein pi 1 (Malik-Hall et al., 2003). Co-expression o f pi 1 with N av 1.8 in CHO
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cells resulted in the translocation o f  the channel from cytosol to plasma membrane. Co­
expression also resulted in the manifestation o f a high-threshold TTX-R sodium current similar 
to that observed in DRG neurons, which was down-regulated by antisense mRNA to p l l  
(Okuse et al.. 2002). Poon et al. (2004) demonstrated that pi 1 binds directly to the N-terminus 
o f  N av 1.8, but not to other VGSCs. The GST pull-down assay was used to map the p 11 - 
Nav 1.8 interaction to residues 33-78 o f pi 1. and residues 74-103 o f  N av 1.8, using sequences 
from the rat. In contrast to the pi 1-interacting domains of TASK-1 and TRPV5/6 (Girard et 
al., 2002;van de Graaf et al.. 2003), this region of Nav 1.8 does not contain a PDZ consensus 
binding sequence, nor any other readily-identifiable domain. The region has a characteristic 
cluster o f  acidic and basic amino acids divided by a putative (3-strand, which is well-conserved 
in other species, including mouse (Poon et al., 2004). Two domains with low homology to 
other sodium channels have been identified (residues 87-90 and 98-102). which may play a role 
in binding to p l l .  Other than these regions, however, a fairly high degree o f  homology with 
other VGSCs is seen.
The involvement o f  annexin 2 in the Nav 1.8-pll interaction has not been investigated. 2 
models for the annexin 2 -pl 1 complex, a heterotetramer and a hetero-octamer, have been 
proposed (Lewit-Bentley et al., 2000). In both cases, the putative binding domains for N av l . 8  
are the most peripheral and exposed (Poon et al., 2004). Since annexin 2 is present in higher 
quantities in the cell than pi 1 (SE Moss, personal communication), it is likely that annexin 2 
forms part o f  the p 1 1  -Nav 1. 8  complex.
No further localisation o f the p l l -  Nav 1.8 interaction has been carried out, possibly due to 
methodological limitations relating to the sensitivity o f the GST pull-down assay. It has been 
postulated, however, that disruption of this interaction may be a valid target for analgesic drug 
design (Okuse et al., 2002). For directed (intelligent) design o f small molecule inhibitors o f 
this interaction, a more precise definition o f the binding region is required. We used 
fluorescence resonance energy transfer (FRET), in combination with the expression o f mutant 
proteins, as a tool to allow more precise mapping o f the p l l  - Nav l . 8  interaction.
3.1.2 Identification o f  binding dom ains for p l l -  protein interactions
The role o f  pi 1 in trafficking proteins to the plasma membrane is not restricted to N av 1.8. 
Since the publication o f  the requirement o f pi 1 for Nav 1.8 functional expression (Okuse et al., 
2002), several other membrane proteins which require pi 1 have been identified. Girard et al. 
(2002) reported that the interaction o f p l l  with the 2-pore domain K channel TASK-1 is 
essential for trafficking to the plasma membrane. The C-terminal sequence Ser-Val-Val o f
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TASK-1 was found to be required for the association. Binding of pi 1 to the channel was found 
to mask an endoplasmic reticulum retention signal. Lys-Arg-Arg, preceding the Ser-Val-Val 
binding domain. In a subsequent publication, however, Renigunta et al. (2006) found no 
requirement o f  this sequence, and instead identified a 40-amino acid region. 120-80 residues 
from the C-terminus. In this study, pi 1 was found to cause the retention o f  TASK-1 in the 
endoplasmic reticulum, in direct contrast to the previous work (Renigunta et al.. 2006). 
Retention was ascribed to residues on p l l  rather than TASK-1, via the putative endoplasmic 
reticulum retention motif (H/K)xKxxx at the C-terminal end of pi 1. No explanation has been 
found for the discrepancy between these studies with respect to the inferred binding site for 
p l l .  The range o f  techniques used in each investigation was similar (yeast 2-hybrid, co- 
immunoprecipitation, GST pull-down, whole-cell patch clamp), as were the model systems 
used. It has been proposed, however, that the stimulatory effect on TASK-1 trafficking 
observed by Girard et al. (2002) may have been mediated by another TASK-1 interacting 
protein. 14-3-3, the binding o f  which may also have been disrupted by deletion o f C-terminal 
amino acids on TASK-1 (Renigunta et al., 2006). The involvement of annexin 2 in the p 1 1 - 
TASK-1 interaction has not been formally tested, but seems unlikely, since the C-terminus o f 
TASK-1 binds to the same or overlapping regions on pi 1 as annexin 2 (Renigunta et al.. 2006).
The functional expression o f the epithelial Ca2 channels TRPV5 and TRPV 6  w as also 
found to require the association o f pi 1 (van de Graaf et al., 2003). These interactions were 
found to take place via a conserved sequence, VATTV, in the C-terminal tails o f  TRPV5 and 
TRPV 6 . The first threonine o f  this sequence was found to play a crucial role in the interaction, 
shown by the analysis o f  mutant channels. No information was given in this report regarding 
residues on p l l  required for the interaction. Using GST pull-down and co- 
immunoprecipitation assays, however, the authors were able to demonstrate that annexin 2  is 
part o f  the TRPV5-pl 1 complex. siRNA-mediated downregulation o f  annexin 2 was shown to 
inhibit TRPV5/6 mediated currents in HEK cells, although this may be explained by the 
observation that under normal conditions, annexin 2  upregulates levels o f  p l l  by a post- 
translational mechanism (Puisieux et al., 1996). This means that downregulation o f  annexin 2 
may act via a reduction in pi 1 levels rather than directly on TRPV5/6.
ASIC la (Donier et al., 2005) and 5-HT!B (Svenningsson et al., 2006) have also been 
shown to interact with p l l ,  but investigation o f the domains involved in binding has yet to be 
undertaken.
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3.1.3 FRET
FRET describes the physical phenomenon whereby energy is transferred non-radiatively from 
an excited fluorophore to an acceptor molecule. Long-range dipole-dipole coupling occurs 
over distances between 1-1 Onm, allowing energy transfer without the emission o f  a photon 
(Forster, 1948). The transfer rate is inversely proportional to the 6 th power o f  the donor- 
acceptor separation distance within this range, allowing its use as a “spectroscopic ruler” 
(Stryer, 1978). These 1-1 Onm distances are relevant for most biomolecular associations (Jares- 
Erijman and Jovin, 2003), meaning that in practice FRET can be used as a surrogate measure of 
molecular interaction, or “binding”. The occurrence of FRET is therefore indicative o f  protein- 
protein interaction in this context.
If the acceptor molecule in this system is itself a fluorophore, the occurrence o f  FRET will 
cause the emission o f  photons of a characteristic wavelength. In this instance, excitation o f  the 
donor fluorophore will cause emission in the spectrum of the acceptor. This is illustrated in 
Figure 3.1, using Cy3 and Cy5 as example fluorophores, and N a y l . 8  and p l l  as interacting 
proteins.
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Figure 3.1 F luorescence resonance energy transfer used to detect protein-protein interactions.
Graph: Red line represents Cy3 excitation spectrum, blue Cy3 emission, yellow Cy5 excitation and green 
Cy5 emission.
FRET can be measured either as quenching o f  the donor fluorescence (in this example 
reduction in output at 570nm) or as an increase in acceptor fluorescence (670nm in this 
example). The former method suffers less from the problem o f  “bleed-through”, where the 
acceptor can be made to fluoresce to a small degree by the donor excitation spectrum. The 
latter method, however, provides a more direct measurement of  the interaction process.
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3.1.4 Protein-protein  interaction models
Site-specific protein-protein interactions can be modelled in the same wav as ligand-receptor 
binding, using the principles o f  the law of mass action. The law of mass action states that the 
rate o f  a reaction is proportional to the concentrations o f the reactants. For the reaction: 
Receptor + Ligand Receptor.Ligand, the rate o f  forward reaction can be given by:
Rate = [Receptor],[Ligand],kon, where kon is the rate constant for the forward reaction. At 
equilibrium, the rates o f forward and reverse reaction are by definition equal, meaning that 
[Receptor].[Ligand].kon = [Receptor.Ligand].kott. Since k0ll and kotT are constants, they can be 
combined into the equilibrium dissociation constant Kd:
Kd = kotr-kon’ 1 = [Ligand].[Receptor]/[Ligand.Receptor].
Kd thus gives a measure o f  the affinity o f the ligand for the receptor, and is the concentration o f 
ligand required to reach half-maximal receptor occupancy. From this, a model for single-site 
binding can be derived:
Fractional Occupancy = [Ligand.Receptor]/[Receptor]i0,al
= [Ligand.Receptor]/([Ligand.Receptor] + [Receptor])
= [Ligand]/([Ligand] + ([Ligand],[Receptor]/[Ligand.Receptor]))
= [Ligand]/([Ligand] + Kd)
Therefore: Specific Binding = BMax.[Ligand]/(Kd+[Ligand]), where BMax is the maximal 
binding (i.e. the total receptor number).
In the case that one receptor can bind two ligand molecules, the equation becomes:
Specific Binding = BMax].[Ligand].(Kd]+[Ligand])'' + BMax:.[Ligand].(Kd2 +[Ligand])''
These equations can be extended to form models for competition binding assays, where 
increasing amounts o f  unlabelled test ligand are added to fixed concentrations o f  labelled 
ligand and receptor. One-site competition can be described as follows:
Binding (labelled) = NS + (Max-NS).(l + 10Log^llgand'"loglC:'0)‘l, where NS represents non-specific 
binding. IC5 0  is the concentration o f unlabelled competitor that is required to block 50% o f  the 
specific binding, and is therefore dependent on the affinity o f  the competitor for the labelled 
"receptor’'. IC50 can be converted to a dissociation constant, K„ using the Cheng and Prusoff 
equation (Cheng and Prusoff, 1973):
K, = ICso/(l + [Ligand*]/Kd*)
Where [Ligand*] is the concentration of labelled ligand, and Kd* is the corresponding 
dissociation constant. This is derived as follows:
For the reactions A + R ^ AR and B + R ^ BR, where R is a receptor capable o f  binding A and 
B, and KA and KB are the association constants for each reaction:
[R]T o ta l -  [R] + [AR] +  [BR]
= [R] + Ka.[A].[R] + Kb.[B].[R]
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= [R].(1 + K a.[A] + Kb.[B])
Therefore [R] = [R ] lola,/(l + Ka.[A] + Kb.[B])
Since [AR] = Ka.[A].[R].
[AR] = KA.[A].[R]Total/(l + Ka.[A] + Kb.[B])
Therefore [AR]/[R]Totai= Ka.[A]/(1 + Ka.[A] + Kb.[B])
When [A] = ICso. [RA]/[R]rota| = 0.5, therefore 0.5 = KA.ICso/(l + KA. ICs() + Kb.[B])
Therefore KA = ( 1  + Kb.[B])/ IC50
And Ki = ICs0/( 1 + Kb.[B])
We employed a combination o f  site-directed mutagenesis and in vitro FRET measurement to 
map the domains o f  N av l - 8  required for interaction with p l l .  This approach allowed direct 
quantitative measurement o f  the effect o f  mutations in Nav 1.8 on its affinity for p l l .  By 
identifying the residues critical for interaction, the design of small molecule or peptide 
inhibitors will be facilitated.
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3.2 M eth ods
Human p l l  cDNA was amplified from human a cDNA library (Invitrogen) by PCR, and 
inserted into the vector pCRII. This construct was made by Lodewijk Dekker. The sequence 
was then ligated into the expression vector pET14b (containing a 5 ’ His-Tag), and expressed as 
described previously.
The process o f  making mutant Nav l . 8  constructs is summarised in Figure 3.2. Human Nav l . 8  
N-terminal cDNA was isolated from DRG RNA (Analytical Biological Services), used as a 
template for SmartTM cDNA synthesis, followed by specific amplification based on public 
sequence information and ligation into the vector pCRII. This was performed by Lodewijk 
Dekker (Dekker et al., 2005). The resulting amino acid sequence for Nav l . 8  1-120 is: 
MEFPIGSLETNNFRRFTPESLVEIEKQIAAKQGTKKAREKHREQKDQEEKPRPQLDLKA 
CNQLPKFYGELPAELIGEPLEDLDPFYSTHRTFMVLNKGRTISRFSATRALWLFSPFNLI 
R
PCR was used to produce three mutant sequences, each with a third o f  the sequence deleted, 
and the fragment 41-80. This was intended to confirm previous work on the interaction region. 
The full sequence was also altered by site-specific primer mismatch mutagenesis, to produce a 
series o f 3-amino acid deletions in the predicted pi 1-binding region. The constructs created are 
shown in Table 3.1.
— — ^ _ ^ - ^ c D N A  
PCR n TOPO-TA
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V
TOPO-TA
pET14b
Figure 3.2 O verview  o f  cloning and generation o f  mutants for N av 1.8 1-120. Human cDNA was 
used to generate the 1-120 fragment, which was cloned into pCRII. Primer mismatch mutagenesis 
allowed the production of mutant sequences, which were subcloned into pCRII then cloned into pET14b.
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Name Description
Nav l . 8  1-120 DNA coding for amino acids 1-120 o f N av l . 8  N-terminus
N av 1.8 41-80 DNA coding for amino acids 41-80 o f Nav l . 8  N-terminus
Nav l . 8  A2-40 N av l . 8  1 - 1 2 0  with amino acids 2-40 deleted
Nav 1.8 A41-80 N av 1. 8  1 - 1 2 0  with amino acids 41 -80 deleted
Nav l . 8  A81-120 N av l . 8  1 - 1 2 0  w ith amino acids 81-120 deleted
N av 1.8 AEIG N av 1. 8  1 -120 with amino acids L1G (74-76) deleted
N av 1.8 AEPL N av l . 8  1-120 with amino acids EPE (77-79) deleted
N av l 8  AEDL N av l . 8  1-120 with amino acids EDL (80-82) deleted
Nav 1.8 ADPF Nav l . 8  1-120 with amino acids DPF (83-85) deleted
Nav 1.8 AYST Nav 1.8 1-120 with amino acids YST ( 8 6 -8 8 ) deleted
Nav 1.8 AHRT Nav 1.8 1-120 with amino acids HRT (89-91) deleted
N av l . 8  AFMV Nav 1.8 1-120 with amino acids FMV (92-94) deleted
Nav 1.8 ALNK Nav l . 8  1-120 with amino acids LNK (95-97) deleted
N av l . 8  AGRT Nav l . 8  1-120 with amino acids GRT (98-100) deleted
Nav l . 8  AISR Nav l . 8  1-120 with amino acids ISR (101-103) deleted
Table 3.1 M utant proteins produced using the His-Tag bacterial express ion/purification  system.
Primers were designed to include an Ndel restriction site at the 5' end o f  the construct, and a 
BamHl site at the 3' end. A stop codon (TAG) was added before the 3' restriction site. PCR 
products were inserted into pCRII using the TOPO-TA cloning reaction. Following 
amplification, they were excised with Ndel and BamHl, and ligated into the expression vector 
pETMb, which had been opened using the same restriction enzymes and treated with SAP to 
prevent re-ligation. Constructs were sequenced by Lark Technologies, then expressed as 
described previously. Purity was assessed by SDS-PAGE. and concentrations measured by 
absorption spectrophotometry. Identities were confirmed by Western blot using anti-His-Tag. 
Following Cy3/5 labelling o f proteins (on average, less than one fluorophore per protein 
molecule), FRET interaction studies were performed, using several experimental designs. 
Initially, binding was validated using a titration approach, adding increasing concentrations o f 
labelled N a v l . 8  to a fixed quantity o f  labelled p l l .  Mutant proteins were then investigated 
using a competition binding approach, adding increasing concentrations o f  unlabelled mutant to 
fixed quantities o f  labelled Nav 1.8 and pi 1. Finally, small peptides (chemically synthesised) 
were used in this competition assay, as shown in Table 3.2.
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Name Sequence
N av 1.8 74-103 Residues 74-103 o f N av l . 8  N-terminus
N av 1.8 74-88 LIGEPLEDLDPFYST
N av 1.8 89-103 HRTFMVLNKGRTISR
N av l . 8  74-81 LIGEPLED
Nav l . 8  82-88 LDPFYST
Nav 1.8 89-96 HRTFMVLN
Nav 1.8 97-103 KGRT1SR
Table 3.2 Peptides produced by chemical synthesis.
For each FRET study, bleed-through was measured and subtracted from the FRET reading, to 
give a measure o f  sensitised emission. This ensures that the values used represent binding 
only, and not other fluorescence effects. For details o f  analysis, see Chapter 2.
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3.3 Results
3.3.1 N av 1.8 N -term inus and p l l  can be expressed at high levels and  
purified to >95%  purity
3.3.1.1 N ayl.8 N-terminus
The protein “N av l .8 1-120” and related mutants were extracted and purified in 8M urea, due to 
their accumulation in inclusion bodies. After purification, these proteins were estimated to be 
>95% pure, assessed by SDS-PAGE. An example gel is shown in Figure 3.3. Occasionally 
proteins were found to have contaminants, probably due to errors in the purification process. 
These proteins were not used in FRET assays. At high concentrations, dimers were often 
observed. These were not considered to be contaminants.
Protein identity was confirmed by Western blotting, using anti-His-Tag for identification. An 
example Western blot is shown in Figure 3.3. Concentrations of these proteins (assessed by 
A 2 8 0 ) were 50-200pM. After transfer from 8M urea to PBS, concentrations were lO-lOOpM.
N lyl.8  
M 1-120 ALIGAEPL
75---------
35~ r
25 —  
15—
1 0  — 1-
10—  »
Figure 3.3 C onfirm ation  o f  protein identity and purity. Coomassie blue-stained SDS-PAGE gel 
(left) and anti-His-Tag Western blot (right). Molecular weight in kDa given on the left of each image. 
M, marker. Other lanes as labelled.
3.3.1.2 p l l
p l l  was extracted and purified under native conditions, using PBS as a buffer. 2mM (3- 
mercaptoethanol was found to be sufficient to minimise dimerisation. Following purification, 
purity was assessed by SDS-PAGE, and found to be in excess of 95%.
p l l  identity was confirmed by anti-His-Tag Western blotting. Concentrations o f  p l l  were 
200-300pM after Cy5 labelling.
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3.3.2 FR E T -based  assays effectively m easure the site-specific interaction
between N av 1.8 and p l l
Before investigating the effects o f N av 1.8 N-terminal mutations on binding to p l l ,  it was 
necessary to validate our FRET methodology using wild-type recombinant proteins. The 
objective o f  this was to show that the FRET signal was arising from the Nav l -8 -p 1 1 interaction, 
and was therefore both selective and site-specific. The reproducibility o f  interaction 
parameters was also examined.
Increasing concentrations o f  Cy3-labelled Nav 1.8 1-120 were added to a fixed concentration 
(250ng/well) o f  Cy5-labelled p l l .  FRET resulting from the interaction (after subtraction o f 
baseline and bleed-through) was found to fit well to a one-site binding model, shown in Figure 
3.4. The Kd for the interaction was typically around lOOnM. A two-site binding model was 
found to offer no improvement o f  fit. A clear saturation was evident at high concentrations o f 
N av 1.8 1-120. imply ing that the increase in FRET with Nav 1.8 1-120 concentration is due to a 
site-specific protein-protein interaction, rather than a non-specific effect o f  increasing 
fluorophore concentrations.
40000CH
300000
2 0 0 0 0 0 -
R = 0.9365
Kd = 0.1085 ± 0 .02596  (.iM1 0 0 0 0 0  -I
0 05 0 100 00 0 15 0 20
[Nav1.8 1-120]/ nM
400000-
300000
2 0 0 0 0 0 -
100000-
■2 5 -2 0 -0.51.5 1.0
Log10[Nav1.8 1-120]/
Figure 3.4  Titration o f  C y3-N av 1.8 against 250ng C y 5 - p l l  (conventional and log plots).  The
equation for one-site binding was used to model the data: Specific Binding =
BMax.[Ligand]/'(Kd^ [Ligand]). A Kd of around lOOnM was observed.
A similar experiment was performed titrating increasing concentrations o f pi l against a fixed 
concentration o f Nav l . 8  l - 120. The data fit well to a one-site binding model and exhibited 
saturation at high concentrations o f pi l, confirming the previous result.
To confirm that the FRET signal observed was due to site-specific protein-protein interactions
between pi l a n d N a v l . 8  l - 1 2 0 . the ability o f  unlabelled Nav l . 8  l-l 2 0  to compete with labelled
Nav l . 8  l - l 20 for the binding site was examined. Increasing concentrations o f  unlabelled
Nav E 8  l - 120 were added to fixed amounts o f  labelled Nav l . 8  l - 120 (200nM) and pi l. Data
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were found to fit well to a one-site competition binding model, as illustrated in Figure 3.5, with 
IC?o=0.49±0.03fiM (n=67) and therefore K,= 160±10nM. This affinity is similar to that 
measured by direct binding assay lOOnM).
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Figure 3.5  C om petition  o f  the C y 3-N av 1.8 - C y 5 -p l l  interaction by unlabelled N av 1.8 1-120. The
IC50 for this competition, averaged over all tests, was 0.49^0.03gM (n=67).
As a final proof that the FRET observed was due to a site-specific interaction between pi 1 and 
N av 1.8, we tested the ability o f  the annexin 2 (p36) N-terminus (acetyl-1-14) to compete for 
N av 1.8 1-120 binding. Previous work has shown that annexin 2 is unable to bind to N av 1.8, 
but does bind to a distinct site on pi 1. This means that any reduction in FRET signal observed 
would be due to non-specific effects. Annexin 2 1-14. however, was unable to decrease the 
FRET signal in this assay, even at relatively high concentrations. This supports our assertion 
that the FRET signal originates from site-specific protein-protein interaction between pi 1 and 
Nav E 8  1-120.
The models and parameters used to describe these interactions apply only if the system is at 
equilibrium. We therefore investigated equilibration time for binding to ensure that this was 
the case. Readings were taken immediately and after 5, 10 and 30 mins. No substantial 
differences were observed, although immediate readings very' occasionally appeared to have 
slightly higher variability. This was ascribed to plate handling procedure. Readings for 
subsequent experiments were therefore taken after 5-10 mins incubation. Additionally, various 
reaction volumes were tested. It was found that a total volume o f  50pl allowed reproducible 
and accurate pipetting whilst conserving reagents.
3.3.3 Annexin 2 and N av 1.8 bind to distinct sites on p l l
To determine whether annexin 2 and Nav 1.8 are likely to bind p l l  simultaneously, we 
investigated whether the binding sites overlap. The N-terminal 14 amino acids o f  annexin 2 
were used for this experiment, using the competition assay format described in the previous
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section (note that prevention o f  simultaneous binding would not prove overlapping sites, but 
simultaneous binding is unlikely to occur if sites do overlap). Fixed concentrations o f  labelled 
pi 1 and annexin 2 (1-14) were used to generate a FRET signal. Increasing concentrations o f  
unlabelled annexin 2 (1-14) o r N a v 1.8 were used to compete for this interaction, measured by a 
reduction in FRET signal. Unlabelled annexin 2 (1-14) was able to displace labelled annexin 2 
(1-14) from p l l ,  as would be expected (Figure 3.6a). with an ICs() o f  2.5j.iM. Unlabelled 
N av 1.8 1-120. however, was unable to compete with labelled annexin 2 (1-14) for pi 1 binding 
in the concentration range tested (Figure 3.6b).
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Figure 3.6 FRET com petition assays illustrating distinct binding sites for annexin  2 and N a v 1.8 on
p l l .  a: Competition for the annexin 2 (l-l4)-Cy3 - Cy5-pl l interaction by unlabelled annexin 2. b: No 
competition for this interaction by unlabelled NavE8  l-l 20.
3.3.4 A m ino  acids 74-103 o f  N av 1.8 are sufficient to bind p l l
Previously it was shown that amino acids 74-103 o f  Nav E 8  are sufficient for binding to pi 1 
(Poon et al., 2004). We tested the ability o f the fragment N av 1.8 74-103 to compete with 
labelled N av 1.8 1-120 for p l l  binding in the FRET assay. Nav 1.8 74-103 was found to 
compete effectively with Nav 1.8 1-120, but displayed a reduced affinity for pi 1. Figure 3.7 
illustrates a typical assay to measure the affinity o f  unlabelled N av 1.8 74-103 for p l l ,  
competing for binding against labelled Nav 1.8 1-120. The IC5 0 measured for N av 1.8 74-103 
was 1.02±0.17pM (therefore K,=340±57nM), approximately 2-3 times that o f  N a y l - 8  1-120 
(p=0.035, 1-tailed t-test). At high concentration, however, Nav 1.8 74-103 is able to extinguish 
most non-background FRET, implying that both can not bind simultaneously. A small amount 
o f  residual FRET was observed in some assays, particularly in older protein preparations, and is 
likely to be due to deterioration o f  the protein over time. This was also observed for older 
preparations o f other Nav l . 8  fragments.
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Figure 3.7 C om petition  o f  the C y 3-N a v 1.8 - C y5-p l 1 interaction by unlabelled N av 1.8 74-103.
3.3.5 A m ino acids 2-40 o f  N av 1.8 do not interact with p i  1
Deletion o f amino acids 2-40 had no effect on IC5(, or other parameters (1C50: Nav 1.8 1-120 
0.330±0.088pM; Nav 1.8A2-40 0.399±0.092pM; p=0.600) (K,: N av 1.8 1-120 110±29nM; 
N av 1.8A2-40 133±31nM; p=0.600) (Figure 3.8). We therefore conclude that these residues do 
not take part in the pi 1-Nav 1.8 interaction.
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Figure 3.8 C om petit ion  by A2-40. Competition of the Cy3-Nav l.8 - Cy5-pl I interaction by unlabelled 
Nav l . 8  A2-40 (dotted line) and Navl . 8  l- 1 20 control (solid line).
3.3.6 A m ino acids 41-80 o f  N av 1.8 interact with p i  1
Deletion o f amino acids 41-80 caused a reduction in affinity for pi 1 o f  approximately 3-fold 
(ICso N av l . 8  1 - 1 2 0  0.323±0.006pM; Nav 1.8A41-80 1,083±0.091 pM; n=4: p=0.003) (K,: 
N av l . 8  1-120 108±2nM; Nav 1.8A41-80 361±30nM; n=4; p=0.003). Nav l .8A41-80, however, 
retained the ability to bind to pi 1 , and was able to compete with the tracer to the same extent as 
N av 1.8 1-120 at high concentration (Figure 3.9a). The peptide consisting o f  amino acids 41-80 
o f Nav 1.8 (Nav 1.8 41-80) showed an affinity for pi 1 comparable to that o f  full-length N av 1.8
1 - 1 2 0  (IC5o ratio 0.92; n=3; p=0.83) (Figure 3.9b).
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Figure 3.9  Binding at residues 41-80. Competition of the Cy3-Nav1.8 - Cy5-pl 1 interaction by: a: 
unlabelled Nav1.8 A41-80: b: Nav 1.8 41-80. Dotted lines represent fragments, while solid lines show 
Nav 1. 8  1 - 1 2 0  control.
3.3.7 A m ino  acids 81-120 o f  N av 1.8 inhibit N av 1.8 1-120 binding to p i  1
Amino acids 81-120 were expected to be essential for the pi 1-Nav 1.8 interaction, since the 
predicted binding domain is contained largely within this region. Deletion o f these residues, 
however, caused a noticeable (~5-fold) increase in affinity for p l l  (IC 50 N av 1.8 1-120 
0.398±0.050pM; Nav l .8A81-120 0.081±0.008pM; n= 6 : p=0.001) (K,: Nav 1.8 1-120 
133±17nM; Nav l .8A81-120 27±3nM: n=6 ; p=0.001), suggesting an inhibitory or obstructive 
role for these residues in p l l  binding. Figure 3.10a shows the results o f  a representative 
competition assay. Since this result was surprising, the data were verified by direct binding 
assay. A81-120 was labelled with Cy3, and was added at increasing concentrations to a fixed 
amount (250ngAvell) o f  p l l ,  with data shown in Figure 3.10b. This was compared to the 
binding curve for N av 1.8 1-120. The Kd o f N a v 1.8 81-120 was found to be approximately 4- 
fold lower (i.e. 4-fold higher affinity) than that of Nav 1.8 1-120 (81-120 Kd=26.04±3.16nM), 
consistent with the competition assay results.
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Figure 3 .10 Inhibition o f  interaction by residues 81-120. a: Competition of the Cy3-Nav 1.8 - Cy5- 
pl 1 interaction by unlabelled Nav 1.8 A81-120 (dotted line) and Nav 1.8 1-120 control (solid line), b: 
Titration of Cy3-Nav 1. 8  A81 -120 against 250ng pl l .
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3.3.8 Sum m ary
Amino acids 2-40 o f N av 1.8 do not take part in the N av 1.8-pl 1 interaction, since deletion of 
these residues has no effect on affinity. Deletion of residues 41-80 reduced affinity for pi 1 by 
approximately 3-fold, while residues 41-80 alone were able to bind p l l  with affinity 
comparable to Nav 1.8 1-120. Deletion of residues 81-120 increased affinity for pi 1 by 4-5- 
fold. Residues 74-103 were able to bind to pi 1. but with an affinity around 2-3 times lower 
than that o f  N av 1.8 1-120.
3.3.9 3-am ino acid deletions in the region 74-103 o f  N a v 1.8 have subtle  
effects on affinity for p l l ,  but do not prevent binding
We attempted to locate the residues critical for binding p l l  in the proposed interaction domain 
(74-103) o f  N av 1.8 by deleting sections o f 3 amino acids from this region, then examining 
changes in affinity for pi 1. In each case, the ability o f  mutant proteins to displace labelled 
N av 1.8 1-120 was compared to wild-type unlabelled Nav 1.8 1-120. Example competition 
assays are shown in Figure 3.11, and the results summarised in Figure 3.12 and Table 3.3. 
Deletion o f  residues EPF or DPF was found to decrease affinity for pi 1 (p<0.05), implying that 
these residues are involved in the interaction with p l l .  Deletion o f residues YST or GRT 
increases affinity for p l l  (p<0.05), showing that these residues mediate the residue 81-120 
inhibition o f the interaction. Deletions of the residues between YST and GRT also show a 
trend towards increased affinity, but this was not found to be significant (AHRT p=0.138, 
AFNK p=0.062). Additionally, deletion of residues FIG or FNK appeared to increase affinity, 
but this effect was not found to reach significance (p=0.064, p=0.062 respectively). This may 
be an allosteric effect via nearby residues, or only a portion o f  an interacting/inhibitory region 
may be contained within each deletion.
/-tests were performed on raw data rather than on relative (ratio) data, to avoid problems with 
non-normal distributions o f ratios.
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Figure 3.11 Exam ples o f  3 -am in o  acid deletion
assays. Competition of the Cy3-Nav 1.8 - Cy5- 
pl 1 interaction by unlabelled mutant Nav 1 . 8  
(dotted lines) and Nav 1 . 8  1 - 1 2 0  control (solid 
lines).
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Figure 3.12 Effects o f  3 -am ino acid deletions. Summary of the effects of 3-amino acid deletions on 
affinity for pi 1. relative to Nav1.8 1-120 control. Internal controls were used for each experiment. An 
increase in relative K, indicates a reduction in affinity for pi 1. *p<0.05. **p<0.01. Error bars represent 
SEM.
Mutant Relative Kj SEM
N ayl.8 1-120 1 0.042534
A74-76 (LIG) 0.621926 0.140270
A77-79 (EPL) 2.801114** 0.233456
A 83-85 (DPF) 1.891907* 0.204136
A86-88 (YST) 0.270146* 0.012406
A89-91 (HRT) 0.448688 0.167565
A92-94 (FM V) 0.677061 0.049715
A95-97 (LNK) 0.413666 0.099779
A98-100 (GRT) 0.361565* 0.071078
A101-103 (ISR) 1.340576 0.234789
Table 3.3 S u m m ary  o f  effects o f  3 -am ino acid deletions. Summary of the effects of 3-amino acid 
deletions on affinity for pl l ,  relative to Nav 1.8 1-120 control. An increase in relative Ki indicates a 
reduction in affinity for pi 1 compared to control. *p<0.05, **p<0 .0 1 .
106
3.3.10 N a y l.8  74-81 is sufficient to bind p l l
The subtle effects o f  small deletions in the predicted pi 1-binding domain o f  N av 1.8 prompted 
the design o f an alternative experimental strategy. Rather than searching for a mutation that 
would prevent the interaction, we attempted to identify the smallest fragment o f  the predicted 
binding domain that would retain the capacity to bind p l l .  The peptide 74-103 was first 
divided into 2 sections, then each o f these divided in half again. Competition binding 
experiments were performed for each peptide, shown in Figure 3.13a. Nav 1.8 74-88 retained 
the ability to interact with pi 1. with an ICso o f 7.229±2.012pM (n=4) (K =2.4±0.7pM). N av 1.8 
89-103, however, did not cause a noticeable reduction in FRET signal in the concentration 
range tested. This implies either that N a v l . 8  89-103 is not capable o f  binding to pi 1 in a site- 
specific manner, or that it does so with such reduced affinity that the effect is not apparent 
within the range o f  concentrations tested.
O f the smaller fragments tested, only Nav 1.8 74-81 retained the ability to bind to p l l .  albeit 
with a reduced affinity compared to Nav l . 8  1-120 (Nav l . 8  74-81 ICsq 23.641 ± 11,892pM; n=3) 
(K,=7.9±3.9). This is shown in Figure 3.13b. The other small peptides were not able to bind 
pi 1 at the concentrations tested.
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Figure 3 .13 Localisation o f  binding site to residues 74-81. a: Competition of the Cy3-Nav 1. 8  - Cy5- 
p ll  interaction by unlabelled Nav1.8 74-88 (dotted line) and NaV1.8 1-120 control (solid line), b: 
Competition of the Cy3-Nav 1.8 - Cy5-pll interaction by unlabelled Nav 1.8 74-81 (dotted line) and 
NaV1.8 1-120 control (solid line).
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3.3.11 Sum m ary o f  Results
For ease of comparison, results are summarised in Figure 3.14.
Protein Relative Kj
N a v l . 8  1-120 -------------------------------------------------------------------------------------  1
N a v l . 8  A2-40 _____________________________________  1.21
N a v l . 8  A 41-80 ----------------------------  ----------------------------  2.98
N a v l . 8  41-80 __________________  0.92
N a v l . 8  A81-120 --------------------------------------------------------  0.20**
Nav l . 8  A74-76------------------------------------------------------------------------------------------  0.62
N a v l . 8  A77-79------------------------------------------------------------------------------------------  2.80
Nav l . 8  A80-82___________________________________________________________ N/A
Nav 1. 8  A83-85 -------------------------------------------------------------------------------------1,89:
* *
N a v l . 8  A8 6 - 8 8  ------------------------------------------------------------------------------------- 0.27*
N a v l . 8  A 8 9 - 9 1 ________________________________________________________ 0.45
Nav l . 8  A92-94 ------------------------------------------------------------------------------------- 0.68
N av l . 8  A95-97 ------------------------------------------------------------------------------------- 0.41
N a v l . 8  A98-100 ------------------------------------------------------------------------------------- 0.36*
N a v l . 8  A 1 01-103 ________________________________________________________ 1.34
N a v l . 8  74-103 ______________  1.82*
N a v l . 8  74-88   13.94**
Nav l . 8  74-81   19.75**
Nav l . 8  89-103 _______ > 1 , 0 0 0
Figure 3 .14 S u m m ary  o f  results. Summary of the involvement of Nav 1.8 residues on affinity for pi 1. 
Relative K, is defined as K, (protein)/K, (Nav1.8 1-120). A decrease in relative K, corresponds to an 
increase in affinity for pi 1. *p<0.05, **p<0.01 (tests performed on raw data).
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3 .4  D i s c u s s i o n
3.4.1 F R E T -based  assays are suitable for the quantitative investigation  o f
protein-protein  interactions
Our data show that this assay system is a powerful tool for the investigation o f  protein-protein 
interactions. Traditional (generally antibody-based) methods, such as GST pull-down and 
immunoprecipitation, are at best considered semi-quantitative with respect to assessment o f  
interaction strength. The detection of interactions is subject to arbitrary factors, such as wash 
stringency and binding conditions, meaning that only large changes in affinity can be detected 
reliably. FRET-based in vitro binding and competition assays allow more quantitative 
measurement o f  interaction affinity, using well-characterised pharmacological analyses. We 
have found measurements o f  affinity' to be highly reproducible both within and betw een protein 
preparations, allowing the detection o f changes in affinity o f  less than 2-fold. Additionally, 
using FRET to measure interactions in vitro allows the assay to be performed in physiological 
buffers, modelling more closely the conditions under which the interactions occur in vivo. The 
use o f  highly purified proteins means that non-specific binding is reduced, and the possibility 
of  an alternative interaction influencing results is removed. The lack o f  intermediary proteins 
also means that direct interaction can be implied.
In order to be certain that the in vitro FRET signal observed was a direct result o f  a site-specific 
protein-protein interaction, it was necessary to show that it satisfied the requirements o f  models 
resulting from the law of mass action, and could therefore be described in terms o f  a chemical 
reaction between the two proteins. Titration curves showed saturation at high concentrations o f 
Nav 1.8 1-120, implying that p l l  levels were limiting the FRET signal. Saturation is a key 
feature o f  site-specific interactions, and generally does not occur for non-specific phenomena. 
Titration curves also fit extremely well to the single-site binding model previously described. 
This demonstrates that the FRET signal followed the expected behaviour o f  a site-specific 
interaction. Titration curves produced from increasing concentrations o f pi 1 against a fixed 
concentration o f  N av 1.8 1-120 were found to have similar properties. Competition binding 
assays were also used to show that the FRET signal observed resulted from a site-specific 
interaction between pi 1 and Nav E 8  1-120. Data from these assays were found to fit the one- 
site competition model described previously. The ability o f  unlabelled protein to compete for 
the interaction site, therefore reducing the FRET signal, is clear evidence that the FRET is due 
to a specific interaction. The high affinity for this competition (K, ~100nM) supports this 
observation, since non-specific effects are generally o f  much lower affinity. Finally, the
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inability o f  annexin 2 to compete for N av 1.8 1-120 binding is persuasive evidence o f a site- 
specific interaction. Annexin 2 binds to pi 1 at a distinct site to N av l . 8  (Rety et al., 1999). but 
is unable to reduce FRET, demonstrating that only proteins binding to a specific site are 
capable of competition.
3.4.2 T he N a v 1 .8 -p l l  interaction is best described by a single-site binding  
m odel
Data from the N av 1.8-pl 1 interaction assays were found to fit well to single-site binding and 
competition models. The loss o f  degrees o f  freedom when switching to 2-site models was 
found to outweigh any improvement in fit, as shown by F -test values. It is important to note, 
however, that 2 -site binding applies to situations where the molar interaction ratio is 1 :2 . 
Where a 1:1 interaction occurs via 2 sites on each protein (i.e. the 2 sites are attached), the 
interaction is best described by a one-site interaction model. In effect. 2 attached domains are 
modelled as a single site, with affinity given by the sum of affinities o f  the 2 attached sites. In 
reality, the situation may be more complex, since binding at the second site may be facilitated 
by binding at the first. In practice, however, a single-site model remains the best method to 
describe this type o f  interaction, since binding at only one site is likely to be an extremely 
transient process, meaning that the vast majority o f  proteins will be either free or fully bound, 
and that partially-bound pairs are unlikely to make a major contribution to the FRET signal. 
This is supported by the fact that unlabelled fragments o f  N av 1.8 1-120, such as Nav 1.8 74- 
103. are able to quench completely the FRET resulting from N av 1. 8  1 -120 -  p 11 interaction.
3.4.3 A m in o  acids 77-85 o f  N av 1.8 are the critical residues in the 74-103  
binding dom ain
Poon et al. (2004) identified amino acids 74-103 o f N av 1.8 as the domain required for binding 
to pi 1. using a GST pull-down assay. Our results show that this fragment is capable o f  binding 
to p l l .  Using the FRET assay, however, we were able to discern a significant reduction in 
affinity for pi 1 compared with the full length N-terminus (Nav 1.8 1-120). We employed this 
assay to characterise the binding site further. The peptide consisting o f  amino acids 74-88 o f 
Na v E 8  retained the ability to interact with p l l ,  whereas the peptide 89-103 did not. The 
peptide 74-88 was then divided into 2 sections, 74-81 and 82-88, o f  which only the former was 
found to retain pi 1-binding activity. We therefore conclude that amino acids 74-81 o f  N av 1.8 
are the pi 1-binding residues in the Nav 1.8 N-terminus. The affinity o f  this peptide, however, 
was greatly reduced compared to the fragment 74-103. This may suggest that residues other 
than 74-81 form part o f  the binding site. It is possible that both fragments 74-81 and 82-88
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contain a portion o f the binding domain, but that the part retained by the latter is not sufficient 
for binding to occur at the concentrations tested.
Data from the 3-amino acid deletion proteins appear to support this hypothesis. Residues 77-79 
and 83-85 both cause a marked loss o f affinity for pi 1 when deleted (80-82 not tested), and are 
therefore likely to be involved in the interaction. It is possible that residues 83-85 affect 
binding via an allosteric mechanism, but the most likely explanation is a direct role in binding 
p l l .
Deletion o f  residues 74-76 o f  Nav 1 . 8  caused a moderate increase in affinity for p l l .  which was 
not found to be statistically significant (p=0.06). Regardless o f  whether this effect is real or 
not, the observation precludes a role for these residues in binding p l l .
Combining these observations allows us to build a picture of the N a \1 .8 -p l l  interaction at 
residues 74-103. Our evidence identifies residues 77-85 o f  N av 1.8 as those required to interact 
with p l l .  These residues possess a characteristic cluster of acidic groups (see Figure 3.15) that 
are well-conserved in other species (mouse, rat. human and dog). The acidic nature o f these 
amino acids may be important for the Nav l .8 -pl 1 interaction, although this has yet to be tested. 
The region 77-85. however, shows a fairly high degree o f  homology with other VGSCs. 
although complete identity is not seen. Evidence from GST pull-down experiments suggests 
some interaction between the N-termini o f  other VGSCs and p l l .  although their relative 
affinities are not known (Poon et al.. 2004).
o oo o • •  •  •  •
Navl • 8 "4LIGEPLEDLDPFYSTHRTFMVLNKGRTISR1J3
Navl. 2 73M-S----------Y-INKK--I------KA--- 102
Navl . 5 70-I----------------QK--L------K--F-105
Navl . 7 7°M------------ Y-ADKK--1------KAIF-"
Navl. 9 73--AK-----------KD-K--I------K--Y-102
Figure 3 .15  H um an N av 1.8 74-103: com parison with other V G SC s. Acidic amino acids (on Navl .8 ) 
are marked by white circles, while basic residues are identified by black circles. A putative (3-strand is 
underlined.
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3.4.4 An additional b inding site at residues 41-74
We observed a significant reduction in the affinity o f  the fragment 74-103 for pi 1 compared 
with the full-length N av 1.8 N-terminus (1-120). This led us to hypothesise that there may be 
other residues involved in or capable o f binding to p l l  in the Nav 1.8 N-terminus. The 
fragment 41-80 binds with an affinity identical to that of the full length N-terminus. despite it 
lacking the major portion o f the 77-85 binding site. W hen residues 41-80 are deleted, affinity 
for pi 1 is markedly reduced. Since the fragment 41-80 binds with higher affinity than 74-103. 
it appears that residues outside the 74-103 region are involved in the binding interaction. The 
relatively subtle effects o f  3-residue deletions in the 77-85 binding domain are most readily 
explained by an additional interaction outside this region.
The lack o f  effect o f  deletion o f residues 2-40 allows the localisation of this additional 
interaction domain to amino acids 41-74. This region was not detected in earlier studies on the 
pi 1 -Nav I - 8  interaction (Poon et al.. 2004). which identified an interaction only in the region 
74-103. It is possible that the greater sensitivity o f  the current study enabled the detection of 
the additional binding region, whereas methodological factors prevented its discovery 
previously. For example, the GST pull-down assays used before rely on washing steps of 
variable stringency to remove background. These steps are often adjusted to give a single, 
distinct band on the membrane, meaning that the band containing the 41-80 interaction domain 
may have been removed from the gel as part o f  the background. Alternatively, this discrepancy 
may be due to the way in which the full-length construct was divided. Poon et al. (2004) tested 
the fragments 1-25. 26-50 and 51-127, and subsequently concentrated on the latter region. It is 
therefore possible that a sequence capable o f  interaction with p l l  in the region 41-80 was 
divided by this division scheme, rendering each section incapable o f  interaction. This 
explanation would require the inclusion o f  amino acids 50-51 in the interaction domain, which 
could be investigated in further studies.
Interestingly, the presence o f an additional binding site provides a mechanism for the 
selectivity o f  pi 1 for Nav 1.8 compared to other VGSCs. Since the binding region 77-85 is 
relatively well conserved, an alternative mechanism for specificity is required. The region 41- 
80 shows low homology to other VGSCs, as illustrated in Figure 3.16, supporting this 
hypothesis. Significantly, there are a number o f  domains common to other VGSCs that are not 
conserved in Nav 1.8. evident in Figure 3.16. These domains may explain the specificity o f  
binding observed.
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Figure 3 .16  A lign m en t o f  protein sequence for hum an V G S C s. Generated using NCB1 Blast.
The existence o f a second binding domain is consistent with the observation that a substantial 
seetion (residues 33-78) o f  pi 1 is required to bind N av l .8 . It was found that the division o f this 
region into smaller fragments, 33-51 and 52-77, prevented the interaction (Poon et al.. 2004). 
This region consists o f  the loop connecting the 2 EF hands o f pi 1 and the first a-helix of the 
second EF hand. While the inactivity o f  the smaller fragments could be due to the disruption of 
the binding domain, it is possible that the entire region 33-78 is involved in the interaction, 
fitting with the presence o f  2 binding domains on N av l .8 . A hydrogen bond connects residues 
48 and 54, which may be important for the pi l-N av E 8  interaction, since it is disrupted in the 
smaller fragments. By analysing the 3D structure o f  p l l .  Poon et al. (2004) predicted 2 
possible areas for the Nav l . 8  binding pockets. In the 2-site model proposed here, both o f these 
areas may bind to N av l .8 , providing a match for each site on Nav l .8 .
3.4.5 R esidues 86-100 o f  N a v 1.8 contain an inhibitory dom ain  for the  
N a v 1 .8 -p l l  interaction
We found that deletion o f residues 81-120 o f Nav l . 8  eauses a substantial increase in affinity for 
p l l .  If residues 74-103 constituted the binding site for pi 1, the opposite effect would have 
been predicted. This was investigated further. Deletion o f  residues 8 6 - 8 8  or 98-100 was found 
to produce a statistically significant increase in affinity, although with slightly reduced 
magnitude. Deletion o f  the intervening residues 89-91, 92-94 or 95-97 did not produce a
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statistically significant difference, but all showed a strong trend towards increased affinity 
(p=0.13, 0.46 and 0.06 respectively ). Since the effect o f  residue deletion beyond amino acid 
103 was not investigated, it remains possible that amino acids 104-120 contribute to the 
increase in affinity observed on deletion o f  residues 81-120. The effect o f  3-amino acid 
deletions in the region 8 6 - 1 0 0 . however, is sufficient to account for the increased affinity 
following residue 81-120 deletion, meaning that the involvement o f  residues 104-120 is not 
required to explain this observation. We therefore conclude that it is residues 8 6 - 1 0 0  o f  Na v l . 8  
that exert an inhibitory effect on the Nav l -8 -pl 1 interaction.
The mechanism o f  this inhibition, however, is unclear. The lack o f cysteine residues in this 
region precludes a role for disulfide bonding. 4 o f  the 15 residues are in a characteristic cluster 
o f  basic amino acids, not shared with other VGSCs but well conserved between species 
(mouse, rat. human and dog), surrounding a putative (3-strand (see Figure 3.15). It is possible 
that acid-base interactions occur between these residues and the acidic residues identified in the 
predicted binding domain. 77-85. reducing the accessibility o f  the binding residues to p l l .  
Alternatively, the effect of residues 86-100 may be via an inhibitor) effect on the binding 
domain identified in residues 41-80. The inhibitor) residues may act bv repelling moieties on 
pi 1. altering the Gibbs free energy change upon interaction. Finally, the inhibitor) effect may 
be due to conformational parameters. The presence o f residues 86-100 may cause a steric 
inhibition o f binding at residues 77-85, which can be relieved by their deletion. Amino acid 
substitution experiments may help to define a mechanism for the inhibition.
The inhibition o f  the Nav 1.8-pll interaction by residues 86-100 also provides an alternative 
explanation for the increased affinity o f  N av 1.8 41-80 relative to Nav 1.8 74-103. Rather than 
the presence o f  an additional binding domain in the region 41-80. it is possible that the 
increased affinity is caused by the removal o f  residue 86-100-mediated inhibition. If this were 
the case, however. N av 1.8 74-103 would be expected to bind to p l l  with equal affinity to 
N av 1.8 1-120, since both contain the predicted binding site 77-85 and the inhibitor ) 7 domain 8 6 - 
100. The increased affinity o f Nav 1.8 1-120 provides strong evidence for the existence o f 
additional residues involved in the interaction with pi 1 . Additionally, the affinity for pi 1 of 
Nav 1.8 41-80 would be expected to be substantially reduced relative to the full-length protein, 
due to the deletion o f  residues 81-85. which are within the predicted binding site, although it is 
possible that this is outweighed by the reduction in inhibition. If residues 77-85 formed the 
sole binding site, the effects o f  the 3-residue deletions in this region would be expected to be 
far greater than observed, giving added weight to a 2-site interpretation o f the data. Overall, a
2 -site interaction provides the best explanation for our observations, and is consistent with all 
results obtained.
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3.4.6 A 2-site model for the N av 1.8-pl 1 interaction
Integration o f  the observations made so far allows us to propose a model for the N av l 8 -pl 1 
interaction. This model is illustrated in Figure 3.17. and consolidates the localisation o f  the 74- 
103 binding domain, the existence o f  a second binding region, and the presence o f  inhibitory 
residues. PKA and PKC phosphorylation sites were predicted using the NetPhosK 1.0 Server 
(Blom et al., 2004), and provide a putative mechanism of  regulation o f the interaction. In the 
FRET assay system, amino acids are unlikely to be phosphorylated, meaning that this is not 
taken into account. Since no information is available on the structure o f  this region, the shape 
shown below is purely hypothetical. In particular, the putative acid-base interactions shown are 
wholly speculative. The mechanism o f  inhibition by residues 86-100 is unknown, as discussed 
previously, and could be via an interaction with one o f the binding sites (illustrated in this 
model), a conformational effect, or steric inhibition o f the interaction with p l l .
1 2 0105
P-strand
^  (-)
1
85
Figure 3.17 Nav1.8 N-terminus domains, pi 1-binding site 1 shown by dark blue line, site 2 by light 
blue amino acids, inhibitory site by red amino acids. Circles represent neutral amino acids, squares 
acidic residues and hexagons basic residues. Phosphorylation sites shown by open circles: Red - PKA; 
Green - PKC. Putative P-strand shown by white rectangle. Potential inhibitory effects shown by red 
lines with blocked ends. Hypothetical acid-base interactions shown by dotted lines.
The validity o f  this model was examined by comparison to predicted secondary structures o f  
the Nav 18 N-terminus. Secondary structure was predicted using an ab initio method, 
HMMSTR, a hidden Markov model based on the I-Sites library o f  sequence-structure motifs 
(Bystroff et al., 2000;Bystroff and Shao, 2002). Visualisation o f  the output form this process 
was performed using the programme RasTop (http://www.geneinfinitv.org/rastop/) (Philippe 
Valadon, 2007). The structure generated appears compatible with the model in Figure 3.17, 
and is shown in Figure 3.18. In particular, predicted inhibitory residues seem to be in a 
position compatible with inhibition o f  binding at the site 77-85.
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Figure 3 .18 Predicted structure o f  Nav 1.8 N-terminus. Amino acids 71-115 shown, from bottom left 
to top right. Yellow arrows (pointing towards C-terminus) represent p-sheets, red coils helices, blue 
lines turns, and green lines randomly coiled regions. The first helix contains residues 82-89.
3.4.7 C om parison  with other p i 1 interactions
O f the proteins identified as binding to p l l ,  a detailed analysis o f  the binding site has been 
performed only for TASK-1 (Girard et al., 2002;Renigunta et al., 2006) and TRPV5/TRPV6 
(van de Graaf et al., 2003). For TASK-1, conflicting evidence implicates pi 1 in the masking o f 
endoplasmic reticulum retention sites (Girard et al., 2002) or the retention in the endoplasmic 
reticulum via motifs in the C-terminal region o f  pi 1 (Renigunta et al., 2006). The trafficking 
mechanism for TRPV5 and TRPV6 , however, appears to be a more direct effect, with p l l  
required for channel transfer between a sub-plasma membrane area and the plasma membrane. 
The effect o f  pi 1 on N av1.8 appears to be similar to the effect on TRPV5/TRPV6, with no 
obvious endoplasmic reticulum localisation in the absence (or presence) or pi 1 (Okuse et al., 
2002).
3.4.8 Annexin 2 binds p l l  at a site distinct from that o f  Nay1.8
The role o f  annexin 2 (p36) in the trafficking o f  Nay 1. 8  is not clear. Current evidence suggests 
indirectly that annexin 2 is likely to bind pi 1 at the same time as N av 1.8, since the binding 
domains on p l l  do not appear to overlap. Amino acids 33-78 o f  p l l  were found to be 
responsible for the interaction with Nav l . 8  (Poon et al., 2004). According to the 3D structure 
o f  the annexin 2-pl 1 complex (Lewit-Bentley et al., 2000), based on both crystallographic and 
energy-modelling data, these residues are peripheral and exposed. It is therefore likely that pi 1
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can bind both annexin 2 and Nav 1.8 simultaneously. In the current study, we found that the 
N av 1.8 N-terminus was unable to displace annexin 2 from p l l .  strongly supporting the 
presence o f distinct binding sites on pi 1 for annexin 2 and N av 1.8. Given the probable molar 
excess o f  annexin 2 compared to pi 1 (Moss SE, personal communication), it is reasonable to 
predict the occurrence o f  an annexin 2 -pl 1-Nav l . 8  complex. The physiological significance o f 
this, however, is unknown. For example, does annexin 2 play a role in the insertion o f  N av 1.8 
into the plasma membrane? Detailed work on the molecular consequences o f  the pi 1-Nav 1.8 
interaction may yield answers to questions o f this nature.
Studies o f  other pi 1-interacting membrane proteins do not provide a consistent role for annexin 
2 in these complexes. While annexin 2 has been co-immunoprecipitated with TPRV5 and 
TRPV 6  (van de Graaf et al.. 2003). the annexin 2 binding site o f  pi 1 overlaps with the site for 
TASK-1 (Renigunta et al.. 2006). implying a mutual exclusivity o f  annexin 2 and TASK-1 
binding.
The stoichiometry o f  the pi 1-Nav 1.8 interaction remains unclear. Although our data support a 
1 : 1  ratio between pi 1 and Nav l .8 . whether the complex exists as a heterodimer, heterotetramer. 
or other conformation has yet to be deduced. Since pi 1 generally exists in dimeric form, the 
existence o f  a p l l - N a v 1.8 heterotetramer is plausible, although steric inhibition from the 
relatively bulky channel may prevent this.
3.4.9 Im portance  o f  the N av 1 .8 -p l l  interaction to analgesic drug discovery
The identification o f  an additional pi 1-interacting domain in N av 1.8 has important 
connotations for the drug discovery process. The Nav l .8 -pl 1 interaction has been proposed as 
a therapeutic target on several occasions (e.g. Okuse et al., 2002). Since N av 1.8 expression is 
restricted to a subset o f  primary afferent sensory neurons (Akopian et al.. 1996) and plays an 
important role in nociception (Akopian et al.. 1999). pharmacological agents targeted to this 
channel would be expected to be both specific and efficacious in their physiological effects. 
The search for a channel blocker specific to Nav 1.8, however, has proven troublesome, 
primarily due to the similarities between Nav 1.8 and other VGSCs in the pore domain. Actions 
at other VGSCs are likely to lead to serious side effects, particularly cardiac arrhythmias and 
CNS irregularities. Attention then turns to modulators o f  Nav 1.8 function, o f  which pi 1 has 
been studied the most extensively. By disrupting the Nav 1.8-pll interaction, it may be 
possible to reduce channel function to a level comparable to that o f  a pore-blocking compound, 
without affecting other VGSCs, which do not interact with p l l .
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To allow the intelligent design o f small molecule or peptide inhibitors o f  the N av 1.8-pll 
interaction, precise knowledge o f the protein domains involved is required. For small molecule 
inhibitors, this allows the design o f chemical entities designed to fit the secondary protein 
structure, with the positioning o f  active moieties such that access to the intended amino acids is 
facilitated. Peptide inhibitors can be modelled on the target sequence, but often exhibit reduced 
cellular penetration and therefore efficacy as their si/e increases. It is therefore advantageous 
to have a precise understanding o f the binding domain, allowing the identification o f small 
regions critical for the interaction and therefore the use o f smaller, more permeant peptides to 
disrupt the interaction.
The 2-site + inhibition model proposed, however, does not lend itself well to drug design, due 
to the need to target multiple sites. Our results suggest that the disruption o f a single binding 
site would be insufficient to achieve a meaningful reduction in binding in the cell. For 
example, complete ablation o f the 74-103 region produces a reduction in affinity o f  around 2- 
fold. Fven given a highly efficacious block o f  this site, a clinically-ev ident reduction in Nav l .8 
trafficking would be highly unlikely. For an efficacious disruption o f the interaction, an 
inhibitor would be required to act at both sites. Small molecules would be required somehow 
to disrupt both interactions, possibly by causing a conformational change in the structure o f the 
Nav 1.8 N-terminus. Peptides could potentially be designed to block both sites, but would be 
large as a consequence. Since the desired site o f action is intracellular, this is likely to prove a 
barrier to the therapeutic efficacy of a peptide. The use o f  carrier groups, targeting for example 
the transferring receptor, to improve transport across the plasma membrane, may be able to 
overcome this limitation. An alternative strategy would be the combined use o f a pair of 
agents, one targeting each interaction site. This has the limitation o f requiring two rounds o f 
the drug screening process, which is both labour- and resource-intensive.
While disruption o f  the Nav 1.8-pl 1 interaction may not affect other VGSCs, the possibility of 
unwanted effects due to disturbance o f other pi 1-membrane protein interactions remains. 
Proteins currently identified as binding to pi 1, including TASK-1. TRPV5/6. A SIC la  and 5- 
H T ib. play important roles in a variety o f  physiological processes, as discussed previously. 
Since the residues o f pi 1 which interact with each o f these proteins have yet to be identified, 
predicting the effect o f  inhibitors o f  the p l l - N a v 1.8 interaction on these processes is 
problematic.
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3.4 .10 FR E T  in teraction  stud ies are su itab le for use w ith  other proteins
The FRET assay used in this study was found to be a useful tool for the investigation of 
protein-protein interactions. Importantly, neither the His-Tag used for protein purification nor 
the Cy3/5 labelling was found to interfere with the interaction. The assay was performed under 
near-physiological conditions, allowing proteins to assume their natural conformation and 
therefore permitting physiologically-relevant interactions to take place. Methods o f  assessing 
protein-protein interaction in culture or ex vivo often require harsh conditions for protein 
extraction, especially for membrane-associated proteins, which can disrupt interactions. The 
use o f a bacterial expression system allows the extraction o f  all types o f protein, followed by 
purification and transfer to a variety o f buffers. Additionally, the high purity o f the proteins 
means that problems due to interactions with or interference by other proteins are eliminated. 
The competition assay format, coupled with the high sensitivity o f  the FRET signal, allows the 
detection o f  relativelv small changes in affinity compared to other methods, allowing detailed 
analysis o f  interaction sites. This in vitro approach will therefore be useful for the study o f  a 
variety o f  protein-protein interactions.
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4 P l l  IN PAIN PATHWAYS
4.1 In t r o d u c t io n
The EF hand superfamily protein p l l  exists as a heterotetramer with the Ca~ - and 
phospholipid-binding protein annexin 2. It is unique among S I00 proteins in its Ca" 
independence due to a mutation in its EF hand loops, resulting in a permanently active 
conformation with respect to annexin binding (for review, see Gerke and Moss. 2002). pi 1 
plays an important role in the trafficking o f transmembrane proteins. It binds directly to several 
channels, regulating the functional expression o f the sensory neuron-specific Na channel 
Nav 1.8 (Okuse et al.. 2002). the acid-sensing ion channel ASICla (Donier et al.. 2005). the 
transient receptor potential vanilloid receptors TRPV5&6 (van de Graaf et al.. 2003). the 
TWIK-related acid-sensitive K channel TASK-1 (Girard et al.. 2002;Renigunta et al.. 2006). 
and the G-protein coupled 5-hydroxytryptamine receptor 5-HTm (Svenningsson et al.. 2006). 
A specialised function in pain pathways has been demonstrated for N av 1.8 (Akopian et al.. 
1999). while A SIC la  and 5-HT1B are expressed at high levels in nociceptive DRG neurons, 
suggesting a role in nociception (Svenningsson et al.. 2006:Voilley et al.. 2001). We therefore 
hypothesised that p l l  plays a role in nociception through its involvement in trafficking o f 
transmembrane proteins. Since different channels appear to bind to distinct sites on p l l .  
although not all have been mapped, the possibility o f  co-localisation through interactions w ith 
pi 1 is also raised. There are currently no small-molecule inhibitors o f pi 1 function, precluding 
the testing o f  our hypothesis by pharmacological means. We therefore considered the use of 
genetic technology to address this question.
4.1.1 G enetic  technology for the investigation  o f  protein  function
Technologies allowing the downregulation o f  pi 1 expression include antisense DNA, RNA 
interference (RNAi) and related techniques, conventional gene deletion in the mouse (“global 
knockout"), and conditional (tissue-specific) gene deletion. Antisense DNA uses single­
stranded DNA complementary to the mRNA o f  the target gene. Translation o f  the target 
mRNA is inhibited by steric inhibition (physical obstruction) o f  the translation machinery. 
This effect is stoichiometric; that is, one antisense molecule prevents the translation o f  a single 
mRNA. While relatively simple and rapid, this method does not always produce complete 
downregulation o f  the target gene, and is highly dose-dependent. As such, it is critical that the 
antisense DNA can access the target tissue efficiently, which can be problematic for relatively 
isolated areas, including DRG neurons. The restriction o f activity to a particular tissue or cell 
type, useful for mechanistic information, can be problematic. Specificity is also difficult to
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achieve in many cases, especially in the presence o f closely related proteins. Even in relatively 
favourable circumstances, it is likely that limited downregulation o f non-target proteins will 
occur.
RNAi is a naturally-occurring process by which degradation o f  target mRNA is controlled by 
short, non-coding RNA sequences. mRNA complementary to these short sequences is 
degraded by argonaute 2, part o f  the RNA-induced silencing complex (RISC). This pathway 
can be harnessed to effect protein downregulation by the introduction o f small inhibitory RNA 
(siRNA) strands complementary to the target mRNA. Longer double-stranded RNA molecules 
are generally not used in mammalian cells due to the induction of the interferon response. 
siRNA-mediated gene knockdown is catalytic in nature: one siRNA molecule can degrade 
multiple copies o f  the target mRNA. meaning that lower doses are required for efficacy. 
Specificity remains a problem, although to a lesser extent than with antisense mRNA. With the 
use o f  specific design software, it is estimated that around 10% of siRNAs will have substantial 
off-target effects (Qiu et al.. 2005).
Conventional global gene deletion produces mice lacking the gene for the protein o f interest, 
and therefore achieves the complete absence of target protein expression in all cells. This 
method is obviously efficacious, but does not allow mechanistic insights by restriction o f 
activity to a particular tissue. Additionally, compensatory upregulation o f other genes has been 
reported in several studies (e.g. Akopian et al.. 1999). complicating analysis, although the 
genetic mechanisms behind this are unclear. The process o f  creating a null-mutant mouse line 
is relatively slow and resource-intensive compared to other methods o f  investigation. The 
process is presently readily available only in the mouse, restricting the range o f  analysis that 
can be performed (for example, behavioural analysis o f  nociceptive thresholds is generally 
believed to be more sensitive in the rat). Conditional or tissue-specific gene deletion uses a 
site-specific recombinase under the control o f  a tissue-specific promoter to effect gene deletion 
only in the tissue o f interest. For proteins with distinct roles in multiple tissues, conditional 
gene deletion allows the investigation o f  a function in a single tissue, removing the 
confounding effects o f  functions in other tissues. This is dependent on the existence o f a 
suitable recombinase-expressing mouse line, available for a relatively large range o f  tissues.
The multiple roles o f  p l l  in various tissues and physiological processes, especially its 
involvement in depression (Svenningsson et al., 2006), suggest that global pi 1 deletion would 
give a complex and potentially confounded phenotype. Its sequence similarity to other S I00 
proteins means that antisense or RNAi would risk significant off-target effects. Since we wish 
to investigate p l l  function in DRG neurons, accessibility is also a limitation o f  these
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technologies. We therefore chose to use conditional gene deletion to delete pi 1 only from 
nociceptive sensory neurons, using the Cre-loxP system and expressing Cre recombinase under 
the control o f  the nociceptor-specific Nav l .8 promoter (Stirling et al.. 2005).
4.1.2 G ene targeting  and hom ologous recom bination
Gene targeting is defined as the site-specific modification o f a gene by homologous 
recombination (reviewed by Muller, 1999). Homologous recombination is a phenomenon 
occurring in mammalian cells, whereby two sections o f identical (or very similar) DNA "cross 
over” : the strands break and rejoin to their opposing partners, via an intermediate structure 
known as a Holliday junction. By designing an exogenous DNA construct with sequences 
homologous to the desired gene, specific parts o f DNA can be replaced with altered sequence. 
Recombination can occur at any point in the homologous region, and was first investigated in 
yeast. In mammalian cells, the targeting frequency is reduced due to the alternative pathway o f 
random integration, which is an important consideration when designing targeting constructs. 
The first successful instance o f gene targeting in mammalian cells was described by Lin et al. 
(1985). using a fibroblast cell line with a selectable locus, and achieved a recombination 
efficiency o f  around 1 cell in 106 (compared to modern methods, which allow an improved 
efficiency o f  around 1 in 104). This was followed by gene targeting at the endogenous (3-globin 
gene in erythroleukemia cells (Smithies et al.. 1985).
For successful gene targeting, the intelligent design o f  the targeting construct is essential. 
There are three essential components o f  a targeting construct: a region o f  homology at each end 
to mediate recombination ("arms of homology"), positive and negative selection markers, and 
the sequence for replacement, illustrated in Figure 4.1.
The arms o f  homology play a critical role in determining targeting efficiency. Since 
homologous recombination is relatively infrequent compared to random, non-homologous 
vector integration (in mammals), it is important to maximise the rate o f  homologous 
recombination. The length o f each arm of homology affects recombination frequency, with 
greater lengths increasing targeting frequency (Hasty et al., 1991;Thomas and Capecchi, 1987). 
Although recombination has been observed with less than 500bp (Hasty et al., 1991), at least 
2kb is desirable (Thomas et al., 1992). Recombination was found to occur in almost all 
introduced sequences when arms o f  homology greater than 5kb were used (Thomas and 
Capecchi, 1987). The degree o f homology between construct and endogenous DNA also 
affects recombination frequency (te et al., 1992). Significant variation between the two 
sequences involved can dramatically reduce the recombination frequency, due to the
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involvement of the DNA mismatch repair system. This is illustrated by the fact that targeting 
frequencies using non-isogenic vectors in cell lines with non-functional DNA mismatch repair 
genes are comparable to levels using isogenic constructs in normal cells (de et al., 1995). 
Choice of the appropriate strain for construct template is therefore important. In addition to 
length and degree of homology, the absolute frequencies of homologous recombination appear 
to be locus dependent, perhaps accounting for differences in chromatin structure (Muller, 
1999).
Since gene targeting frequency is relatively rare, the molecular screening of all potential 
transformants is not desirable. The use of enrichment schemes for correctly-targeted cells is 
therefore advantageous. Positive selection allows enrichment for cells that have stably 
incorporated the vector DNA. The gene Neo is often incorporated into the targeting vector, 
within the arms of homology, for this purpose. Neo encodes the protein neomycin 
phosphotransferase, which confers resistance to geneticin (G418). Cells unaffected by the 
presence of geneticin are therefore likely to contain the targeting construct. Since homologous 
recombination is relatively rare compared to random integration, however, many of the cells 
surviving geneticin selection will not contain correctly-targeted DNA. To enrich for cells 
containing the correct targeting event over those where random integration has occurred, 
negative selection is used. The most commonly used negative selection marker is the Herpes 
simplex thymidine kinase gene. This gene confers sensitivity to gancyclovir. By positioning 
this gene outside the region enclosed by the arms of homology, the gene will be incorporated 
by random insertion events, but not by homologous recombination. Cells surviving both 
selection steps therefore have a greatly increased chance of containing the correct targeting 
event.
Replacement 
Sequence
pBS pBS
Neo TK
5’ arm 3’ arm
Figure 4.1. G ene targeting construct design. This diagram illustrates the general form of gene 
targeting constructs, with pBS representing pBluescript, a vector used to contain the construct, Neo the 
positive selection marker, and TK the negative selection marker. 5’ arm and 3’ arm represent the arms of 
homology.
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4.1.3 P roduction  o f  a m utant m ouse
The process o f  gene targeting can theoretically be used in any cell type capable o f  homologous 
recombination. By targeting pluripotent embryonic stem (ES) cells, it is possible to create an 
entire animal containing the targeted allele. ES cells are derived from the inner cell mass o f  the 
blastocysts, and can differentiate into all cell types including, importantly, the gametes. In 
chimaeric mice, they are capable o f  contributing to all embryonic tissues. They can also be 
maintained in culture in an undifferentiated state by the use o f appropriate conditions (Evans 
and Kaufman. 1981:Martin. 1981). Transformed (successfully targeted) ES cells, from a 129 
strain (white) can be microinjected into a blastocysts from a C57B1/6 strain (black), which can 
then be implanted into the uterus o f  a pseudopregnant mouse (i.e. a surrogate mother). The 
chimaeric embryo generated by this process will then develop into an adult chimaera. itself 
capable o f  reproduction, and recognisable by coat colour. Since ES cells are capable of 
forming all tissues, a proportion of the gametes o f this mouse will derive from the implanted, 
transformed cells. If this is the case, the offspring o f  this chimaera will contain animals derived 
from the targeted cells, heterozygous for the desired mutation, with a brown coat colour. 
Homozygotes can then be produced by the use o f an appropriate breeding strategy. The 129 
strain is most often used for ES cell generation as it is the strain from which ES cells are most 
easily established, although this is possible for other strains (Kawase et al.. 1994).
Gene targeting is often used to produce null-mutant ("knockout") mice. While this approach 
can be extremely revealing, in some cases problems inherent in the design can prevent the 
collection o f  meaningful data (Joyner and Guillemot. 1994). For example, a recent paper 
examining the role o f  the sodium channel gene Scn9a  found that global deletion (from all 
tissues) caused perinatal lethality (Nassar et ah. 2004). preventing phenotypic analysis. Other 
gene deletions may have developmental effects, leading to gross morphological phenotypes 
which preclude analysis, or may affect the expression o f other genes, resulting in a complex 
phenotype. Even when the effects of gene deletion are relatively subtle, multiple actions in 
different tissues can hinder mechanistic explanations of gene function in a particular 
physiological process. The use o f site-specific recombinases provides a solution to many of 
these limitations.
4.1 .4  S ite-specific recom bination
Site-specilic recombinase systems have been exploited in numerous studies to delete genes 
only in specific tissues (e.g. Nassar et ah. 2004). Site-specific recombination, in contrast to 
other forms, requires an enzyme capable o f recognising specific DNA sequences on the 
recombining molecules. Recombination occurs with absolute fidelity, which is important for
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several applications o f  this process. Depending on the relative placement and orientation o f  the 
DNA recognition sites, various outcomes are possible as a result of recombination. Where both 
sites are present on a single molecule o f  DNA. in the same orientation, the region between the 
sites is excised as a circular fragment. By placing recombinase recognition sites flanking a 
particular gene, the action o f  the recombinase will excise this gene from the genomic DNA. 
The circular fragment produced is not replicated, and rapidly lost. These permutations are 
illustrated in Figure 4.2. Insertion o f the gene for a recombinase enzyme into the genome of a 
mouse, under the control o f  a tissue-specific promoter, allows conditional (tissue-specific) gene 
deletion to be effected (Takeda et ah. 1998;Tsien et ah, 1996). This facilitates the investigation 
o f  gene function in a particular tissue of interest, without confounding effects from actions of 
the gene in other tissues. This is particularly useful when global gene deletion is lethal (e.g. 
Nassar et ah. 2004).
The efficiency o f  site-specific recombination decreases with distance between recognition sites. 
For example, even using an exceptionally strong CMV promoter to drive Cre recombinase 
expression, including the addition o f a nuclear localisation signal, a 400kb genomic region was 
excised with around 50% efficiency (Nivva et ah. 1991). Although this in itself is impressive, 
when using site-specific recombinase systems to examine whole-animal behavioural effects, it 
is vital that the targeted gene is deleted in all cells in which the recombinase is expressed. 
Since main gene targets are relatively large, it is often not feasible to place recombinase sites 
flanking the entire gene. To address this problem, the location o f recombination sites can often 
be designed such that the translational ATG (methionine), the major part o f  protein coding 
sequence, or a section o f DNA essential for protein activity is deleted. In some cases, it is 
possible to place recombination sites such that a STOP codon is introduced upon excision. The 
introduction o f  more than one pair o f  recognition sites for the same recombinase is not 
generally desirable, due to the range o f recombination scenarios which may occur.
An additional use o f site-specific recombinases is the removal o f  positive selection markers 
from the genome following targeting. This is important due to the observation that the strong 
promoter present in the Neo cassette can affect the expression o f  nearby genes. Reduction in 
expression o f  the target gene (Fiering et al.. 1995). o f  surrounding genes (Olson et al., 1996), 
and o f  genes distant from the site o f  insertion (Pham et al.. 1996) have all been observed. This 
problem can be circumvented by using a site-specific recombinase to remove the Neo cassette 
before phenotypic analysis. In some cases, however, analysis o f  the allele with Neo remaining 
can be informative, giving information on the effect o f  a partial gene “knock-dow n” (Meyers et 
al.. 1998;Nagy et al.. 1998).
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4.1.4.1 The Crc/loxP  recombination system
Cre recombinase is a 38kDa protein produced by the PI bacteriophage. It is a member o f  the 
integrase family o f  site-specific recombinases. and catalyses recombination between two 
identical loxP  recognition sites without the need for additional cofactors or sequences. 
Recombination is catalysed regardless o f  cellular environment and properties o f  DNA. making 
it a powerful tool for alteration o f the mouse genome. The loxP  (/ocus o f  crossover .v in /H) 
site recognised by Cre is a 34bp consensus sequence, with a core spacer sequence o f  8bp 
Hanked by two palindromic 13bp sequences (Figure 4.2). The directionality o f  the loxP  site is 
determined by the orientation o f the central spacer sequence. Recombination occurs when one 
Cre molecule binds to each palindromic sequence of each loxP  site. The Cre molecules form a 
tetramer. which brings two loxP  sites into conjunction (Voziyanov et al.. 1999). The enzymatic 
activity o f  the recombinases catalyses the DNA cutting, exchange and resealing reactions 
within the core spacer region, forming a small heteroduplex joint at the point o f  union. The 
recombination process is conservative, meaning that the reverse reaction exactly reproduces the 
original sequences. The rate o f  the reverse reaction, however, is slow, due to the need for 
accessory proteins not expressed in mammalian cells.
Importantly. loxP  sites are sufficiently small that insertion into an intron is unlikely to interfere 
with normal gene expression in the absence o f Cre recombinase. The random occurrence o f a 
34bp sequence, however, requires a length o f DNA o f  10l8bp (Nagy. 2000). Since the mouse 
genome is only around 3 x 10'’bp. the likelihood o f  an endogenous loxP  site occurring is small. 
It was therefore thought that the mouse genome contains no endogenous loxP  sites. It was 
shown, however, that Cre can mediate recombination between sequences divergent from the 
loxP site, and that pseudo-/av sites exist in the mouse genome (Thyagarajan et al.. 2000). For a 
review o f  the Crd lo xP  sy stem in mouse genetics, see Nagy (2000).
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5 ’ ATAACTTCGTATA A T G T A T G C T ATACGAAGTTAT 3 ’ 
5 ’ TATTGAAGCATATTACATACGATATGCTTCAATA 3 ’
B
D eletion  In version
t>  — I X — 4
t> loxP site
C re recom b in ase  
m on om er
D N A  seq u en ce
Figure 4.2 T he C re-loxP recom bination system . The loxP sequence is shown in the uppermost panel, 
with the non-palindromic core indicated in bold. A: Deletion of intervening sequence between 2 loxP 
sites orientated in the same direction. B: Inversion of sequence between 2 inverted loxP sites.
4.1 .4 .2  T h e F lp /FRT  recom bination  system
In many cases, it is desirable to use site-specific recombination for multiple purposes in the 
same construct, most commonly for effecting excision of the positive selection marker, then 
deleting the gene under investigation. Although this is possible using partial excision with a 
single recombinase system, this approach is inconvenient and requires the screening of a large 
number of ES cells. An alternative is to use different recombinase systems for each process. 
The recombinase Flp recognises DNA sequences known as FRT (Flp recognition target), 8bp of 
directional core surrounded by inverted 13bp repeats. The ¥\p/FRT system, however, is less 
efficient than CrdloxP  (e.g. Dymecki and Tomasiewicz, 1998). Flp displays a low level of 
activity at 37°C, due to its origin - Flp is derived from the yeast Saccharomyces cerevisiae. A 
more thermostable Flp derivative (FLPe), made using cycling mutagenesis to emulate an 
evolutionary process, has since been shown to be 3-5 times more efficient in mammalian cells 
(Buchholz et al., 1998). Importantly, it was shown that FLPe works with high efficiency in 
germ cells (Rodriguez et al., 2000). Farley et al. (2000) targeted the constitutively-expressed
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ROSA26 locus with the gene for FLPe. creating the mouse strain “FLPeR" (“ flipper"), which 
has become a v aluable tool for excision o f  positive selection markers.
4.1.4.3 The Na\1.8Cre mouse
Stirling et al. (2005) recently generated a “knock-in" mouse strain expressing Cre under the 
control o f  the N av l .8 promoter. The coding sequence for Nav l .8 was replaced by the gene for 
Cre. using the initiator methionine of Nav 1.8 and therefore allowing retention o f all regulatory 
elements controlling spatial and temporal expression patterns. Since Nav 1.8 is expressed in a 
subset o f  sensory neurons, o f  which over 85% are nociceptors (Akopian et al.. 1996:Djouhri et 
al.. 2003a). this is a useful tool for the investigation o f gene function in peripheral nociceptive 
processes. The expression pattern o fN a v 1.8, discussed previously, has been well-characterised 
(Djouhri et al.. 2003a;Novakovic et al.. 1998). The expression pattern o f Cre. examined using 
ROSA26 reporter mice, was found to match exactly that o f  Nav 1.8. Onset o f  expression was at 
embryonic day 14, in small diameter, unmyelinated neurons o f  dorsal root, trigeminal and 
nodose ganglia. Limited expression was also observed in some large, myelinated DRG 
neurons. CNS and non-neuronal cells were shown to have no Cre expression. N av 1.8 Cre 
heterozygotes were found to have no deficits in sodium channel expression, measured using 
whole-cell patch-clamp. Motor function was normal, and the mice were shown to have normal 
acute pain thresholds. The development o f inflammatory and neuropathic pain was also shown 
to be unaffected, as predicted by the lack of phenotype o f  heterozygous Nav 1.8 null-mutants 
(Akopian et al., 1999). The Navl.8Cre mouse is therefore a suitable tool for nociceptor- 
specific gene deletion.
4.1 .5  B eh aviou ral assessm ent o f nociceptive thresholds
The use o f  animal models for human pain is widespread. Human studies are able to use the 
visual-analogue scale to assess the intensity o f  pain (including the affective component) evoked 
by a given stimulus (e.g. Jones et al., 2004). Since this approach is unsuitable for use with non­
verbal populations, animal behavioural assays focus on the measurement o f  thresholds o f 
nociception. In general, a stimulus o f increasing intensity is presented, and the intensity at 
which a response is evoked is taken as the output o f  the experiment. Different tests o f  
nociception, depending on the particular behaviour being assessed, are likely to involve 
different amounts o f  supraspinal processing. For example, Hargreaves' test, in which a rapid 
w ithdrawal o f  the hind paw is considered an endpoint, is likely to be mediated almost entirely 
by spinal reflex circuitry. In contrast, the hot plate, in which jumping or other escape 
behaviour is sometimes measured, requires a more coordinated response and is therefore likely
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to involv e higher centres o f the brain. It is consequently standard practice to perform a range of 
behavioural tests o f  nociception when examining the effect o f  gene deletion.
In humans, acute pain is rare as a clinical presentation, and is generally well-managed. Chronic 
inflammatory and neuropathic pain states are the most significant clinical problems, and a 
number o f animal models o f  these pain states have therefore been developed. Neural plasticity , 
both in the peripheral and central nervous systems, is demonstrated by these models 
(Dickenson, 1997:Woolf, 1983). Animal models o f  chronic pain generally rely on the 
measurement o f  hyperalgesia or allodynia. requiring the use o f acute stimuli to evoke a 
response. Spontaneous pain, perhaps the most relevant phenomenon from a clinical viewpoint, 
has proven difficult to quantify in animal models. A recent study from the Lawson group 
reported progress in this field, presenting several models for spontaneous pain in the rat 
quantified by spontaneous foot lifting (Djouhri et al.. 2006). Despite these limitations, animal 
models o f  nociception have been shown to have relevance to human conditions, for example as 
a predictor o f  efficacy for many analgesics (Taber. 1973).
Stimulus intensity is a critical parameter in nociceptive behav ioural assays. There is a body o f 
evidence to suggest that noxious stimuli of different intensities are differentially processed; for 
example, different rates of skin heating evoke capsaicin-sensitive C-fibres and capsaicin- 
insensitive A5-fibres (Yeomans et al.. 1996:Yeomans and Proudfit. 1996). Interestingly, 
certain proteins have been found to be involved in the process o f nociception within specific 
intensity ranges. For example, disruption o f the gene encoding substance P and a related 
tachykinin in mice reduced sensitivity to stimuli only in the moderate to intense noxious range 
(Cao et al.. 1998). These findings mean that a range o f  nociceptive assays, o f  vary ing stimulus 
nature and intensity , must be used to investigate the effects o f  gene deletion.
Nociceptive testing o f  genetically-altered mice is complicated by the substantial differences in 
nociceptive thresholds between strains. Various inbred strains have been compared in a wide 
range o f nociceptive assays, showing 1.2- to 54-fold ranges o f sensitivity (Mogil et al., 1999). 
The genetic background o f  test mice is therefore an important factor to be considered. Since 
null-mutant mice are generally derived from 129-C57BL/6 chimeras, resulting in a mixed 
background, the potential for strain differences to affect results exists. This can be reduced by 
repeated backcrossing to C57BL/6. but tightly-linked genes are likely to persist (Crusio, 1996), 
complicating analysis. This effect can be reduced by the use o f site-specific recombination, 
since both test and control mice are derived from the same source. Genes linked to the locus in 
which the recombinase has been inserted, however, may still interfere with analysis. The 
recombinase-expressing mouse used in this study was tested extensively before use to ensure
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that nociceptive phenotypes were identical to wild-type C57BL/6 (Stirling et al.. 2005). 
remov ing this concern. Gender has also been shown to affect pain-related behav iour in certain 
nociceptive assays in mice (Mogil et al.. 2006). Results were therefore separated by gender in 
this study, unless values for each gender were not significantly different.
4.1.5.1 Measurement of noxious mechanical thresholds
4 .1 .5 .1 .1 Randcill-Selitto
The Randall-Selitto test was first described in its current form by Takesue et al. (1969). The 
basic principle is that an increasing pressure (via increasing force with fixed area) is applied to 
the tail (mouse) or hind paw (rat) of the animal, until a stimulus is evoked. For the mouse, the 
area over which the force is applied is typically 2mm diameter, with force at the onset o f  tail 
flick/struggling used as the endpoint. Restraint is required for this test, which is likely to be 
stressful for the mouse, possibly leading to altered nociceptive thresholds, although mice are 
not tested until calm.
4.1 .5 .1 .2  von  F rey
von Frey hairs are graded filaments o f increasing diameter, such that the force applied upon 
flexion is known for each hair. Typically, each increment is a constant on a logarithmic scale. 
Filaments are applied sequentially to the plantar aspect o f  the hind paw through a mesh floor, 
until a sharp withdrawal o f the paw is seen. Main groups have used von Frey hairs to assess 
noxious mechanical thresholds, particularly for the evaluation o f  analgesic drugs or models o f 
neuropathic pain (Fuchs et al.. 1999;Kim and Chung. 1992;Seltzer et al.. 1990). Traditionally, 
a battery testing approach was used, applying each filament 5-10 times before moving to the 
next, in order o f  increasing magnitude. More recently, however, the up-down method was 
described (Chaplan et al., 1994). This uses a statistical technique, first described by Dixon 
(1980). which makes greater use o f the number o f observations obtained (or in practice, to 
make fewer measurements for a given level o f  certainty). Here, if a response to a given 
filament is observed, the subsequent test is performed with the filament one increment below 
the first, and vice versa. The pattern o f responses, along with the final filament tested, can be 
used to calculate an estimate o f  the 50% withdrawal threshold, that is, the filament to which a 
response would be expected 50% of the time. Chaplan et al. (1994) demonstrated a good 
correlation between both methods, despite the reduced labour required for the latter.
In contrast to the Randall-Selitto test, von Frey filaments present a relatively sudden stimulus to 
the animal. Whilst this has the advantage of allowing the animal to remain in a relaxed state 
immediately prior to the test, the contribution o f the startle reflex to the response must be taken
130
into account. Gradual presentation o f each filament is necessary to ensure that withdrawal is a 
response to nociception rather than non-noxious mechanosensation. Responses to von Frey 
filaments are generally considered to be mediated by spinal reflex arcs rather than higher-order 
processing.
4.1.5.2 Thermal nociception
4.1.5.2.1 H u rg rea ves  ' test
Hargreaves' test (Hargreaves et al.. 1988) uses a focused light source to apply radiant heat to 
the hind paw. via a plexiglass plate. Animals are not restrained, and the gradually-increasing 
nature o f  the stimulus removes any contribution o f the startle reflex. Since the response 
observed is a rapid withdrawal o f  the paw, this test is considered to involve only the spinal 
reflex arc. Since the tail is the major organ o f thermoregulation in mice, thermal tests using the 
paw are generally considered more reliable (Hargreaves et al.. 1988).
4.1 .5 .2 .2  H o tp la te
The endpoint o f  the hot plate test is hind paw licking. In contrast to Hargreaves' test, this 
response involves higher-level processing o f the noxious stimulus (Jensen and Yaksh. 1984). 
This is consistent with the observation o f behav ioural tolerance for the test: repetition within a 
30 minute period results in a marked reduction in latency (Wilson and Mogil. 2001).
4.1.5.3 Inflammatory pain models
4.1.5.3.1 F orm alin
Formalin is an aqueous solution o f  37% formaldehy de. Injection o f  a 5% solution o f  formalin 
is commonly used as a model o f  nociception, providing a moderate, spontaneous pain caused 
by damaged tissue (Tjolsen et al.. 1992). In this way. it differs from most other pain models, 
which rely on an external stimulus to evoke pain-related behaviour. Licking and biting o f  the 
hind paw is measured, since this is not a frequent component o f  normal grooming behaviour 
(Tjolsen et al., 1992), and has been validated as the best behavioural measure for mice (Sufka 
et al.. 1998). Two distinct phases of response are seen following injection o f  formalin. The 
early phase, beginning almost immediately and lasting for around 5 mins, is reduced by 
systemic administration o f opioids, paracetamol and aspirin, but not other NSAIDS or 
corticosteroids (Hunskaar and Hole, 1987). The late phase response begins around 15 mins 
post-injection, lasts for approximately 15 mins, and is blocked by opioids, NSAIDS, 
corticosteroids, paracetamol and aspirin (Hunskaar and Hole, 1987). The differing responses to
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pharmacological inhibition suggest differing nociceptive mechanisms for each phase. It is 
generally believed that the early phase is a result of direct chemical stimulation o f  C-fibres. 
while the late phase is dependent on a combination o f an inflammatory response and functional 
changes in the dorsal horn o f  the spinal cord, probably initiated by the C-fibre afferent barrage 
during the early phase (Tjolsen et al.. 1992).
4.1 .5 .3 .2  N erve  G row th  Factor
The subcutaneous injection o f  small doses of NGF induces a rapid onset thermal hyperalgesia 
that persists for many hours. This is thought to be due to a peripheral action, since no 
contralateral effects are observed (Andreev et al.. 1995). Around 40% o f  DRG primary 
afferents express trkA. the receptor for NGF. most o f which are nociceptors (Averill et al.. 
1995;McMahon et al.. 1994;Verge et al.. 1989). While this provides a mechanism for the direct 
sensitisation o f  nociceptors by NGF. current evidence suggests that a large component o f  the 
sensitisation observed is mediated indirectly, via actions on post-ganglionic sympathetic 
neurons (Andreev et al.. 1995). Sympatholytic treatment was found to reduce NGF-induced 
hyperalgesia, although there is some evidence that mast cell degranulation also makes a 
significant contribution to the initial phase of hyperalgesia (Andreev et al.. 1995).
Significantly. NGF expression is upregulated in most animal models o f  inflammation, 
including Freund's adjuvant and carrageenan (Woolf et al.. 1994). This suggests that NGF may 
act as a mediator o f  the inflammatory pain produced by these models.
4.1.5.3 .3  C 'arrageenan
Carrageenan is a collective term for a group of polysaccharides prepared by alkaline extraction 
from the red seaweed Rhodophycae. The injection of ^-carrageenan produces an inflammatory 
response, maximal 3-5 hours post-injection, causing hyperalgesia that can be detected by a 
reduction in mechanical or thermal nociceptive thresholds (Kavser and Guilbaud, 1987). This 
is in contrast to the formalin test, in which pain is assessed without additional stimuli.
4.1.5.4 Neuropathic pain models
Traditionally, animal models o f  neuropathic pain used mechanical damage to the sciatic nerve 
to elicit allodynia and spontaneous pain. These allowed the predictable localisation o f  pain to 
the ipsilateral hindpaw. and demonstrated good levels o f  reproducibility (e.g. Kim and Chung, 
1992). Clinical neuropathic pain, however, rarely arises from purely mechanical nerve 
damage; more common is nerve damage due to metabolic (e.g. diabetes), viral (e.g. HIV, 
herpes), or pharmacological (paclitaxel, vincristine) factors. Recent work has focused on the
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generation o f animal models for specific conditions, with varying success. For example, the 
intrathecal injection o f the HIV envelope glycoprotein gp 120 was shown to produce thermal 
hyperalgesia and mechanical allodynia in the rat (Milligan et al., 2000). Intraperitoneal 
streptozocin has also been used to model diabetic neuropathy (Courteix et al.. 1993). Paclitaxel 
and v incristine are also used in rodents to generate neuropathic pain resembling that occurring 
in human chemotherapy (Cavaletti et al.. 1995;Nozaki-Taguchi et al.. 2001). These models, 
however, are not generally well-characterised, especially in the mouse. The models described 
below trade clinical relevance for increased reproducibility, thus improving experimental 
power.
The most commonly used models o f  neuropathic pain in the mouse derive from paradigms 
described by Kim and Chung (1992) in the rat. Two models were described, the first involving 
the tight ligation o f  the T< and L6 spinal nerves, and the second requiring the ligation o f  Ls 
alone. Both models produce mechanical hypersensitivity, maximal around one week post­
surgery and lasting for around 14 weeks, and thermal hyperalgesia. The Chung model has 
certain advantages over the earlier models o f neuropathic pain, the chronic constriction injury 
(CCI) (Bennett and Xie, 1988) and sciatic nerve ligation (SNL) (Seltzer et al.. 1990) models. 
The surgical procedure has less scope for variation in ligature tension or number o f  fibres 
ligated, meaning that the only major source o f variation in the procedure is the normal 
biological variability in the sciatic nerve. It also allows the contribution o f both injured and 
uninjured fibres to be examined. The behavioural and neurochemical responses to Ls ligation 
have been shown to be conserved between rat and mouse, validating this method for use in the 
mouse (Honore et al., 2000). The Chung model, however, required more invasive surgery than 
the CCI or SNL models, increasing the inflammatory contribution to altered pain states.
More recently, Decosterd and Woolf (2000) described a new model o f  neuropathic pain, the 
spared nerve injury (SNI ). This involves a lesion o f two o f  the three terminal branches o f  the 
sciatic nerve (tibial and common peroneal nerves) leaving the remaining sural nerve intact and 
therefore restricting interactions between intact and degenerating axons. In contrast to some 
models, no changes in thermal thresholds are observed in this model.
Models o f  neuropathic pain are illustrated in Figure 4.3.
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F igure 4.3 M odels o f  neuropathic pain. From Campbell and Meyer (2006).
4.1.6 E lectrophysiology
While whole-animal behavioural assays allow the assessment of the contribution of a given 
factor to nociceptive processes, little mechanistic information is revealed by these approaches. 
Electrophysiological analysis permits the discrimination of actions at different levels of 
nociceptive pathways, and can provide insights into the effects of gene deletion (and other 
factors) at the molecular level. Due to the wide range of parameters that can be investigated, it 
can be useful to hypothesise on the effects that might be expected, and focus analysis 
accordingly.
4.1.6.1 W h ole-cell patch-clam p o f  DRG  neurons
The electrophysiological properties of acutely-cultured DRG neurons can be studied by whole­
cell patch-clamp, providing information on the effects of gene deletion on primary afferent 
nociceptor function. The patch-clamp technique (Hamill et al., 1981) allows the recording of 
membrane currents or voltage, whilst controlling the other. A simplified circuit for a voltage- 
clamp experiment is shown in Figure 4.4. A high-gain operational amplifier is used to compare 
the pipette potential ( Vp) to a pre-determined command potential (Fref). A current (If) is passed 
through the feedback resistor to maintain the pipette potential at the same level as the reference
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potential. Since the input resistance o f  the amplifier is high (and therefore passes little current), 
this current is equal to that passing across the plasma membrane (/p). The output v oltage o f the 
amplifier is given by IpR\ + Tret. since 7p7?tas the potential required to pass the current 7P through 
the resistance R t. Since Rt and VKf are known, 7P can be calculated. The amplifier output, 
however, differs from that at the pipette tip due to the series resistance (access resistance) o f  the 
pipette. Since this resistance was typically less than 5mQ, compensated at 70% to give an 
effective resistance o f  3.5mQ, and currents recorded were around 2nA. the residual 1R drop 
across the pipette was around 7mV. The junction potential at the interface o f  the pipette 
solution and the extracellular solution adds an additional source o f error. This can be estimated 
and thus accounted for. however, using the Henderson equation (Barry and Lynch. 1991). 
which takes into account the relative mobility o f  each ion.
Output
^Ou. = W K
Amp
Patch
pipette,
Ref
F igure 4 .4 T he w h ole-ce ll patch-clam p circuit. Adapted  from Aidley and Stanfield (1996). Current 
passing across  the p lasm a membrane, equal to /p. is measured by the voltage drop across the feedback 
resistor /?, by the h igh-gain amplifier Amp.
4.1.6.2 Electrophysiological recording from wide dynamic range neurons of the 
spinal cord
Whole-cell patch-clamp of DRG neurons is a useful tool for the investigation o f  neuronal
properties, but its physiological relevance is limited by the need to use dissociated cells in
culture. Removal o f  these neurons from their physiological environment and associated growth
factors, cellular contacts and support cells is likely to produce at least a degree o f phenotypic
alteration. In vivo recording removes this barrier, and is possible from a range o f  nervous
tissues, both peripheral and central. Single unit extracellular recordings from WDR neurons in
the spinal cord (laminae IV-V) allow the measurement o f  neuronal activity in the native
environment. This approach is complementary to that in cultured DRG neurons, assessing
effects o f  gene deletion at a higher point in the sensory circuitry, and allowing the investigation
o f  dorsal horn phenomena such as wind-up and LTP, both o f which can play important roles in
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chronic pain states. This technique is described in Urch and Dickenson (2003). An added 
benefit o f  this approach is that, in contrast to most behav ioural assays, quantitative measures o f  
supra-threshold activity can be obtained. Since the majority o f  clinical pain conditions fall into 
this category, these measurements are particularly interesting.
4.1.7 A ngiogenesis
p 11. through its interaction with tissue plasminogen activator (tPA). is thought to play an 
important role in angiogenesis. This section gives an ov erv iew of this process.
Angiogenesis is the formation o f new blood vessels from the pre-existing vasculature 
(Folkman. 1995a). It involves the migration, proliferation and differentiation o f  endothelial 
cells and results in the formation o f vascular loops (Risau. 1997). Angiogenesis is required for 
many physiological processes, including wound healing, and plays a vital role in pathological 
processes, particularly tumour growth (Folkman. 1995b) and diabetic retinopathy.
The plasma serine protease plasmin degrades fibrin, a fibrillar protein involved in thrombus 
formation. It also activates collagenases, such as matrix metalloproteases. either directly 
(Netzel-Arnett et al.. 2002) or indirectly (Ramos-DeSimone et al.. 1999). Plasmin is produced 
through the activation o f  plasminogen, by tissue plasminogen activator (tPA) or urokinase 
plasminogen activator (uPA) cleavage. Plasmin has been reported to promote angiogenesis. 
and this appears to be via several mechanisms (Browder et al.. 2000). Pro-neoangiogenic 
programmes o f  gene expression are activated by plasmin. resulting in migration and 
proliferation of endothelial cells, and other changes (Tarui et al.. 2002). Gene expression 
changes include the induction o f Cyr61. a growth factor-like gene implicated in cell 
proliferation, adhesion and migration, via MAP kinase pathways (Pendurthi et al., 2002). In 
addition to fibrin, plasmin degrades substrates such as laminin, fibronectin and the protein core 
o f  proteoglycans (Chen and Strickland, 1997;Werb et al., 1980). all components o f  the 
extracellular matrix that must be degraded for effective angiogenesis. This degradation may 
release basic fibroblast growth factor (bFGF) trapped within the extracellular matrix (Falcone 
et al., 1993), which promotes angiogenesis by both direct effects on endothelial cells and 
indirectly via upregulation o f vascular endothelial growth factor (VEGF) expression (Stavri et 
al., 1995). which is itself pro-angiogenic. Plasmin also activates transforming growth factor-(3 
(TGF-P), a pro-invasive endothelial cell-differentiating factor (Lyons et al., 1990). 
Importantly, plasmin-generated fibrin degradation products (e.g. A(61), fragment E, 
angiostatin) may stimulate endothelial cell proliferation (Thompson et al., 1992), while plasmin 
itself attenuates fibrin-mediated endothelial cell adhesion via specific integrins (Thiagarajan et
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al.. 1996). Finally, plasmin regulates vascular-endothelial cell cadherin-mediated association 
(Bach et al., 1998b;Bach et al.. 1998a). It is apparent from this multitude o f  actions that 
plasmin plays a central role in the regulation of angiogenesis. promoting neovascularisation by 
a variety o f mechanisms.
The formation o f plasmin from plasminogen (Figure 4.5) is a central step in angiogenesis. 
Regulators o f  this process may thus exert powerful control over angiogenesis. w ith subsequent 
effects on tumour growth and other angiogenesis-dependent events.
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F igure 4 .5 P lasm in  form ation  and dow nstream  effects. tPA and uPA catalyse the formation o f  
plasmin from plasminogen. Plasmin promotes angiogenesis  by fibrin degradation and activation o f  
matrix m eta lloproteases (M M P). which degrade the extracellular matrix (ECM ). PAI: p lasm inogen  
activator inhibitor.  Solid lines represent stimulatory effects; dotted lines indicate inhibitory actions.
4.1.8 A im s
This section aims to use a tissue-specific pi 1-null mouse to investigate the role o f  pi 1 in 
nociception. A range o f  molecular, electrophysiological and behavioural techniques will be 
used for this purpose. Additionally, a global pi 1-null mouse line will be used to determine the 
role o f  pi 1 in angiogenesis using a tumour growth model.
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4 .2  M e t h o d s
4.2.1 G ene targeting: generation  o f  /ojc/M lanked S100A 10  m ice
The design and manufacture o f the floxed p l l  targeting construct were performed by 
Mohammed Nassar and Tim Lane.
We chose to control the deletion o f the S100AJ0  gene using the Cre-loxP system. This sy stem 
allow s the deletion o f  a /av/Mlanked gene to be restricted to tissues expressing the enzyme Cre 
recombinase. By placing Cre under the control o f  a tissue-specific promoter, the Boxed gene 
can be deleted only in the cell type of interest. This system was chosen for several reasons. 
First, it would allow any phenotype observed to be ascribed to the role o f  pi 1 in the particular 
tissue from which it had been deleted. Second, it allows the generation o f  test and littermate 
control mice from a single litter, with no unusable genotypes. Finally, it provides a valuable 
tool for groups researching the role o f  pi 1 in other systems.
When using the Cre-loxP system, it is generally not considered possible to delete an entire 
gene, due to a hypothetical reduction in Cre-mediated recombination efficiency over very' large 
distances. We therefore chose to flox only a single exon o f  the S100A10 gene. The exon 
structure o f  S I0 0 A 10, as shown in Figure 4.6, shows that the first exon is a 5' untranslated 
region, w ith translation beginning at the start o f  exon 2. We therefore chose to flox exon 2. to 
minimise the chance o f  a (potentially functional) truncated fragment being expressed after 
recombination. This deletion also induces a frame shift in the remaining exons, meaning that 
any protein expressed would bear little resemblance to pi 1. A stop codon was also introduced 
to prevent partial protein expression.
Exon 1 Exon 2
5 ’ UTR Start codon and 44
amino acids
0  ■
9.48kb
Figure 4.6. Exon stru ctu re o f  SI00A10 gene. N on-coding regions show n in white, cod ing  sequence  
shown in black.
Exon 3
53 amino acids and 
3 ’ I T R
I
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Since the targeting construct would later be electroporated into 129-derived embryonic stem 
cells, all sequences were based on the 129 strain genome. A 200bp probe for SIOOAIO was 
prepared by PCR, using 129-derived embryonic stem cell DNA as a template with primers 
gccaactggagcactggtaccccc and ggatacaaacaatataaaactcagaagc. This probe was used to identify 
genomic clones from an RCP1-22 129S6/SvEvTac mouse bacterial artificial chromosome 
(BAC) library by Southern blotting. The targeting vector was derived from two overlapping 
Bum HI and Apa\ genomic subclones that contained both exons 2 and 3 o f  pi 1. The 5' arm is 
the 4412 bp BamH\-Xha\  fragment upstream of exon 2. The /o.xP-ftanked (floxed) exon 2 was 
obtained as a 990 bp Xba\-Apa\  fragment. The 3' arm is the 6422 Apa\-Xma\  fragment 
downstream o f  exon 2. The three genomic fragments were inserted into a plasmid containing 
two loxP  sites and an FLP recombination target (FRT)-flanked (flrted) Neo cassette (Nassar et 
al.. 2004). The complete targeting vector was linearized and electroporated into 129-derived 
embryonic stem cells and screened as described by Nassar et al. (2004). using 5' and 3' 
external probes for Southern blot. Two correctly targeted clones were injected into C57BL/6J 
blastocysts to generate chimeras. Electroporation and injection were performed by the 
University o f  Michigan (Ann Arbor, MI).
4.2.2 B reed in g  strategy
The chimeras were crossed to C57BL/6 animals. This was followed by a cross to FLPe deleter 
mice (Farley et al.. 2000) to excise the positive selection marker (Neo). Correct targeting was 
confirmed by Southern blot (digestion by £cy;R I or Bam  HI) and PCR (primers pi 1 Sequencing 
1 (ccttctctgctgaacttgataatgaa) and pi 1 Sequencing 4 (tcttggcacagaacatgtaattcttt)), with genomic 
DNA extracted from tail samples in both cases. These mice were then crossed to mice 
expressing Cre under the control of the Nav 1.8 promoter (Stirling et al., 2005). These mice 
express Cre in small-diameter (<25pm) neurons arising from the DRG, o f  which >85% are 
nociceptors (Akopian et al.. 1996; Djouhri et al., 2003). Further crosses between floxed mice 
and floxed mice heterozygous for N av 1.8 Cre generated conditional-null mutants and floxed 
littermate controls for analysis. This ensured an identical genetic background between pi 1 
conditional-null and control animals, which had been backcrossed to F5 on a C57BL/6 
background. Genotyping for floxed versus wild-type mice was performed using the primers 
p l l  Sequencing 1 (ccttctctgctgaacttgataatgaa) and p l l  Sequencing 4 
(tcttggcacagaacatgtaattcttt), whereas the presence o f  the gene for Cre was detected using the 
primers Cre 2s (ctgcattaccggtcgatgcaacga) and Cre 5a (aaatgttgctggatagtttttactgcc). The floxed 
p l l  mice were also crossed to a “global” Cre-expressing strain (Schwenk et al., 1995) to 
produce a global pi 1-null animal for certain experiments requiring either complete pi 1 deletion 
or pi 1 deletion in non-neuronal tissues. These pi 1-null mice were then bred to remove the
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gene for Cre. Deletion o f p l l  was confirmed by PCR, using primers p l l  Sequencing 1 
(ccttctctgctgaacttgataatgaa) with p l l  Sequencing 4 (tcttggcacagaacagtaattcttt). and p l l  
Sequencing 1 with pi 1 Sequencing 3 (tttgttcctattcatccagcaactaa). pi 1-null mice were expected 
to produce no product with primers 1 & 4. and a product of~450bp with primers 1 & 3. p l l  
floxed mice yielded a 400bp product from primers 1 & 4. and a product greater than 1,5kb with 
primers 1 & 3. p l l  deletion was confirmed by western blotting, using brain lysate. The mass 
o f  pi 1-null mice was compared to control animals, and fertility was monitored.
4.2.3 C onfirm ation  o f  correct gene targeting
Correct targeting o f  the SIOOAK) gene in the mouse was shown by Southern blotting and PCR, 
using genomic DNA extracted from the tail. Southern blotting was performed using CovRI and 
Bam  HI to digest DNA. with 5' and 3 ‘ probes respectively. PCR primers were designed either 
side o f  a loxP  site. Primers pi 1 Sequencing 1 (ccttctctgctgaacttgataatgaa) and pi 1 Sequencing 
4 (tcttggcacagaacatgtaattcttt) were used, with the floxed allele resulting in a band 
approximately lOObp larger than the wild-type.
4.2.4 P roving selective/g lobal deletion
The selective deletion o f the SIOOAK) gene in cells expressing N av 1.8 was confirmed at the 
level o f  genomic DNA, mRNA and protein.
Deletion o f  exon 2 from genomic DNA was tested using primers pi 1 Sequencing 1 
(ccttctctgctgaacttgataatgaa) and pi 1 Sequencing 3 (tttgttcctattcatccagcaactaa). pi 1 Sequencing 
1 binds to the 5' arm o f  homology, while pi 1 Sequencing 3 binds to the 3* arm, a distance o f 
around 1.5kb. Upon deletion o f exon 2 of pi 1. however, the distance between the primers is 
reduced to approximately 450bp. Confirmation o f  this result was obtained using primers pi 1 
Sequencing 1 & 4: pi 1 Sequencing 4 binds to exon 2 of pi 1, meaning that no band would be 
expected following deletion. DNA extracted from DRG was compared to that extracted from 
spinal cord, brain and tail.
Tissue-specific deletion o f exon 2 ofSlOOAIO  was confirmed at the level o f  mRNA, using RT- 
PCR. cDNA was synthesised from mRNA template extracted from DRG and a variety o f  other 
tissues. The primers p l l  RT-PCR Fwd 1 (tgtgcccagctcttccaagg) and p l l  RT-PCR Rev 1 
(acaagaagcagtggggcagat) were used in the PCR reaction, giving a band 150bp smaller 
follow ing deletion o f  exon 2.
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These approaches to verification o f tissue-specific deletion, however, are confounded by the 
fact that each DRG contains a multitude o f cell types, some expressing N av 1.8 (and therefore 
Cre) but many, for example Schwann cells, not. To demonstrate conclusively that pi 1 was 
deleted only in cells expressing Nav 1.8, we used immunocytochemistry. Dual labelling with 
antibodies to pi 1 (a kind gift from Prof. Volker Gerke) and Nav l .8 was used to define precisely 
from which cells pi 1 had been deleted.
The global deletion o f the SIOOAK) gene from the mouse was confirmed at the level of 
genomic DNA and mRNA as above, using a wider range o f tissues. Deletion o f  exon 2 at the 
level o f  protein was verified by western blotting, using anti-pl 1 antibody R&D Systems) to 
probe crude brain lysate.
4.2.5 E ffect on cell survival
The effect o f  pi 1 deletion on the survival of DRG neurons was investigated, to verify that any 
phenotype observed was not due to neuronal death. DRG were sectioned and stained with anti- 
peripherin and the anti-neurofilament antibody N200. identifying small unmyelinated and large 
myelinated neurons respectively. The number and proportions o f these cells were compared 
between pi 1 conditional null-mutant and floxed pi 1 control DRG.
4.2.6 A nalysis o f  p l l  conditional-null phenotype
Trafficking o f  N av 1.8 to the plasma membrane was investigated by western blotting of 
membrane preparations from DRG. Functional expression o f Nav 1.8 was then measured using 
whole-cell patch-clamp to measure TTX-R Na currents in dissociated small-diameter DRG 
neurons. Following this, single unit recording were made from wide dynamic range neurons in 
the dorsal horn o f the spinal cord (performed by Dr Elizabeth Matthews). Nociceptive 
behavioural responses were examined using acute, inflammatory and neuropathic models.
4.2.7 U rine A nalysis
Analysis o f  urine Ca~ and Na levels was performed by the laboratory' o f  Prof. Rene Bindels. 
Radboud University Nijmegen.
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4.2.8 T um our grow th /angiogenesis testing
Cells from the B16 murine melanoma line, derived from the C57BL/6 strain, were injected 
subcutaneously into the dorsal neck region of each mouse (1.000.000 cells, in 200f.il PBS). 
After 1 1 days, during which time the health o f  the animals was monitored carefully, the 
animals were humanely sacrificed and the tumours excised. Tumour volume was measured by 
multiplying the maximum length, breadth and depth measurements.
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4 .3  R e s u l t s
4.3.1 A successfu l recom bination  event w as detected  in 129 em b ryon ic  
stem  cells
The wild-tvpe pi 1 allele, targeting construct, correct targeting event and effect o f  Cre-mediated 
deletion are shown in Figure 4.7.
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F igure 4.7 G en e targetin g  process, p i  1 genomic allele, targeting construct, correct ta rgeting  event and 
C re-m edia ted  excision. loxP  sites represented by white triangles, exons by black rectangles, positive 
selection m arker  N e o  and negative selection m arker TK. B represents B am H l restriction sites, 1-3 exons 
1-3. pBS: pBluescript .
Southern blotting was used to confirm the correct targeting o f the pi 1 locus in 129 ES cells. 
Both EcoRl and BamHl digests were analysed to detect the correct gene targeting event, using 
both 5'and 3 ‘ external probes. An EcoRl digest probed with a 5' external probe and a BamHl 
digest probed with a 3' external probe are shown in Figure 4.8. The correct targeting event 
introduced an additional BamHl site, reducing the fragment size from 13.4kb to 8kb.
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F igure 4 .8  Southern  b lotting to detect p ll-f lo x e d  cells. In each case, insertion of loxP sites 
introduced an additional restriction site, reducing fragment size. Following a successful recombination 
event, cells are heterozygous for the desired mutation, thus giving 2 bands.
A clone o f  cells containing the correct targeting event was transplanted into an early-stage 
blastocyst, which was then implanted into a pseudopregnant surrogate female. The resulting 
chimaeric offspring were then crossed to wild-type (C57BL/6) animals. This was performed by 
the University o f  Michigan.
4.3.2 E m bryonic stem  cell transplantation produced viable p l l  floxed m ice
The transplantation o f  targeted (pl l  floxed) 0129 ES cells into C57BL/6 (wild-type) 
blastocysts produced chimaeric mice, identified by a mixed coat colour due to contributions 
from 0129 (white) and C57BL/6 (black) cell types. These were crossed with C57B1/6 animals, 
with the expectation that a proportion o f  the offspring would be derived from targeted cells (i.e. 
that germline transmission o f  the targeted mutation would occur). Mice in which this had 
occurred were identified by coat colour (brown, from one C57BL/6 and one 0129 allele), and 
genotyped by PCR using primers p l l  Sequencing 1 and p l l  Sequencing 4 (Figure 4.9a), 
confirmed using Southern blot (Figure 4.9b). Germline transmission occurred in a relatively 
small proportion o f  offspring (-10%).
The positive selection marker encoded by the Neo cassette was excised by crossing pi 1 floxed 
animals with transgenic mice constitutively expressing the FLPe gene (Farley et al., 2000). 
The FLPe recombinase protein recognises the FRT  sites flanking the Neo  cassette and deletes 
the intervening region. This deletion was confirmed by PCR, using the primers pi 1 
Sequencing 2 and pi 1 Sequencing 3 (data not shown).
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Figure 4.9 Genotyping of p l l  floxed mice, a: PCR using primers p l l  Seq.l and p l l  Seq.4 using 
DNA from wild-type and heterozygous floxed mice. The larger band represents the floxed pi 1 allele, b: 
Southern blotting to confirm genotypes of heterozygous and homozygous floxed pi 1 mice. The smaller 
bands represent the floxed pi 1 allele.
4.3.3 C ond itional deletion: p l l  is deleted from N av1.8-expressing neurons,
but not from  other tissues
Following breeding to obtain homozygous floxed p l l  animals, a cross was made with the 
N av 1.8Cre mouse line (Stirling et al., 2005), which expresses Cre recombinase under the 
control o f  the N av 1.8 promoter. Tissues from the resulting offspring were examined at the 
level o f  DNA, mRNA and protein, to assess the extent o f  pi 1 deletion.
Genomic DNA extracted from DRG, brain and spinal cord was subjected to PCR, using 
primers p l l  Sequencing 1 and p l l  Sequencing 3. The deletion o f  exon 2 o f  p l l  by Cre 
resulted in a band o f  around 450bp, while the floxed allele gave a 1.5kb band. DNA extracted 
from DRG gave both bands, due to the presence o f  a mixed population o f  cells, a proportion of 
which express N av 1.8 and therefore Cre. The larger band was weaker than the smaller 
counterpart, probably due to the more efficient amplification o f  the smaller fragment (Figure 
4.10b). DNA from brain (not shown) or spinal cord, or from wild-type DRG, gave only the 
larger band, due to the absence o f  Cre expression and thus pi 1 exon 2 deletion. These results, 
illustrated in Figure 4.10, demonstrate that pi 1 is deleted from a subset o f  cells in the DRG but 
not from other tissues.
mRNA was extracted from a range of tissues in the pi 1 floxed N av 1.8Cre mouse. The cDNA 
yielded from subsequent reverse transcriptase reactions was analysed by PCR. cDNA from 
conditional-null mutant DRG yielded a truncated (290bp) band, in addition to the full length 
product (440bp). cDNA from other tissues, or from pi 1 floxed control animals, showed only
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the full-length band. These results confirm that pi 1 is deleted from a subset o f  DRG cells but 
not other tissues in the conditional-null mutant, and are shown in Figure 4.10.
n
—  <*-1.5 kb 
i  <4-450 bp
Figure 4 .10 C onfirm ation  o f  conditional p i 1 deletion, a: RT-PCR using cDNA from conditional-null 
DRG. The smaller band represents pi 1 deletion from Nav 1.8-positive cells, b: PCR using primers pi 1 
Seq.l and pi 1 Seq.3 on genomic DNA from DRG and spinal cord (SC). The smaller band represents 
pi 1 deletion.
A monoclonal antibody to pi 1 was used to define more precisely the subset o f  cells from which 
p l l  had been deleted in the conditional-null mutant. Attempts to use this antibody on DRG 
sections were unsuccessful, even following extended optimisation, due to high background 
reactivity (data not shown). Immunocytochemistry on acute DRG cultures, however, was more 
successful. In acute DRG cultures from control (floxed p l l )  animals, more than 85% of 
neurons displayed an intense staining with a distinct membrane localisation, consistent with the 
expected subcellular localisation o f  pi 1. In conditional-null mutant mice, however, fewer than 
30% of  neurons displayed anti-pl 1 immunoreactivity, although non-neuronal cells (defined by 
morphology) were generally stained. These results are illustrated in Figure 4.11, and show that 
pi 1 is deleted from a subset o f  DRG neurons in the conditional-null animal.
440 bp 
290 bp
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F igu re 4.11 C on d ition a l deletion  o f  p l l .  Acutely-cultured DRG neurons are labelled with a 
monoclonal antibody to pl l .  Many more pi 1-positive cells are seen in wild-type cultures than in 
the conditional knockout (cKO). The bright field image is of the same field as the pi 1 cKO image, 
demonstrating the presence of neurons (white arrows) but not pi 1 immunoreactivity.
To define more precisely the subpopulation o f  DRG neurons from which p i  1 was deleted, 
co-staining with anti-Nav l .8 was performed. Deletion o f  p i 1 would be expected to show a 
precise correlation with Nav 1.8 expression, since Cre expression is controlled by N av 1.8 
regulatory sequences. In conditional-null cultures, p i 1 and Nav 1.8 immunoreactivity were 
mutually exclusive, p l l  immunoreactivity was absent from all N av 1.8-positive cells, 
while all cells which continued to express pi 1 did not display N av 1.8 immunoreactivity. 
In control cultures, however, many cells displayed both pi 1 and N av 1.8 immunoreactivity. 
A small proportion o f  cells in both control and conditional-null cultures displayed neither 
N av 1.8 nor p l l  immunoreactivity. The proportion o f  cells in this category was similar 
between control and conditional-null cultures, and therefore is likely to represent a 
naturally-occurring neuronal subset. This is supported by in situ hybridisation data from 
previous studies (Okuse et al., 2002n). Figure 4.12 shows representative neurons from 
control and conditional-null DRG cultures labelled with anti-pl 1 and anti-Nav l .8.
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W ild-type p l l  cK O
F igure  4.12 D istr ibution  o f  p i  1-null neurons in the condit ional-null an im al.  Acutely-cultured 
DRG neurons labelled with anti-pll (green) and anti-Nav1.8 (red). Colocalisation is evident in 
wild-type neurons. In conditional-null (cKO) cultures, labelling is mutually exclusive: cells are 
either green or red (or neither), but not both.
4 .1 .8  C on d ition al p l l  deletion  does not affect the surv iva l o f  D R G  
neurons
Whole sectioned DRG were examined to test for effects o f  p l l  deletion on neuronal 
survival. The purpose o f  this was to ensure that any phenotype observed was not due to 
loss o f  neurons, but due to a more subtle action o f  pi 1. Small unmyelinated cells, most o f  
which are nociceptors, were labelled with an antibody to peripherin. Larger myelinated 
neurons (less likely to express Nav 1.8) were labelled with the anti-neurofilament antibody 
N200. Sections from control and conditional-null DRG appeared normal, showing a 
characteristic ring o f  small-diameter peripherin-positive cells surrounding larger N200- 
positive neurons (Figure 4.13). The proportions o f  peripherin- and N200-positive neurons 
were not significantly different between control and conditional-null animals (Figure 4.13).
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F igure 4.13 C on d it ion a l deletion o f  p l l  does not affect neuronal survival.  DRG sections from 
floxed p ll littermate control (wild-type) and pll conditional-null (cKO) animals labelled with 
peripherin (green) and N200 (red). No difference in ratio was observed between littermate control 
(«= 11) and pi 1 conditional-null (w=24) sections. Peripherin control (Peri), 67±3%; pi 1 conditional- 
null, 64±4%; N-200 control, 37±3%; pi 1 conditional-null, 38±4%. Error bars represent mean±SEM.
The cell size distribution o f  DRG neurons in culture was examined as a further check that 
pi 1 deletion did not affect the survival o f  certain groups o f  neurons. It should be noted 
that the culture methods used tend to favour smaller-diameter cells and therefore may not 
be representative o f  actual size distributions in vivo. Since p i 1 is primarily deleted from 
small- to medium-diameter cells in the conditional-null mutant, however, this was not 
considered to affect the validity o f  this exercise. Cultures from both control and 
conditional-null lines yielded a similar cell density. The mean diameter o f  control neurons 
(22.55±0.65pm, n=180) was not significantly different to p l l  conditional-null neurons 
(21.76±0.75pm, n=190). Additionally, the proportion o f  cells with diameter <25pm 
(considered to represent Nav 1.8-expressing cells) was similar between groups (control 
70.55%, n=180, conditional-null 73.16%, n=190). These results are illustrated in Figure 
4.14.
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Figure 4.14 Effect o f  p i  1 deletion on neuron size. Neuronal diameter was measured for floxed pi 1 
littermate control (white) and pi 1 conditional-null animals (black), and expressed as mean diameter (left 
graph; error bars represent SEM), or % of neurons <25pm, taken to represent Nav 1.8-expressing cells 
(right graph). No significant differences were seen between pi 1 conditional-null and control with either 
presentation.
4.3.5 G lobal deletion: p l l  is deleted from all tissues
A global pi 1 null mouse was produced by crossing the pi 1 floxed line with a global Cre strain 
(Schwenk et al., 1995) for use in certain experiments, pi 1 deletion was confirmed by RT-PCR, 
using mRNA extracted from a variety of tissues, pi 1 was found to be deleted from all tissues 
tested (Figure 4.15).
Figure 4.15 p l l  is deleted from all tissues in the global-null mouse line. RT-PCR using RNA 
extracted from liver (Li), heart (He), lungs (Lu), kidney (Ki), spinal cord (SC), brain (Br), gut (Gu) and 
spleen (Sp). The heterozygous reference shows 2 bands, while all tissues show only the smaller band, 
representing the deleted allele. The lowest band represents primer dimers, also seen in the negative 
control (no template).
Tissues from the global-null mouse were tested for p ll expression by Western blot (Figure 
4.16). Brain lysate from control animals gave a distinct 1 lkDa band, whereas that from pi 1
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global-null mice did not show any detectable p ll immunoreactivity, even when loading 
relatively large amounts of protein.
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Figure 4 .16  Global deletion o f  p i 1. Western blot using brain lysate from floxed pi 1 control (WT) and 
global-null animals (K.O). The 1 lkDa band seen in the WT but not KO preparations represents pi 1 
protein. “Control” represents Na7K+ ATPase loading control.
pi 1 global-null mice were apparently healthy, with no gross morphological differences from 
wild-type animals. Mass and litter size were not found to differ significantly from floxed pi 1 
control animals, although a higher proportion of breeding pairs did not produce any litters 
among the pi 1-null population.
4.3.6 Plasm a m em brane trafficking o f N av1.8 in DRG neurons is reduced  
by p i 1 deletion
The trafficking to the plasma membrane of Nav1.8 in DRG was examined by western blot, 
using membrane protein preparations. Previous experiments in heterologous expression 
systems found that pi 1 was required for Nav1.8 presence at the plasma membrane (Okuse et 
al., 2002). Following normalisation to a reference protein, the constitutively-expressed Na+/K - 
ATPase, we found that membrane levels of Nav1.8 in pll-null preparations were 
approximately half that of preparations from control animals (Figure 4.17a). To confirm that 
this difference was attributable to trafficking and not to changes in expression levels of Nay 1.8, 
western blots were performed on total DRG cell lysates. No difference was observed between 
control and pi 1-null preparations (Figure 4.17b).
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Figure 4 .17  P lasm a m em b ra n e  traffick ing  o f  N a v 1.8, assessed by w estern  blot, a: Anti-Nav1.8 
(250kDa) and reference Na+/K+-ATPase (Control) staining of membrane preparations from pi 1 
global-null (KO; 20, 40pg) and control (WT; 20, 40pg) animals. A reduction in membrane levels 
was observed upon pi 1 deletion (KO range 50-65% of WT, following normalisation to reference 
gene), b: As a, but using total cell lysates. No changes in total Nav1.8 cellular expression were 
observed.
We attempted to corroborate this result using immunocytochemistry in acutely-cultured 
DRG neurons. Anti-Nav1.8 staining was evident in a subset of small- to medium-diameter 
neurons, as expected. As previously reported, however, the majority of Nav1.8 
immunoreactivity appears to be cytoplasmic (or at least non-plasma membrane), with the 
result that staining at the plasma membrane is difficult to distinguish. Normally this could 
be addressed by the use of non-permeablised cultures, but the Nav1.8 antibody is directed 
against a cytoplasmic region of the channel, meaning that in non-permeablised cells the 
required antigen is not accessible. These results, however, do confirm that the expression 
of Nav1.8 is not reduced by p ll  deletion. Representative pictures are shown in Figure 
4.18.
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Figure 4 .18  A n ti-N av 1.8 im m u n ocytoch em istry .  Acutely-cultured DRG neurons from floxed 
p l l  littermate control (wild-type) and p l l  conditional-null (cKO) animals. No changes were 
obvious from this preparation.
4.1.11 N o ch an ges in p lasm a m em brane traffick ing  o f  annexin  2, A SIC 1
or 5-HT1B in DRG neurons were seen following deletion of p l l
p ll forms a heterotetramer with annexin 2. It is likely that the majority of cellular 
functions of pi 1 are mediated by this complex. To exclude the possibility that effects of 
pi 1 deletion were mediated by annexin 2 membrane downregulation, we examined levels 
of annexin 2 in DRG membrane preparations from pi 1 global-null mice. Following 
normalisation to reference protein (Na+/K+-ATPase) levels, no significant differences in 
membrane levels of annexin 2 were observed (Figure 4.19b). This result was confirmed 
using immunocytochemistry. Acutely-cultured DRG neurons from pll-null or littermate 
control animals were stained with an antibody to annexin 2. A characteristic membrane 
localisation was observed (Figure 4.19a), in agreement with previous reports. No 
differences were seen between pi 1-null and control neurons.
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Figure 4 .19  Plasm a m em b ran e  trafficking o f  annexin  2. a: Immunocytochemistry using anti- 
annexin 2 on cultured DRG neurons from control (wild-type) and p l l  conditional-null (cKO) 
animals. No differences in membrane localisation were observed, b: Western blot using anti- 
annexin 2 (36kDa) and anti-Na+/K+-ATPase (Control) on membrane preparations from floxed p l l  
(WT; 20, 40pg) and pi 1 global-null (KO; 20, 40pg) DRG. No differences in annexin 2 trafficking 
were seen.
p ll has been shown to mediate plasma membrane trafficking of ASIC la and 5-HT1B. We 
therefore examined the effect of pi 1 deletion on plasma membrane levels of these proteins 
by western blot on DRG membrane preparations. Global-null mice were used to avoid the 
confounding effects of non-Cre-expressing cell populations. Following normalisation to
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reference protein (Na7K+-ATPase) levels, no significant differences in membrane levels of 
these proteins were observed (Figure 4.20). In this case, however, membrane preparations may 
represent not only the plasma membrane but also internal cellular membranes, including 
endoplasmic reticulum. This means that changes in plasma membrane levels may be masked 
by channel presence in other membrane bodies. These results do not therefore contradict 
previous studies showing an effect of pi 1 on plasma membrane trafficking of proteins.
W T KO W T KOs ..
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Figure 4.20. Plasma mem brane trafficking assessed by western blot. DRG membrane preparations 
from control (WT; 20, 40|ig) and pi 1 global-null (KO; 20, 40gg) mice, probed with a: anti-5-HT1Band b: 
anti-ASICl. Anti- Na7K+-ATPase was used as a loading control. No differences in membrane 
trafficking were observed.
4.3.8 p l l  deletion does not affect C a2+ excretion
Since p ll is required for TRPV5&6 trafficking, and these channels are involved in Ca2+ 
transport in the kidney, we measured Ca2 and Na~ levels in urine from pll-null mice. 
Measurement of concentrations was performed by staff in the laboratory of Rene Bindels. 
Concentrations were normalised to creatinine levels, p ll deletion had no effect on Ca2+ 
excretion: Ca2+ levels in pi 1-null mice were 2.1 ± 0.3 mM Ca2+/mM creatinine (n= ll), 
compared to 2.0 ± 0.4 mM Ca2+/mM creatinine (n=8) in floxed pi 1 control animals. This is 
illustrated in Figure 4.21.
A trend towards increased Na+ excretion was observed in pi 1-null mice, although significance 
was not reached. Na+ levels in pi 1-null mice were 55.8 ± 14.0 mM Na+/mM creatinine (n=l 1), 
compared to 29.7 ± 4.0 mM Na7mM creatinine (n=8) in floxed pi 1 control animals. This is 
illustrated in Figure 4.21.
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Figure 4.21 Excretion o f  C a2+ and Na+ in the pi 1-null mouse. White bars represent floxed p i 1 
control, black bars p i  1-null animals. Mean ± SEM.
4.3.9 T T X -R  N a+ current density is reduced in p l l  con d ition al-n u ll
Voltage-activated sodium currents were recorded from acutely-cultured DRG neurons, from 
pi 1-null and floxed pi 1 littermate control mice. Voltage recordings were subject to a junction 
potential between intra- and extracellular solutions, calculated to be -3.7mV (using the method 
described by Barry and Lynch (1991)). but were not adjusted to compensate. A series o f  steps 
o f  increasing voltage were applied to each neuron, and the peak current recorded. Capacitance 
was taken as a measure o f cell size, allowing the calculation o f current density. Neurons o f 
<25pm diameter were chosen, taken to be Cre-expressing nociceptors. Currents arising from 
channel subpopulations were discriminated between using TTX. Both TTX-R and TTX-S 
currents appeared similar between pi 1-null and control neurons, each showing a distinctive 
shape. Example traces are shown in Figure 4.22.
m utants
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Figure 4.22 Electrophysiology o f  p i 1-null DRG neurons. Example TTX -R  and T TX -S  currents in 
acu te ly-cultured DRG neurons from pi 1-null mice. Currents appeared similar in floxed p i 1 controls.
Deletion o f p l l  caused a statistically significant reduction in TTX-R Na current density o f 
approximately 50%. compared to control neurons (Figure 4.23) (pi 1-null 0.037±0.0056nA/pF, 
n=42; control 0.071 ±0.016nA/pF. n=26; />=0.016. Mann-Whitney Rank Sum test). TTX-S 
current densities, however, were not significantly different between pi 1-null and control 
neurons (pi 1-null 0 .14±0.017nA/pF, n=42; control 0.1 l±0.024nA/pF. n=22; /?=0.19). A slight 
increase in mean current density was observed in p ll-nu ll  neurons, although this was not 
statistically significant (Figure 4.23). Results for both TTX-R and TTX-S current densities in 
floxed pi 1 control neurons corresponded well with those obtained from wild-type mice 
(C57BL/6) in previous studies (Nassar et al., 2004).
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Figure 4.23 Current densities in sm all-d iam eter DRG neurons. Whole-cell voltage clam p. T T X - 
sensitive (T TX -S) and TTX-resis tant (T T X -R ) peak sodium current densities in tloxed p i 1 (white; « 24) 
and pi I-null (black; /7 42) mice. A significant decrease in TTX -R  sodium current density  was observed 
in the p i 1-null mice, {jr  0.016; Mann Whitney Rank Sum test). No significant difference was observed  
in TTX -S current density. Data expressed as mean ± SEM. * p<0.05.
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To determine whether the reduction in TTX-R current density was due to a reduction in 
channel membrane density or effects o f pi 1 on the biophysical properties o f  N av 1.8, TTX-R 
current-voltage relationships were examined. Comparable current-voltage relationships were 
observed in pi 1-null (n=7) and floxed pi 1 control (n=7) neurons (Figure 4.24). This shows 
that the increased current density observed is likely due to the presence o f more functional 
channels at the membrane, rather than a shift in channel voltage-dependence.
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Figure 4.24 Current-voltage relationship for T T X -R  currents in sm all-d iam eter  DRG neurons.
N o differences were observed between floxed p l l  control (white; n=7) and p i 1-null (b lack; n=7) 
neurons. Data expressed as mean ± SEM.
Since pi 1 is known to interact with the K channel TASK-1, which may have a role in setting 
neuronal resting potentials, the effect of p l l  deletion on resting potential was investigated. 
Using physiological solutions, DRG neurons were found to fall into two groups: one with a 
resting potential around -50mV, the other around -70mV. This is consistent with previous 
research in DRG neurons (Renganathan et al„ 2001), and may be related to the expression o f 
N av 1.9 in a subset o f  sensory neurons (Herzog et ah, 2001c). No significant differences, 
however, were seen in resting potentials between pi 1-null and control neurons (Figure 4.25). 
Control neurons had mean resting potentials o f  -49.68±1.54mV (n=12) and -73.30±3.40mV 
(n=7), while values for pi 1-null neurons were -47.92±1.27mV (n=17) and -68.43±4.12mV 
(n=4). The proportion o f neurons in the -50mV group was greater than that in the -70mV 
group, consistent with the relatively infrequent occurrence o f N av l .9-mediated currents 
observed in voltage-clamp recordings.
Attempts to record ASIC-mediated currents, by whole-cell and perforated-patch techniques 
were unsuccessful, matching experiences o f other groups working on these channels in mouse 
DRG neurons (personal communications).
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Figure 4 .25 Resting potentials o f  cultured DRG neurons. No significant differences in resting 
potential were observed between tloxed pi 1 control (white: n 0 9 )  and pi 1-null (black; n 21) neurons. 
Cells were grouped according to Herzog et al. (2001a). Data expressed as mean SEM.
4.3 .10 W ide dynam ic range neurons in the spinal cord show  deficits in
noxious som atosensory coding follow ing p l l  deletion
Electrophysiological recordings from the dorsal horn were performed by Dr Elizabeth 
Matthews. Recordings were made from a total of 22 WDR neurons in p l l  conditional-null 
(n=l 1) and littermate control floxed pi 1 (n=l 1) mice. The mean depths o f the neurons from 
the surface o f the spinal cord were 471±30pm and 508±39pm respectively, corresponding to 
the deep laminae.
Single-unit neuronal responses evoked by a range o f stimuli were reduced in pi 1 conditional- 
null mice compared to littermate controls, p l l  conditional-null mice showed deficits in both 
mechanical coding in the noxious range (above the behavioural withdrawal threshold (0.6-0.8g 
in this study)) compared to control (Figure 4.26a). This difference was found to be statistically 
significant when expressed as total evoked neuronal activity (p<0.05, ANOVA) (Figure 4.26b). 
Responses to lower intensity mechanical stimuli (up to lg von Frey) were not significantly 
different from control animals, p l l  conditional-null mice also showed deficits in thermal 
coding, statistically significant when expressed as total neuronal activity (p<0.05, ANOVA). 
Additionally, p l l  conditional-null mice showed a statistically significant reduction in dorsal 
horn neuronal activity in response to noxious pinch stimuli (/;<0.05) (Figure 4.26e&f). WDR 
neuronal responses to cold (0°C water) and non-noxious tactile (brush) or thermal stimulation 
were not significantly different between p l l  conditional-null and control animals (Figure
4.26e&0-
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Figure 4.26 E lectrophysiological recordings from W D R  neurons in the dorsal horn. a,b: p l l
conditional-null mice (black boxes) display marked deficits in mechanically-evoked dorsal horn neuronal 
activity com pared with littermate controls (white boxes). W D R  neurons recorded from p i  1-null mice 
(« = 1 1) show significantly reduced activity (p<0.05) to punctate mechanical von Frey stimuli . Data are 
shown during stimulus application (a) and for total evoked activity to the st imulus (b) com pared  with 
li ttermate control mice (w=l 1). c,d: The same neurons show significantly reduced response (p<0.05)  to 
thermal stimuli (water jet). Data are shown during stimulus application (c) and for total evoked activity 
to the stimulus (d). e,f: These neurons also show significantly reduced activity to noxious pinch stimuli 
(p<0.05). but not to brush or noxious cold (1°C) when com pared with controls for the duration o f  the 
stimuli (e) and for total evoked activity to the stimulus (0- Stimuli were applied for 10s to the peripheral 
receptive field o f  the neuron on the hindpaw. Data are expressed as mean ± SEM ; */?<0.05.
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Evoked responses to transcutaneous electrical stimulation o f the peripheral receptive field were 
measured to examine effects o f  pi 1 deletion on axonal transmission properties, post-discharge 
and wind-up. No differences in electrical threshold for activation o f A- and C-fibre afferents 
were observed. No differences in electrically-evoked neuronal responses or related input or 
wind-up parameters were observed between pi 1 conditional-null and wild-type animals. 
Spontaneous ongoing firing occurrence and rate were similar between groups. A significant 
reduction in post-discharge, however, was observed in pi 1 conditional-null animals compared 
to control (pi 1 conditional null 34.4±11.0. //= 12; control 6.2±2.9. n=10; /;=0.028. /-test)
4.3.11 p l l  conditional-nu ll m ice show  no gross abnorm alities
pi 1 conditional-null mice were healthy, fertile and apparently normal. They showed no overt 
differences from floxed pi 1 littermates in appearance or spontaneous behaviour. Weight (age- 
and sex-matched) was found to be comparable between pi 1 conditional-null and pi 1 floxed 
littermates (control male 27.25±1.13g, n=6; p l l  conditional-null male 26.38±0.82g, n=4; 
control female 22.04±0.50g, n=8; pi 1 conditional-null female 22.49±0.43g, n=l 1). Genotype 
frequencies followed Mendelian ratios as expected.
To ensure that pi 1 conditional-null mice had normal motor coordination, allowing differences 
in response to noxious stimuli to be ascribed to sensory rather than motor deficits, the Rotarod 
test was used. Motor coordination performance on this apparatus was comparable between pi 1 
conditional-null animals and littermate controls (pi 1 conditional-null 189±8.21s. n= 12: control 
205± 12.85s, n=12).
4.3.12 p l l  conditional-nu ll mice show  behavioural deficits in n oxious  
m echanosensation
Behavioural responses to noxious mechanical stimuli were assessed using von Frey hairs and 
the Randall-Selitto test. No difference in withdrawal threshold to von Frey hairs was observed 
between pi 1 conditional-null and control animals (Figure 4.27a). Thresholds were comparable 
to previous studies undertaken in this group (floxed p l l  control 0.059±0.008g, n=5; p l l  
conditional-null 0.067±0.01 Og, n=7).
The Randall-Selitto test, in contrast, revealed a deficit in behavioural responses to noxious 
blunt mechanical stimulation o f  the tail in p l l  conditional-null mice (Figure 4.27b). A 
significant increase in withdrawal/response threshold was observed in pi 1 conditional-null 
mice compared to littermate controls (floxed p l l  control 0.0026±0.00025N, n=13; p l l
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conditional-null 0 .0019±0.0 0 0 12N, n=13; /?=0.013). A deficit in one model o f  
mechanosensation but not another has been observed in a number o f studies, for example in the 
analysis o f  the N av 1.8-null mouse line by Akopian et al.(1999), and is probably due to 
differences in the nature o f  the stimulus (blunt pressure increasing gradually compared to sharp, 
sudden and punctate).
a b
Figure 4.27 Acute mechanical pain behaviour in p l l  conditional-null and littermate control  
(floxed p l l )  mice, a: Response to mechanical stimulation using von Frey hairs was not significantly 
different between littermate control floxed pi 1 (white; n=5) and pi 1 conditional-null (black; w=7) mice, 
b: pi 1 conditional-null mice (black; n= 13) showed partial analgesia to noxious mechanical pressure 
applied to the tail using the Randall-Selitto apparatus compared with littermate controls (white; /?= 13) 
(/?=0.013, Student's /-test). All results are shown as mean ± SEM: * p<0.05.
4.3.13 p l l  cond itional-nu ll m ice do not show  behavioural deficits in noxious  
therm osensation
Responses to noxious thermal stimuli were assessed using Hargreaves' apparatus and the hot 
plate test. Paw withdrawal latency in Hargreaves' test was not altered by p l l  conditional 
deletion (Figure 4.28a) (control 7.41±0.35s, n = l l ;  p l l  conditional-null 8.28±0.50s, n=12,). 
There were no significant differences in latency to response on the hot plate at either 50 or 
55°C (Figure 4.28b) (50°C: control 22.4±1.9s, n=14; p l l  conditional-null 25.1±2.4s, n=15; 
p= 03S) (55°C: control 10.9±0.6s, n=14; p l l  conditional-null 13.1±1.3s, n = 15; p=0.12). In 
each test, however, pi 1 conditional-null mice showed a trend towards increased latency o f  
response, suggesting that there may be a slight tendency to thermal analgesia, similar to that 
observed in the Nav 1.8 null-mutant mouse (Akopian et al., 1999).
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Figure 4 .28  A cute therm al pain behaviour in p l l  conditional-null and littermate control (f loxed  
p l l )  mice, a: N oxious  thermal stimulation using Hargreaves' apparatus. N o significant difference in 
latency o f  h indpaw  withdrawal was observed between littermate control (white: n-  11) and p l l  
conditional-null (black: n= 12) mice, b: Response to noxious thermal stimulation using the hotplate 
appara tus was not significantly different between littermate control (white; /?=14) and p i 1 conditional- 
null (black; n = \5) mice. At 50 C. p=0.38 (S tudent 's  /-test). At 55CC. p=0.12 (S tuden t 's  /-test). All 
results are shown as mean 3 = SEM.
4.3.14 p l l  conditional-nu ll m ice show  no deficits in response to noxious cold
Behavioural responses to noxious cold were assessed using the cold plate at 0°C. Substantial 
variation in response was seen between individual animals, with some consistently displaying 
higher or lower responses. This variation, however, was found to be distributed evenly 
between p l l  conditional-null and control animals. No significant differences were seen 
between pi 1 conditional-null and littermate control animals (Figure 4.29). Previous studies 
have on occasion observed differences in response between male and female groups; results 
were separated on this basis. Results, expressed as the number o f  hind paw lifts or jum ps over 
5 mins, were as follows: Male: p l l  conditional-null 35.4±4.37s, n= 15; control 27.19±6.54s, 
n=8; p=0.31. Female: p l l  conditional-null 17.29±4.50, n=7: control 27.73±4.45. n= 11;
p=0.12.
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Figure 4 .29  A cu te  cold pain behaviour in p l l  conditional-null and littermate control (floxed p l l )  
mice. No significant differences were seen between floxed pll  littermate control (white) or p l l  
conditional-null (black) animals, in either males (M) or females (F).
4.3.15 p l l  con d ition a l-n u ll m ice show  no deficits in m odels o f  in flam m atory  
pain
Inflammatory pain behaviour was assessed using Hargreaves' test to measure thermal 
hyperalgesia in response to intraplantar carrageenan and NGF. Spontaneous inflammatory pain 
behaviour was assessed using the intraplantar formalin model.
Following intraplantar injection o f carrageenan, profound thermal hyperalgesia was observed 
from lh post-injection, persisting for at least 6h. Both baseline latencies and the extent o f  
hyperalgesia were similar between pi 1 conditional-null animals (n=6) and littermate controls 
(n=6) (Figure 4.30a). Values obtained were comparable to those from previous studies 
(Akopian et al.. 1999).
Intraplantar injection o f  NGF produced a thermal hyperalgesia with similar qualities to that 
induced by carrageenan, although with a slightly reduced magnitude. No significant 
differences were observed between p l l  conditional-null animals (n=7) and littermate controls 
(n=5) (Figure 4.30b).
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Figure 4 .30 Inflam m atory  pain behaviour in p l l  conditional-null and littermate control (f loxed  
p l l )  mice, a: Thermal hyperalgesia, tested using Hargreaves ' apparatus, after intraplantar injection o f  
2 %  carrageenan (20pl). Both floxed p i  1 littermate control (white; /7=6) and p i 1 conditional-null (b lack; 
/7=6) mice developed pronounced hyperalgesia, with no significant difference between genotypes, b: 
N G F -induced  hyperalgesia. Both li ttermate control (white; «=5) and p l l  conditional-null (black; n=l)  
m ice developed profound thermal hyperalgesia.
The formalin model produced a characteristic biphasic response, eliciting spontaneous 
nocifensive behaviour. The second phase of response in this model is believed to model 
chronic pain, including a centrally-driven component. The total pain behaviour in each phase 
was not significantly different between p l l  conditional-null animals and littermate controls 
(Figure 4.31a) (1st phase: p l l  conditional-null 100.6±22.2s, n=5: control 87.4±5.3s, n=7) (2nd 
phase: pi 1 conditional-null 283.2±432s, n=5; control 286.8±33.9s. n=7). This is consistent 
with results obtained for N av l.8-null mice (Nassar et al., 2005). When viewed on a more 
detailed level, it appears that the 2nd phase occurs slightly earlier, and to a higher maximum 
level, in pi 1 conditional-null mice, before subsiding more rapidly (Figure 4.31b). This is a 
purely qualitative change, however, and was not found to be statistically significant. 
Environmental or observer-related parameters may be responsible for this slight difference.
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Figure 4.31 F orm alin-induced inflam m atory pain behaviour in p i 1 conditional-null and littermate  
contro l (f loxed p i  1) mice. Behaviour following intraplantar injection of 20pl of 5% formalin, a: Time 
spent licking/biting the injected hindpaw was recorded in 5 min sections. No significant reduction in time 
of pain behaviour was seen at Phase 1 (0-10 mins) or at Phase 2 (10-55 mins) between littermate control 
(white; n=l) and pll  conditional-null (black; n=5) mice, b: Time course of the formalin test. A 
characteristic biphasic response was observed, with no significant differences between pi 1 conditional- 
null (black) and littermate controls (white).
4.3.16 p l l  conditional-nu ll m ice display reduced neuropath ic pain  
behaviour
The Chung model (injury to the L5 spinal nerve) was used to assess the effect o f  pi 1 deletion 
on the development and maintenance o f neuropathic pain. Surgery was performed by Bjarke 
Abrahamsen and Mohammed Nassar. von Frey hairs were used to measure mechanical 
allodynia. pi 1 conditional-null animals displayed similar baseline thresholds to littermate 
controls. Floxed pi 1 control animals showed a substantial decrease in mechanical threshold, to 
around 25% o f  baseline by Day 5, which gradually returned towards baseline levels, to a value 
o f around 65% at Day 25. Thresholds for p l l  conditional-null animals, in contrast, did not 
drop below 50% o f  baseline, and generally remained around 60% before recovery to around 
80% at day 25. These results are shown in Figure 4.32. Overall mechanical allodynia was 
significantly greater in floxed pi 1 littermate controls (n=5) than in pi 1 conditional-null (n=7) 
mice (p=0.03 1, 2-way repeated measures ANOVA). A number o f individual time points were 
also found to be significantly different between groups (Days 6 & 7, /?<0.05).
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Figure 4 .32 Neuropathic pain behaviour in p l l  conditional-null and litterm ate control (floxed  
p l l )  mice. Mechanical allodynia. measured by using von Frey hairs, resulting from the C hung  model o f  
neuropathic  pain. A significant reduction in mechanical allodynia (/?=0.031; tw o-w ay repeated measures 
A N O V A ) was observed overall in the pi 1 conditional-null (black; n=l)  when com pared  with the 
littermate control (white; 5) mice. Data are expressed as mean ± SEM; * /?<0.05 (individual points).
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4.3.17 p l l  p lays a com p lex  role in neoangiogenesis and tum our grow th
To assess the role o f  pi 1 in neoangiogenesis, we used a model o f  tumour growth. The size to 
which the tumour grows is dependent on the extent o f  neoangiogenesis. 106 cells from a 
melanoma-derived cell line (B16F0) were injected subcutaneously under the dorsal surface of 
p l l -n u l l  and floxed p l l  control animals. After 11 days, the mice were culled and tumours 
excised, pi 1-null animals were found to have significantly greater tumour volumes than pi 1 
floxed control mice (Figure 4.33).
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Figure 4.33 Effect o f  p l l  deletion on tum our growth. Melanoma growth over 11 days following 
subcutaneous injection of lxlO6 B16F0 cells in pi 1-null (black. n=10; mean volume 131,3±51.9mm') 
and floxed pi 1 littermate control (white, n=10; mean volume 456.2± 124.6mm') mice. p=0.033 (2-tailed 
/-test, unequal variance).
Blood vessel morphology was examined histologically in skin samples and in sections from the 
tumour. Preliminary' results suggest an abnormal morphology in pi 1-null animals, although 
this will be confirmed in subsequent studies.
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4 .4  D is c u s s io n
Previous studies suggested a role for p ll in the detection of noxious stimuli in peripheral 
sensory neurons. In particular, effects on pain thresholds via regulation of the nociceptor- 
specific VGSC Nav1.8 were predicted (Okuse et al., 2002). We investigated this hypothesis 
using pll-null mutant mice, p ll  is broadly expressed in a range of tissues and has been 
implicated in many cellular processes, meaning that a global-null mutant would be expected to 
display a complex phenotype, precluding a definitive analysis of its role in nociceptive 
processes in DRG neurons. In particular, recently described effects on depression-related 
behaviour (Svenningsson et al., 2006) would be likely to confound the interpretation of 
nociceptive behavioural phenotypes. We therefore created a conditional (tissue-specific) p 11 - 
null mutant mouse to examine the role of pi 1 in nociceptive sensory neurons.
Exon 2 of pi 1 was deleted, since this contains the translational start codon (ATG) required for 
protein expression. Figure 4.34 shows the amino acids encoded by exon 2.
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Figure 4.34 Deleted regions of p l l .  A: 3-D structure of the p l l  dimer. Deleted residues 1-54 in 
white, remaining residues 55-96 in blue, annexin 2 N-terminus in red. B: p l l  protein linear structure, 
illustrating deleted region and annexin 2 binding site. H I-IV represent helices I-IV.
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In this study, we demonstrated a role for pi 1 in nociception in DRG neurons. Deletion o f  pi 1 
resulted in reduced Nav 1.8 expression and thus TTX-R current density7 in cultured sensory 
neurons. Deficits in noxious coding were observed at the dorsal horn, and behaviour in 
response to noxious mechanical stimuli was attenuated. No effects on inflammatory pain 
behaviour were observed, but reduced allodynia was observed in a model o f  neuropathic pain.
4.4.1 E ffects o f  p l l  deletion  on protein trafficking and n ocicep tor  
properties
To investigate the role o f  pi 1 in nociception, a conditional pi 1-null mouse was created, pi 1 is 
known to show anti-apoptotic activity via its interaction and interference with the pro-apoptotic 
BAD (Bcl-xL/Bcl-2-Associated Death Promoter) (Hsu et al., 1997a). It was therefore possible 
that pi 1-null cells would undergo apoptosis. precluding meaningful analysis o f the conditional- 
null mouse. The effect o f  pi 1 deletion on cell survival was therefore examined carefully, p 11 - 
null cells did not appear to undergo premature apoptosis, nor were the numbers or proportions 
o f cells different between the pi 1 conditional-null animal and littermate controls. Additionally, 
pi 1 global-null mice survived and were viable. The phenotype o f pi 1 conditional-null mice 
could thus be described.
To ensure that any phenotype observed was a direct result o f  pi 1 deletion, rather than an effect 
on annexin 2 trafficking, annexin 2 membrane localisation was assessed using 
immunocytochemistry7 and western blotting. Deora et al. (2004) reported pi 1-dependent 
trafficking o f  annexin 2 to the plasma membrane, controlled by phosphory lation, suggesting 
that pi 1 deletion may well affect annexin 2 function. In the present study, however, we found 
no effect o f  pi 1 deletion on annexin 2 trafficking. Likewise, although the presence o f annexin 
2 upregulates cellular levels o f  pi 1 by a posttranslational mechanism (Puisieux et al., 1996), no 
changes in annexin 2 levels were observed following pi 1 deletion (see Figure 4.19).
Okuse et al. (2002) found that pi 1 was essential for the functional expression o f  N avl.8  at the 
plasma membrane in heterologous expression systems. In the study presented in this chapter, 
deletion o f  pi 1 from DRG neurons was found to reduce Navl.8 protein levels at the plasma 
membrane by around half. In correlation with this. Nav l.8-mediated Na currents were 
reduced by a similar level. While a reduction in Nav 1.8 membrane trafficking is in agreement 
with the previous work, it is interesting to note that Nav 1.8 functional expression was not 
completely abolished by pi 1 deletion. This observation can be explained in one o f  two ways: 
either N av 1.8 is capable of functional expression in the absence o f accessory factors, or that a 
protein other than p l l  can perform this function. In a previous study, CHO cell stable
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transfection with N av 1.8 cDNA did not produce a TTX-R current, despite displaying 
immunoreactivity associated with the plasma membrane (Okuse et al., 2002), suggesting that 
N av 1.8 alone is not capable o f  functional expression. Antisense mRNA knockdown o f  pi 1 in 
cultured DRG neurons produced a reduction in TTX-R current density o f  around 3-fold, 
leaving a detectable N av l .8-mediated current and showing that the presence o f  pi 1 is not an 
absolute requirement for Nav 1.8 functional expression in DRG neurons (Okuse et al., 2002). 
These results suggest that the remaining N av l .8 functional expression following pi 1 deletion is 
due to trafficking by other factors present in DRG neurons but not CHO cells. Candidates for 
N av 1.8 trafficking include those identified by yeast two-hybrid screening, such as Papin or 
PAF67 (Malik-Hall et al., 2003). Both Papin and PAF67 (but not calmodulin) have recently 
been shown to promote functional expression o fN a v 1.8 (Shao et al., 2005). Contactin was also 
shown to regulate TTX-R current density (Rush et al., 2005c). Alternatively, pi 1 homologues 
may bind to N av 1.8 under conditions o f  high local Ca2 concentration (binding thus not 
detected in the yeast two-hybrid assay), allowing for control o f  nociceptive thresholds by 
intracellular signalling pathways. The S100 protein S 100A 11 shares the putative Nav 1.8 
binding site o f  pi 1, and thus may be capable o f  Nav l .8 trafficking (Poon et al., 2004).
The reduction in VGSC functional expression appears to be specific to Nav 1.8, since TTX-S 
currents were not reduced by pi 1 deletion. A non-significant trend towards increased TTX-S 
current density was observed in pi 1-null neurons. This may represent a degree o f  functional 
compensation, perhaps via reduced competition for insertion into membrane microdomains. 
Alternatively, this difference may represent nothing more than the natural variation between 
cells.
The regulation o f  N av l .8 functional expression by pi 1 provides a mechanism for the control o f  
noxious thresholds. It has been shown that Nav l .8 contributes substantially to electrogenesis in 
small DRG neurons, and maintains excitability in the presence o f modest depolarisation 
(Renganathan et al., 2001), acting as a key determinant o f  excitability under these conditions 
due to its resistance to inactivation (Rush et al., 2006b). This means that relatively subtle 
changes in channel density at the membrane may produce sizeable changes in neuronal 
properties. Additionally. Nayl.8 channels have been shown to cluster at nerve termini (Brock 
et al., 1998a) and in neuroma (Kretschmer et al., 2002d), perhaps requiring p l l .  This 
localisation is thought to set thresholds of depolarisation at free nerve endings (Akopian et al., 
1999). It is possible that further sublocalisation exists, but this has yet to be addressed. Acute 
cultures o f  DRG neurons, which do not show this morphology, may therefore underestimate the 
effect o f  pi 1 deletion on local neuronal properties in vivo.
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Interactions o f  p l l  with other membrane proteins appear to show similar variability in p l l  
requirement. For example, ASIC la is expressed (functionally) in the absence o f  p l l .  but at 
relatively low levels, p l l  causes an increase in membrane levels o f  ASICla, but does not 
appear to be essential for its functional expression (Donier et al., 2005). In contrast, pi 1 has 
reported to be essential for the trafficking o f TASK-1 to the plasma membrane (Girard et al., 
2002), although this has been disputed in a subsequent study (Renigunta et al., 2006), and for 
the functional expression o f TRPV5&6 (van de Graaf et al., 2003). These mixed results imply 
that either pi 1 acts via several different mechanisms to promote trafficking, or that in some 
cases other proteins are capable o f substituting for pi 1 function.
No changes in resting potentials were observed upon pi 1 deletion. It had been hypothesised 
that T A S K -1-mediated effects could alter neuronal excitability by this method, although given 
the current contradictory data on the pi 1-TASK interaction, the direction expected was unclear. 
It appears that either deletion o f  pi 1 does not affect TASK-1 functional expression, or that any 
effects are not sufficiently large to be detectable.
The ion channels TRPV5 and TRPV6 are the most Ca2 -selective o f the TRP family, and 
constitute the rate limiting step in the Ca2 influx required for reabsorption in kidney, proximal 
intestine and placenta (Hoenderop et al., 200Ia;Hoenderop et al., 2002). TRPV5 is expressed 
along the apical membrane o f  the distal convoluted and collecting tubules (Hoenderop et al., 
2001 b;Lofflng et al., 2001b), while TRPV6 is expressed at the brush-border membrane o f 
duodenum, and both are prominently expressed in placenta and pancreas. A significant amount 
o f  TRPV5 is localised subapically in the distal tubules o f  the kidney, suggesting a shuttling 
mechanism for regulation o f  functional channel density' (Loffing et al., 2001a). The p l l  
global-null mouse did not show deficits in epithelial Ca2 transport, measured by urine Ca2 
excretion. This indicates that functional compensation is able to counter a reduction in p 11 - 
induced channel trafficking to restore normal levels of Ca2 flux. This compensation may be a 
result o f  TRPV5/6 trafficking by another molecule, perhaps a member o f the S I 00 protein 
family. In particular, S100B and S100A11 show similarities to pl 1, with S100A1 1 capable o f  
annexin 2 binding (Rintala-Dempsey et al., 2006b). Alternatively, increased activity o f  other 
epithelial Ca" -permeant channels may be sufficient for physiological compensation, allowing 
physiological levels o f Ca2 excretion. Other members of the TRP family may fulfil this role, 
although many have reduced permeability to Ca2 .
It is possible that the pl 1-null mouse displays a more subtle phenotype with respect to 
TRPV5/6 trafficking. The Ca" excretion assay presented here is relatively crude, and does not 
take into account urine volume, meaning that smaller changes in Ca2 excretion are unlikely to
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be detected. Nevertheless, the substantial effect o f  pl 1 deletion predicted by previous studies 
was not observed.
A non-statistically significant increase in Na* excretion was observed in the pl 1-null mouse. 
While this may be a non-meaningful variation, as suggested by the statistical analysis, the 
relatively low power o f the study means that a real difference may underlie this observation. 
Although TRPV5 and TRPV6 allow Na flux, it is likely that other channels mediate alterations 
in Na excretion, due to the lack o f  effect o f  pl 1 deletion on Ca2 excretion. Epithelial Na 
channels are not among the proteins currently identified as interacting with p l l ,  although this 
remains possible. Alternatively, changes in K currents resulting from altered membrane 
trafficking o f  TASK-1 in the absence o f  pl 1 (Girard et al., 2002;Renigunta et al., 2006) may 
influence the activity o f  Na -K exchange processes, resulting in reduced Na excretion through 
an indirect mechanism.
The physiological significance o f p l l  deletion from nociceptive DRG neurons was examined 
by recording electrical activity from wide dynamic range neurons in the dorsal horn. This was 
performed in vivo, meaning that any effects o f Nav 1.8 clustering were included. Since this 
procedure is performed in anaesthetised mice, responses to supra-threshold stimuli can be 
assessed. This is an advantage over behavioural assessment o f  noxious thresholds, since most 
clinically-occurring pain is o f  this nature. This may account for differences between 
behavioural and electrophysiological data. Neurons innervated by p ll-nu ll  C-fibres showed 
reduced activity in response to thermal and mechanical stimuli (including pinch but not brush), 
particularly in the noxious range, while results from floxed littermate control animals correlated 
well with those from previous studies (Matthews et al., 2006). This reflects a reduction in the 
sensitivity o f  noxious transduction, as might be expected as a result o f  reduced functional 
N av 1.8 expression. These results, however, differ from those obtained in the N av 1.8-null 
mouse line, where deficits in mechanical but not thermal nociception were observed (Matthews 
et al., 2006). It is not clear why one modality but not another was affected in the N av l .8-null 
study, although the authors propose a possible restriction o f N av l .8 expression to mechano- but 
not heat-sensitive primary afferents. Further evidence to support this hypothesis, however, has 
yet to be produced. While this disparity between the two studies may be due to experimental 
factors, it provides the first hint that p l l  may affect nociceptor properties by mechanisms 
additional to Nav 1.8 trafficking. Candidate mechanisms include trafficking o f  other channels 
such as TASK-1 or ASICla. Additionally, similar magnitudes o f  effect were seen in the pl 1- 
and Nav 1.8-null mouse lines (for mechanical stimuli), despite the observation that pl 1 deletion 
reduces trafficking o f  the channel by only around 50% (based on electrophysiological and 
immunological data). No deficits in response to noxious cold were observed in the pl 1
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conditional-null mouse, despite electrophysiological and (unpublished) behavioural evidence 
for a critical role o f  N av 1.8 in cold nociception (Matthews et al., 2006). The most probable 
explanation for this discrepancy is that the remaining population o f N av i.8 channels in the 
plasma membrane is sufficient to allow the transmission of noxious cold, with any differences 
being below the sensitivity o f  the experimental procedures.
pi 1 conditional-null mice showed no difference from control animals in response to electrical 
stimulation o f  neuronal peripheral receptive fields. This result was also seen in Nav l.8-null 
mice, and is consistent with the localisation o fN a v 1.8 channels at peripheral termini o f  sensory 
neurons (Brock et al.. 1998c). These findings support the hypothesis that Nav 1.8 is closely 
associated with transducers o f  noxious stimuli, providing the initial VGSC-mediated current 
which subsequently activates TTX-S channels along the axon. As a result, direct electrical 
excitation o f neurons is unaffected by changes in Nav 1.8 levels. Other measures o f  neuronal 
properties, input, wind-up and post-discharge, were also assessed in pi 1 conditional-null mice. 
While no differences in input or wind-up were observed, post-stimulus electrical discharge was 
significantly attenuated. Post-discharge is generally regarded as postsynaptic in origin, 
involving relief o f  Mg2 block o f  spinal NMDA receptors (Matthews et al., 2006). In this case, 
however, the conditional (primary afferents only) deletion of pi 1 allows the attribution o f  this 
observation to presynaptic mechanisms, pi 1 may act, perhaps in conjunction with annexin 2. 
on processes underlying presynaptic components o f  synaptic plasticity. Alternatively, it is 
possible that the role o f  Nav 1.8 in determining excitability under conditions o f  sustained 
depolarisation may explain this finding (Renganathan et al., 2001;Rush et al., 2006a). Since 
this effect was not observed in the Nav l.8-null mouse, however, another action o f  pi 1 is likely 
to underlie this observation. ASIC la, the functional expression o f which is enhanced by pi 1 
(Donier et al., 2005), is involved in synaptic plasticity and fear conditioning in the brain 
(Wemmie et al., 2002;Wemmie et al., 2003), with loss of ASIC associated with impaired 
hippocampal long-term potentiation. Reduced trafficking o f  ASICla in the pi 1 conditional- 
null mouse may therefore explain this observation. It is uncommon for an effect on post­
discharge to be observed in the absence of effects on wind-up. since both are a consequence o f 
removal o f  Mg2 block from NMDA receptors. This can be explained, however, by an effect 
upon sustained firing o f  peripheral nerves in the p l l  conditional-null animal. To calculate 
wind-up, it is assumed that input is constant over the course o f stimulation (16 trains), using the 
equation: Wind-up = total action potentials (16 trains) - action potentials from first train x 16. 
If the actual input is different from the calculation o f input (first train x 16), the value generated 
for wind-up may be inaccurate. An effect of pi 1 deletion on the ability o f  peripheral nerves to 
fire repeatedly in response to trains o f  pulses may therefore explain the discrepancy between 
wind-up and post-discharge results.
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The rate and occurrence o f  spontaneous firing was normal in pi 1 conditional-null mice. Since 
a decrease in occurrence o f  spontaneous firing was observed in Nav l.8-null mice, it is possible 
that T A S K -1-mediated effects partially compensated for this change, although no change in 
resting potential was seen. Alternatively, small changes could be below the threshold of 
detection for this study.
In conclusion, this work has shown a reduction in Nav 1.8 functional expression as a result of 
pi 1 deletion. While no differences in membrane levels of other proteins trafficked by pi 1 were 
observed, direct functional tests were not performed, meaning that pi 1 deletion may affect 
functional expression o f  ASIC la, TASK-1, 5-HT|B or TRPV5/6 in the DRG, as proposed by 
previous studies. Electrophyisiological recordings from wide dynamic range neurons in the 
spinal cord revealed deficits in noxious somatosensory coding as a result o f  conditional pi 1 
deletion. While the majority o f  this observation can be explain through actions o f  pi 1 on 
N av 1.8, certain phenomena were seen that were not present in the Nav l.8-null mouse. These 
are therefore ascribed to actions o f p l l  through other effector molecules, perhaps including 
ASIC la, some o f  which may be currently unidentified.
4.4.2 E ffects o f  p l l  deletion  on pain behaviour
pi 1 conditional-null mice appeared healthy and were found to show no motor deficits, allowing 
their use in assays o f  nociception. As predicted by the electrophysiological results described 
previously, conditional-null mice were found to have deficits in certain aspects o f  pain-related 
behaviour, p l l  conditional-null mice displayed increased behavioural thresholds to acute 
noxious mechanical stimuli in the Randall-Selitto test, similar to the deficits observed in the 
N av 1.8-null mouse (Akopian et al., 1999). The magnitude o f analgesia in the absence o f  pi 1 
was -5 0 %  o f  that seen in the Nav l .8-null mutant, correlating with the reduction in TTX-R Na 
currents observed in the pi 1-null. This suggests that the mechanical analgesia observed in the 
p l l  conditional-null mouse is mediated by reduced trafficking o f  N av 1.8 to the plasma 
membrane. An involvement o f  ASIC la is unlikely, since this was shown not to contribute to 
cutaneous mechanoreceptor function (Page et al., 2004a), and a mechanism for the involvement 
o f  other channels trafficked by p l l  is lacking. No differences in mechanical thresholds, 
however were observed between p l l  conditional-null and littermate controls when assessed 
using von Frey hairs. Although this seems to conflict with the results obtained from the 
Randall-Selitto test, this was not unexpected: a similar discrepancy was observed in both 
Nav l .8-null and Nav l .7 conditional-null mice (Akopian et al., 1999;Nassar et al., 2004), and is 
likely to be due to low- versus high-intensity, or other qualitative differences in the stimulus. It 
is likely that the Randall-Selitto apparatus requires a higher intensity stimulus for behavioural
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response than graded von Frey hairs due to the experimental design (continuous versus sudden 
pressure). Additionally, the blunt pressure applied by the Randall-Selitto apparatus contrasts 
with the punctate nature o f  von Frey hair stimulation. It is possible that the behavioural 
response to low-intensity von Frey hairs represents a non-nociceptive process, or that Randall- 
Selitto and von Frey methods assess differing nociceptive pathways. For example, the Randall- 
Selitto stimulus is o f  much higher intensity than that of the von Frey method, and is applied 
over a larger area, to a different body region. The diminished response to von Frey hair 
stimulation detected by spinal cord recording can be explained by the use o f high intensity, 
supra-threshold stimulation in this model, in contrast to the threshold-detection behavioural 
approach.
No deficits in noxious thermosensation were observed in the pi 1 conditional-null mouse. The 
modality-specific effect o f  pi 1 deletion may be explained via its effects on Nav 1.8 trafficking, 
since N av l.8-null mice were found to show only minor thermal analgesia: the -50%  reduction 
in expression achieved by p l l  deletion would not be likely to cause a detectable effect using 
behavioural methods (although a slight increase in threshold (non-significant) was seen in all 
tests). The modality-specific effect of Nav 1.8 deletion, however, has not been explained. It 
may imply that Nav l .8 is not highly-expressed in neurons that detect noxious heat, as suggested 
by Matthews et al. (2006). Alternatively, coupling to a specific transducer o f  mechanical 
stimuli is possible, but perhaps unlikely. It has been noted that handling elevates body 
temperature in mice, partially confounding thermal assays o f nociception (Hole and Tjolsen, 
1993), which may explain the difference in results between behavioural and 
electrophysiological thermal nociception assays. Reduced visceral pain and referred 
hyperalgesia were observed in the Nav l.8-null mouse (Laird et al., 2002). It would therefore 
be interesting to test pi 1 conditional-null mice in models o f  visceral pain.
pi 1 is upregulated by a variety o f inflammatory mediators, including NGF (Masiakowski and 
Shooter, 1988) and interferon-y (anti-inflammatory) (Huang et al., 2003b), suggesting a role in 
inflammatory pain processes. Glucocorticoids and nitric oxide, induced during inflammation, 
also upregulate p l l  (Pawliczak et al., 2001;Yao et al.. 1999c). Additionally, NGF-induced 
hyperalgesia has been shown to be strongly dependent on the presence o f  N av 1.8 (Kerr et al.,
2001), which is upregulated by NGF (Okuse et al., 1997), and ASIC la channels on sensory 
neurons may respond to local acidification occurring during inflammation. N av 1.8 has also 
been found to contribute to PGE2-induced hyperalgesia through PKA- and PKC-mediated 
phosphorylation causing changes in biophysical properties, increasing excitability (FitzGerald 
et al., 1999;Gold et al., 1998). These factors suggest that pi 1 deletion from nociceptors may 
result in reduced hyperalgesia in models o f  inflammatory' pain. Surprisingly, no differences
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from control were observed in three models (intraplantar NGF, carrageenan and formalin) o f  
inflammatory pain. This implies that the upregulation o f Nav 1.8 function by NGF is 
independent o f  p l l ,  perhaps involving channel phosphorylation or increased trafficking by 
another molecule. An alternative explanation is that the study by Kerr et al. (2001) used a 
systemic injection o f  NGF to induce inflammation, in contrast to the local subcutaneous 
delivery used in the p l l  conditional-null mutant, which may produce inflammatory 
hyperalgesia through subtly different mechanisms. The Nav l.8-null mouse did not show any 
resistance to carrageenan-induced thermal hyperalgesia until a phenotype was “unmasked” 
using lidocaine. in agreement with the lack o f effect of pi 1 deletion. It thus appears that 
neither p ll-m ediated  N av 1.8 trafficking nor any other actions of p l l  in primary afferent 
neurons are required for inflammatory hyperalgesia. This finding is in agreement with a recent 
paper using nociceptor-specific gene deletion to show that Nav 1.7 plays a major role in 
inflammatory pain (Nassar et al., 2004). Since pi 1 does not interact with Nav l .7 (Okuse et al.,
2002), any minor role o f  pi 1 would likely be hidden by the much larger contribution o f this 
channel.
A marked reduction in neuropathic pain was observed in the p l l  conditional-null mouse, 
despite the observation that p l l  mRNA was not found to be upregulated in an orofacial 
neuropathic pain model (Eriksson et al., 2005). During the initial period (days 2-10), a 
substantial difference was seen between groups, which reduced over time. The generation and 
maintenance o f neuropathic pain are often considered as distinct processes, with a primary 
afferent barrage generating conditions under which chronic central sensitisation can occur, 
prolonging hypersensitivity beyond the duration o f primary input (e.g. Coull et al.. 2003b;Coull 
et al.. 2005c). Our result therefore can be interpreted as illustrating the contribution o f  p 11 - 
containing primary afferent nociceptors to the generation, but not maintenance o f  neuropathic 
pain. The downstream effectors through which this action o f pi 1 is mediated have yet to be 
identified; it is not clear if previously identified p l l  interactors, such as N av 1.8, ASIC la, 
TASK-1, 5 -H T, b  and TRPV5/6 are responsible, or if these effects are mediated by as yet 
unidentified proteins.
The role o f N a v 1.8 in neuropathic pain has been scrutinised by several groups, using a variety 
o f  experimental approaches. Initial investigations by Okuse et al. (1997) described a 
substantial downregulation o f  Nav 1.8 transcript and membrane associated immunoreactivity 
following neuropathic nerve damage, supported by a later investigation studying trigeminal 
ganglia in an orofacial neuropathic pain model (Eriksson et al., 2005). A similar 
downregulation was observed in animal models o f diabetic neuropathy, although a significant 
increase in both TTX-S and TTX-R currents was reported, possibly via post-translational
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(phosphorylation) mechanisms (Hong et al.. 2004). Kerr et al. (2001) used the Nav 1.8-null 
mouse to show a lack o f  contribution to neuropathic pain, using the Seltzer model o f partial 
sciatic nerve injury (Seltzer et al., 1990), although this was subjected to the criticism that the 
compensatory upregulation o f  N av l .7 observed by Akopian et al. (1999) may have masked any 
effects o f  N av 1.8 deletion. This was addressed subsequently when a double knockout o f 
N av l .7 and N av l .8 also failed to show deficits in the Chung model o f  neuropathic pain (Nassar 
et al., 2005). A reduction in neuropathic pain behaviour was reported after antisense mRNA 
knockdown o f  N av l .8 (Lai et al., 2002), although strangely no changes in acute thresholds were 
seen. It is likely that the reduction in neuropathic pain observed here was due to actions o f the 
antisense mRNA on other targets, perhaps including TTX-S Na channels, since no data was 
provided to demonstrate specificity. The hypothesis that redistribution o f Nav l .8 from cell 
body to axon in uninjured neurons was proposed by the same group (Gold et al., 2003), 
although this remains incompatible with the results observed in the Nav l .7/Nav l .8 double 
knockout (Nassar et al., 2005). Deletion of Nav 1.8, however, did prevent spontaneous activity 
in damaged sensory axons, and reduced late-phase ectopic discharge in neuroma C-fibres (Roza 
et al., 2003). This may be due to a role of Nav 1.8 in determining excitability under 
depolarising conditions (Renganathan et al., 2001;Rush et al., 2006c). Nav 1.8 and N av 1.7 have 
also been show n to accumulate in painful human neuromas, although the contribution o f  this to 
the pain observed is not clear (Kretschmer et al., 2002c). Recently, the discovery o f  the 
conotoxin MrVIB, a specific blocker o f  Nav1.8 channels, was reported, along with the 
observation that its intrathecal administration reduced neuropathic pain behaviour in the rat 
(Ekberg et al.. 2006). The authors report, however, a lack of selectivity o f  the toxin for TTX-R 
currents in mouse DRG neurons, raising doubts about the mechanism through which the toxin 
acts. Additionally, it is unclear how the intrathecal administration o f a peptide toxin could 
result in activity at N av 1.8, which is expressed solely in the periphery: a combination o f  low 
membrane permeability and rapid degradation would render concentrations low in primary 
afferent neurons. Overall, the published data do not support a major role for N av 1.8 in 
neuropathic pain, although there limited evidence for a contribution to spontaneous activity in 
damaged fibres. On balance, therefore, it is likely that the effect o f  pi 1 deletion on neuropathic 
pain does not result from attenuated trafficking o fN a v 1.8, but from the interaction o f  pi 1 with 
another protein.
The roles o f TA SK -1, 5-HTm or TRPV5/6 in neuropathic pain have not been examined. The 
contribution of TASK channels to the resting membrane potential suggests a mechanism for 
1 A SK -1 -mediated regulation o f neuronal excitability. Although no change in resting potential 
was observed in acutely-cultured DRG neurons upon pi 1 deletion, it remains possible that p 11 - 
mediated changes in TASK-1 membrane levels become significant following nerve damage.
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Conflicting data on the role o f  pi 1 in TASK-1 trafficking, however, make the probable effect 
o f  pi 1 deletion on K currents unclear (Girard et al.. 2002;Renigunta et al., 2006). The 
physiological function o f  5-HT!B in primary afferent neurons has not been described, and a 
mechanism by which altered trafficking could reduce neuropathic pain is not obvious. 
Coupling o f  the receptor to the inhibitory G-protein G, allows manipulation o f  second 
messenger pathways, but little research exists on the role o f  5-HT in nociceptors during 
neuropathic pain. There are no data on the expression or possible role o f  TRPV5/6 in DRG 
neurons.
ASIC la mRNA has been shown to be downregulated in several models o f  neuropathic pain, 
with corresponding reduced functional expression (Poirot et al., 2006). The authors o f  this 
paper suggest an inhibitory contribution o f ASIC la-related currents in neuropathic pain, via an 
inhibitory effect on actively firing neurons (Vukicevic and Kellenberger. 2004). This is 
inconsistent with a role for ASIC la in pll-enhanced neuropathic pain behaviour. Although 
ASIC2 and ASIC3 have been shown to have an involvement in nociception, these channels do 
not bind p l l .  and are therefore not responsible for the effects of pi 1 deletion.
Neuropathic pain involves complex interactions between damaged and intact neuron, either 
axonally or at the level o f  the DRG (Boucher and McMahon, 2001a). In particular, the release 
of signalling molecules by degenerating nerves may underlie a proportion o f  the 
hypersensitivity observed following nerve damage (Boucher and McMahon, 2001b). Since pi 1 
interferes with BAD-induced apoptosis (Hsu et al., 1997c), it is possible that pi 1-null damaged 
neurons undergo apoptosis more readily than wild-type damaged neurons. This would reduce 
the extent to which cell contents were released, possibly reducing the effect o f  nerve damage on 
uninjured neurons and therefore neuropathic pain.
Finally, certain effects o f  p l l  may be mediated through brain-derived neurotrophic factor 
(BDNF). The extracellular protease plasmin was reported to convert the BDNF precursor 
proBDNF into active BDNF, and was shown to be required for hippocampal long-term 
potentiation (Pang et al., 2004a). Since pi 1 regulates the production o f plasmin by tPA 
(Kassam et al.. 1998d). it is reasonable to suggest that p l l  deletion would reduce levels o f  
BDNF. BDNF released from microglia in the spinal cord has been shown to play a central role 
in the development o f  neuropathic pain, through shifts in CF gradients (Coull et al., 
2003a;Coull et al.. 2005b). In the present study, however, pi 1 was deleted only from a subset 
o f  primary afferent neurons, precluding an effect on microglial BDNF release. Deletion o f 
BDNF from the same subset o f  neurons was reported to reduce inflammatory pain and 
secondary hyperalgesia, but was found to have no effect on the development o f  neuropathic
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pain (Zhao et al.. 2006). Although it is possible that nociceptor-derived plasmin may be 
required for the generation o f  active BDNF in the spinal cord, it is likely that the effect o f  pi 1 
deletion on neuropathic pain is best explained by another mechanism. The observation that pi 1 
deletion from nociceptors does not attenuate inflammatory pain would suggest that BDNF 
levels are not significantly altered in the pi 1 conditional-null mouse line.
A definitive mechanism for the involvement o f  pi 1 in the generation o f neuropathic pain has 
yet to be determined. While several molecules identified as interacting with pi 1 are plausible 
effectors, a lack o f  information o f the mechanisms behind the generation o f neuropathic pain 
makes further speculation difficult. It remains possible that the effect o f  p l l  deletion on 
neuropathic pain is orchestrated not through interaction with a specific transmembrane protein, 
but through effects on membrane microdomain organisation. p l l .  via the annexin 2 
heterotetramer, has been proposed to organise microdomains in the cell membrane through the 
formation o f  cholesterol-stabilised phosphatidylinositol 4.5-bisphosphate clusters (Gokhale et 
al., 2005). These lipid domains may organise channel distribution to affect neuronal 
excitability, allowing not only trafficking to the membrane but subsequent membrane 
localisations to be determined by p l l .  Disruption o f this organisation may provide an 
alternative explanation for the effect o f  pi 1 deletion on neuropathic pain. Actin dynamics are 
regulated by the annexin 2 -p l l  heterotetramer (Hayes et al., 2006b), resulting in the 
stabilisation o f actin-rich lipid rafts (Hayes et al., 2004) and raising the possibility o f  their 
disruption in sensory nerve termini upon p l l  deletion. The annexin 2 heterotetramer also 
interacts with the protein AHNAK. to regulate plasma membrane cytoarchitecture in epithelial 
cells (Benaud et al., 2004;De et al., 2006b), which may also occur in neurons, producing a more 
general effect o f  pi 1 deletion. Likewise, the inhibition o f phospholipase A2 by pi 1 (Bailleux 
et al., 2004a) may result in alterations in second messenger pathways in the absence o f p l l ,  
although this is likely to support a pro-inflammatory' result of pi 1 deletion (Wu et al., 1997a).
Effective pharmacological agents for the treatment o f  neuropathic pain are currently scarce. 
The present study does not explicitly identify a novel therapeutic target, but does highlight the 
role o f Nav l.8-containing neurons in the generation o f neuropathic pain. Although small- 
molecule inhibition o f  total pi 1 function would be likely to result in substantial adverse effects, 
future research to identify the effector through which pi 1 deletion reduces neuropathic pain 
may permit the development o f therapies targeted towards a specific interaction between pi 1 
and this molecule.
The effects o f conditional pi 1 deletion reported here must be viewed in light o f  the expression 
profile o f the Cre recombinase used for this deletion. While over 85% o f  N av l .8-positive cells
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are reported to be nociceptors (Akopian et al., 1996;Djouhri et al., 2003a), it is not clear that all 
nociceptors express N av 1.8; indeed, it is likely that a subset of nociceptors do not express 
N av l .8 (Djouhri et al., 2003a). This means that although the neurons from which pi 1 has been 
deleted are likely nociceptors, a population of nociceptors in which pi 1 is present may remain. 
This study may thus underestimate the importance o f p l l  in nociception. This nociceptor 
population, however, has yet to be characterised, making a more precise prediction difficult. It 
would therefore be interesting to investigate the role o f  p l l  in nociception using other Cre- 
expressing mouse lines, especially one expressing Cre in all DRG neurons. If the effects o f  pi 1 
deletion on nociception were mediated solely by attenuated trafficking o f Nav 1.8, this issue 
would not arise, but our data in combination with the pre-existing literature suggests that this 
may not be the case.
4.4.3 Sources o f  com pensation for p l l  deletion
Compensatory changes in gene expression are a commonly-cited limitation o f  transgenic 
studies. Additionally, a degree o f functional redundancy between proteins can limit the effect 
o f  gene deletion. In this study, we observed a 50% reduction in N av l.8 functional expression 
following pi 1 deletion, whereas previous work in heterologous expression systems found 
N av l .8-mediated currents to be almost negligible in the absence o f p l l .  This suggests that in 
DRG neurons, other molecules are capable of Nav 1.8 trafficking in place o f pi 1: there is a 
degree o f  functional redundancy. A variety of proteins have been identified as capable o f  
binding to N av 1.8, either by yeast two-hybrid studies (Malik-Hall et al., 2003) or by more 
directed approaches (e.g. Choi et al., 2006e). Of proteins identified by yeast two-hybrid 
screening, Papin and PAF67 appear capable o fN a v 1.8 trafficking in heterologous cells (Shao et 
al., 2005). Choi et al. (2006c) recently demonstrated that calmodulin binds to the C-terminus 
o f N av 1.8 and increases current density, without altering voltage-dependency o f  activation or 
inactivation, although this result was not replicated in heterologous expression systems (Shao et 
al., 2005). The same group also reported a role for contactin, a neuronal cell surface 
glycoprotein, in the trafficking o f  Nav 1.8 and Nav 1.9, showing reduced immunostaining and 
TTX-R current density in DRG neurons from contactin-null mice (Rush et al., 2005b). 
Alternatively, N av 1.8 trafficking in the absence o f p l l  may be carried out by other S I 00 
proteins, especially S100A11, which shares the putative Nav 1.8 binding site (Poon et al., 2004) 
and can bind to annexin 2 (Rintala-Dempsey et al.. 2006a) and may therefore be capable o f  
N av l .8 trafficking under conditions o f high Ca2 concentration.
Candidates for compensatory actions in the trafficking o f  other proteins are less well defined. 
The 14-3-3 family o f  proteins have been shown to promote plasma membrane expression o f
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TASK-1 (Renigunta et al., 2006), and incidentally have similar anti-apoptotic actions to p l l  
through interference with BAD (Hsu et al., 1997d). S I00 proteins that share conserved binding 
site residues with p l l  may be able to replace p l l  functions in the presence o f  high Ca2 
concentration, although this has not been tested.
In conclusion, we have demonstrated for the first time the importance o f  the SI 00 protein pi 1 
in nociceptive pathways in primary' sensory neurons. A proportion o f the phenoty pe observed 
upon pi 1 deletion is due to attenuated N av l .8 trafficking, but certain aspects are proposed to be 
due to other actions o f pi 1 in nociceptors. We have also created a powerful tool in the p 11 - 
fo x ed  mouse line for the tissue-specific investigation o f pi 1 function.
4.4.4 p l l  deletion enhances tum our growth and neoangiogenesis
Since pi 1 cataly ses the formation o f  plasmin. required for the formation o f new vasculature, it 
was predicted that pi 1-null mice would display decreased neoangiogenesis. Reduced tumour 
growth was expected as a direct consequence, since oxygen and nutrient supply would limit 
cell growth. We tested tumour growth follow ing the injection o f a melanoma-derived cell line 
as a surrogate model o f  angiogenesis. Surprisingly , tumour volume at the end o f  the test period 
was found to be substantially greater in pi 1-null animals than in floxed p l l  controls. 
Additionally, blood vessel morphology was found to be abnormal in preliminary' investigations, 
although this will be investigated in more detail in subsequent studies. A mechanism for pi 1- 
mediated suppression o f tumour growth is not immediately apparent from the current literature. 
Since the injected cell line was not pi 1-null, effects o f  p l l  deletion on the tumour cells 
themselves are excluded. Cells in the host system, particularly endothelial cells, must therefore 
be the focus o f pi 1 action in this assay.
It is possible that the formation o f  plasmin is not critical for neoangiogenesis under these
conditions, a hypothesis which will be investigated in subsequent studies using Matrigel assays
as a more direct measure of angiogenesis. This appears unlikely, however, since annexin 2-null
mice, which displayed fibrin deposition as a result o f  reduced plasmin activity, also displayed
markedly attenuated angiogenesis in a variety o f assay systems (Ling et al., 2004). From this
study, annexin 2 (heterotetramer)-dependent plasmin formation appears to be essential for
neoangiogenesis. A lack o f consequences o f  decreased plasmin production is therefore
unlikely to explain the increased tumour growth in pi 1-null mice. An alternative explanation is
that plasmin formation by uPA is more important than formation by tPA in this assay, or that
increased uPA activity can compensate for the reduction in pi 1-catalysed tPA function. Aside
from a lack o f evidence to support this hypothesis, the reduced angiogenesis observed in the
annexin 2-null mouse would seem to preclude this explanation. Differences in models o f
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angiogenesis used, and in the angiogenic mechanisms responsible, may account for this, 
howev er. In support o f  this. uPA is generally thought to be involved in pericellular proteolysis 
during cell migration, wound healing and tissue remodelling, while tPA mediates mainly 
intravascular fibrinolysis (Kwon et al., 2005b). The tumour growth model may be more 
dependent on uPA activity than tPA, in contrast to angiogenesis assays used in the annexin 2- 
null study.
Perhaps the most likely explanation for the pro-tumour growth effect o f  pi 1 deletion is an anti- 
angiogenic action o f pi 1 in endothelial cells. Several mechanisms have been suggested for this 
by previous studies. The annexin 2-pl 1 heterotetramer was reported to act as a plasmin 
reductase via cysteine residues on p l l ,  resulting in plasmin autoproteolysis (Kwon et al.. 
2002). Aside from reducing the local concentration o f active plasmin, this proteoly sis results in 
the formation o f  A(61), an angiostatin-like protein with anti-angiogenic activity (Kassam et al., 
2001). Angiostatin may also be released from this process, likewise inhibiting angiogenesis. 
The annexin 2-pl 1 heterotetramer also acts more directly to inhibit angiogenesis. inhibiting 
plasmin-dependent fibrinolysis (Choi et al.. 1998b;Choi et al., 2001). pi 1 is thus capable o f 
inhibiting plasmin-mediated fibrinolysis and subsequent angiogenesis, in addition to its pro- 
angiogenic activity. The possible anti-angiogenic actions o f p l l  are summarised in Figure 
4.35.
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F igure 4 .35  A nti-angiogen ic effects o f  p l l .  Red arrows represent effects of pi 1. Solid lines represent 
a positive (stimulatory) effect, dotted lines inhibition, pi 1 acts as a plasmin reductase, reducing plasmin 
levels and catalysing the formation of A(61), an anti-angiogenic plasmin fragment, p l l  also inhibits 
plasmin-dependent fibrinolysis, and may have anti-angiogenic activity in endothelial cells (although this 
is purely hypothetical). MMP: matrix metalloproteases; ECM: extracellular matrix; PA1: plasminogen 
activator inhibitor.
Although preliminaiy and far from complete, our data suggest an anti-angiogenic role o f  pi 1 in 
endothelial cells in tumour growth models. Previously reported pro-tumour (through effects on 
invasion and metastasis) discussed previously therefore appear to be due to actions o f  pi 1 in 
the tumour cells themselves. In our study, p l l  was not deleted from the implanted tumour 
cells, meaning that this effect was not observed. This distinction, once confirmed and 
investigated mechanistically, may have implications for the design o f  novel anti-cancer 
therapies targeting p l l .
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5 SUMMARY
The work presented in this thesis describes a specialised role for the S100 protein p l l  in 
nociceptive pathways. The C t q - I o x P  system was used to delete pi 1 exclusively from 
nociceptive sensory neurons in the mouse, allowing the investigation o f  pi 1 function in this 
system without the confounding effects o f  pi 1 deletion from other tissues. This mouse line 
displayed deficits in noxious mechanosensation and neuropathic pain behaviour. A proportion 
o f these effects were likely to be due to the role o f  pi 1 in the plasma membrane trafficking o f  
the voltage-gated sodium channel Nav 1.8. We therefore examined the pi 1-Nav 1.8 interaction 
on a molecular level to find key determinants o f  binding. Finally, global pi 1-null mice were 
used to investigate the role o f  pi 1 in angiogenesis. Global-null mutants showed enhanced 
angiogenesis-dependent tumour growth and altered vascular morphology.
Deletion o f  pi 1 from nociceptors reduced plasma membrane levels o f  N av 1.8, consistent with 
previous studies in heterologous expression systems (Okuse et al.. 2002). This effect was 
detectable in terms o f  both protein levels and electrophysiological current density, indicating 
the functional significance o f  this reduction. Since Nav 1.8 has been shown to have a 
specialised function in pain pathways (Akopian et al., 1999), reduced functional expression via 
blockade o f its interaction with pi 1 may be a valid therapeutic target. Although the plasma 
membrane expression o f N av l-8 was reduced by deletion o f p l l ,  however, it was not 
completely abolished. This implies that p l l  is not the sole modulator o f  N av 1.8 plasma 
membrane trafficking, and that DRG neurons must therefore contain other proteins capable o f 
this process. Currently-identified candidates include Papin and PAF-67 (Malik-Hall et al., 
2003;Shao et al., 2005), S100A11 (Poon et al., 2004), and the 14-3-3 proteins (Rajan et al., 
2002a). A more detailed understanding o f  the proteins involved in the functional expression o f  
Nav 1.8 will not only increase our understanding o f  ion channel trafficking, but may also 
provide novel therapeutic strategies for the treatment o f pain.
Nociceptor-specific pi 1-null mice displayed deficits in noxious coding in recordings from wide 
dynamic range projection neurons in the spinal cord. Consistent with this, behavioural deficits 
in noxious mechanosensation, but not inflammatory' pain, were observed. This phenotype is 
qualitatively similar to that reported for the Nav 1.8-null mouse (Akopian et al., 1999), 
suggesting that reduced trafficking o f Nav l .8 may be responsible for the effect o f  pi 1 deletion. 
Significant deficits in mechanical allodynia in a model o f  neuropathic pain were seen in the 
nociceptor-specific pi 1-null mouse. The N av l.8-null mouse, in contrast, developed 
neuropathic pain comparable to wild-type animals (Kerr et al., 2001). In combination with
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subtle electrophysiological differences observed between these mice, these data provide 
evidence that p l l  deletion affects pain behaviour through both Nav l .8-dependent and - 
independent mechanisms. Since neuropathic pain is a significant clinical problem, N av 1.8- 
independent effects o f  pi 1 in nociceptors are of great interest. The most plausible mechanisms 
for these effects may include trafficking o f ASIC la (Donier et al., 2005). which is involved in 
synaptic plasticity (Wemmie et al., 2003;Wemmie et al., 2004), or o f  TASK-1, which may 
affect neuronal excitability (Girard et al., 2002;Renigunta et al.. 2006). Subsequent studies 
may also reveal novel targets o f pi 1 through which effects on neuropathic pain are mediated. 
Investigation o f  the mechanisms by which the Nav l.8-independent effects of pi 1 on pain 
pathways are produced may yield results useful to the understanding and treatment of 
neuropathic pain.
To aid the process o f intelligent drug design, the interaction of pi 1 and Nav 1.8 was examined 
at a molecular level. Using FRET to measure protein-protein affinities in vitro, two distinct 
pi 1-binding sites were identified in the Nav 1.8 N-terminus. Previous studies, using less 
sensitive methods, had detected only one o f these regions (Poon et al.. 2004). Additionally, the 
FRET assay was able to locate an autoinhibitory domain, the deletion o f  which increased 
affinity for p l l .  The complex nature of this interaction, occurring in two sections over a 
relatively large distance, may preclude the intelligent design of small-molecule inhibitors. The 
inhibition o f  more general properties of pi 1, such as its expression or interaction with annexin 
2, would be prone to substantial adverse effects, including those related to angiogenesis. 
Future studies o f  the nature o f interactions between pi 1 and its specific targets may therefore 
prove beneficial, allowing targeting o f therapies towards specific actions of pi 1.
Previous studies have suggested a role for p l l  in angiogenesis, via the plasmin formation 
process (Kassam et al., 1998c). We used the global pi 1-null mouse for a preliminary 
investigation using a model o f  angiogenesis-dependent tumour growth. These mice display 
enhanced tumour growth, and altered vascular morphology. Subsequent studies will 
investigate this effect in more detail. An understanding of the role o f pi 1 in angiogenesis may 
inform the development o f  novel anti-cancer therapies.
In the floxed pi 1 mouse line, we have created a valuable tool for investigation o f  pi 1 function. 
The use o f other tissue-specific Cre mice will allow detailed study o f  the roles o f  p l l  in 
specific tissue types, without interference from confounding effects in other tissues. Several 
collaborations have been initiated to ensure the exploitation of this novel resource. In 
particular, the use of endothelial Cre mice will allow a more comprehensive investigation o f  the 
role o f  pi 1 in plasmin formation and related angiogenic phenomena.
185
6 REFERENCES
Ahluwalia J, Rang H, Nagy I (2002) The putative role of vanilloid receptor-like protein-1 in 
mediating high threshold noxious heat-sensitivity in rat cultured primary sensory neurons. Eur J 
Neurosci 16: 1483-1489.
Aidley DJ. Stanfield PR (1996) Ion Channels: Molecules in Action. Cambridge University 
Press.
Akiba S, Hatazavva R. Ono K, Hayama M, Matsui H, Sato T (2000b) Transforming growth 
factor-alpha stimulates prostaglandin generation through cytosolic phospholipase A(2) under 
the control o f  pi 1 in rat gastric epithelial cells. Br J Pharmacol 131: 1004-1010.
Akiba S. Hatazawa R, Ono K. Hayama M, Matsui H, Sato T (2000a) Transforming growth 
factor-alpha stimulates prostaglandin generation through cytosolic phospholipase A(2) under 
the control o f  p 1 1 in rat gastric epithelial cells. Br J Pharmacol 131:1004-1010.
Akopian AN. Sivilotti L. Wood JN (1996) A tetrodotoxin-resistant voltage-gated sodium 
channel expressed by sensory neurons. Nature 379: 257-262.
Akopian AN, Souslova V, England S. Okuse K, Ogata N, Ure J, Smith A, Kerr BJ, McMahon 
SB, Boyce S, Hill R, Stanfa LC, Dickenson AH. Wood JN (1999) The tetrodotoxin-resistant 
sodium channel SNS has a specialized function in pain pathways. Nat Neurosci 2: 541-548.
Amaya F. Decosterd I, Samad TA, Plumpton C, Tate S, Mannion RJ, Costigan M, W oolf CJ 
(2000a) Diversity o f  expression of the sensory neuron-specific TTX-resistant voltage-gated 
sodium ion channels SNS and SNS2. Mol Cell Neurosci 15: 331-342.
Amaya F, Decosterd I, Samad TA, Plumpton C, Tate S, Mannion RJ, Costigan M, W oolf CJ 
(2000b) Diversity o f  expression of the sensory neuron-specific TTX-resistant voltage-gated 
sodium ion channels SNS and SNS2. Mol Cell Neurosci 15: 331-342.
Amaya F, Wang H, Costigan M, Allchorne AJ, Hatcher JP. Egerton J, Stean T, Morisset V, 
Grose D, Gunthorpe MJ, Chessell IP, Tate S, Green PJ, Woolf CJ (2006a) The voltage-gated 
sodium channel Na(v)1.9 is an effector o f peripheral inflammatory pain hypersensitivity. J 
Neurosci 26: 12852-12860.
186
Amaya F, Wang FI, Costigan M, Allchorne AJ, Hatcher JP. Egerton J, Stean T. Morisset V, 
Grose D. Gunthorpe MJ, Chessell IP, Tate S, Green PJ, Woolf CJ (2006b) The voltage-gated 
sodium channel Na(v)1.9 is an effector o f  peripheral inflammatory pain hypersensitivity. J 
Neurosci 26: 12852-12860.
Andreev NY. Dimitrieva N. Koltzenburg M, McMahon SB (1995) Peripheral administration o f 
nerve growth factor in the adult rat produces a thermal hyperalgesia that requires the presence 
of sympathetic post-ganglionic neurones. Pain 63: 109-115.
Armstrong CM (1981b) Sodium channels and gating currents. Physiol Rev 61: 644-683.
Armstrong CM (1981a) Sodium channels and gating currents. Physiol Rev 61: 644-683.
Averill S, McMahon SB. Clary DO, Reichardt LF, Priestley JV (1995) Immunocytochemical 
localization o f trkA receptors in chemically identified subgroups of adult rat sensory neurons. 
Eur J Neurosci 7: 1484-1494.
Babes A. Zorzon D, Reid G (2006) A novel type of cold-sensitive neuron in rat dorsal root 
ganglia with rapid adaptation to cooling stimuli. Eur J Neurosci 24: 691-698.
Babiychuk EB, Monastyrskaya K, Burkhard FC, Wray S. Draeger A (2002) Modulating 
signaling events in smooth muscle: cleavage o f annexin 2 abolishes its binding to lipid rafts. 
FASEB J 16: 1177-1184.
Bach TL, Barsigian C, Chalupowicz DG, Busier D, Yaen CH, Grant DS, Martinez J (1998a) 
VE-Cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels. Exp 
Cell Res 238: 324-334.
Bach TL, Barsigian C, Yaen CH, Martinez J (1998b) Endothelial cell VE-cadherin functions as 
a receptor for the beta 15-42 sequence o f fibrin. J Biol Chem 273: 30719-30728.
Bailleux A, Wendum D, Audubert F, Jouniaux AM, Koumanov K, Trugnan G, Masliah J 
(2004a) Cytosolic phospholipase A2-pl 1 interaction controls arachidonic acid release as a 
function o f epithelial cell confluence. Biochem J 378: 307-315.
Bailleux A, Wendum D, Audubert F, Jouniaux AM, Koumanov K, Trugnan G, Masliah J 
(2004b) Cytosolic phospholipase A2-pl 1 interaction controls arachidonic acid release as a 
function o f epithelial cell confluence. Biochem J 378: 307-3 15.
187
Baker MD, Chandra SY, Ding Y, Waxman SG, Wood JN (2003) GTP-induced tetrodotoxin- 
resistant Na+ current regulates excitability in mouse and rat small diameter sensory neurones. J 
Physiol 548: 373-382.
B a m  PH. Lynch JW (1991) Liquid junction potentials and small cell effects in patch-clamp 
analysis. J Membr Biol 121: 101-117.
Bautista DM. Jordt SE, Nikai T. Tsuruda PR. Read AJ. Poblete J. Yamoah EN. Basbaum Al. 
Julius D (2006d) TRPA1 mediates the inflammatory actions of environmental irritants and 
proalgesic agents. Cell 124: 1269-1282.
Bautista DM. Jordt SE. Nikai T. Tsuruda PR, Read AJ, Poblete J, Yamoah EN. Basbaum Al. 
Julius D (2006a) TRPA1 mediates the inflammatory actions of environmental irritants and 
proalgesic agents. Cell 124: 1269-1282.
Bautista DM. Jordt SE. Nikai T, Tsuruda PR, Read AJ, Poblete J, Yamoah EN, Basbaum Al, 
Julius D (2006b) TRPA1 mediates the inflammatory actions o f  environmental irritants and 
proalgesic agents. Cell 124: 1269-1282.
Bautista DM, Jordt SE, Nikai T, Tsuruda PR. Read AJ, Poblete J, Yamoah EN, Basbaum Al, 
Julius D (2006c) TRPA1 mediates the inflammatory actions of environmental irritants and 
proalgesic agents. Cell 124: 1269-1282.
Bayliss DA, Talley EM, Sirois JE, Lei Q (2001) TASK-1 is a highly modulated pH-sensitive 
'leak' K(+) channel expressed in brainstem respiratory neurons. Respir Physiol 129: 159-174.
Benaud C. Gentil BJ, Assard N, Court M, Garin J, Delphin C, Baudier J (2004) AHNAK 
interaction with the annexin 2/S100A10 complex regulates cell membrane cytoarchitecture. J 
Cell Biol 164: 133-144.
Bennett DL, Boucher TJ, Armanini MP, Poulsen KT, Michael GJ, Priestley JV, Phillips HS, 
McMahon SB, Shelton DL (2000) The glial cell line-derived neurotrophic factor family 
receptor components are differentially regulated within sensory neurons after nerve injury. J 
Neurosci 20: 427-437.
Bennett GJ, Xie YK (1988) A peripheral mononeuropathy in rat that produces disorders o f  pain 
sensation like those seen in man. Pain 33: 87-107.
Benson CJ, Xie J, Wemmie JA, Price MP, Henss JM, Welsh MJ, Snyder PM (2002) 
Heteromultimers o f  DEG/ENaC subunits form H+-gated channels in mouse sensory neurons. 
Proc Natl Acad Sci U S A 99: 2338-2343.
188
Bernard JF, Bester H, Besson JM (1996) Involvement o f the spino-parabrachio -amygdaloid 
and -hypothalamic pathways in the autonomic and affective emotional aspects o f  pain. Prog 
Brain Res 107: 243-255.
Bester H, Chapman V. Besson JM, Bernard JF (2000) Physiological properties o f  the lamina 1 
spinoparabrachial neurons in the rat. J Neurophysiol 83: 2239-2259.
Bevan S, Geppetti P (1994) Protons: small stimulants of capsaicin-sensitive sensory nerves. 
Trends Neurosci 17: 509-512.
Bevan S. Yeats J (1991) Protons activate a cation conductance in a sub-population of rat dorsal 
root ganglion neurones. J Physiol 433: 145-161.
Bird AP (1986) CpG-rich islands and the function o f DNA methylation. Nature 321: 209-213.
Black JA, Cummins TR. Plumpton C, Chen YH, Hormuzdiar W, Clare JJ, Waxman SG (1999) 
Upregulation o f a silent sodium channel after peripheral, but not central, nerve injury in DRG 
neurons. J Neurophysiol 82: 2776-2785.
Black JA, Dib-Hajj S. Baker D, Newcombe J, Cuzner ML, Waxman SG (2000a) Sensory 
neuron-specific sodium channel SNS is abnormally expressed in the brains o f  mice with 
experimental allergic encephalomyelitis and humans with multiple sclerosis. Proc Natl Acad 
Sci U S A 97: 11598-11602.
Black JA, Dib-Hajj S, Baker D, Newcombe J, Cuzner ML, Waxman SG (2000b) Sensory 
neuron-specific sodium channel SNS is abnormally expressed in the brains o f  mice with 
experimental allergic encephalomyelitis and humans with multiple sclerosis. Proc Natl Acad 
Sci U S  A 97: 11598-11602.
Black JA, Waxman SG (2002) Molecular identities of two tetrodotoxin-resistant sodium 
channels in corneal axons. Exp Eye Res 75: 193-199.
Blackburn-Munro G, Fleetwood-Walker SM (1999) The sodium channel auxiliary subunits 
betal and beta2 are differentially expressed in the spinal cord of neuropathic rats. Neuroscience 
90: 153-164.
Blair NT, Bean BP (2002) Roles o f  tetrodotoxin (TTX)-sensitive Na+ current, TTX-resistant 
Na+ current, and Ca2+ current in the action potentials of nociceptive sensory neurons. J 
Neurosci 22: 10277-10290.
189
Blom N, Sicheritz-Ponten T, Gupta R, Gammeltoft S, Brunak S (2004) Prediction o f post- 
translational glycosylation and phosphorylation of proteins from the amino acid sequence. 
Proteomics 4: 1633-1649.
Borgonovo B, Cocucci E, Racchetti G, Podini P. Bachi A, Meldolesi J (2002) Regulated 
exocytosis: a novel, widely expressed system. Nat Cell Biol 4: 955-962.
Boucher TJ. McMahon SB (2001a) Neurotrophic factors and neuropathic pain. Curr Opin 
Pharmacol 1: 66-72.
Boucher TJ. McMahon SB (2001b) Neurotrophic factors and neuropathic pain. Curr Opin 
Pharmacol 1: 66-72.
Boucher TJ. McMahon SB (2001c) Neurotrophic factors and neuropathic pain. Curr Opin 
Pharmacol 1: 66-72.
Boucher TJ, Okuse K, Bennett DL, Munson JB, Wood JN, McMahon SB (2000) Potent 
analgesic effects o f  GDNF in neuropathic pain states. Science 290: 124-127.
Brock JA. McLachlan EM. Belmonte C (1998c) Tetrodotoxin-resistant impulses in single 
nociceptor nerve terminals in guinea-pig cornea. J Physiol 512 ( Pt 1): 211 -217.
Brock JA, McLachlan EM, Belmonte C (1998d) Tetrodotoxin-resistant impulses in single 
nociceptor nerve terminals in guinea-pig cornea. J Physiol 512 ( Pt 1): 211 -217.
Brock JA, McLachlan EM, Belmonte C (1998a) Tetrodotoxin-resistant impulses in single 
nociceptor nerve terminals in guinea-pig cornea. J Physiol 512 ( Pt 1): 211-217.
Brock JA, McLachlan EM, Belmonte C (1998b) Tetrodotoxin-resistant impulses in single 
nociceptor nerve terminals in guinea-pig cornea. J Physiol 512( Pt 1): 211-217.
Browder T, Folkman J, Pirie-Shepherd S (2000) The hemostatic system as a regulator o f  
angiogenesis. J Biol Chem 275: 1521-1524.
Buchholz F, Angrand PO, Stewart AF (1998) Improved properties o f  FLP recombinase evolved 
by cycling mutagenesis. Nat Biotechnol 16: 657-662.
Buck MR, Karustis DG, Day NA, Honn KV, Sloane BF (1992) Degradation o f  extracellular- 
matrix proteins by human cathepsin B from normal and tumour tissues. Biochem J 282 ( Pt 1): 
273-278.
190
Burgard EC. Niforatos W, van BT, Lynch KJ, Touma E, Metzger RE, Kowaluk EA, Jarvis MF
(1999) P2X receptor-mediated ionic currents in dorsal root ganglion neurons. J Neurophysiol 
82: 1590-1598.
Burgess GM. Mullaney I, McNeill M, Dunn PM, Rang HP (1989a) Second messengers 
involved in the mechanism o f  action o f bradykinin in sensory neurons in culture. J Neurosci 9: 
3314-3325.
Burgess GM, Mullaney I, McNeill M, Dunn PM, Rang HP (1989b) Second messengers 
involved in the mechanism o f  action o f  bradykinin in sensory neurons in culture. J Neurosci 9: 
3314-3325.
Bystroff C, Shao Y (2002) Fully automated ab initio protein structure prediction using l-SITES, 
HMMSTR and ROSETTA. Bioinformatics 18 Suppl 1: S54-S61.
Bystroff C. Thorsson V. Baker D (2000) HMMSTR: a hidden Markov model for local 
sequence-structure correlations in proteins. J Mol Biol 301: 173-190.
Caldwell JH. Schaller KL, Lasher RS, Peles E, Levinson SR (2000) Sodium channel Na(v)1.6 
is localized at nodes o f  ranvier, dendrites, and synapses. Proc Natl Acad Sci U S A 97: 5616- 
5620.
Camilleri M, Andrews CN, Bharucha AE, Carlson PJ, Ferber I, Stephens D, Smyrk TC, Urrutia 
R, Aerssens J, Thielemans L, Gohlmann H, van dW, I, Coulie B (2007) Alterations in 
expression o f pi 1 and SERT in mucosal biopsy specimens o f patients with irritable bowel 
syndrome. Gastroenterology 132: 17-25.
Campbell JN, Meyer RA (2006) Mechanisms o f neuropathic pain. Neuron 52: 77-92.
Campo E, Munoz J, Miquel R, Palacin A, Cardesa A, Sloane BF, Emmert-Buck MR (1994) 
Cathepsin B expression in colorectal carcinomas correlates with tumor progression and 
shortened patient survival. Am J Pathol 145: 301-309.
Cao YQ, Mantyh PW, Carlson EJ, Gillespie AM, Epstein CJ, Basbaum Al (1998) Primary 
afferent tachykinins are required to experience moderate to intense pain. Nature 392: 390-394.
Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz K.R, Koltzenburg 
M, Basbaum Al, Julius D (2000d) Impaired nociception and pain sensation in mice lacking the 
capsaicin receptor. Science 288: 306-313.
191
Caterina MJ, Leffler A, Malmberg AB, Martin WJ. Trafton J, Petersen-Zeitz KR, Koltzenburg 
M. Basbaum Al, Julius D (2000c) Impaired nociception and pain sensation in mice lacking the 
capsaicin receptor. Science 288: 306-313.
Caterina MJ. Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg 
M, Basbaum Al, Julius D (2000b) Impaired nociception and pain sensation in mice lacking the 
capsaicin receptor. Science 288: 306-313.
Caterina MJ. Leffler A, Malmberg AB, Martin WJ, Trafton J. Petersen-Zeitz KR. Koltzenburg 
M, Basbaum Al, Julius D (2000e) Impaired nociception and pain sensation in mice lacking the 
capsaicin receptor. Science 288: 306-313.
Caterina MJ, Leffler A. Malmberg AB, Martin WJ, Trafton J. Petersen-Zeitz KR. Koltzenburg 
M, Basbaum Al, Julius D (20000 Impaired nociception and pain sensation in mice lacking the 
capsaicin receptor. Science 288: 306-313.
Caterina MJ, Leffler A. Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg 
M, Basbaum Al, Julius D (2000a) Impaired nociception and pain sensation in mice lacking the 
capsaicin receptor. Science 288: 306-313.
Caterina MJ, Rosen TA, Tominaga M, Brake AJ, Julius D (1999a) A capsaicin-receptor 
homologue with a high threshold for noxious heat. Nature 398: 436-441.
Caterina MJ, Rosen TA, Tominaga M, Brake AJ, Julius D (1999b) A capsaicin-receptor 
homologue with a high threshold for noxious heat. Nature 398: 436-441.
Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D (1997a) The 
capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389: 816-824.
Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D (1997b) The 
capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389: 816-824.
Catterall WA (2000) From ionic currents to molecular mechanisms: the structure and function 
o f  voltage-gated sodium channels. Neuron 26: 13-25.
Cavaletti G, Tredici G, Braga M, Tazzari S (1995) Experimental peripheral neuropathy induced 
in adult rats by repeated intraperitoneal administration o f taxol. Exp Neurol 133: 64-72.
Cesare P, Dekker LV, Sardini A, Parker PJ, McNaughton PA (1999) Specific involvement o f  
PKC-epsilon in sensitization o f the neuronal response to painful heat. Neuron 23: 617-624.
192
Cesare P, McNaughton P (1996) A novel heat-activated current in nociceptive neurons and its 
sensitization by bradykinin. Proc Natl Acad Sci U S A 93: 15435-15439.
Cestele S. Qu Y. Rogers JC. Rochat H, Scheuer T, Catterall WA (1998) Voltage sensor- 
trapping: enhanced activation o f  sodium channels by beta-scorpion toxin bound to the S3-S4 
loop in domain II. Neuron 21: 919-931.
Chahine M, Ziane R, Vijayaragavan K, Okamura Y (2005) Regulation o f Na v channels in 
sensory neurons. Trends Pharmacol Sci 26: 496-502.
Chaplan SR, Bach FW. Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment o f 
tactile allodynia in the rat paw. J Neurosci Methods 53: 55-63.
Chaplan SR, Guo HQ. Lee DH, Luo L, Liu C, Kuei C, Velumian AA, Butler MP, Brown SM, 
Dubin AE (2003a) Neuronal hyperpolarization-activated pacemaker channels drive neuropathic 
pain. J Neurosci 23: 1169-1178.
Chaplan SR, Guo HQ, Lee DH, Luo L, Liu C, Kuei C, Velumian AA, Butler MP, Brown SM, 
Dubin AE (2003b) Neuronal hyperpolarization-activated pacemaker channels drive neuropathic 
pain. J Neurosci 23: 1169-1178.
Chen C, Bharucha V, Chen Y, Westenbroek RE, Brown A, Malhotra JD, Jones D, Avery C, 
Gillespie PJ, III, Kazen-Gillespie KA, Kazarinova-Noyes K, Shrager P, Saunders TL, 
Macdonald RL, Ransom BR, Scheuer T, Catterall WA, Isom LL (2002a) Reduced sodium 
channel density, altered voltage dependence of inactivation, and increased susceptibility to 
seizures in mice lacking sodium channel beta 2-subunits. Proc Natl Acad Sci U S A 99: 17072- 
17077.
Chen C, Westenbroek RE, Xu X, Edwards CA, Sorenson DR, Chen Y, McEwen DP, O'Malley 
HA, Bharucha V, Meadows LS, Knudsen GA, Vilaythong A, Noebels JL, Saunders TL, 
Scheuer T, Shrager P, Catterall WA, Isom LL (2004) Mice lacking sodium channel betal 
subunits display defects in neuronal excitability, sodium channel expression, and nodal 
architecture. J Neurosci 24: 4030-4042.
Chen CC, Akopian AN, Sivilotti L, Colquhoun D, Burnstock G. Wood JN (1995) A P2X 
purinoceptor expressed by a subset of sensory neurons. Nature 377: 428-431.
Chen CC, Zimmer A, Sun WH, Hall J, Brownstein MJ, Zimmer A (2002b) A role for ASIC3 in 
the modulation o f  high-intensity pain stimuli. Proc Natl Acad Sci U S A 99: 8992-8997.
193
Chen CC, Zimmer A. Sun WH, Hail J, Brownstein MJ, Zimmer A (2002c) A role for AS1C3 in 
the modulation o f  high-intensity pain stimuli. Proc Natl Acad Sci U S A 99: 8992-8997.
Chen CC. Zimmer A, Sun WH, Hall J, Brownstein MJ, Zimmer A (2002d) A role for AS1C3 in 
the modulation o f  high-intensity pain stimuli. Proc Natl Acad Sci U S A 99: 8992-8997.
Chen DS, Barraclough R (1996) Regulatory elements in the first intron o f  the rat S100A4 
(p9Ka) gene. Biochem Soc Trans 24: 352S.
Chen ZL. Strickland S (1997) Neuronal death in the hippocampus is promoted by plasmin- 
catalyzed degradation o f  laminin. Cell 91: 917-925.
Cheng Y. Prusoff WH (1973) Relationship between the inhibition constant (K.1) and the 
concentration o f  inhibitor which causes 50 per cent inhibition (150) o f  an enzymatic reaction. 
Biochem Pharmacol 22: 3099-3108.
Chetcuti A, Margan SH, Russell P, Mann S, Millar DS, Clark SJ, Rogers J. Handelsman DJ, 
Dong Q (2001a) Loss o f  annexin 11 heavy and light chains in prostate cancer and its precursors. 
Cancer Res 61: 6331-6334.
Chetcuti A. Margan SH, Russell P, Mann S, Millar DS, Clark SJ, Rogers J, Handelsman DJ, 
Dong Q (2001b) Loss o f annexin II heavy and light chains in prostate cancer and its precursors. 
Cancer Res 61: 6331 -6334.
Choi JS, Dib-Hajj SD, Waxman SG (2006b) Inherited erythermalgia: limb pain from an S4 
charge-neutral Na channelopathy. Neurology 67: 1563-1567.
Choi JS, Dib-Hajj SD, Waxman SG (2006a) Inherited erythermalgia: limb pain from an S4 
charge-neutral Na channelopathy. Neurology 67: 1563-1567.
Choi JS, Hudmon A, Waxman SG, Dib-Hajj SD (2006c) Calmodulin regulates current density 
and frequency-dependent inhibition o f sodium channel Navl.8 in DRG neurons. J 
Neurophysiol 96: 97-108.
Choi JS, Hudmon A, Waxman SG, Dib-Hajj SD (2006e) Calmodulin regulates current density 
and frequency-dependent inhibition o f sodium channel Navl.8  in DRG neurons. J 
Neurophysiol 96: 97-108.
Choi JS, Hudmon A, Waxman SG, Dib-Hajj SD (2006d) Calmodulin regulates current density 
and frequency-dependent inhibition o f sodium channel Navl.8  in DRG neurons. J 
Neurophysiol 96: 97-108.
194
Choi KS. Fitzpatrick SL, Filipenko NR, Fogg DK, Kassam G, Magliocco AM, Waisman DM 
(2001) Regulation o f plasmin-dependent fibrin clot lysis by annexin II heterotetramer. J Biol 
Chem 276: 25212-25221.
Choi KS, Fogg DK, Yoon CS, Waisman DM (2003) p l l  regulates extracellular plasmin 
production and invasiveness o f  H T 1080 fibrosarcoma cells. FASEB J 17: 235-246.
Choi KS. Ghuman J. Kassam G. Kang HM, Fitzpatrick SL, Waisman DM (1998a) Annexin II 
tetramer inhibits plasmin-dependent fibrinolysis. Biochemistry 37: 648-655.
Choi KS. Ghuman J. Kassam G, Kang HM, Fitzpatrick SL, Waisman DM (1998b) Annexin 11 
tetramer inhibits plasmin-dependent fibrinolysis. Biochemistry 37: 648-655.
Chung CY, Erickson HP (1994) Cell surface annexin II is a high affinity receptor for the 
alternatively spliced segment o f  tenascin-C. J Cell Biol 126: 539-548.
Cockayne DA, Dunn PM, Zhong Y, Rong W, Hamilton SG, Knight GE, Ruan HZ, Ma B, Yip 
P, Nunn P, McMahon SB. Burnstock G, Ford AP (2005) P2X2 knockout mice and P2X2/P2X3 
double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory 
effects o f  ATP. J Physiol 567: 621-639.
Cockayne DA, Hamilton SG, Zhu QM, Dunn PM, Zhong Y, Novakovic S, Malmberg AB, Cain 
G, Berson A, Kassotakis L, Hedley L, Lachnit WG, Burnstock G, McMahon SB, Ford AP 
(2000a) Urinar> bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient 
mice. Nature 407: 1011-1015.
Cockayne DA, Hamilton SG, Zhu QM, Dunn PM, Zhong Y, Novakovic S, Malmberg AB, Cain 
G, Berson A, Kassotakis L, Hedley L, Lachnit WG, Burnstock G, McMahon SB, Ford AP 
(2000b) Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient 
mice. Nature 407: 1011-1015.
Cohn MA, Hjelmso I, Wu LC, Guldberg P, Lukanidin EM, Tulchinsky EM (2001) 
Characterization o f  Spl, AP-1, CBF and KRC binding sites and minisatellite DNA as 
functional elements o f  the metastasis-associated mtsl/S100A4 gene intronic enhancer. Nucleic 
Acids Res 29: 3335-3346.
Cook SP, Vulchanova L, Hargreaves KM, Elde R, McCleskey EW (1997) Distinct ATP 
receptors on pain-sensing and stretch-sensing neurons. Nature 387: 505-508.
Corey DP, Garcia-Anoveros J, Holt JR, Kwan KY, Lin SY, Vollrath MA, Amalfitano A, 
Cheung EL, Derfler BH, Duggan A, Geleoc GS, Gray PA, Hoffman MP, Rehm HL,
195
Tamasauskas D. Zhang DS (2004a) TRPA1 is a candidate for the mechanosensitive 
transduction channel o f  vertebrate hair cells. Nature 432: 723-730.
Corey DP, Garcia-Anoveros J. Holt JR, Kwan KY. Lin SY, Vollrath MA, Amalfitano A, 
Cheung EL, Derfler BH, Duggan A, Geleoc GS, Gray PA, Hoffman MP, Rehm HL, 
Tamasauskas D, Zhang DS (2004b) TRPA1 is a candidate for the mechanosensitive 
transduction channel o f  vertebrate hair cells. Nature 432: 723-730.
Costigan M. Befort K, Karchewski L, Griffin RS, D'Urso D, Allchorne A, Sitarski J. Mannion 
JW. Pratt RE. W oolf CJ (2002) Replicate high-density rat genome oligonucleotide microarrays 
reveal hundreds o f  regulated genes in the dorsal root ganglion after peripheral nerve injury. 
BMC Neurosci 3: 16.
Coull JA, Beggs S. Boudreau D, Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW, De KY 
(2005c) BDNF from microglia causes the shift in neuronal anion gradient underlying 
neuropathic pain. Nature 438: 1017-1021.
Coull JA, Beggs S, Boudreau D. Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW, De KY 
(2005a) BDNF from microglia causes the shift in neuronal anion gradient underlying 
neuropathic pain. Nature 438: 1017-1021.
Coull JA. Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW, De KY 
(2005b) BDNF from microglia causes the shift in neuronal anion gradient underlying 
neuropathic pain. Nature 438: 1017-1021.
Coull JA, Boudreau D, Bachand K, Prescott SA, Nault F, Sik A, De KP, De KY (2003a) Trans- 
synaptic shift in anion gradient in spinal lamina 1 neurons as a mechanism o f  neuropathic pain. 
Nature 424: 938-942.
Coull JA, Boudreau D, Bachand K, Prescott SA, Nault F, Sik A, De KP, De KY (2003b) Trans- 
synaptic shift in anion gradient in spinal lamina I neurons as a mechanism o f  neuropathic pain. 
Nature 424: 938-942.
Coull JA, Boudreau D, Bachand K, Prescott SA, Nault F, Sik A, De KP, De KY (2003c) Trans- 
synaptic shift in anion gradient in spinal lamina I neurons as a mechanism o f  neuropathic pain. 
Nature 424: 938-942.
Courteix C, Fschalier A, Favarenne J (1993) Streptozocin-induced diabetic rats: behavioural 
evidence for a model o f  chronic pain. Pain 53: 81-88.
196
Cox JJ. Reimann F. Nicholas AK. 'Fhornton G. Roberts 1:. Springell K. Karbani G. Jafri H. 
Mannan J. Raashid Y, Al-Gazali L. Hamamy H. Valente HM. Gorman S. Williams R. McHale 
DP. Wood JN. Gribble HM. Woods CG (2006a) An SCN9A channelopathy causes congenital 
inabi 1 it\ to experience pain. Nature 444: 894-898.
Cox JJ. Reimann F. Nicholas AK. Thornton G. Roberts H. Springell K. Karbani G. Jafri H. 
Mannan J. Raashid Y. Al-Gazali H. Hamamy H. Valente HM. Gorman S. Williams R. McHale 
DP. Wood JN. Gribble HM. Woods CG (2006b) An SCN9A channelopatln causes congenital 
inability to experience pain. Nature 444: 894-898.
Craner MJ. Ho AC. Black JA. Baker D. Newcombe J. Cuzner Ml.. Waxman SG (2003b) 
Annexin 1 I/p 1 1 is up-regulated in Purkinje cells in HAH and MS. Neuroreport 14: 555-558.
Craner MJ. Ho AC. Black JA. Baker D. Newcombe J. Cuzner MH. Waxman SG (2003a) 
Annexin II/pl 1 is up-regulated in Purkinje cells in HA I: and MS. Neuroreport 14: 555-558.
Crowley C. Spencer SD. Nishimura MC. Chen KS. Pitts-Meek S. Armanini MP. Hing HH. 
McMahon SB. Shelton DL.. Hevinson AD. . (1994) Mice lacking nerve growth factor display 
perinatal loss o f  sensory and sympathetic neurons yet develop basal forebrain cholinergic 
neurons. Cell 76: 1001-1011.
Crusio W'H (1996) Gene-targeting studies: new methods, old problems. Trends Neurosci 19: 
186-187.
Cummins TR. Aglieco F. Renganathan M. Herzog Rl. Dib-Hajj SD. Waxman SG (2001) 
N a v l .3 sodium channels: rapid repriming and slow closed-state inactivation display 
quantitative differences after expression in a mammalian cell line and in spinal sensory 
neurons. J Neurosci 21: 5952-5961.
Cummins TR. Dib-Hajj SD. Waxman SG (2004a) Electrophysiological properties o f  mutant 
N a v l .7 sodium channels in a painful inherited neuropathy. J Neurosci 24: 8232-8236.
Cummins TR. Dib-Hajj SD. Waxman SG (2004b) Hlectrophysiological properties o f  mutant 
N a v l .7 sodium channels in a painful inherited neuropathy. J Neurosci 24: 8232-8236.
Cummins TR, Waxman SG (1997a) Downregulation o f tetrodotoxin-resistant sodium currents 
and upregulation o f  a rapidly repriming tetrodotoxin-sensitive sodium current in small spinal 
sensory neurons after nerve injury . J Neurosci 17: 3503-3514.
197
Cummins IR. Waxman SG (1997b) Dovvnregulation o f tetrodotoxin-resistant sodium currents 
and upregulation o f  a rapidlx repriming tetrodotoxin-sensitive sodium current in small spinal 
sensory neurons after nerve injury. J Neurosci 17: 3503-3514.
Czirjak G. Fischer I. Spat A. Lesage F. Enyedi P (2000) TASK (TWIK-related acid-sensitive 
K+ channel) is expressed in glomerulosa cells o f  rat adrenal cortex and inhibited by angiotensin 
II. Mol Endocrinol 14: 863-874.
Damarjian FG. Craner MJ. Black JA. Waxman SG (2004) Cpregulation and colocali/ation of 
p75 and N a v i .8 in Purkinje neurons in experimental autoimmune encephalomyelitis. Neurosci 
Lett 369: 186-190.
I)a \is  JIT Gray J. Gunthorpe MJ. Hatcher JP. Davey P I . Overend P. Harries MU. Lateham J. 
Clapham C. Atkinson K. Hughes SA. Ranee K. Grau IT Harper AJ. Pugh PE. Rogers DC. 
Bingham S. Randall A. Sheardown SA (2000b) Vanilloid receptor-1 is essential for 
inflammatory thermal hvperalgesia. Nature 405: 183-187.
Dav is JB. Grav J. Gunthorpe MJ. Hatcher JP. Davey P I .  Overend P. Harries MU. Lateham J. 
Clapham C. Atkinson K. Hughes SA. Ranee K. Grau E. Harper AJ. Pugh PL.. Rogers DC. 
Bingham S. Randall A. Sheardown SA (2000a) Vanilloid receptor-1 is essential for 
inflammatory thermal hvperalgesia. Nature 405: 183-187.
De EM. Van Eldik LJ. Shooter EM (1991) Differential regulation o f  S100 beta and mRNAs 
coding for SI00-like proteins (42A and 42C) during development and after lesion o f  rat sciatic 
nerve. J Neurosci Res 29: 155-162.
De SS. Benaud C. Assard N. Khediri S. Gerke V. Baudier J. Delphin C (2006b) Identification 
o f  an AHNAK binding motif specific for the Anne.xin2/S100A10 tetramer. J Biol Chem 281: 
35030-35038.
De SS. Benaud C. Assard N. Khediri S. Gerke V. Baudier J. Delphin C (2006a) Identification 
of an AHNAK binding motif specific for the Annexin2/S100A10 tetramer. J Biol Chem 281: 
35030-35038.
de WN. Dekker M. Berns A. Radman M. te RH (1995) Inactivation o f the mouse Msh2 gene 
results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and 
predisposition to cancer. Cell 82: 321-330.
Decosterd I, Ji RR. Abdi S. Fate S. Woolf CJ (2002) The pattern o f  expression o f  the voltage- 
gated sodium channels Na(v)1.8 and Na(v)1.9 does not change in uninjured primary sensory 
neurons in experimental neuropathic pain models. Pain 96: 269-277.
198
Decosterd I. Woolf CJ (2000) Spared nerve injury: an animal model o f  persistent peripheral 
neuropathic pain. Pain 87: 149-158.
Dekker LV. Daniels Z. Hick C. Elsegood K. Bowden S. Szestak T. Burley JR. Southan A. 
Cronk D. James IF (2005) Analysis o f  human N a v i .8 expressed in SH-SY5Y neuroblastoma 
cells. Fair J Pharmacol 528: 52-58.
Dempsey AC. Walsh MP. Shaw GS (2003) Unmasking the annexin I interaction from the 
structure o f  Apo-SlOOAl 1. Structure 11: 887-897.
Deora AB. Kreit/er G. Jacovina AT. Hajjar KA (2004) An annexin 2 phosphory lation switch 
mediates pi 1-dependent translocation o f annexin 2 to the cell surface. J Biol Chem 279: 4341 1- 
43418.
Devor M (2006) Sodium channels and mechanisms o f neuropathic pain. J Pain 7: S3-S12.
Dib-Hajj S. Black JA. Felts P. Waxman SG (1996) Dovvn-regulation o f  transcripts for Na 
channel alpha-SNS in spinal sensory neurons following axotomy. Proc Natl Acad Sci U S A 
93: 14950-14954.
Dib-Hajj SD. Rush AM. Cummins TR. Hisama FM. Novella S. Tyrrell L. Marshall L. W axman 
SG (2005a) Gain-of-function mutation in N a v i .7 in familial erythromelalgia induces bursting 
o f  sensory neurons. Brain 128: 1847-1854.
Dib-Hajj SD. Rush AM. Cummins TR. Hisama FM. Novella S. Tyrrell L. Marshall L. Waxman 
SG (2005b) Gain-of-function mutation in N a v i .7 in familial erythromelalgia induces bursting 
o f  sensory neurons. Brain 128: 1847-1854.
Dib-Flajj SD. Tyrrell L. Black JA. Waxman SG (1998b) NaN. a novel voltage-gated Na 
channel, is expressed preferentially in peripheral sensory neurons and down-regulated after 
axotomy. Proc Natl Acad Sci U S A  95: 8963-8968.
Dib-Hajj SD. Tyrrell L. Black JA. Waxman SG (1998c) NaN. a novel voltage-gated Na 
channel, is expressed preferentially in peripheral sensory neurons and down-regulated after 
axotomy. Proc Natl Acad Sci U S A 95: 8963-8968.
Dib-Hajj SD. Tyrrell F. Black JA. Waxman SG (1998a) NaN. a novel voltage-gated Na 
channel, is expressed preferentially in peripheral sensory neurons and down-regulated after 
axotomy. Proc Natl Acad Sci U S A 95: 8963-8968.
199
Dickenson AH (1997) Plasticity: implications for opioid and other pharmacological
interventions in specific pain states. Behav Brain Sci 20: 392-403.
Dirajlal S. Pauers EE. Stuck) CL (2003) Differential response properties o f  IB(4)-positive and 
-negative unmyelinated sensory neurons to protons and capsaicin. J Neurophysiol 89: 5 13-524.
Dixon WJ (1980) Efficient analysis o f  experimental observations. Annu Rev Pharmacol 
Toxicol 20: 441-462.
Djouhri E. Bleazard E. Law son SN (1998a) Association o f somatic action potential shape with 
sensorv receptive properties in guinea-pig dorsal root ganglion neurones. J Physiol 513 ( Pt 3): 
857-872.
Djouhri E. Bleazard E. Law son SN (1998b) Association o f somatic action potential shape with 
sensory receptive properties in guinea-pig dorsal root ganglion neurones. J Phy siol 513 ( Pt 3): 
857-872.
Djouhri E. Eang X. Okuse K. W ood JN. Berry CM. Law son SN (2003a) The TTX-resistant 
sodium channel N av i .8 (SNS/PN3): expression and correlation with membrane properties in 
rat nociceptive primary afferent neurons. J Phy siol 550: 739-752.
Djouhri E. Koutsikou S. Fang X. McMullan S. Eavvson SN (2006) Spontaneous pain, both 
neuropathic and inflammatory , is related to frequency o f spontaneous firing in intact C-fiber 
nociceptors. J Neurosci 26: 1281-1292.
Djouhri E. Newton R. Lev inson SR. Berry CM. Carruthers B. Eavvson SN (2003b) Sensory and 
electrophy siological properties o f  guinea-pig sensory neurones expressing Nav 1.7 (PN1) Na+ 
channel alpha subunit protein. J Physiol 546: 565-576.
Domoto I. Miyama Y. Suzuki H. Teratani T. Arai K. Sugiyaina T. Takayama T. Mugiya S. 
Ozono S. Nozavva R (2006b) Evaluation o f  S100A10. annexin II and B-FABP expression as 
markers for renal cell carcinoma. Cancer Sci.
Domoto T. Miyama Y. Suzuki H. Teratani T. Arai K. Sugiyama T. Takayama T. Mugiya S. 
Ozono S. Nozavva R (2006a) Evaluation of S100A10. annexin II and B-EABP expression as 
markers for renal cell carcinoma. Cancer Sci.
Donato R (1986a) S-100 proteins. C'ell Calcium 7: 123-145.
Donato R( 1986b) S-100 proteins. Cell Calcium 7: 123-145.
200
Donato R (2001) SI 00: a nuiltigenic family o f calcium-modulated proteins of the FF-hand type 
with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33: 637-668.
Donato R (2003) Intracellular and extracellular roles o f  S100 proteins. Microsc Res Tech 60: 
540-551.
Donicr F. Rugiero F. Okuse K. Wood JN (2005) Annexin II Light Chain pi 1 Promotes 
Functional expression o f  Acid-sensing Ion Channel ASIC la. J Biol Chem 280: 38666-38672.
Dovle CA. Hunt SP (1999) Substanee P receptor (neurokinin-1 (-expressing neurons in lamina I 
o f  the s, ' 1 eord encode for the intensity o f  noxious stimulation: a c-Fos study in rat.
Neuroscience 89: 17-28.
Drew LJ. Rohrer DK. Priee MP. Blaver KF. Cockayne DA. Cesare P. Wood JN (2004) Acid- 
sensing ion channels ASIC2 and ASIC3 do not contribute to mechanically activated currents in 
mammalian sensory neurones. J Physiol 556: 691-710.
Drew LJ. W ood JN (2007b) FM1-43 is a permeant blocker o f  mechanosensitive ion channels in 
sensor\ neurons and inhibits behavioural responses to mechanical stimuli. Mol Pain 3: 1.
Drew LJ. W ood JN (2007a) FM1-43 is a permeant blocker o f  mechanosensitiv e ion channels in 
sensory neurons and inhibits behavioural responses to mechanical stimuli. Mol Pain 3: 1.
Drew LJ. Wood JN. Cesare P (2002) Distinct mechanosensitive properties o f  capsaicin- 
sensitive and -insensitive sensory neurons. J Neurosci 22: RC228.
Dube GR. Lehto SG. Breese NM. Baker SJ. W'ang X. Matulenko MA. Honore P. Stewart AO. 
Moreland RB. Brioni JD (2005) Electrophysiological and in vivo characterization o f  A-3 17567, 
a novel blocker o f  acid sensing ion channels. Pain 117: 88-96.
Duda T. Goraczniak RM. Sharma RK (1996) Molecular characterization o f  S100A1-S100B 
protein in retina and its activation mechanism of bovine photoreceptor guanylate cyclase. 
Biochemistry 35: 6263-6266.
Duprat F. Lesage F. Fink M. Reyes R. Heurteaux C. Lazdunski M (1997) TASK, a human 
background K+ channel to sense external pH variations near physiological pH. LMBO J 16: 
5464-5471.
Dvmecki SM. lomasievvicz II (1998) Using Flp-recombinase to characterize expansion o f 
Whit 1 -expressing neural progenitors in the mouse. Dev Biol 201: 57-65.
201
67
Ekberg J. Adams DJ (2006) Neuronal voltage-gated sodium channel subtypes: kev roles in 
inflammatory and neuropathic pain. Int J Biochem Cell Biol 38: 2005-2010.
Ekberg J. Jayamanne A. Vaughan CW, Aslan S. Thomas E. Mould J. Drinkwater R. Baker 
MD. Abrahamsen B. Wood JN, Adams DJ. Christie MJ. Lewis RJ (2006) {micro JO-conotoxin 
MrVlB selectively blocks N a v i .8 sensory neuron specific sodium channels and chronic pain 
behavior without motor deficits. Proc Natl Acad Sci V S A 103: I 7030-1 7035.
Elliott AA. Tlliott JR (1993) Characterization o f  TTX-sensitive and 11 X-resistant sodium 
currents in small cells from adult rat dorsal root ganglia. J Plnsiol 463: 39-56.
Emmert-Buck MR. Roth MJ. Zhuang Z, Campo T. Rozhin J. Sloane BE. Liotta LA. Stetler- 
Stevenson WG (1994) Increased gelatinase A (MMP-2) and eathepsin B activity in invasive 
tumor regions of human colon cancer samples. Am J Pathol 145: 1285-1290.
Fmgland. S. Okuse K. Ogata N. & Wood J. N. Heterologous expression o f  the sensory neurone- 
specific sodium channel (SNS) -subunit in rat sympathetic neurones. J.Plnsiol. [511. 124PJ. 
1998.
Ref Type: Generic
Eriksson J. Jablonski A. Persson AK. Hao JX. Kouya PF, Wiesenfeld-Hallin Z. Xu XJ. Fried K 
(2005) Behavioral changes and trigeminal ganglion sodium channel regulation in an orofacial 
neuropathic pain model. Pain 1 19: 82-94.
Ernstrom GG. Chalfie M (2002) Genetics o f  sensory mechanotransduction. Annu Rev Genet 
36: 41 1-453.
Evans MJ. Kaufman MH (1981) Establishment in culture o f  pluripotential cells from mouse 
embryos. Nature 292: 154-156.
Falcone DJ. McCaffrey LA. Haimovitz-Friedman A. Vergilio JA. Nicholson AC (1993) 
Macrophage and foam cell release o f matrix-bound growth factors. Role o f  plasminogen 
activation. J Biol Chem 268: 1 1951-1 1958.
Fang X. Djouhri E. Black JA. Dib-Hajj SD. Waxman SG. Eavvson SN (2002) The presence and 
role of the tetrodotoxin-resistant sodium channel Na(v)1.9 (NaN) in nociceptive primary 
afferent neurons. J Neurosci 22: 7425-7433.
Fang X. Djouhri E. McMullan S. Berry C, Okuse K. Waxman SG, Eavvson SN (2005) trkA is 
expressed in nociceptive neurons and influences electrophysiological properties via N a v i .8 
expression in rapidly conducting nociceptors. J Neurosci 25: 4868-4878.
202
Farley FW, Soriano P, Steffen LS, Dymecki SM (2000) Widespread recombinase expression 
using FLPeR (flipper) mice. Genesis 28: 106-110.
Ferreira J, Santos AR, Calixto JB (1999) Antinociception produced by systemic, spinal and 
supraspinal administration of amiloride in mice. Life Sci 65: 1059-1066.
Fertleman CR, Baker MD, Parker KA, Moffatt S, Elmslie FV, Abrahamsen B, Ostman J, 
Klugbauer N, Wood JN, Gardiner RM, Rees M (2006a) SCN9A mutations in paroxysmal 
extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 
52: 767-774.
Fertleman CR, Baker MD, Parker KA, Moffatt S, Elmslie FV, Abrahamsen B, Ostman J, 
Klugbauer N, Wood JN, Gardiner RM, Rees M (2006b) SCN9A mutations in paroxysmal 
extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 
52: 767-774.
Fiering S, Epner E, Robinson K, Zhuang Y, Telling A, Hu M, Martin DI, Enver T, Ley TJ, 
Groudine M (1995) Targeted deletion of 5'HS2 of the murine beta-globin LCR reveals that it is 
not essential for proper regulation of the beta-globin locus. Genes Dev 9: 2203-2213.
FitzGerald EM, Okuse K, Wood JN, Dolphin AC, Moss SJ (1999) cAMP-dependent 
phosphorylation of the tetrodotoxin-resistant voltage-dependent sodium channel SNS. Journal 
of Physiology-London 516: 433-446.
Fjell J, Cummins TR, Davis BM, Albers KM, Fried K, Waxman SG, Black JA (1999a) Sodium 
channel expression in NGF-overexpressing transgenic mice. J Neurosci Res 57: 39-47.
Fjell J, Cummins TR, Dib-Hajj SD, Fried K, Black JA, Waxman SG (1999b) Differential role 
of GDNF and NGF in the maintenance of two TTX-resistant sodium channels in adult DRG 
neurons. Brain Res Mol Brain Res 67: 267-282.
Fogg DK, Bridges DE, Cheung KK, Kassam G, Filipenko NR, Choi KS, Fitzpatrick SL, 
Nesheim M, Waisman DM (2002) The pi 1 subunit of annexin II heterotetramer is regulated by 
basic carboxypeptidase. Biochemistry 41: 4953-4961.
Folkman J (1995a) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 
27-31.
Folkman J (1995b) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 
27-31.
203
Forster. I. Intermolecular energs migration and fluorescence. Ann.Pins. 2. 55-75. 1-1-1948. 
Ref Tspe: Cienerie
Prosch BA. Berquin I. Pmmert-Buek MR. Moin K. Sloane BP (1999) Molecular regulation, 
membrane association and secretion of tumor eathepsin B. APM1S 107: 28-57.
Fuchs PN. Ro/a G. Sora I. I Id (i. Raja S \  (1999) Characterization of mechanical withdrawal 
responses and effects of mu-, delta- and kappa-opioid agonists in normal and mu-opioid 
receptor knockout mice. Brain Res 821: 480-486.
Ganju P. ( VBrsan JP. I)er C. Winter J. James IF (1998) Differential regulation of SI 1C proteins 
In ner\e  growth factor in sensors neurons and PC I 2 cells. Pur J Neurosci 10: 1995-2008.
( iareia-Anoseros J. Samad I A. /usela-.lelaska P. WoolfC.I. Gores DP (2001) Transport and 
localization of the DPC PNaC ion channel BNaClalpha to peripheral mechanosensors 
terndnals of dorsal root ganglia neurons. J Neurosci 21: 2678-2686.
Cierke V. Moss SP (2002) Anne.xins: from structure to function. Physiol Res 82: 55 1-571.
Gerke V. Weber k  (1984) Identity o f  p56k phosphor) lated upon Rous sarcoma sirus 
transformation ssith a protein purified from brush borders: calcium-dependent binding to non- 
ersthroid spectrin and P-actin. FMBO J 5: 227-255.
Gerke V. W eber K (1985c) The regulators chain in the p56-kd substrate complex o f siral 
tsrosine-speciflc protein kinases is related in sequence to the S-100 protein o f glial cells. 
PMBO J 4: 2917-2920.
Gerke V. Weber k  (1985a) The regulators chain in the p56-kd substrate complex o f  siral 
tyrosine-specific protein kinases is related in sequence to the S-100 protein o f glial cells. 
PMBO J 4: 2917-2920.
Gerke V. Weber k  (1985b) The regulators chain in the p56-kd substrate complex o f siral 
tsrosine-speciflc protein kinases is related in sequence to the S-100 protein o f glial cells. 
PMBO J 4: 2917-2920.
Gingrich JA. Hen R (2001) Dissecting the role of the serotonin ssstem in neuropsychiatric 
disorders using knockout mice. Psschopharmacologs (Berl) 155: 1-10.
Girard G. 'Finel N. Terrenoire G. Romes G. Pazdunski M. Borsotto M (2002) pi 1. an annexin 
II subunit, an auxiliary protein associated vsith the background k+  channel. I A S k -P  PMBO J 
21: 4459-4448.
204
Gladwin M I.  Yao XI.. C owan VI. Huang XL. Schneider R. Grant I.R. I.ogun C . Shelhamer .111
(2000) Retinoic acid reduces pi 1 protein levels in bronchial epithelial cells bv a 
posttranslational mechanism. Am J Plnsiol Lung C ell Mol Plnsiol 270: LI 103-1.1 100.
Gokhale NA. Abraham A. Digman MA. Gratton L. C ho W (2005) Phosphoinositide specified) 
o f  and mechanism of lipid domain formation by annexin A2-pl 1 heterotetramer. J Biol C hem 
280: 42831-42840.
Ciold MS. Levine .11). C orrea AM (1008) Modulation of I I X-R (Na) bv PkC and PKA and 
their role in PGL( 2 )-induced sensitization of rat sensor) neurons in vitro. Journal of 
Neuroscience 18: 10345-10355.
Ciold MS. Shuster MJ. Levine .11) (1006) C haracterization of six voltage-gated ko currents in 
adult rat sensor) neurons. J Neuropil)siol 75: 2620-2646.
Ciold MS. Weinreieh I), kim C'S. Wang R / .  I 'realtor J. Porreca L. Lai J (2003) Redistribution 
o f Na(V) 1.8 in uninjured axons enables neuropathic pain. Journal of Neuroscience 23: 158-166.
Goldstein ML. House SB. Gainer H (1001) NL-L and peripherin immunoreaetiv ities define 
distinct classes o f rat sensor) ganglion cells. J Neurosci Res 30: 02-104.
Graeser R. Gannon J. Poon RY. Dubois I . Aitken A. Hunt I (2002) Regulation o f the C'Dk- 
related protein kinase PCTAIRL-1 and its possible role in neurite outgrowth in Neuro-2A cells. 
J C ell Sei 115: 3470-3400.
Green BG (1002) The sensor) effects o f  l-menthol on human skin. Somatosens Mot Res 0: 
235-244.
CJreen GM. Scarth J. Dickenson A (2000) An excitatorv role for 5-1 IT in spinal inflammatory 
nociceptive transmission: state-dependent actions via dorsal horn 5-111(3) receptors in the 
anaesthetized rat. Pain 80: 81-88.
C j tireje (). Von kM . Simon GL. Gater R (1008) Persistent pain and well-being: a World Health 
Organization Stud) in Primary C are. JAMA 280: 147-151.
Haase II. Podzuweit I . Putsch G. Hohaus A. kostka S. I.indschau C. kott M. kralt R. Morano 
I (1000) Signaling from beta-adrenoeeptor to L-type calcium channel: identilleation o f a newel 
cardiac protein kinase A target possessing similarities to AHN Ak. I ASLB J 13: 2161-2172.
205
Ilains BG. Klein JP. Saab C Y. Craner MJ. Black JA. Waxman S(i (2003) I ^regulation of 
sodium channel Navl.3 and functional involvement in neuronal h\perexcitabi 1 it\ associated 
with central neuropathic pain after spinal cord injur). J Neurosci 23: 8881-8892.
Hajjar KA. Jaeovina AT. C'haeko J (1994) An endothelial cell receptor for plasminogen tissue 
plasminogen activator. 1. Identitv with annexin II. J Biol C hem 269: 21 191-21 197.
Halaehmi I). 141am Y (1993) Calcium homeostasis in veast cells exposed to high 
concentrations of calcium. Roles of vacuolar H( G-A I Pase and cellular A I P. I BBS Lett 316: 
73-78.
Hamill OP. Mart) A. Neher L. Sakmann B. Sigworth 1J (1981) Improved pateh-elamp 
techniques for high-resolution current recording from cells and cell-free membrane patches. 
Ptlugers Arch 391: 83-100.
Han G. I.ampert A. Rush AM. Dib-Hajj SI). Wang X. Yang Y. Waxman S(i (2007) 
Temperature dependence of ervthromelalgia mutation I.838L in sodium channel Navl.7. Mol 
Pain 3: 3.
Han C. Rush AM. Dib-Hajj SD. 14 S. Xu / .  W ang Y. Tvrrell I.. Wang X. Yang Y. Waxman 
S(i (2006b) Sporadic onset o f  ervthermalgia: a gain-of-function mutation in Navl.7. Ann 
Neurol 39: 333-338.
Han G. Rush A.M. Dib-Hajj SD. Li S. Xu / .  Wang Y. Tyrrell L. Wang X. Yang Y. Waxman 
SG (2006a) Sporadic onset of erv thermalgia: a gain-of-function mutation in Navl.7. Ann 
Neurol 39: 333-338.
Han HG. Lee DH. C luing JM (2000) Cdiaraeteristies of ectopic discharges in a rat neuropathic 
pain model. Pain 84: 233-261.
Harder I . Kube L. Gerke V (1992) Gloning and characterization of the human gene encoding 
pi 1: structural similaritv to other members o f  the S-100 gene familv. Gene 1 13: 269-274.
Hargreaves K. Dubner R. Brown L. I lores C. J oris J (1988) A new and sensitive method for 
measuring thermal nociception in cutaneous hvperalgesia. Pain 32: 77-88.
Hartv I P. Dib-Hajj SD. Tyrrell L. Blackman R. Hisama 1M. Rose JB. Waxman SG (2006a) 
Na(V)l.7 mutant A863P in erv thromelalgia: effects of altered activation and steady-state 
inactivation on exe itabi lit) o f  nociceptive dorsal root ganglion neurons. J Neurosci 26: 12366- 
12373.
206
Hartv I P. Dib-Hajj SI). Tvrrell L. Blackmail R. Hisama I'M. Rose .IB. Waxman S(i (2006b) 
Na(V)1.7 mutant A863P in ervthromelalgia: effects of altered activation and steady-state 
inactivation on excitabiIit\ of nociceptive dorsal root ganglion neurons. J Neurosci 26: 12566- 
12575.
Hastv P. Rivera-Pere/ J. C hang C. Bradlev A (1901) Target frequencv and integration pattern 
for insertion and replacement vectors in embrvonic stem cells. Mol Cell Biol 1 1: 4509-45 1 7.
Haves M.l. Reseller I . (ierhe V. Moss SI. (2004) Annexin-actin interactions. Traffic 5: 571- 
576.
Haves M.l. Sliao I). Bailk M. Moss SI. (2006a) Regulation of actin dvnamics bv annexin 2. 
PM Ik )  J 25: 1816-1826.
Haves M.l. Sliao I). Bailk M. Moss SP (2006b) Regulation of actin dynamics b> annexin 2. 
PMBO J 25: 1816-1826.
Hebert SC. Desir (i. Giebisch G. W ang W (2005) Molecular diversity and regulation of renal 
potassium channels. Plnsiol Rev 85: 319-371.
Heinemann SH. Terlau H. Stuhmer W. Imoto K. Numa S (1992) Calcium channel 
characteristics conferred on the sodium channel bv single mutations. Nature 356: 441-443.
HPNSPP H. /O T T P R M A N  Y (1951) The effect of menthol on the thermoreceptors. Acta 
Plnsiol Scand 24: 27-34.
ller/og  RI. Cummins PR. W axman SG (2001a) Persistent IPX-resistant Na^ current affects 
resting potential and response to depolarization in simulated spinal sensorv neurons. J
Neurophysiol 86: 1351-1364.
Herzog RI. C ummins I R. Waxman SG (2001c) Persistent IPX-resistant Na+ current affects 
resting potential and response to depolarization in simulated spinal sensorv neurons. J
Neuroplnsiol 86: 1351-1364.
Herzog RI. C ummins PR. W axman SG (2001b) Persistent I I X-resistant Na+ current affects
resting potential and response to depolarization in simulated spinal sensorv neurons. J
Neuroplnsiol 86: 1351-1364.
Herzog RI. Pin C. Waxman SG. Cummins PR (2003a) Calmodulin binds to the C terminus of 
sodium channels Nav 1.4 and Nav 1.6 and differentially modulates their functional properties. J 
Neurosci 23: 8261-8270.
207
I l e r / o g  Kl.  I . in C .  W a x m a n  S G .  C u m m i n s  I R ( 2 0 0 3 b )  C a l m o d u l i n  b i nd s  to  t he  C' t e r m i n u s  o f  
s o d i u m  c h a n n e l s  N a v i . 4 an d  N a \  1.6 an d  d i f fe ren t i a l ! }  m o d u l a t e s  t he i r  f un c t i o n a l  p ro pe r t i e s .  J 
N e u r o s c i  23:  8 2 6 1 - 8 2 7 0 .
H o e n d e r o p  J G .  Ni  1 ins B. B in d e l s  RJ ( 2 0 0 2 )  M o l e c u l a r  m e c h a n i s m  o f  a c t i ve  Ca2-*- r e a b s o r p t i o n  
in the d is ta l  n e p h r o n .  A n n u  Rev P l n s i o l  64:  5 29 -5 4 9 .
H o e n d e r o p  JG .  V e n n e k e n s  R. M u l l e r  I). P r en en  J. D r o o g m a n s  G.  B in de l s  RJ.  N i  1 ins B ( 2 0 0 1 b )  
f  u nc t i on  a n d  e x p r e s s i o n  o f  t he  ep i t he l i a l  C a ( 2 ~ )  c ha nn e l  f a m i k :  c o m p a r i s o n  o f  m a m m a l i a n  
1’C'aC'l a n d  2. J P l n s i o l  537:  74 7 - 7 6 1 .
H o e n d e r o p  JG .  V e n n e k e n s  R.  M u l l e r  I). P r en en  J. D r o o g m a n s  G.  B in de l s  RJ.  N i I ins B ( 2 0 0 1 a )  
f u n c t i o n  a n d  e x p r e s s i o n  o f  t he  ep i t he l i a l  C ' a ( 2 - ) c ha n n e l  f a m i k :  c o m p a r i s o n  i d ' m a m m a l i a n  
I .C ' aC l  an d  2. J P l n s i o l  537 ;  7 4 7 - 7 61 .
H o e n d e r o p  J ( j. V e n n e k e n s  R. M u l l e r  I).  P r e n en  J. D r o o g m a n s  ( j .  B in d e l s  RJ.  N i I ins B ( 2 0 0  Id)  
f  un c t i o n  an d  e x p r e s s io n  o f  t he  ep i t he l i a l  C 'a (2-  ) ch a n n e l  f a m i k :  c o m p a r i s o n  o f  m a m m a l i a n  
fX' aC' l  an d  2. J P hys io l  537:  7 47 -7 6 1 .
H o e n d e r o p  JG .  V e n n e k e n s  R. M u l l e r  D.  P r e n e n  J. D r o o g m a n s  G .  B in d e l s  RJ.  N i l i u s  B (2 0 0 1 c )  
f u n c t i o n  an d  e x p r e s s io n  o f  t he  ep i t he l i a l  C ' a (2M  c ha n n e l  f a m i k :  c o m p a r i s o n  o f  m a m m a l i a n  
TCaC ' l  an d  2. J Phys i o l  537 :  7 4 7 - 76 1 .
H o h a u s  A.  P e r s on  V.  B e h lk e  J. S c h a p e r  J. M o r a n o  I. H a a s e  H ( 2 0 0 2 )  T h e  c a r bo xv  l - t e rmina l  
r eg i o n  o f  a l m a k  prov i des  a l ink b e t w e e n  ca r d i ac  T - tv pe  C a 2 ~  c h a n n e l s  an d  t he  a c t i n -b a s e d  
e y t o s k e l e t o n .  I A S T B  J 16: 1205 - 121 6 .
H o le  K.  I j o l s en  A ( 1 9 9 3 )  T h e  t a i l - f l i ck  an d  fo r ma l in  te s t s  in r oden t s :  c h a n g e s  in skin 
t e m p e r a t u r e  as  a c o n f o u n d i n g  factor .  Pain  53: 2 4 7 - 2 5 4 .
H o n g  S. M o r r o w  I J.  P a u l s o n  PP2 I som TT.  W ilex JW ( 2 0 0 4 )  Tarlv pa in fu l  d i a b e t i c  n e u r o p a t h y  
is a s s o c i a t e d  w i th  d i f f e r en t i a l  c h a n g e s  in t e t r o d o t o x in - s e n s i t i v e  an d  - r e s i s t an t  s o d i u m  c h a n n e l s  
in do rsa l  r oot  g a n g l i o n  n e u r o n s  in t he  rat.  J Biol  C h e m  279 :  2 9 3 4 1 - 2 9 3 5 0 .
H o n o r e  P. R o g e r s  S D .  Sc lnv e i  MJ .  S a l a k - J o l m s o n  JT.  f u g c r  N M .  S a b i n o  M G .  C loh i s v  DR.  
M a n t y h  PW ( 2 0 0 0 )  M u r i n e  m o d e l s  o f  i n f l a m m a t o r y ,  n e u r o p a t h i c  a n d  c a n c e r  pa in  e ach  
g en e ra t e s  a u n iq u e  set  o f  n e u r o c h e m i c a l  c h a n g e s  in the sp ina l  co rd  an d  s enso rv  n e u ro n s .  
N e u r o s c i e n c e  98:  5 85 -5 9 8 .
208
Hsu  SY.  k a i p i a  A.  / h u  L. l i s u c h  A.I ( 1 9 9 7 c )  I n t e r f e r en ce  o f  B A D  ( B c l - \ L  B c l - 2 - a s s o c i a t e d  
de a t h  p r o m o t c r ) - i n d u c e d  a p o p t o s i s  in m a m m a l i a n  ce l l s  bv 14-7-3 i s o f o r m s  a n d  P 1 1. M o l  
L n d o c r i n o l  11: 1 8 58 -1 86 7 .
Hsu  S Y .  K a ip i a  A.  / h u  L. H s u c h  AJ  ( 1 9 9 7 a )  I n t e r f e r e n ce  o f  B A D  ( B c l - x L  B e l - 2 - a s s o e i a t e d  
de a t h  p r o m o t e r ) - i n d u c e d  a p o p t o s i s  in m a m m a l i a n  cel l s  bv 14-3-3 i s o f o r m s  a n d  P 1 1. Mo l  
b n d o e r i n o l  1 1: 1 8 58 -1 86 7 .
Hsu  S Y .  k a i p i a  A.  / h u  I.. H s u e h  AJ ( 1 9 9 7 e )  I n t e r f e r enc e  o f  B A D  ( B c l - x L  B c l - 2 - a s s o e i a t e d  
d e a th  p r o m o t e r ) - i n d u c e d  a p o p t o s i s  in m a m m a l i a n  cel l s  bv 14-3-3 i s o f o r m s  a n d  P 1 1. Mo l  
B n d o e r in o l  1 1: 18 58 -1 86 7 .
H s u  S Y .  k a i p i a  A.  / h u  L. H s u e h  AJ ( 1 9 9 7 b )  I n t e r f e r e nee  o f  B A D  ( B c l - \ L  B c l - 2 - a s s o c i a t e d  
d e a t h  p r o m o t e r ) - i n d u c e d  a p o p t o s i s  in m a m m a l i a n  ce l l s  bv 14-3-3 i s o fo rm s  an d  P 1 1. Mo l  
L n d o c r i n o l  11: 185 8 -1 86 7 .
H su  S Y .  k a i p i a  A.  / h u  I.. H s u e h  AJ ( 1 9 9 7 d )  I n t e r f e r e nee  o f  B A D  ( B c l -x L  B c l - 2 - a s s o c i a t e d  
d e a th  p r o m o t e r ) - i n d u c e d  a p o p to s i s  in m a m m a l i a n  cel l s  bv 14-3-3 i s o f o r m s  an d  PI 1. Mo l  
b n d o e r i n o l  I I :  18 58 - 18 67 .
H u a n g  X. P a w l i c / a k  R. Y a o  X L .  M a d a r a  P. Al saa tv  S. S h e l h a m e r  JH .  C o w a n  M.l ( 2 0 0 3 a )  
C h a r a c t e r i z a t i o n  o f  t he  h u m a n  p i  1 p r o m o t e r  s e q ue n ce .  G e n e  310:  133 -142 .
H u a n g  X L .  P a w l i c / a k  R. C o w a n  MJ .  G l a d w i n  M I .  M a d a r a  P. L o g u n  C .  S h e l h a m e r  J H  ( 2 0 0 2 )  
H p id e rm a l  g r o w t h  f ac t o r  i n d u ce s  p i  1 g e n e  an d  p ro t e in  e x p r e s s io n  a n d  d o w n - r e g u l a t e s  c a l c i u m  
i o n o p h o r e - i n d u c e d  a r a c h i d o n i c  a c id  r e l e a se  in h u m a n  ep i t he l i a l  eel l s .  J B iol  C h e m  277 :  3 8 4 3 1 -  
3 8 4 4 0 .
H u a n g  X L .  P a w l i e / a k  R.  Y a o  X L .  C o w a n  MJ .  G l a d w i n  M l .  W a l t e r  MJ .  H o l t / m a n  M J .  M a d a r a  
P. L o g u n  C.  S h e l h a m e r  JH  ( 2 0 0 3 b )  I n t e r f e r o n - g a m m a  in d u c e s  p i  1 g e n e  a nd  p ro t e in  e x p r e s s io n  
in h u m a n  ep i t h e l i a l  c e l l s  t h r o u g h  i n t e r f e r o n - g a m m a - a c t i v a t e d  s e q u e n c e s  in t h e  p i  1 p r o m o t e r .  J 
Biol  C h e m  278 :  9 2 9 8 - 9 3 0 8 .
H u n s k a a r  S. H o le  k  ( 1 9 8 7 )  T h e  fo r ma l i n  tes t  in mice :  d i s so c i a t i o n  b e t w e e n  i n f l a m m a t o r y  an d  
n o n - i n f l a m m a t o rv  pa in .  Pa in  30:  103-1 14.
Hu n t  SP.  M a n t y h  P W  ( 2 0 0 1 a )  T h e  m o l e c u l a r  d y n a m i c s  o f  pa in  con t r o l .  N a t  Re v  N e u r o s c i  2: 
85-91 .
Hu n t  SP.  M a n t y h  P W  ( 2 0 0 1 b )  T h e  m o l e c u l a r  d y n a m i c s  o f  pa in  con t r o l .  N a t  Rev N e u r o s c i  2: 
83 -91 .
209
I keb uc h i  N \V .  W a i s m a n  D M  ( 1 6 6 0 )  C a l c i u m - d e p e n d e n t  r e gu l a t i on  o f  a c t i n  f i l amen t  b u n d l i n g  
bv l i po eo r t i n -85 .  J Biol  C h e m  265 :  5 3 6 2 - 5 4 0 0 .
I m m k e  D C .  M c C l e s k e v  PW ( 2 0 0 1 )  L ac t a t e  e n h a n c e s  t he  a c i d - s e n s i n g  Na-*- c h a n n e l  on  
i s c h e m i a - s e n s i n g  n e u ro n s .  N a t  N e u r o s c i  4: 86 6 -8 7 0 .
Ino u e  M.  I ' e d a  H ( 2 0 0 0 a )  P ro t e in  k i n a s e  C - m e d i a t e d  a cu t e  t o l e r a nc e  to  pe r i p he ra l  m u - o p i o i d  
a n a l g e s i a  in t he  bradv k i n i n - n o e i e e p t i o n  test  in m ice .  J P h a r m a c o l  L \ p  l i ter 263:  6 6 2 - 6 6 6 .
Ino u e  M.  L e d a  11 ( 2 0 0 0 b )  P ro t e in  k i n a s e  C - m e d i a t e d  a c u t e  t o l e r an ce  to pe r i p he ra l  m u - o p i o i d  
a n a l g e s i a  in t he  b r a d v k i n i n - n o e i e e p t i o n  tes t  in m ice .  J P h a r m a c o l  L \ p  l iter 263:  6 6 2 -6 6 6 .
I s om  1.1. ( 2 0 0 0 )  I. C e l l u l a r  an d  m o l e c u l a r  b iologv o f  s o d i u m  ch a n n e l  be t a - s u bu n i t s :  t he r a p eu t i c  
im p l i c a t i o n s  for  p a in ?  I. C e l l u l a r  a n d  m o l e c u l a r  b iologv o f  s o d i u m  c h a n n e l  be t a - su b un i t s :  
t h e r a p e u t i c  im p l i ca t i on s  for  pa in ?  A m  .1 P h \ s i o l  ( i a s t r o i n t e s t  L i \ e r  Ph\s icsl  278 :  ( i 3 4 6 - ( i 5 5 3 .
I s o m  1.1. ( 2001  ) S o d i u m  c h a n n e l  be t a  subun i t s :  a n y t h i n g  but  a u x i l i a r y  N e u r o s c i e n t i s t  7: 4 2 - 5 4 .
I s om 1.1.. Ca t t e r a l l  W A ( 1 6 6 6 )  N a ~  c h a n n e l  s u bu n i t s  and  Ig d o m a i n s .  N a t u r e  383 :  3 0 7 - 3 0 8 .
I s om 1.1.. De  J o n g h  KS .  Ca t t e r a l l  W A ( 1 6 6 4 )  Auxi l i a ry  su b u n i t s  o f  \ o l t a g e - g a t e d  ion c h a n n e l s .  
N e u r o n  12: I 183-1 164.
I s om I.I. .  De  J o n g h  KS .  Pa t t on  D h .  R e b e r  BF.  O f f o rd  J. C h a r b o n n e a u  H.  W a l s h  K.  G o l d i n  A L .  
Ca t t e r a l l  W A ( 1 6 6 2 )  P r ima rv  s t r uc tu r e  an d  func t i ona l  e x p r e s s io n  o f  t h e  be t a  1 s u b u n i t  o f  t he  rat  
b r a i n  s o d i u m  c h a n n e l .  S c i e n c e  256:  83 6 - 84 2 .
I s om I I . . S e h e u e r  I .  B rovvns t e in  A B .  R a g s d a l e  DS .  M u r p h v  BJ.  C a t t e r a l l  W A  ( 1 6 6 5 )  
F u n c t i o n a l  c o - e x p r e s s i o n  o f  t he  be t a  1 a nd  t y p e  11A a l p h a  su b u n i t s  o f  s o d i u m  c h a n n e l s  in a 
m a m m a l i a n  cel l  l ine.  J Biol  C h e m  270:  3 3 0 6 - 3 3 1 2 .
J a r e s - L r i jm a n  L A .  J o \ i n  ' I 'M ( 2 0 0 3 )  F R L T  im ag in g .  N a t  B i o t e e h n o l  21:  1 3 8 7 - 1 36 5 .
J e n s en  I S. Y a k s h  T L  ( 1 6 8 4 )  L f l ee t s  o f  an  i n t r a theca l  d o p a m i n e  ag on i s t ,  a p o m o r p h i n e .  on  
t h e r m a l  and  c h e m i c a l  e v o k e d  n o x i o u s  r e s p o n s e s  in rats.  B ra in  Re s  266 :  2 8 5 - 2 6 3 .
Ji RR.  S a m a d  I A.  J i n  S X .  S c h m o l l  R. W o o l f  CJ ( 2 0 0 2 )  p 38  M A P K  a c t i va t i o n  by  N G I  in 
p r i m a r y  s enso rv  n e u r o n s  a f t e r  i n f l a m m a t i o n  i nc r ea s e s  I RPV1  l eve l s  a n d  m a i n t a i n s  hea t  
hv pe r a l ge s i a .  N e u r o n  36:  57 -68 .
J o h n  V I 1. Ma in  M.l. P ow e l l  AJ .  Gladvvel l  X M .  H ick  C .  S id h u  IIS.  C l a r e  J.l. l a t e  S. I revi s e  DJ 
( 2 0 0 4 )  H e t e r o l o g o u s  e x p r e s s i o n  a n d  fun c t i o na l  an a l v s i s  o f  rat  Nav 1.8 ( S N S )  v o l t a g e - g a t e d
210
s o d i u m  c h a n n e l s  in t he  do r s a l  r oot  g a n g l i o n  n e u r o b l a s t o m a  cel l  l ine N D 7 - 2 3 .  
N e u r o p h a r m a c o l o g v  46:  4 2 5 - 4 3 8 .
J o n e s  N G .  S l a t e r  R.  C a d i o u  H.  M e N a u g h t o n  P. M c M a h o n  S B  ( 2 0 0 4 )  A e i d - i n d u e e d  pa in  a nd  its 
m o d u l a t i o n  in h u m a n s .  J N e u r o s c i  24:  1 0 0 7 4 -1 0 0 7 0 .
Jo r d t  SB.  B au t i s t a  D M .  C h u a n g  H U .  M c k e m y  DI ) .  Z y g m u n t  P M .  I l o g e s t a t t  14) .  M e n g  II).  
J u l i u s  I) ( 2 0 0 4 )  M u s t a r d  o i l s  a n d  c a n n a b i n o i d s  exc i t e  s e n s o r )  n e r \ e  f i br es  t h r o u g h  t he  T R P  
c h a n n e l  A N K  I M 1 .  N a t u r e  427 :  2 6 0 -2 6 5 .
Jo rd t  SB.  T o m i n a g a  M.  J u l i u s  I) ( 2 0 0 0 )  A c i d  po t e n t i a t i on  o f  the  c ap sa i c in  r e c e p t o r  d e t e r m i n e d  
b \  a kev e x t r a c e l l u l a r  si te.  P roc  Na t l  A c a d  Sci  I S A  07:  8 1 34 -8 13 0 .
J o \ n e r  AB.  Ci i i i l lemot  B ( 1004)  G e n e  t a rg e t i n g  an d  d e v e l o p m e n t  o f  the  n e r v o u s  sv s t e m .  C u r r  
O p i n  N e u r o b i o l  4: 37 -42 .
J u l i u s  I). B a s b a u m  A1 ( 2 0 0  Id )  M o l e c u l a r  m e c h a n i s m s  o f  noc i c e p t i o n .  N a tu r e  413 :  2 0 3 - 2 1 0 .
J u l i u s  I). B a s b a u m  AI ( 2 0 0 1 b )  M o l e c u l a r  m e c h a n i s m s  o f  noc i c e p t i o n .  N a tu r e  413 :  2 0 3 -2 1 0 .
Ju l i u s  I). B a s b a u m  AI ( 2 0 0 1 a )  M o l e c u l a r  m e c h a n i s m s  o f  n o c i c e p t i o n .  N a t u r e  41 3 :  20 3 -2 1 0 .
J u l i u s  I). B a s b a u m  AI ( 2 0 0  l e )  M o l e c u l a r  m e c h a n i s m s  o f  n o c i c e p t i o n .  N a t u r e  41 3 :  2 0 3 -2 1 0 .
k a s s a m  ( j . C hoi  k S .  G h u m a n  J. k a n g  I I M .  B i t / p a t r i c k  SB.  Z a c k s o n  I . Z a e k s o n  S. T o b a  M.  
S h i n o m i v a  A.  W a i s m a n  D M  (1 9 9 8 a )  T h e  ro le  o f  a n n e x i n  II t e t r a m e r  in t h e  a c t i v a t i o n  o f  
p l a s m i n o g e n .  J Biol  C h e m  273:  4 7 9 0 - 4 7 9 9 .
k a s s a m  G .  C h o i  k S .  G h u m a n  J. k a n g  IBM. B i t / p a t r i c k  SB.  Z a c k s o n  I .  Z a c k s o n  S. T o b a  M.  
S h i n o m i v a  A.  W a i s m a n  D M  ( 1 9 9 8 b )  I h e  ro le  o f  a n n e x i n  II t e t r a m e r  in t he  a c t i v a t i o n  o f  
p l a s m i n o g e n .  J B io l  C h e m  273 :  4 7 9 0 - 4 7 9 9 .
k a s s a m  G.  kvv o n  M.  Y o o n  C S .  G r a h a m  k S .  Y o u n g  M k .  G l u c k  S. W a i s m a n  D M  ( 2 0 0 1 )  
Pu r i f i c a t i on  an d  c h a r a c t e r i z a t i o n  o f  A 6 1 .  A n  an g io s t a t i n - l i k e  p l a s m i n o g e n  f r a g m e n t  p r o d u c e d  
by p l a s m in  a u to d i g e s t i o n  in t he  a b s e n c e  o f  su l f h yd ry l  do n o r s .  J Biol  C h e m  276 :  8 9 2 4 - 8 9 3 3 .
k a s s a m  G.  Be BIB  C h o i  k S .  k a n g  H M .  B i t / p a t r i c k  SB.  P o u i e  P. W a i s m a n  D M  ( 1 9 9 8 d )  I h e  
p i  1 subun i t  o f  the a n n e x i n  II t e t r a m e r  p l avs  a kev ro l e  in t he  s t im u la t i o n  o f  t - P A - d e p e n d e n t  
p l a s m i n o g e n  ac t i v a t i on .  B ioch em is t ! ' )  37:  16 9 5 8 -1 6 9 6 6 .
21 1
K a s s a m  ( i .  l . e  B l l .  C hoi  KS .  K a n g  H M .  I i t zpa t r i ck  SL .  L ou i e  P. W a i s m a n  D M  ( 1 9 9 8 e )  T h e  
p i  1 su bun i t  o f  t he  a n n e x i n  II t e t r a m e r  p l a ys  a key ro l e  in t he  s t im u la t i o n  o f  t - P A - d e p e n d e n t  
p l a s m i n o g e n  ac t i va t i o n .  B io c h e m is t ry  37:  16 C>58 -1 6 96 6 .
K a s s a m  ( i .  Le  B IT  C hoi  KS .  K a n g  H M .  F i t zp a t r i ck  SL .  L o u i e  P. W a i s m a n  D M  ( 1 9 9 8 e )  T h e  
p i  1 s ub un i t  o f  t he  a n n e x i n  II t e t r a m e r  p l a y s  a key ro l e  in t he  s t im u la t i o n  o f  t - P A - d e p e n d e n t  
p l a s m i n o g e n  a c t i va t i o n .  B io c h e m is t ry  37:  1 6 9 58 -1 69 66 .
Kavvase  L. S u e m o r i  11. ' l a k a h a s h i  N.  O k a / a k i  K.  I l a s h i m o t o  K. N a k a t s u j i  N ( 1 9 9 4 )  S t r a in  
d i f f e r e n c e  in e s t a b l i s h m e n t  o f  m o u s e  e m b r y o n i c  s t e m  ( L S )  cel l  l ines,  lnt  J I ) e \  Biol  38:  3 85 -  
390 .
K a y s e r  \  . ( i u i l b a u d  ( i  ( 1987)  Loca l  an d  r e m o t e  m o d i f i c a t i o n s  o f  no c i c e p t i v e  sens i t i vi t y d u r i n g  
c a r r a g e e n i n - i n d u c e d  i n f l a m m a t i o n  in t he  rat. Pain  28:  9 9 -1 07 .
K a / e n - ( i i l l e s p i e  K A .  R a g s d a l e  DS .  D 'A n d r e a  M R .  Ma t t e i  LN.  R o g e r s  KL .  I som LI.  ( 2 0 0 0 )  
C l o n i n g ,  l oca l i z a t i on ,  a n d  func t i o na l  e x p r e s s io n  o f  s o d i u m  c h a n n e l  be t a  1A subun i t s .  J Biol  
C h e m  275 :  10 79 - 108 8 .
K e r r  B.l. S o u s l o v a  V.  M c M a h o n  SB.  W o o d  JN  ( 2 0 0 1 )  A rol e  for  t he  I I X- r e s i s t an t  s o d i u m  
c h a n n e l  Nav 1.8 in N C b - i n d u c e d  hy pe ra lg e s i a ,  but  not  n e u ro p a t h i c  pa in .  N e u r o r e p o r t  12: 3 0 7 7 -  
30 80 .
K id d  BL .  C r b a n  L A  ( 2 0 0 1 )  M e c h a n i s m s  o f  i n f l am ma to ry  pa in .  B r  J A n a e s t h  87:  3 -11 .
K i m  S H .  C h u n g  J M  ( 1 9 9 2 )  An  e x p e r i m e n t a l  m o d e l  fo r  pe r i phe ra l  n e u ro p a t h y  p r o d u c e d  by 
s e g m e n t a l  sp i na l  n e r v e  l i ga t i on  in t he  rat.  Pain  50: 35 5 -3 6 3 .
K l i g m a n  D.  H il t  D C  ( 1 9 8 8 )  T h e  S I 00  p ro t e in  fami ly . T r e n d s  B i o c h e m  Sci  13: 4 3 7 - 4 4 3 .
K o b a y a s h i  H.  S c h m i t t  M.  G o r e t z k i  L. C hucho lovvski  N .  C a l v e t e  J. K r a m e r  M.  G u n z l e r  W A .  
J a n i ck e  L. G r a e f f  II ( 1 9 9 1 )  C a t h e p s i n  B ef f ic i en t ly  a c t i v a t e s  t he  so l u b l e  a n d  t he  t u m o r  cel l  
r e c e p t o r - b o u n d  f o r m  o f  t h e  p r o e n z y m e  u r o k i n a s e - t y p e  p l a s m i n o g e n  a c t i v a t o r  ( P r o - u P A ) .  .1 Biol  
C h e m  266:  5 147-5 1 52.
K o b a y a s h i  K. L u k u o k a  I .  O b a t a  K. Y a m a n a k a  11. Dai  Y.  f o k u n a g a  A.  N o g u c h i  K ( 2 0 0 5 )  
D is t inct  ex p r e s s io n  o f  T R P M 8 .  1 R P A 1 .  an d  I R P V I  m R N A s  in rat  p r i ma ry  a f f e r en t  n e u r o n s  
w i th  ad e l t a / c - f i be r s  a nd  co lo c a l i z a t i o n  w i th  t rk r e ce p to r s .  J C o m p  N e u r o l  4 93 :  5 9 6 -6 0 6 .
212
k o n t i s  k. l .  R o u n a g h i  A.  Cioldin AI .  ( 1 9 9 7 )  S o d i u m  c h a n n e l  a c t i va t i o n  g a t i n g  is a f f e c t e d  by 
s u bs t i t u t i on s  o f  v o l t ag e  s e n s o r  po s i t i ve  c h a r g e s  in all f ou r  d o m a i n s .  J Cien Phy s i o l  1 10: 39 1 -  
401 .
k r e t s e h m e r  I . H a p p e l  I T.  T n g l a n d  JD .  N g u y e n  D l l .  Tie l  RI. .  B e u e r m a n  R W . k l i n e  I )G  
( 2 0 0 2 c )  A c c u m u l a t i o n  o f  PN 1 a n d  PN 3  s o d i u m  c h a n n e l s  in pa in fu l  h u m a n  n e u r o m a - e v  ide nc e  
f r om i m m u n o c v t o c h e m i s t r v  . A c t a  N e u r o c h i r  (W ien ) 144: 80 3 -8 10 .
k r e t s e h m e r  I .  H a p p e l  I T.  T n g l a n d  .11). N g u v e n  1)11. Tiel  RI. .  B e u e r m a n  R\Y.  k l i n e  I ) ( j 
( 2 0 0 2 a )  A c c u m u l a t i o n  o f  PN I a n d  PN 3  s o d i u m  c h a n n e l s  in pa infu l  h u m a n  n e u ro m a -e v  i de nc e  
f r om  i m m u n o c v  t o c h e m i s t r v .  A c t a  N e u r o c h i r  ( W ien ) 144: 80 3 - 81 0 .
k r e t s e h m e r  T.  H a p p e l  I T.  I m g la n d  JI ) .  N g u v e n  1)11. Tiel  RI. .  B e u e r m a n  R W .  k l i n e  I ) ( i 
( 20 ( ) 2d )  A c c u m u l a t i o n  o f  PN 1 an d  PN3  s o d i u m  c h a n n e l s  in pa infu l  h u m a n  n e u ro m a -e v  i d enc e  
f r om  im m u n o c v  t o c h e m i s t r v . A c t a  N e u r o c h i r  ( W ien ) 144: 803 -81 0 .
k r e t s e h m e r  T.  H ap p e l  I I . T n g l a n d  JI ) .  N g u v e n  I )H.  Tiel  RI. .  B e u e r m a n  R W .  k l i n e  DCi 
( 2 0 0 2 b )  A c c u m u l a t i o n  o f  PN 1 a nd  PN3  so d i u m  c h a n n e l s  in pa in fu l  h u m a n  n e u r o m a - e v  i d e nc e  
f r om  i m m u n o c v t o c h e m i s t r v . A c t a  N e u r o c h i r  ( W ien ) 144: 80 3 - 81 0 .
k u b e  T. B e c k e r  I .  W e b e r  k .  G e r k e  V ( 1 9 9 2 )  P r o t e i n -p ro t e in  i n t e r a c t i on  s t u d i e d  bv s i te-  
d i r ec t e d  m u t a g e n e s i s .  C h a ra c t e r i z a t i o n  o f  the  an n e x in  I l - b in d i n g  si te  on  p i  1. a m e m b e r  o f  t he  
S I 00  p ro t e in  f ami lv .  J Biol  C h e m  267 :  1 4 1 75 -1 41 82 .
k u d o h  J. W a n g  V.  M i n o s h i m a  S. H a s h i m o t o  I .  A m a g a i  \ 1 .  N ish ikavva  I .  S h t i v e l m a n  T. 
B i s h o p  J M .  S h i m i z u  N ( 1 9 9 5 )  L o ca l i z a t i on  o f  t he  h u m a n  A H N  A k / d e s m o y o k i n  g e n e  
( A H N A k )  t o  c h r o m o s o m e  ba n d  1 1 q 12 bv s o m a t i c  cel l  h y b r id  an a lv s i s  an d  f l u o r e s c e n c e  in si tu 
h yb r i d i z a t i o n .  C y t o g e n e t  Ce l l  G e n e t  70: 2 1 8 -2 2 0 .
kvvan  k Y .  A l l c h o r n e  AJ .  Vo l l r a th  M A .  C h r i s t e n s e n  A P .  / . h a n g  DS .  W o o l f  CJ .  C o r e y  D P  
( 2 0 0 6 0  T R P A 1  c o n t r i b u t e s  to  co ld ,  m e c h a n i c a l ,  an d  c h e m i c a l  n o c i c e p t i o n  but  is not  e s s en t i a l  
for  ha i r -ce l l  t r a n s d u c t i o n .  N e u r o n  50: 2 77 -2 8 9 .
kvvan  k Y .  A l l c h o r n e  A.I. V o l l r a t h  M A .  C h r i s t e n s e n  A P .  / h a n g  DS ,  W o o l f  CJ .  C o r e y  D P  
( 2 0 0 6 a )  T R P A 1  c o n t r i b u t e s  to  co ld ,  m e c h a n i c a l ,  an d  c h e m i c a l  n o c i c e p t i o n  but  is not  e s s en t i a l  
l o r  ha i r -ce l l  t r a n sd u c t i o n .  N e u r o n  50: 27 7 - 2 8 9 .
kvvan  k Y .  A l l c h o r n e  A.I. V o l l r a t h  M A .  C h r i s t e n s e n  A P .  / . h a n g  DS .  W o o l f  C'J, C' orev  D P  
(2 0 0 6 c )  TR PA 1 c o n t r i b u t e s  to co ld ,  m e c h a n i c a l ,  an d  c h e m i c a l  n o c i c e p t i o n  bu t  is not  e s s en t i a l  
for  hai r -cel l  t r a n s d u c t i o n .  N e u r o n  50:  2 7 7 -2 8 9 .
213
kvvan  k Y .  A l l c h o r n e  AJ .  V o l l r a th  M A .  C h r i s t e n s e n  A P .  / h a n g  I)S.  W o o l f  CJ .  C'orev D P  
( 2 0 0 6 b )  T R P A 1  c o n t r i b u t e s  to  co ld ,  m e c h a n i c a l ,  an d  c h e m i c a l  n o c i c e p t i o n  but  is not  e s s en t i a l  
for  ha i r - ce l l  t r a n sd u c t i o n .  N e u r o n  50:  2 7 7 -2 8 0 .
kvvan  k Y .  A l l c h o r n e  AJ .  V o l l r a th  M A .  C h r i s t e n s e n  AP .  / h a n g  DS .  W o o l f  CJ .  C o r e y  D P  
( 2 0 0 6 e )  T R P A 1  c o n t r i b u t e s  to  co ld ,  m e c h a n i c a l ,  an d  c h e m i c a l  n o c i c e p t i o n  but  is not  e s s en t i a l  
fo r  ha i r - ce l l  t r a n s d u c t i o n .  N e u r o n  50:  27 7 -2 8 9 .
kvvan  k Y .  A l l c h o r n e  AJ .  V o l l r a th  M A .  C h r i s t e n s e n  AP .  / h a n g  DS .  W o o l f  CJ .  C'orev D P  
( 2 0 0 6 d )  T R P A 1  c o n t r i b u t e s  to  co ld ,  m e c h a n i c a l ,  and  c h e m i c a l  n oc i c e p t i o n  but  is not  e s s en t i a l  
for  ha i r - ce l l  t r a n sd u c t i o n .  N e u r o n  50:  2 7 7 - 2 89 .
k v v o n  \ 1 .  C a p l a n  JP.  F i l i p e nk o  N R .  C h o i  k S .  I i t / p a t r i ek  S P .  / h a n g  P.  W a i s m a n  D M  ( 2 0 0 2 )  
I de n t i f i c a t i o n  o f  a n n e x in  II h e t e r o t e t r a m e r  as  a p l a s m i n  r educ t a s e .  J Biol  C h e m  277 :  10903 -  
1 091 1.
k vv on  M.  M a c l e o d  PI. / h a n g  Y.  W a i s m a n  D M  ( 2 0 0 5 a )  S 1 0 0 A 1 0 .  a n n e x in  A2 .  an d  a n n e x i n  a2 
h e t e r o t e t r a m e r  a s  c a n d i d a t e  p l a s m i n o g e n  r ecep t o r s .  F ron t  B io sc i  10: 3 0 0 -3 2 5 .
kvv on  VP Y o o n  C S .  J e o n g  W.  R h e e  S G .  W a i s m a n  D M  ( 2 0 0 5 b )  A n n e x i n  A 2 - S 1 0 0 A 1 0  
he t e r o t e t r a m er .  a nove l  subs t r a t e  o f  t h io r e do x i n .  J Biol  C h e m  280 :  2 3 5 8 4 - 2 3 5 9 2 .
P a h  I F. B u c k  M R .  H o n n  k V .  C ' r i s sman  JD .  R a o  N C .  P io t t a  P A .  S lo a n e  BP  ( 1 9 8 9 )  
D e g r a d a t i o n  o f  l am in i n  by h u m a n  t u m o r  c a t h e p s i n  B. C l i n  P x p  M e t a s t a s i s  7: 4 6 1 - 4 6 8 .
P a i  J. G o l d  M S .  k i r n  C S .  B i an  D. Oss ipo v  M i l .  H u n t e r  JC .  P o r r e ca  I ( 2 0 0 2 )  I n h i b i t i on  o f  
n e u r o p a t h i c  pa in  bv d e c r e a s e d  e xp re s s i o n  o f  t he  t e t r o d o t o x in - r e s i s t a n t  s o d i u m  c h a n n e l .  
N a V  1.8. Pa in  95:  143 -152 .
Bai rd  J M .  S o u s l o v a  V.  W o o d  JN .  C e r v e r o  P ( 2 0 0 2 )  D e f i c i t s  in v is ce r a l  pa in  a n d  r e f e r r ed  
h v p e r a l g e s i a  in Nav 1.8 ( S N S / P N 3 ) - n u l l  m ice .  J N e u r o s c i  22:  8 3 5 2 - 8 3 5 6 .
B am pe r t  A.  D ib - H a j j  S D .  Ty r r e l l  P.  W a x m a n  S G  ( 2 0 0 6 a )  S i / e  ma t t e r s :  P r v t h r o m e l a l g i a  
m u ta t i on  S 2 4 1 T  in Nav 1.7 a l t e r s  c ha n ne l  ga t i ng .  J Biol  C h e m  281 :  3 6 0 2 9 - 3 6 0 3 5 .
B am pe r t  A.  D ib -H a j j  S D .  Ty r r e l l  P.  W a x m a n  SC j ( 2 0 0 6 b )  S i / e  ma t t e r s :  P r v t h r o m e l a l g i a  
mu ta t i on  S241 I in Nav  1.7 a l t e r s  ch a n n e l  ga t i ng .  J Biol  C h e m  281 :  3 6 0 2 9 - 3 6 0 3 5 .
Cau r i t z en  I. / a n / . o u r i  VP I l o n o r e  IP D up ra t  P. P h r e n g r u b e r  M U ,  P a / d u n s k i  M,  Pate l  AJ  ( 2 0 0 3 )  
k  + - d e p e n d e n t  c e r e b e l l a r  g r a n u l e  n e u ro n  a po p t o s i s .  R o l e  o f  t a sk  leak k +  c h a n n e l s .  J B iol  C h e m  
278 :  3 2 0 6 8 - 3 2 0 7 6 .
214
I . a u s o n  SN ( 1979)  T h e  po s t na t a l  d e v e l o p m e n t  o f  la rge  l ight  an d  sma l l  d a rk  n e u r o n s  in m o u s e  
do r sa l  r oo t  gang l i a :  a s ta t i s t i ca l  a n a ly s i s  o f  cel l  n u m b e r s  an d  s i / e .  J N e u r o c y t o l  8: 2 7 5 - 2 9 4 .
Lavs son  SN  ( 2 0 0 2 )  P h e n o t y p e  a n d  fu nc t i o n  o f  so m a t i c  p r ima rv  a f f e r en t  n o c i c e p t i v e  n e u r o n e s  
w i th  C- .  A d e l t a -  o r  A a l p h a ,b e t a - f i b r e s .  L \ p  P l n s i o l  87: 2 3 9 - 2 44 .
L a w s o n  S N .  H a r p e r  A A .  H a r p e r  LI.  G a r s o n  JA .  A n d e r t o n  BH ( 1 9 8 4 )  A m o n o c l o n a l  an t i bo dv  
ag a i n s t  n e u r o f i l a m e n t  p ro t e in  sp ec i f i c a l l y  labe l s  a su b p o p u l a t i o n  o f  rat  s ensorv  n e u ro n e s .  J 
C o m p  N e u r o l  228 :  2 6 3 - 2 7 2 .
Le  BL.  C a p d e v i e l l e  .1. G u i l l e m o t  JC .  S l a d e c / e k  L ( 1 9 9 8 )  C h a r ac t e r i z a t i o n  o f  b r a in  PC  I AI RL- 1  
k i n a s e  im m u n o r e a c t i v i t v  an d  its i n t e r ac t i o ns  w i th  p i  1 an d  14-3-3 pro t e ins ,  l a i r  J B i o c h e m  257:
1 1 2 - 1 2 0 .
L e s a g e  L. L a / d u n s k i  M ( 2 0 0 0 )  M o l e c u l a r  an d  func t i ona l  p ro pe r t i e s  o f  t w o - p o r e - d o m a i n  
p o t a s s i u m  ch a n n e l s .  A m  J Phy s i o l  R ena l  Phys io l  279;  I 793-1 801.
Lew in G R .  M e n d e l l  L \1  ( 1 9 9 4 )  R eg u l a t i o n  o f  c u t a n e o u s  C - f i b e r  heat  n o c i c e p to r s  bv n e rv e  
g r o w t h  f ac to r  in t he  d e v e l o p i n g  rat .  J N e u r o p h y s i o l  71: 94 1 -9 4 9 .
L e w i s  C.  N e i d h a r t  S. H o ly  C.  N o r t h  RA.  Buel l  G.  S u rp r e n an t  A ( 1 9 9 5 )  C o e x p r e s s i o n  o f  P 2 X 2  
a n d  P 2 X 3  r e c e p t o r  s ub un i t s  c an  a c c o u n t  for  A I P -ga t ed  cu r r en t s  in s enso rv  n e u ro n s .  N a t u r e  
377 :  4 3 2 - 4 3 5 .
L e w i t - B e n t l e y  A.  Retv S. S o p k o v a - d e  O l i v e i r a  SJ.  G e r k e  V ( 2 0 0 0 )  S l O O -a n n e x in  c o m p l e x e s :  
s o m e  i n s igh t s  f r om  s t ruc tu r a l  s t ud ies .  Cel l  Biol  Int 24:  7 9 9 - 8 02 .
L i e d t k e  W.  C h o e  Y.  M a r t i - R e n o m  M A .  Bel l  A M .  D e n i s  C S .  Sal i  A.  H u d s p e t h  AJ .  F r i e d m a n  
J M .  H e l l e r  S ( 2 0 0 0 b )  V a n i l l o id  r e cep to r - r e l a t e d  o s m o t i c a l l y  a c t i v a t ed  c h a n n e l  ( V R - O A C ) .  a 
c a n d i d a t e  v e r t e b r a t e  o s m o r e c e p t o r .  Ce l l  103: 5 2 5 - 53 5 .
L i ed t ke  W .  C h o e  Y.  M a r t i - R e n o m  M A .  Bel l  A M .  D e n i s  C S .  Sal i  A.  H u d s p e t h  AJ .  F r i e d m a n  
J M .  He l l e r  S ( 2 0 0 0 a )  V a n i l l o id  r e ce p t o r - r e l a t e d  o s m o t i c a l l y  a c t i v a t e d  c h a n n e l  ( V R - O A C ) .  a 
c a n d id a t e  v e r t e b r a t e  o s m o r e c e p t o r .  Cel l  103: 52 5 -5 3 5 .
L i ed tk e  W,  F r i e d m a n  J M  ( 2 0 0 3 )  A b n o r m a l  o s m o t i c  r e gu l a t i on  in t r p v 4- / -  m ice .  P roc  Na t l  A c a d  
Sci  L  S A 100: 1 3 6 9 8 - 1 3 7 0 3 .
Lin I L. Spe r l e  K.  S t e r n b e r g  N ( 1 9 8 5 )  R e c o m b i n a t i o n  in m o u s e  L ce l l s  b e t w e e n  D N A  
in t ro du ce d  into ce l l s  an d  h o m o l o g o u s  c h r o m o s o m a l  s e q u e n c e s .  P roc  Na t l  A c a d  Sci  U S A  82: 
13 9 1 -1 3 9 5 .
215
Lin g  Q.  J a c o x i n a  A T .  D e o r a  A.  l e b b r a i o  VI. S im an to x  R. S i l xe r s t e i n  RL.  H e m p s t e a d  B. M a r k  
\VH.  H a j j a r  K A  ( 2 0 0 4 )  A n n e x i n  II r e g u l a t e s  f i br in  h o m e o s t a s i s  a nd  n e o a n g i o g e n e s i s  in x ixo.  J 
C l i n  Inxes t  113: 38 -4 8 .
I . i n gu eg l i a  L. de  W .  Jr . .  B a s s i l a n a  L. H e u r t e a u x  C.  Saka i  H. W a l d m a n n  R. L a / d u n s k i  M 
( 1 0 0 7 b )  A m o d u l a to r x  s u b u n i t  o f  a c id  s e n s in g  ion c h a n n e l s  in b ra in an d  do r s a l  r oo t  g a n g l i o n  
eel  Is. J B iol  C h e m  272 :  2 0 7 7 8 - 2 0 7 8 3 .
I . i ng u eg l i a  L. de  \Y. Jr . .  B a s s i l a n a  L. H e u r t e a u x  C.  Saka i  II. W a l d m a n n  R. L a / d u n s k i  M 
( 1 0 0 7 a )  A m o d u l a to r x  s u b u n i t  o f  a c id  s e n s in g  ion c h a n n e l s  in b r a in  an d  do r sa l  r oo t  g a n g l i o n  
ce l l s .  J Biol  C h e m  272 :  2 0 7 7 8 - 2 0 7 8 3 .
L iu  Y.  C h e n g  K.  ( i o n g  K.  Lu A K .  Ip N Y  ( 2 0 0 6 )  Pe t a i r e l  pho sph o r x  la tes  N - e t l n  I m a l e i m i d e -  
s e n s i t i x e  fu s ion  p ro t e in :  im p l i c a t i o n s  in t he  r egu l a t i on  o f  its h e x a m e r i / a t i o n  an d  ex o c x to s i s .  J 
B io l  C h e m  281 :  0 8 3 2 - 0 8 3 8 .
L o f t i n g  J. L o f t l n g - C u e n i  I). V a l d e r r a b a n o  V.  K lausl i  L. He be r t  SC.  R o s s i e r  BC .  H o e n d e r o p  
JG .  B in d e l s  RJ.  K a i s s l i n g  B (2 0 0 1 a )  D i s t r i b u t i on  o f  t r an se e l l u l a r  c a l c iu m  an d  s o d i u m  t r an sp o r t  
pa thxxaxs  a l o n g  m o u s e  dis ta l  n e p h ro n .  A m  J P l n s i o l  R ena l  Phys io l  281 :  I 1021 -L 1027.
L o f t i n g  J. L o f t l n g - C u e n i  D. V a l d e r r a b a n o  V.  K laus l i  L. H eb e r t  SC .  R o s s i e r  BC .  H o e n d e r o p  
JG .  B in de l s  RJ.  K a i s s l i n g  B ( 2 0 0 1 b )  D i s t r i bu t i o n  o f  t r an se e l l u l a r  c a l c i u m  an d  s o d i u m  t r an sp o r t  
pa thxxaxs  a l o n g  m o u s e  dis ta l  n e p h ro n .  A m  J P l n s i o l  R ena l  Phys io l  281 :  I 1021 - F 1027.
L u m b  B M .  L o x i e k  T A  ( 1 9 9 3 )  The ros t ral  h y p o t h a l a m u s :  an  a r e a  for  t h e  i n t e g ra t i o n  o f  
a u t o n o m i c  an d  s e n s o r y  r e s p o n s i x e n e s s .  J N e u r o p h y s i o l  70: 137 0 -1 37 7 .
L u m p k i n  L A .  C a t e r i n a  MJ  ( 2 0 0 7 )  M e c h a n i s m s  o f  s enso rx  t r a n s d u c t i o n  in t h e  skin.  N a t u r e  443 :  
8 38 -8 63 .
Lu o  Z D .  C a l e u t t  N A .  H i g u e r a  KS. V a ld e r  C R .  S o n g  Y l l .  S x e n s s o n  C L  M y e r s  R R  ( 2 0 0 2 )  In jury  
t \ p e - s p e c i t l c  c a l c i u m  c h a n n e l  a l p h a  2 d e l t a - 1 su b un i t  u p - r e g u l a t i o n  in rat  n e u r o p a t h i c  pa in  
m o d e l s  co r r e l a t e s  xxith an t i a l l o d x n i c  e f f ec t s  o f  g a b a p e n t i n .  J P h a r m a c o l  L x p  f l ie r  303 :  1 199- 
1203.
L y on s  R M .  Gen t rx  LL .  P u rc h i o  A I . M o s e s  III .  ( 1 9 9 0 )  M e c h a n i s m  o f  a c t i x a t i o n  o f  la t ent  
r e c o m b in a n t  t r a n s f o r m i n g  groxxth f ac to r  be t a  1 by p l a sm in .  J Ce l l  Biol  1 10: 1 3 61 -1 36 7 .
M a c l e o d  LI. Kxxon M.  I i l i p en k o  N R .  W a i s m a n  D M  ( 2 0 0 3 )  P h o s p h o l i p i d - a s s o c i a t e d  a n n e x i n  
A 2 - S I 0 0 A I 0  h e t e r o t e t r a m e r  a n d  its subun i t s :  ch a r a c t e r i z a t i o n  o f  t he  i n t e r a c t i on  w i th  t i s sue  
p l a s m i n o g e n  ac t i xa to r .  p l a s m i n o g e n ,  a n d  p l a s m i n .  J Biol  C h e m  278 :  2 3 3 7 7 - 2 3 3 8 4 .
216
Mai  J. l i n l e v  RH. Jr . .  W a i s m a n  D M .  S lo a n e  BI ( 2 0 0 0 )  H u m a n  p ro c a t h e p s i n  B i n t e r ac t s  w i th  
t he  a n n e x in  II t e t r a m e r  on  t he  s u r f a c e  o f  t u m o r  cel l s .  J Biol  C h e m  275 :  1 2 8 0 6 -1 2 8 1 2 .
Mal ik-1 lal l  M .  P o o n  \ \  Y.  B a k e r  V1D. W o o d  JN .  O k u s e  K ( 2 0 0 7 )  S e n s o r )  n e u r o n  p ro t e in s  
in te r ac t  w i th  t he  i n t r ace l l u l a r  d o m a i n s  o f  s o d i u m  c h a n n e l  N a V 1 . 8 .  B ra in  Res  Viol B ra in  Res  
110: 2 0 8 - 3 0 4 .
M a r o t e a u x  I.. S a u d o u  H. A m l a i k y  N.  B o s c h e r t  I . P la s sa t  .IL. Hen  R ( 1 0 0 2 )  M o u s e  5111 IB  
s e r o to n in  r ece p t o r :  c l o n in g ,  f u nc t i on a l  e x p re s s i o n ,  and  l oca l i za t i on  in m o t o r  co n t r o l  c en t e r s .  
P roc  N a t l  A c a d  Sci  C S A 80:  5 0 2 0 -3 0 2 4 .
M a r s d e n  B.I. Sh aw  CiS. S v k e s  B I )  ( 1 0 0 0 )  C a l c i u m  b in d i n g  p ro t e in s ,  e l u c i d a t i n g  the  
c o n t r i b u t i o n s  to  c a l c iu m  a f l l n i t )  f r om  an an a lv s i s  o f  spe c i e s  va r i an t s  a nd  pe p t i de  f r a gm en t s .  
B i o c h e m  Ce l l  Biol  68:  58 7 -6 0 1 .
M a r t i n  C R  ( 1 0 8 1 )  I so l a t ion  o f  a p lu r i p o t e n t  cel l  l ine f r om ea r l )  m o u s e  e m b r v o s  c u l t u r e d  in 
m e d i u m  c o n d i t i o n e d  bv t e r a t o c a r c i n o m a  s t e m cel l s .  Proc  Na t l  A c a d  Sci C S A 78: 7 6 3 4 - 7 6 3 8 .
M a s i a k o w s k i  P. S h o o t e r  P M  ( 1 0 8 8 )  N e r v e  g r o w t h  f ac to r  i n duc es  t he  g e n e s  for  t w o  p ro t e in s  
re l a t ed  to a f a m i k  o f  c a l c i u m - b i n d i n g  p ro t e in s  in PC '12 cel l s .  P roc  Nat l  A c a d  Sci  I S A  85: 
12 77 - 128 1 .
M a s i a k o w s k i  P. S h o o t e r  HM ( 1 0 0 0 )  C h a n g e s  in PC '12 cel l  m o r p h o lo g v  i n d u c e d  by t r an s f ec t i o n  
w i t h  4 2 C  c D N A .  c o d i n g  for  a m e m b e r  o f  t he  S -1 0 0  p ro t e in  f a m i k .  J N e u r o s c i  R es  27:  2 6 4 -  
260 .
M a t s u d a  Y.  Y o s h i d a  S. Y o n e z a w a  T  ( 1 0 7 8 )  T e t r o d o t o x i n  s ens i t i v i t y  a n d  C a  c o m p o n e n t  o f  
a c t i on  p o t en t i a l s  o f  m o u s e  do r s a l  roo t  ga n g l i o n  ce l l s  c u l t u r e d  in v i tro.  B ra in  R e s  154: 6 0 -8 2 .
M a t t h e w s  HA.  W o o d  J N .  D ic k e n s o n  A H  ( 2 0 0 6 )  Nav 1.8-nul l  m i c e  show  s t i m u l u s - d e p e n d e n t  
de f i c i t s  in sp ina l  n e u r o n a l  a c t i vi t y .  Mo l  Pa in  2: 5.
M cC ar th v  P W .  Haw son  SN ( 1 0 0 7 )  D i f f e r i ng  ac t i on  po ten t i a l  s h a p e s  in rat  do r s a l  r oo t  g a n g l i o n  
n eu r o n e s  r e l a t ed  to  t h e i r  s u b s t a n c e  P and  ca l c i t o n i n  g e n e - r e l a t e d  p ep t i d e  im m u n o r e a e t i v  i t v . J 
C o m p  N e u ro l  388 :  5 4 1 - 5 4 0 .
M c K e r n y  D D .  N e u h a u s s e r  W M .  Ju l i u s  D ( 2 0 0 2 b )  I de n t i f i c a t i on  o f  a co ld  r e c e p t o r  r e ve a l s  a 
gene ra l  rol e  for I R P  c h a n n e l s  in t h e r m o s e n s a t i o n .  N a tu r e  416 :  52 -58 .
M c K e m y  DD .  N e u h a u s s e r  W M .  J u l i u s  I) ( 2 0 0 2 a )  I de n t i f i c a t i on  o f  a c o ld  r e c e p t o r  r e v ea l s  a 
g en e r a l  rol e  for I R P  c h a n n e l s  in t h e r m o s e n s a t i o n .  N a t u r e  416 :  52 -58 .
217
M c M a h o n  SB .  A r m a n i n i  M P .  L in g  LH.  Ph i l l i p s  I IS ( 1 0 0 4 )  L x p re s s io n  a nd  c o e x p r e s s i o n  o f  I rk 
r e c ep t o r s  in s n b p o p u l a t i o n s  o f  a du l t  p r ima rv  s enso rv  n e u r o n s  p r o j ec t i n g  to  i den t i f i ed  pe r i ph e ra l  
t a rge ts .  N e u r o n  12: 1 161-1 171.
M e n k e  M.  G e r k e  V.  S t e i n e m  G ( 2 0 0 5 )  Ph osp ha t i dv  ls er i ne  m e m b r a n e  d o m a i n  c l u s t e r i n g
ind u ce d  by a n n e x i n  A 2  S 1 0 0 A 1 0  h e t e r o t e t r a m e r .  B ioc hem is t ry  44:  1 5206-1  530 3 .
M e r r i t l e l d  GJ .  Res e l l e r  L .  A i m e r s  W.  P rous t  .1. G e r k e  V.  Sech i  AS .  M o s s  SL  (2001  ) A n n e x i n  2 
has  an  e s se n t i a l  r o l e  in a e t i n -b a s e d  m a c r o p i n o c y t i c  r ocke t i ng .  C'urr  Biol  11 :1  136-1 141.
M e u s e r  I . P i e t r uc k  G. R a d b r u e h  L. S tu t e  P. L e h m a n n  KA .  G r o n d  S (2001 ) S v m p t o m s  d u r i n g  
c a n c e r  pa in  t r e a tm e n t  f o l l o w in g  W H O - g u i d e l i n e s :  a l ong i t ud ina l  f o l l ow -u p  s t ud )  o f  s y m p t o m  
p r e v a l e n c e .  seve r i tv  an d  e t i o l o g y  Pa in  03:  24 7 - 2 5 7 .
M e u t h  SG .  B u d d e  T.  k a n v s h k o v a  T.  B r o i e h e r  T.  M u n s e h  T.  Pa pe  11C ( 2 0 0 3 )  C o n t r i b u t i o n  o f  
T \ V l k - r e l a t e d  a c i d - s e n s i t i \ e  k ~  c h a n n e l  1 ( T A S K ! )  an d  T A S K 3  c h a n n e l s  to t he  con t r o l  o f
ae t i vi t v m o d e s  in t h a l a m o c o r t i c a l  ne u ro ns .  J N e u r o s c i  23:  6 4 6 0 -6 4 6 0 .
Viewer RA.  D a v i s  K D .  C o h e n  RH.  I r e e d e  R D.  C a m p b e l l  JN  (1 0 0 1 )  M e ch a n i ca l l v  i n se ns i t i ve  
a f f e r en t s  ( M l A s )  in c u t a n e o u s  n e rv e s  o f  m o n k e y  B ra i n  Res  561:  2 52 -2 61 .
Viewers LN.  Lewvandoski  M.  Ma r t i n  G R  ( 1 0 0 8 )  A n  LgfS m u t an t  a l le l ic  s er i es  g e n e r a t e d  by  Cre -  
an d  L ip -m e d ia t e d  r e c o m b in a t i o n .  N a t  G e n e t  18: 136-141 .
M i c h a e l i s  VI. H a b l e r  ILL J a e n i g  W ( 1 0 0 6 )  S i l en t  a f f e r en t s :  a s e pa ra t e  c l a s s  o f  p r i ma rv  
a f f e r e n t s ’? C' lin L x p  P h a r m a c o l  P l n s i o l  23:  0 0 - 1 0 5 .
M i l l a r  JA .  Ba r r a t t  L. S o u t h a n  A P .  Page  KV1. Fy f f e  RL .  R o b e r t s o n  B. M a t h i e  A ( 2 0 0 0 b )  A 
fu nc t i o na l  r o l e  fo r  t h e  t w o - p o r e  d o m a i n  p o t a s s i u m  c h a n n e l  T A S K - 1  in c e r e b e l l a r  g r a n u l e  
ne u ro ns .  P roc  N a t l  A c a d  Sci  U S A  07:  3 6 1 4 - 3 6 1 8 .
Mi l l a r  JA .  Ba r r a t t  L. S o u t h a n  AP .  Pa ge  K M .  Lv ff e  RL .  R o b e r t s o n  B. M a t h i e  A ( 2 0 0 0 c )  A 
func t i ona l  ro l e  fo r  t h e  t w o - p o r e  d o m a i n  p o t a s s i u m  c h a n n e l  T A S K - 1  in c e r e b e l l a r  g r a n u l e  
neu r ons .  P roe  Na t l  A e a d  Sci  G S A 07:  3 6 1 4 - 3 6 1 8 .
Mi l l a r  JA .  Bar ra t t  L. S o u t h a n  A P .  P age  K M .  I y f f e  RIG R o b e r t s o n  B. M a t h i e  A ( 2 0 0 0 a )  A 
func t i onal  role  for  t he  t w o - p o r e  d o m a i n  p o t a s s i u m  c h a n n e l  T A S K - 1  in c e r e b e l l a r  g r a n u l e  
neu r ons .  Proe Nat l  A e a d  Sei  L  S A 07:  3 6 1 4 - 3 6 1 8 .
Mi l l i ga n  LI) .  M e h m e r t  K K .  I l i n d e  JL .  H a r v e y  LO.  M ar t i n  I). T r a c e y  KJ .  M a i e r  SL.  W a t k i n s  
LR  ( 2 0 0 0 )  I he rm a l  hv p e r a l g e s i a  an d  m e c h a n i c a l  a l l o d y n i a  p r o d u c e d  by  i n t r a theca l
218
a d m i n i s t r a t i o n  o f  t he  h u m a n  i m m u n o d e f i c i e n c v  \ i n i s - 1 (11IV-1)  e m e l o p e  g ly  c o p r o t e in .  gp l2 ( ) .  
Bra in  Res  861:  105-1 16.
Mo g i l  JS .  B r e e s e  N M .  Wi t t y  M F .  R i t ch i e  J. R a i n v i l l e  M L .  A se  A.  A b b a d i  N.  S t u c k )  C L .  
S e g u e l a  P ( 2 0 0 5 )  T r a n s g e n i c  e x p r e s s i o n  o f  a d o m i n a n t - n e g a t i \ e  A S I C 3  s u b u n i t  l e ads  to 
i n c r ea s ed  s ens i t i v i t y  to  m e c h a n i c a l  an d  i n f l a m m a to rv  s t imu l i .  J N e u r o s c i  25:  0 8 0 3 - 0 9 0 1 .
M o g i l  JS .  R i t ch i e  J. S o to c i na l  SG .  S m i t h  SB .  C r o t e a u  S. Levi t i n  DJ.  N a u m o v a  A K  ( 2 0 0 6 )  
S c r e e n i n g  for  pa in  p h e n o tv p e s :  a n a k s i s  o f  t h r ee  c o n g e n i c  m o u s e  s t r a i ns  on  a ba t t e r )  o f  n ine  
n o c i c e p t i v e  a s sa v s .  Pain  126: 24 -3 4 .
M o g i l  JS .  W i l s o n  SG.  B on  k .  Lee  SL .  C h u n g  k .  R a b e r  P. P i ep e r  JO .  I lain IIS.  B e l k n a p  . Ik.  
H u b e r t  L. L l m e r  G l .  C h u n g  J M .  D e v o r  M ( 1 0 0 0 )  1 l er i t abi l i t )  o f  n oc i c e p t i o n  I: r e s p o n s e s  o f  1 1 
i n b r ed  m o u s e  s t r a in s  cm 12 m e a s u r e s  o f  n o c i c e p t i o n .  Pain 80: 67 -82 .
M o l l i v e r  DC.  S n i d e r  W I) ( 1 0 0 7 )  N e r v e  g r o w t h  f ac to r  r e ce p t o r  T r k A  is d o w n - r e g u l a t e d  d u r i n g  
po s t n a t a l  d e v e l o p m e n t  bv a su b se t  o f  do r s a l  r oot  g an g l i o n  n eu ron s .  J C o m p  N e u r o l  381 :  4 2 8 -  
438 .
M o l l i v e r  DC.  W r igh t  D L .  L e i t n e r  M L .  P a r s ad an i a n  AS .  D o s t e r  k .  W en D.  Y a n  Q .  S n i d e r  W D 
( 1 0 0 7 )  1134-binding DRCJ n e u r o n s  sw i t ch  f rom  N G L  to G D N L  d e p e n d e n c e  in e a r l y  pos tn a t a l  
life. N e u r o n  10; 84 0 - 8 6 1 .
M o r c t  C.  Bri lev M ( 2 0 0 0 a )  T h e  po s s ib l e  rol e  o f  5 -HT(  IB  D)  r e c e p t o r s  in p s y ch i a t r i c  d i s o rd e r s  
an d  t he i r  po t en t i a l  as  a t a r ge t  for  t h e r a p v . L u r  J P h a r m a c o l  404 :  1-12.
Ylore t  C.  Br i l ev M ( 2 0 0 0 b )  T h e  pos s ib l e  ro le  o f  5-1 IT (1 B I ) ) r e ce p t o r s  in p s yc h i a t r i c  d i s o r d e r s  
a n d  t he i r  po t en t i a l  as  a t a rge t  for  t her apv  . L u r  J P h a r m a c o l  404 :  1-12.
M o r g a n  k .  S t e v e n s  143. S h a h  B. C o x  PJ. D ix o n  A k .  Le e  k .  P in n o c k  R D .  H u g h e s  J. R i c h a r d s o n  
PJ.  M i z u g u e h i  k .  J a c k s o n  A P  ( 2 0 0 0 )  be t a  3: an  a d d i t i o na l  a ux i l i a ry  s u b u n i t  o f  t he  vo l t ag e -  
s ens i t i ve  s o d i u m  c h a n n e l  t ha t  m o d u l a t e s  c h a n n e l  g a t i n g  w ith d i s t i nc t  k ine t i cs .  P roc  Na t l  A c a d  
Sci  L  S A 97:  2 3 0 8 - 2 3 1 3 .
Mor i  M.  k o n n o  I . O / a v v a  I . M u r a t a  M.  Im o to  k .  N a g a v a m a  k  ( 2 0 0 0 )  Nov  el i n t e r a c t i on  o f  t he  
v o l t a g e - d e p e n d e n t  s o d i u m  c h a n n e l  ( V D S C )  w i th  c a lm o d u l i n :  d o e s  V D S C  a c q u i r e  c a l m o d u l i n -  
m e d i a t ed  C a2 " t - s e ns i t i v i t y ?  B i o c h e m i s t r y  30:  1 316 -13 23 .
M o r r i s  C L .  H orn  R ( 1 0 0 1 )  F a i l u r e  to  e l ic i t  n eu ro n a l  m a c r o s c o p i c  m e c h a n o s e n s i t i v e  c u r r e n t s  
an t i c i p a t ed  by s i n g l e - c h a n n e l  s t ud i e s .  S c i e n c e  251 :  124 6 -1240 .
219
M u l l e r  I ( l 1-)1)1)) 1 en  y e a r s  o f  g e n e  t a rge t i ng :  t a rg e t ed  m o u s e  m u t a n t s ,  f r om v e c t o r  d e s i g n  to  
p h e n o t v p e  analv  sis.  M e e h  Dev 82:  3 -21 .
M u n n s  C .  A lq a t a r i  M.  K o l t z e n b u r g  M ( 2 0 0 6 )  M a i n  co ld  s ens i t i ve  p e r i p h e r a l  n e u r o n s  o f  t he  
m o u s e  d o  no t  e x p r e s s  T R P M 8  o r  T R P A 1 . Cel l  C a l c i u m .
N a g a t a  K.  D u g g a n  A.  K u m a r  G .  G a r c i a - A n o v e r o s  J ( 2 0 0 5 )  N o c i c e p t o r  a n d  ha i r  cel l  t r a n s d u c e r  
p r o p e r t i e s  o f  T R P A 1 .  a c h a n n e l  f o r  pain  an d  hea r i ng .  J N e u ro s c i  25:  4 0 5 2 - 4 0 6 1 .
N a g \  A ( 2 0 0 0 )  C r e  r e c o m b i n a s e :  the  un ive r s a l  r e age n t  for  g e n o m e  t a i lo r ing .  G e n e s i s  26:  99 -  
109.
N ag v  A.  M o e n s  C.  I \  any i P.  P aw l i n g . ! .  G e r t s e n s t e i n  M.  l l a d j a n t o n a k i s  A K .  Piritv M.  R o s s a n t  J 
( 1 9 9 8 )  D i s s e c t i n g  t he  ro le  o f  N - m y c  in d e v e l o p m e n t  u s i ng  a s i ng l e  t a rg e t i ng  v e c t o r  to  g e n e r a t e  
a s e r i e s  o f  a l l e les .  C u r r  Biol  8: 6 61 -6 6 4 .
N a g y  1. R a n g  H ( 1 9 9 9 )  N o x i o u s  hea t  a c t i va t e s  all c a p sa i c i n - s e n s i t i v e  an d  a l so  a s u b - p o p u l a t i o n  
o f  c a p s a i c in - i n s e n s i t i v e  do r sa l  r oo t  g a n g l i o n  n e u r on s .  N e u r o s c i e n c e  88: 99 5 - 9 9 7 .
N a s s a r  M A .  B a k e r  M D .  L ev a to  A.  I n g r a m  R. M a l lu c c i  G .  M c M a h o n  SB.  W o o d  JN  ( 2 0 0 6 )
N e r v e  injurv i n du ce s  robus t  a l l o d v n i a  an d  e c t o p i c  d i s c h a r g e s  in Nav 1.3 nul l  m u t a n t  m ic e .  M o l
Pa in  2: 33.
N a s s a r  M A .  L e v a to  A.  S t i r l i ng  I X .  W o o d  JN  ( 2 0 0 5 )  N e u r o p a t h i c  pain  d e v e l o p s  n o r m a l l y  in 
m i c e  l a ck i n g  bo th  Nav 1.7 and  Nav 1.8. M o l  Pa in  1: 24.
N a s s a r  M A .  S t i r l i ng  LC .  Fo r l an i  G.  B a k e r  M D .  M a t t h e w s  LA.  D i c k e n s o n  A H .  W o o d  JN
( 2 0 0 4 )  N o e i e e p t o r - s p e c i f i c  g e n e  d e l e t i on  r e ve a l s  a m a j o r  ro l e  f o r  Nav l . 7  ( P N 1 )  in a c u t e  an d  
i n f l a m m a t o r y  pa in .  P roc  Nat l  A c a d  Sci  U S A  101: 12 706 -12 71  1.
N e t z e l - A r n e t t  S.  M i to l a  DJ .  Y a m a d a  SS.  C h r y s o v e r g i s  K.  H o l m b e c k  K.  B i r k e d a l - H a n s e n  H, 
B u g g e  T H  ( 2 0 0 2 )  C o l l a g e n  d i s so l u t i on  by k e r a t i n o c v t e s  r e qu i r e s  cel l  su r f a ce  p l a s m i n o g e n  
ac t i va t i on  an d  m a t r i x  m e t a l l o p r o t e i n a s e  ac t i v i t y .  J B iol  C h e m  277 :  4 5 1 5 4 - 4 5 1 6 1 .
N i l i u s  B. P r e ne n  J. H o e n d e r o p  JG .  V e n n e k e n s  R. H o e f s  S. W e i d e m a  AL.  D r o o g m a n s  G.  
B inde l s  RJ ( 2 0 0 2 )  l as t  a n d  s l ow inac t i va t i on  k ine t i c s  o f  t he  C a 2 +  c h a n n e l s  L C a C l  an d  L C a C 2  
( T R P V 5  and  T R P V 6 ) .  R o l e  o f  t he  i n t r ace l l u l a r  l oo p  l oca t ed  b e t w e e n  t r a n s m e m b r a n e  s e g m e n t s  
2 an d  3. J Biol  C h e m  277 :  3 0 8 5 2 - 3 0 8 5 8 .
N i l i u s  B. P r en en  J. V e n n e k e n s  R.  H o e n d e r o p  JG .  B in d e l s  RJ.  D r o o g m a n s  G  ( 2 0 0 1 )  M o d u l a t i o n  
o f  t he  ep i t he l ia l  c a l c i u m  c h a n n e l .  L C a C .  by i n t r ace l l u l a r  C a 2 + .  Ce l l  C a l c i u m  29:  4 1 7 - 4 2 8 .
220
N i w a  U. Y a m a m u r a  k .  M i y a z a k i  J ( 1 9 9 1 )  L f f i c i en t  s e l ec t i on  t or  h i g h - e x p r e s s i o n  t r a n s i e e t a n t s  
w i th  a no ve l  e u k a r v o t i c  vec to r .  ( i e n e  108: 193 -199 .
N o d a  M.  S u / u k i  H.  N u m a  S. S t u h m e r  W ( 1 9 8 9 )  A s i ng l e  point  m u t a t i o n  c o n f e r s  t e t r o d o t o x in  
a nd  s a x i t ox in  insensi t i v i tv  on  t he  s o d i u m  ch a n n e l  II. F H B S  Let t  259:  2 1 3 - 2 1 6 .
N o \ a k o \ i c  S D .  T z o u m a k a  12 M e G i v e r n  JG .  H a ra g u e h i  M.  S a n g a m e s w a r a n  L. G o g a s  K R.  
1-glen R M .  H u n t e r  JG  ( 1 9 9 8 )  D i s t r i b u t i on  o f  t he  t e t r o d o t o x in - r e s i s t a n t  s o d i u m  c h a n n e l  PN 3  in 
rat  s enso rv  n e u r o n s  in n o rm a l  an d  n e u ro p a t h i c  c on d i t i on s .  J N e u r o s c i  18: 2 1 7 4 - 2 1 8 7 .
N o / . ak i -1  a g u c h i  N.  G h a p l a n  SR .  H ig u e r a  LS.  Ajakvve RG.  Y a k s h  11. ( 2 0 0 1 )  V in e r i s t i n e -  
i n d u e e d  a l l o d y n i a  in the  rat. Pain  93:  69 -76 .
O b a t a  k .  k a t s u r a  11. M i / u s h i m a  1. Y a m a n a k a  11. k o b a y a s h i  k .  Dai  Y.  F u k u o k a  1. T o k u n a g a  
A.  I o m i n a g a  M.  N o g u c h i  k  ( 2 0 0 5 )  1R PA1  in du ce d  in s enso rv  n e u r o n s  c o n t r i b u t e s  to  co ld  
h y p e r a l g e s i a  af t er  i n f l a m m a t io n  an d  n e rv e  injury .  J C lin Inves t  1 15: 2 3 9 3 - 2 4 0 1 .
O k u s e  k .  G h ap l a n  SR.  M c M a h o n  SB .  L u o  / I ) .  Ga l e u t t  N A .  Sco t t  BP.  A k o p i a n  A N .  W o o d  JN  
( 1 9 9 7 )  Re g u l a t i o n  o f  ex p re s s i o n  o f  t he  s enso rv  n e u r o n - s p e c i f i c  s o d i u m  c h a n n e l  S N S  in 
i n f l a m m at o r y  and  n e u ro p a t h i c  pain .  Mo l  Gel l  N e u r o s c i  10: 196 -207.
O k u s e  k .  Via 1 i k -1 la 11 M.  B ak e r  M D .  P oo n  \VY.  k o n g  H. G h a o  M V .  W o o d  JN  ( 2 0 0 2 )  A n n e x i n  
II l ight  ch a in  r e gu l a t e s  sensorv  n e u ro n - s p e c i f i c  s o d i u m  ch a n n e l  e x p re s s i o n .  N a t u r e  41 7 :  65 3 -  
656 .
O l s o n  L N .  A r n o l d  H H .  R ig by  PW’. W o l d  BJ ( 1 9 9 6 )  k n o w  v o u r  ne ig h bo r s :  t h r ee  p h e n o t y p e s  in 
nul l  m u t a n t s  o f  t h e  m y o g e n i c  b l l L H  g e n e  M R F 4 .  Gel l  85:  1-4.
O za k i  T.  S a k i v a m a  S ( 1 9 9 3 )  M o l e c u l a r  c l o n i n g  o f  rat  c a lp a c t i n  I h e a v y - c h a i n  c D N A  w h o s e  
ex p re s s io n  is i n d u c e d  in v - s r c - t r a n s f o r m e d  rat  cu l t u r e  cel l  l ines .  O n c o g e n e  8: 17 07 -1 71 0 .
Page  AJ .  Br i er lev S M .  M a r t i n  G M .  M a r t i n e z - S a l g a d o  G. W e m m i e  JA .  B r e n n a n  I J.  S y m o n d s  L. 
O m a r i  T.  Lew in G R .  W e l sh  MJ .  B lackshavv L A  ( 2 0 0 4 a )  1 lie ion c h a n n e l  ASIG1  c o n t r i b u t e s  to 
v i sceral  but  not  c u t a n e o u s  m e c h a n o r e c e p t o r  f un c t i on .  G a s t r o e n t e r o l o g y  127: 17 39 - 17 47 .
P age  A.I. Br ier lev S M .  M a r t i n  G M .  M a r t i n e z - S a l g a d o  G.  W e m m i e  JA .  B r e n n a n  I J.  S y m o n d s  L. 
O m a r i  I . Levvin G R .  W e l s h  MJ .  Blackshavv L A  ( 2 0 0 4 b )  T h e  ion c h a n n e l  AS IG1  c o n t r i b u t e s  to 
v i s ce ra l  but  not  c u t a n e o u s  m e c h a n o r e c e p t o r  f unc t i on .  G a s t r o e n t e r o l o g y  127: 1 73 9 - 17 47 .
221
Pa n g  PT .  T e n g  I IK.  Za i t sev  P.  W o o  N T .  S ak a t a  K.  / h e n  S. I e n g  K K .  Y u n g  W H .  H e m p s t e a d  
BL.  I.u B (2 0 0 4 a )  C l e a v a g e  o f  p r o B D N P  bv tP A  p l a sm in  is e s s en t i a l  f or  l o ng - t e rm
h i p p o e a m p a l  p l as t ie i t v .  S c i e n c e  306 :  4 8 7 -4 9 1 .
P a n g  PT .  I e n g  H K .  Za i t sev T. W o o  N T .  S a k a t a  K.  / h e n  S. I e n g  K K .  Y u n g  W H .  H e m p s t e a d
BI. .  I .u B ( 2 0 0 4 b )  C l e a v a g e  o f  p r o B D N F  bv t P A ' p l a s m i n  is e s s en t i a l  f o r  l o n g - t e rm
h i p p o e a m p a l  p la s t i e i t v .  S c i e n c e  306 :  4 8 7 -4 9 1 .
P a n g  PT .  I e n g  11K. Za i t sev  T. W oo  N T .  S a k a t a  K.  / . h en  S. T e n g  K K .  Y u n g  W 11. H e m p s t e a d  
BI. .  I.ii B ( 2 0 0 4 c )  C l e a v a g e  o f  p r o B D N f  by tPA  p l a s mi n  is e s s en t i a l  fo r  l o n g - t e rm
h i p p o e a m p a l  p las t i e i tv .  S c i e n c e  306 :  4 8 7 - 4 9 1 .
Pao l e t t i  P. A s c h e r  P ( 1 9 9 4 )  M e c h a n o s e n s i t i v  it\ o f  N M D A  rece p t o r s  in cu l t u r e d  m o u s e  cen t r a l  
n e u r o n s .  N e u r o n  13: 6 45 -6 3 3 .
P a s s m o r e  G M .  S e l v a n k o  A A .  Ylistrv Y1. A l - Q a t a r i  M.  Ylarsh SJ.  M a t t h e w s  KA.  D i c k e n s o n  A H .  
B r o w n  I A.  B u r b id g e  SA.  M a i n  M.  B r o w n  D A  ( 2 0 0 3 )  KC N O  M cu r r en t s  in s enso rv  n e u r on s :  
s i gn i f i c a n c e  for  pa in  t he r a pv .  J N e u r o s c i  23:  7 2 2 7 - 7 2 3 6 .
Pavv l i e /ak  R. C o w a n  MJ .  H u a n g  X.  N a n a v a t y  K B.  A l saa tv  S. L o gu n  C.  S h e l h a m e r  J H  ( 2 0 0 1 )  
p l l  ex p re s s io n  in h u m a n  b r on ch i a l  ep i t he l i a l  c e l l s  is i nc r ea sed  by ni t r ic  o x id e  in a c G M P -  
d e p e n d e n t  pat l nvav involv ing  p ro t e in  k i n a s e  (J a c t i va t i on .  J Biol  C h e m  276 :  4 4 6 1 3 - 4 4 6 2 1 .
P e i e r  A M .  M o q r i c h  A.  H e r g a r d e n  A C .  R e e v e  AJ .  A n d e r s s o n  D A .  S to r y  G M .  P a r l e y  TJ .  
D r a g o n i  I. M c I n t y r e  P. B e v a n  S. P a t a p o u t i a n  A ( 2 0 0 2 )  A T R P  ch a n n e l  t ha t  s e n s e s  co ld  s t imu l i  
a n d  m e n t h o l .  Ce l l  108: 70 5 -7 15 .
P en du r t h i  U R.  N g y u e n  M.  n d r a d e - G o r d o n  P. P e t e r s e n  LC.  R ao  LV  ( 2 0 0 2 )  P l a s m i n  i n d u ce s  
Cyr61  g e n e  e x p r e s s i o n  in f i b ro b l a s t s  v ia  p r o t e a s e - a c t i v a t e d  r e c e p t o r - 1 a n d  p 4 4 / 4 2  m i t o g e n -  
a c t i va t ed  p ro t e in  k i n a s e - d e p e n d e n t  s i g n a l i n g  pa t l n vav .  A r t e r i o s c l e r  T h r o m b  V a s e  B io l  22:  
1421 -1426 .
Perl  P R  ( 1 9 9 2 )  f  un c t i on  o f  D or s a l  R o o t  G a n g l i o n  N e u r o n s .  In: Sen so rv  N e u r o n s .  D ive r s i t y .  
D e v e l o p m e n t ,  and  Plas t ie i tv (S eo t t  S A .  ed) .  N e w  Y o rk :  O x f o r d  U n iv e r s i t y  Pres s .
P e t e r s on  PA.  S u th e r l a n d  M R .  N e s h e i m  M P .  Pry/ .dial  P P  ( 2 0 0 3 )  T h r o m b i n  i n d u c e s  en d o th e l i a l  
c e l l - su r f ac e  e x p o s u r e  o f  t he  p l a s m i n o g e n  r e c e p t o r  a n n e x i n  2. J Ce l l  Sei  1 16: 2 3 9 9 - 2 4 0 8 .
P l a i t !  M W  ( 2 0 0 1 )  A new  m a t h e m a t i c a l  m o d e l  for  r e l a t i ve  q u a n t i f i c a t i o n  in r e a l - t im e  R T - P C R .  
N u c l e i c  A c id s  Res  29:  e45 .
P h a m  (  I.  M a c l v o r  D M .  H u g  B A .  H e u se l  .IW. Ley LI ( 1 9 % )  L o n g - r a n g e  d i s ru p t i o n  o f  g en e  
e x p r e s s io n  by a s e l ee t a b l e  m a r k e r  e a s s e t t e .  P roe  Nat l  A c a d  Sei U S A  93:  1 3 0 9 0 - 1 3 0 9 5 .
Poi ro t  () .  Be r t a  T.  D e e o s t e r d  1. K e l l e n b e r g e r  S ( 2 0 0 6 )  D i s t i ne t  ASIC'  e u r r e n t s  a r e  e x p r e s s e d  in 
rat  pu t a t i ve  n o e i e e p to r s  an d  a r e  m o d u l a t e d  by ne rv e  injury.  J Physio l .
P o on  W Y .  M a l ik - H a l l  M.  W o o d  JN .  O k u s e  K ( 2 0 0 4 )  I de n t i f i e a t i on  o f  b i n d i n g  d o m a i n s  in the  
s o d i u m  e h a n n e l  N a ( V ) 1 . 8  i n t r aee l l u l a r  N - t e r m in a l  r eg ion  an d  a n n e x i n  II l ight  c h a i n  p i  1. L L B S  
Let t  558 :  114 -118 .
P r i ce  1)1) ( 2 0 0 0 )  P sy ch o l og i c a l  and  neu ra l  m e c h a n i s m s  o f  t he  a f f ec t i ve  d i m e n s i o n  o f  pain .  
S c i e n c e  288 :  1769 -1 772 .
P r i c e  M P .  Lew in G R .  Mel lvvra th  SL .  C h e n g  C . X ie  .1. H e p p e n s t a l l  PA .  S tu c k y  C'L.  M a n n s f e l d t
A ( i . B r e n n a n  TJ .  D r u m m o n d  H A .  Q i a o  J. B e n s o n  C'J. T a r r  DL .  I l r s t k a  RL.  Y a n g  B.
W i l l i a m s o n  RA.  W e l s h  MJ  ( 2 0 0 0 b )  T h e  m a m m a l i a n  s o d i u m  e h a n n e l  BNC ' l  is r e qu i r e d  for  
n o r m a l  t o uc h  s ensa t ion .  N a tu r e  407 :  1007-101 1.
P r i c e  M P .  Lew in CiR. Me l lvvra th  SI. .  C h e n g  C.  X ie  J. H ep p e n s t a l l  PA .  S t u e k y  C'L. M a n n s f e l d t
A G .  B r e n n a n  TJ .  D r u m m o n d  H A .  Q i a o  J. B e n s o n  C'J. T a r r  DL .  I l r s t k a  RL.  Y a n g  B.
W i l l i a m s o n  RA.  W e l s h  MJ  (2 0 0 0 a )  T h e  m a m m a l i a n  s o d i u m  c h a n n e l  BNC ' l  is r e q u i r e d  for  
n o rm a l  t o u ch  s en sa t i on .  N a t u r e  407 :  1007-101 1.
P r i c e  M P .  Me l lvvra th  SL .  X ie  J. C h e n g  C.  Q i a o  J. T a r r  DLL S lu k a  K A .  B r e n n a n  TJ .  Tew in G R .  
W e l s h  MJ  ( 2 0 0  Id )  T h e  D R  ASIC'  c a t i on  eh a n n e l  c o n t r i b u t e s  to  t he  d e t ec t i o n  o f  c u t a n e o u s  t o u c h  
a n d  ac id  s t im u l i  in m ice .  N e u r o n  32:  1071 -10 83 .
P r i ce  MIL Me l lvv ra th  SL .  X ie  J. C h e n g  C.  Q i a o  J. T a r r  DLL S lu k a  K A .  B r e n n a n  TJ .  Lew in G R .  
W e l sh MJ  ( 2 0 0 1 a )  I he  D R A S I C  ca t i o n  e ha n ne l  c o n t r i b u t e s  to  t he  d e t ec t i o n  o f  c u t a n e o u s  t o u c h  
and  ac id  s t imu l i  in m ic e .  N e u r o n  32:  1071 -1083 .
Pr i ce  M P.  Me l lvvra th  SL .  X ie  J.  C h e n g  C.  Q i a o  J. T a r r  D P .  S lu k a  K A .  B r e n n a n  TJ .  Tew in G R .  
W elsh  MJ  ( 20 0  l e )  T h e  D R A S IC '  c a t i o n  e ha n ne l  co n t r i b u t e s  to t he  d e t e c t i on  o f  c u t a n e o u s  t o u c h  
an d  ac id  s t imul i  in m i ce .  N e u r o n  32:  1071 -108 3 .
Pr i ce  MP .  Mel lvvra th  SL .  X ie  J. C h e n g  C.  Q i a o  J. T a r r  DL .  S lu k a  K A .  B r e n n a n  TJ .  Lew in CiR, 
W e l s h  MJ ( 2 0 0 1 b )  I lie D R A S I C  c a t i o n  e h a n n e l  co n t r i b u t e s  to  t he  d e t ec t i on  o f  c u t a n e o u s  t o u c h  
a n d  ac id  s t imu l i  in m i ce .  N e u r o n  32:  10 71 - 10 83 .
Pr i es t  BT.  M u r p h y  B A .  L in d i a  J A .  D ia z  C.  A b b a d i e  C.  R i t t er  A M .  L ib e r a to r  P. I ye r  I .M.  K as h  
SL.  K o h le r  M G .  Kaczo rovvsk i  CiJ. M a c I n t y r e  D L .  M ar t i n  WJ  ( 2 0 0 5 )  C o n t r i b u t i o n  o f  t he
223
t e t r o d o t o x in - r e s i s t a n t  v o l t a g e - g a t e d  s o d i u m  c h a n n e l  NaY'1 .9  to s ensorv  t r a n s m i s s i o n  an d  
n o c i c e p t i v e  behav ior.  P roc  Na t l  A c a d  Sci  U S A  102: 9 3 8 2 - 9 3 8 7 .
P u i s i e u x  A.  Ji J. O / t u r k  M ( 1 9 9 6 )  Anne .x in  II u p - r e g u l a t e s  c e l l u l a r  level s  o f  p i  1 p r o t e in  by  a 
pos t - t r an s l a t i on a l  m e c h a n i s m s .  B i o c h e m  J 3 13 ( Pt 1): 5 1-55.
Pu l l a rka t  SR .  Mv se l s  IXI. I an  M.  Covven  D S  ( 1 9 9 8 )  C o u p l i n g  o f  s e ro ton in  5-1LF1 B r e c e p t o r s  to 
a c t i va t i o n  o f  m i t o g e n - a c t i v a t e d  p ro t e in  k in a s e  ( L R K - 2 )  an d  p7() S6  k in a s e  s i g n a l i n g  sy s t e m s .  J 
N e u r o c h e m  71: 10 59 -1 06 7 .
Q iu  S. A d e m a  C M .  L a n e  1 ( 2 0 0 5 )  A c o m p u t a t i o n a l  s tudv o f  o f f - t a rge t  e f f ec t s  o f  R N A  
in t e r f e r ence .  N u c l e i c  A c i d s  R es  33:  18 34 -1 84 7 .
R a j an  S. P r e i s i g - M u l l e r  R.  W i s c h m e v e r  L. N e h r i n g  R. 1 lanlev PJ.  R e n i g u n t a  V.  M u s se t  B. 
S ch l i ch th o r l  ( i .  De r s t  U.  K a r s c h i n  A.  D au t  J ( 2 0 0 2 b )  I n t e r ac t i on  w i th  14-3-3 p ro t e i n s  p r o m o t e s  
f unc t i o na l  e x p r e s s i o n  o f  t h e  p o t a s s i u m  c h a n n e l s  T A S K - 1  and  T A S K - 3 .  J Ph ys io l  545:  13-26.
R a j an  S. P r e i s i g - M u l l e r  R. W i s c h m e v e r  T. N e h r i n g  R. I lan lev PJ.  R e n i g u n t a  V.  M u s s e t  B. 
S c h l i ch th o r l  CL Der s t  CL K a r s c h i n  A.  D au t  J ( 2 0 0 2 a )  I n t e rac t i on  w i th  14-3-3 p r o t e in s  p r o m o t e s  
f un c t i o n a l  e x p r e s s i o n  o f  t h e  p o t a s s i u m  c h a n n e l s  T A S K -1  an d  T A S K - 3 .  J Phys io l  545 :  13-26.
R a m o s - D e S i m o n e  N .  H a h n - D a n t o n a  T. Siplev J. N a g a s e  H. F r e n ch  D L .  Qu ig l e v  J P  ( 1 9 9 9 )  
A c t i v a t i o n  o f  m a t r i x  m e t a l l o p r o t e in a s e - 9  ( M M P - 9 )  v ia  a c o n v e r g i n g  p l a s m i n / s t r o m e ly s i n - 1  
c a s c a d e  e n h a n c e s  t u m o r  cel l  i nvas ion .  J Biol  C h e m  274:  13 06 6 -1 3 0 7 6 .
R e id  CL B a b e s  A.  P l u t e a n u  F ( 2 0 0 2 )  A co ld -  an d  m e n t h o l - a c t i v a t e d  cu r r e n t  in rat  do r s a l  r oo t  
g a n g l i o n  n e u ro n e s :  p r o p e r t i e s  a n d  ro le  in co ld  t r an sd u c t i o n .  J Phys i o l  545 :  5 9 5 - 6 1 4 .
Re id  CL F lo n t a  M  ( 2 0 0 1 b )  C o l d  t r an sd uc t i on  by i nh ib i t i on  o f  a b a c k g r o u n d  p o t a s s i u m  
c o n d u c t a n c e  in rat  p r i m a r y  s enso rv  ne u r on es .  N e u r o s e i  Le t t  297:  171-174 .
Re id  G .  F lo n t a  M ( 2 0 0 1 a )  C o l d  t r an sd u c t i o n  by  i nh i b i t i on  o f  a  b a c k g r o u n d  p o t a s s i u m  
c o n d u c t a n c e  in rat  p r i m a r y  s e n s o r y  n e u r o ne s .  N e u r o s e i  Le t t  297:  171 -174 .
Re id  ( j . Flont a  M L  ( 2 0 0 1 c )  P h ys i o lo gy .  C o ld  cu r r en t  in t h e r m o r e c e p t i v e  ne u ro n s .  N a t u r e  413 :  
480 .
R e m p e l  SA .  R o s e n b l u m  M L .  M i k k e l s e n  1. Y an  PS.  Ll l is  K D .  G o l e m b i e s k i  W A .  S a m e n i  M.  
R o / h i n  J, / i e g l e r  G .  S l o a n e  BF ( 1 9 9 4 )  C a t h e p s i n  B e x p r e s s io n  an d  l oca l i z a t i on  in g l i o m a  
p ro g r e s s i o n  a nd  i nvas ion .  C a n c e r  R e s  54: 6 0 2 7 - 6 0 3  I .
224
R e n g a n a t h a n  M.  C u m m i n s  T R .  W a x m a n  SCi ( 2 0 0 1 )  C o n t r i b u t i o n  o f  N a ( v ) l . 8 s o d i u m  c h a n n e l s  
to a c t i o n  po t en t i a l  e l e c t r o g e n e s i s  in D R G  n eu ro n s .  J N e u r o p l n s i o l  86: 6 2 9 -6 4 0 .
R e n i g u n t a  V.  Y u a n  H. / u / . a r t e  M.  R in n e  S. K o c h  A.  W i s c h m e v e r  L. Sc h l i c h th o r l  G .  G a o  Y. 
K a r s c h i n  A.  J a c o b  R. S c h w a p p a c h  B. D au t  J. P r e i s i g - M u l l e r  R ( 2 0 0 6 )  T h e  r e t e n t i on  f ac t o r  p i  1 
co n f e r s  an  e n d o p l a s m i c  r e t i c u l u m - l o c a l i / a t i o n  s i gnal  to t he  p o t a s s i u m  c h a n n e l  T A S K - 1 .  T ra f f i c  
7: 168 -181 .
R e t \  S.  S o p k o v a  J. R e n o u a r d  M.  O s t e r l o h  I). G e r k e  V.  I a b a r i e s  S. R u s s o - M a r i e  P. Lewi t -  
Ben t l ev  A ( 1 9 9 9 )  T h e  c rv s t a l  s t r uc tu r e  o f  a c o m p l e x  o f  p i  1 w i th  the a n n e x i n  II N - t e r m i n a l  
pe p t i d e .  N a t  S t ruc t  Biol  6: 89 -95 .
R h o a d s  A R .  I r i e d b e rg  F ( 1 9 9 7 )  S e q u e n c e  m o t i f s  for  c a lm o d u l i n  r e cog n i t i o n .  F A S L B  J 11: 
5 5 1 - 5 4 0 .
R i n t a l a - D e m p s e v  A C .  S a n t a m a r i a - K i s i e l  1.. L i ao  Y.  l . a j o i e  G.  Shaw G S  ( 2 0 0 6 a )  I n s igh t s  into 
S I 00  t a rge t  spec i f i c i t y  e x a m i n e d  by a new  in t e rac t i on  b e tw e e n  S 1 0 0 A 1 1  an d  a n n e x i n  A2.  
B io ch em is t r v  45:  14 69 5 - 14 70 5 .
R i n t a l a - D e m p s e v  A C .  S a n t a m a r i a - K i s i e l  L. L i ao  Y.  La jo i e  Ci. S h aw  G S  ( 2 0 0 6 b )  I n s igh t s  into 
S I 00  t a rge t  spec i f i c i t y  e x a m i n e d  by a new in t e r ac t i on  b e tw e e n  S 100A 1 1 a nd  a n n e x i n  A2.  
B i o c h e m i s t r y  45:  1 4 6 9 5 - 14 70 5 .
R i sa u  W  ( 1 9 9 7 )  M e c h a n i s m s  o f  an g io g en e s i s .  N a tu r e  586 :  6 7 1 - 6 74 .
R i t t e r  A M .  M e n d e l l  L M  ( 1 9 9 2 )  S o m a l  m e m b r a n e  p ro p e r t i e s  o f  p h y s i o lo g i c a l l y  i den t i f i ed  
s ensorx  n e u r o n s  in t he  rat: e f f ec t s  o f  ne rve  g r o w th  fac tor .  J N e u r o p l n s i o l  68:  2 0 5 5 - 2 0 4 1 .
R o d r i g u e /  C L  B u c h h o l z  L. G a l l o w a y  J. S e q u e r r a  R. K a s p e r  J. A y a l a  R. S t e w a r t  AL.  D y m e c k i  
S M  ( 2 0 0 0 )  H i g h - e f f i c i e n c y  d e l e t e r  m ic e  show that  F L P e  is an a l t e r n a t i v e  to  C r e - l o x P .  N a t  
G e n e t  25:  159-140 .
R o ge r s  JC.  Q u  Y.  P an a d a  I N .  S c h e u e r  I . Ca t t e r a l l  W A  ( 1 9 9 6 )  M o l e c u l a r  d e t e r m i n a n t s  o f  h igh  
af f in i t y  b in d i ng  o f  a l p h a - s c o r p i o n  t ox in  an d  sea  a n e m o n e  t oxin  in t he  S 5 - S 4  e x t r a c e l l u l a r  l oop  
in d o m a i n  IV o f  t he  N4u e h a n n e l  a l p h a  subun i t .  J Biol  C h e m  271 :  1 5 9 5 0 -1 5 9 6 2 .
R o / a  C.  La i rd  J M .  S o u s l o v a  V.  W o o d  JN .  C e r v e r o  P ( 2 0 0 5 )  T h e  t e t r o d o t o x in - r e s i s t a n t  N a+  
ch a n n e l  N a v i . 8 is e s s en t i a l  for  t he  e x p r e s s io n  o f  s p o n t a n e o u s  ac t i v i t y  in d a m a g e d  s enso rv  
a x o n s  o f  m ice .  J P hvs io l  550:  9 2 1 - 9 2 6 .
225
R u se  VI. L a m b e r t  A.  R o b i n s o n  N .  R ya n  I). Sl ion K.l. b e k e r t  R L  ( 2 0 0 1 )  S 1 0 0 A 7 .  S 1 0 0 A 1 0 .  and  
S 10 0A 1  1 a re  t r a n s g l u t a m i n a s e  sub s t r a t e s .  B io ch em is t ry  40:  3 1 6 7 - 3 1 7 3 .
R us h  A M .  C r a n e r  MJ .  k a g e y a m a  I . D ib -H a j j  SD .  W a x m a n  SCL R a n s c h t  B ( 2 0 0 3 b )  C 'ontae t i n 
r eg u l a t e s  t he  cu r r en t  dens i t y  an d  a xo na l  ex p re s s i o n  o f  t e t r o d o t o x in - r e s i s t a n t  bu t  not  
t e t r o d o t o .x in - s en s i t i \ e  s o d i u m  c h a n n e l s  in D R G  neu ro ns ,  b u r  J N e u ro s e i  22:  30 -4 9 .
R us h  A M .  C r a n e r  MJ .  k a g e y a m a  I . D ib -H a j j  SI) .  W a x m a n  SCi. R a n sc h t  B ( 2 0 0 3 c )  C 'on tae t i n  
r eg u l a t e s  t he  cu r r en t  densi ty  an d  a x on a l  e xp re s s i o n  o f  t e t r o do t o x i n - r e s i s t a n t  bu t  not  
t e t r o d o t o x i n - s e n s i t i v e  s o d i u m  c h a n n e l s  in DRC j n eu ro ns ,  b u r  J N e u ro se i  22:  30 -49 .
R u s h  A M .  C r a n e r  M J .  k a g e y a m a  I . D ib - H a j j  SD .  W a x m a n  SCi. R an sc h t  B ( 2 0 0 3 a )  C 'on taet i n  
r e g u l a t e s  t he  cu r r en t  densi ty  an d  ax o n a l  ex p re s s io n  o f  t e t r o d o t ox in - r e s i s t a n t  but  not  
t e t r o d o t o x in - s en s i t i v  e so d i u m  c h a n n e l s  in DRCJ ne u ro ns ,  b u r  J N e u ro s e i  22:  30 -49 .
R u s h  A M .  D ib -H a j j  SD .  b in  S. C u m m i n s  T R .  B l ac k  JA. W a x m a n  SCj ( 2 0 0 6 c ) A s i ng l e  s o d i u m  
e h a n n e l  m u t a t i o n  p r o d u c e s  h yp e r -  o r  hy poexc i t ab i l i t y  in d i f f e r en t  t y p es  o f  ne u r on s .  P roe  Nat l  
A c a d  Sei  L  S A 103: 8 2 4 3 - 8 2 5 0 .
R us h  A M .  D ib - H a j j  S D .  b in  S. C u m m i n s  T R .  B l a c k  JA .  W a x m a n  S G  ( 2 0 0 6 b )  A s i ng l e  s o d i u m  
c ha n ne l  m u ta t i o n  p r o d u c e s  h yp e r -  o r  hy poexc i t ab i l i t y  in d i f f e r en t  t y p es  o f  ne u r on s .  P roc  Na t l  
A c a d  Sei  b  S A 103: 8 2 4 5 - 8 2 5 0 .
R us h  A M .  D ib -H a j j  SD .  b in  S. C u m m i n s  T R .  B l a ck  JA .  W a x m a n  SG  ( 2 0 0 6 a )  A s i ng l e  s o d i u m  
c h a n n e l  m u t a t i o n  p r o d u c e s  h y p e r -  o r  hy poexc i t ab i l i t y  in d i f f e r en t  t y p e s  o f  ne u ro n s .  P roc  Na t l  
A c a d  Sei  L  S A 103: 8 2 4 5 - 8 2 5 0 .
Rus t  R.  V i s s e r  L. van  d e r  LJ.  H a r m s  G.  B lokz i j l  T.  D e l o u l m e  JC .  van  d. V.  k a m p s  W .  k o k  k .  
b i m  M.  P o p p e m a  S. va n  de n  B A  ( 2 0 0 5 b )  H igh  e x p r e s s io n  o f  c a l c i u m - b i n d i n g  p ro t e in s .  
S 1 0 0 A 1 0 .  S 1 0 0 A 1  1 a nd  C A L M 2  in an ap l a s t i c  la rge  cel l  l y m p h o m a .  B r  J H a e m a t o l  131: 596 -  
608.
Rust  R. V i s s e r  L. van  d e r  LJ .  H a r m s  G.  B lokz i j l  I . D e l o u l m e  JG.  van  d.  V.  k a m p s  W'. k o k  k .  
b i m  M.  P o p p e m a  S. van  d en  B A  ( 2 0 0 5 a )  H igh  e x p r e s s io n  o f  c a l c i u m - b i n d i n g  p ro t e in s ,  
S 1 0 0 A 1 0 .  S1 00 A 1  1 a nd  G A I . M 2  in an ap l a s t i c  la rge  cel l  l y m p h o m a .  B r  J H a e m a t o l  131: 596 -  
608.
S a a b  GY,  C r a n e r  MJ ,  k a t a o k a  Y.  W a x m a n  SG  ( 2 0 0 4 )  A b n o r m a l  P u rk i n j e  ce l l  a c t i vi t y in v iv o  
in e xp e r i m en t a l  a l l e rg i c  e n c e p h a l o m y e l i t i s ,  b x p  Bra in  Re s  158: 1-8.
226
S a m b r o o k  J. Lr i t seh  LL.  M a n i a t i s  1 ( 1 9 8 9 )  M o l e c u l a r  C lon ing :  A L ab o ra to ry  M a n u a l .  C o ld  
S p r i n g  H a r b o u r  L a b o r a t o r y .
S a n g a m e s w a r a n  L. D e l g a d o  SCi. F ish  L M .  K o c h  BD.  J a k e m a n  LB.  S t e w a r t  G R .  S / e  P. H u n t e r  
JC .  L g l e n  R M .  H e r m a n  RG ( 1 9 9 6 )  S t r uc tu r e  and  func t i on  o f  a nove l  v o l t a g e -g a t e d ,  
t e t r o d o t o x in - r e s i s t a n t  s o d i u m  e h a n n e l  spec i f i c  to  sensory  ne u r on s .  J Biol  C’h e m  271:  59 5 3 -  
5956 .
S a n t a m a r i a - K i s i e l  L. R in t a l a - D e m p s e v  AG.  Sha w G S  ( 2 0 0 6 )  C a l c i u m - d e p e n d e n t  an d  - 
i n d e p e n d e n t  i n t e r a c t i o n s  o f  t he  S 1 0 0  p ro t e in  f ami ly.  B i o c h e m  J 396 :  2 0 1 -2 1 4 .
S a r i s  G.l. K r i s t e n se n  I .  D T .u s t a ch io  P. H ick s  LJ.  N o o n a n  D.l. H u n t e r  1. l a c k  BL ( 1 9 8 7 a )  
e D N A  s e q u e n c e  an d  t i s sue  d i s t r i bu t i o n  o f  t he  m R N A  for  b o v in e  a nd  m u r i n e  p i  1. t he  S 1 0 0 -  
r e l a t ed  l ight  ch a in  o f  the  prot ein- t y r o s in e  k ina s e  subs t r a t e  p36  ( ea lp ae t i n  I). J Biol  C’h e m  262 :  
1 0 6 6 3 - 1 0 6 7 1 .
Sa r i s  C.I. K r i s t e n se n  I . D 'L u s t a e h io  P. H ic k s  LJ.  N o o n a n  D.l. H u n t e r  I . l a c k  I f f  ( 1 9 8 7 b )  
e D N A  s e q u e n c e  a nd  t i s sue  d i s t r i b u t i o n  o f  t h e  m R N A  for  b o v in e  an d  m u r i n e  p l l .  t h e  S 1 0 0 -  
r e l a t ed  l ight  cha i n  o f  the  prot ein- t y r o s i ne  k ina s e  su bs t r a t e  p 36  ( ea lp a e t i n  1). J B io l  C h e m  262:  
1 06 63 -1 06 71 .
Sa t i n  J. K y l e  J \V.  C h e n  M.  Bel l  P. G r ib bs  LL.  L oz za r d  HA .  R o g a r t  R B  ( 1 9 9 2 )  A m u t a n t  o f  
I T X - r e s i s t a n t  c a rd i a c  so d i u m  c h a n n e l s  w i th  T T X - s e n s i t i v e  p ro pe r t i e s .  S c i e n c e  256 :  1202-  
1205.
S a u d o u  L. A m a r a  D A .  D ie r i ch  A.  L e M e u r  M.  R a m b o z  S. S e g u  L. B u h o t  M G .  H e n  R ( 1 9 9 4 )  
E n h a n c e d  a g g r e s s i v e  behav  ior  in m i c e  l a ck ing  5 - H T 1 B  r ecep to r .  S c i e n c e  265 :  1 8 7 5 - 1 87 8 .
S c h a f e r  B W .  H e i z m a n n  C W  (1 9 9 6 a )  T h e  S 1 0 0  family o f  Id  - h a n d  c a l c i u m - b i n d i n g  p ro t e in s :
fun c t i o ns  an d  p a th o l og y  . T r e n d s  B i o c h e m  Sei  21:  134 -140 .
S ch a f e r  B W .  H e i z m a n n  C W  ( 1 9 9 6 b )  T h e  S 1 0 0  family o f  Id - ha nd  c a l c i u m - b i n d i n g  p ro t e in s :
func t i ons  and  p a t ho lo gy  . T r ends  B i o c h e m  Sei  21:  134 -140.
Sell l i ef  T\ S c h o n h e r r  R.  Im o t o  K.  H e i n e m a n n  SH  ( 1 9 9 6 )  Po re  p r o p e r t i e s  o f  rat  b r a in  II s o d i u m  
c h a n n e l s  m u ta t e d  in t he  se l ec t i v ity 11 Iter d o m a i n .  l a i r  B i o p h y s  J 25:  75 -91 .
Schvvenk T. B a ro n  U.  Rajevvsky K ( 1 9 9 5 )  A e r e - t r an s g en i e  m o u s e  s t ra in  for  t he  u b iq u i t o u s  
d e l e t i on  o f  l o x P - l l a n k e d  g e n e  s e g m e n t s  i n c l u d in g  d e l e t i on  in g e rm  cel l s .  N u c l e i c  A c i d s  R es  23: 
5 0 8 0 - 5 0 8 1 .
227
S e l t / e r  / .  D u b n e r  R. Sh i r  Y (1 c>c>0) A nove l  b eh a v i o r a l  m o d e l  o f  n e u r o p a t h i c  pa in  d i s o r d e r s  
p r o d u c e d  in ra t s  bv par t ia l  s c i a t i c  n e r ve  injurv.  Pa in  43:  2 05 -2 1 8 .
Se th  I). L e o  VIA.  M c G u i n n e s s  PH .  l . i ebe r  C S .  B r e n n a n  Y.  W i l l i a m s  R. W a n g  X M .  
M c C a u g h a n  G W .  Ciorrel  1 \ 1 D .  H a b e r  PS ( 2 0 0 3 )  G e n e  e x p re s s i o n  p ro f i l i n g  o f  a l c o h o l i c  l iver  
d i s e a se  in t he  b a b o o n  ( P a p i o  h a m a d r v a s )  an d  h u m a n  l iver.  A m  .1 Pa tho l  163: 2 3 0 3 - 2 3  1 7.
S h ah  BS.  S t e v e n s  LB .  G o n z a l e z  M L  Bramvvel l  S. P i nn oc k  RI) .  Lee  k .  D ix on  A k  ( 2 0 0 0 )  be t a3 .  
a no ve l  aux i l i a ry  su bu n i t  for  t he  v o l t a g e -g a t e d  so d i u m  c ha n ne l ,  is e x p r e s s e d  p r e f e r e n t i a l l y  in 
s enso rv  n e u r o n s  an d  is u p r e g u l a t e d  in t he  c h ro n i c  con s t r i c t i on  injurv m o d e l  o f  n e u ro p a t h i c  
pa in .  L u r  J N e u r o s e i  12: 3 0 8 5 - 3 0 0 0 .
S h a o .  I). .  Bak e r .  M.  I).. Poon .  W . Y. .  M a l ik - l l a l l .  M. .  A k ta r  S. W’ood .  J. N. .  an d  O k u s e .  k .  
N o v e l  e x p r e s s i o n  r eg u l a to r s  t o r  t he  s enso rv  n eu ro n - sp e c i f i c  so d i u m  c h a n n e l  N a V l . 8 .  11th 
W o r ld  C o n g r e s s  on  Pain .  I n t e rna t i ona l  A s s o c i a t i o n  for  t he  S t udy  o f  Pain .  Svdnev  . 200 5 .  
R e f T v p e :  A bs t r a c t
S h a r m a  M R .  ko l t ovvsk i  L. O w n  b ey  R I .  T u s z y n s k i  CjP. S h a r m a  M G  (2 0 0 6 a )  A n g i o g e n e s i s -  
a s s oc i a t e d  p ro t e in  a n n e x i n  II in b rea s t  c anc e r :  s e l ec t i ve  ex p re s s i o n  in i n vas ive  b r ea s t  c a n c e r  
an d  c o n t r i b u t i o n  to  t u m o r  i nv as io n  an d  p r og r e s s io n .  L x p  Mol  Pa tho l  81: 146-156 .
S h a r m a  M R .  R o t h m a n  V.  T u s z y n s k i  G P .  S h a r m a  M C  ( 2 0 0 6 b )  A n t i b o d y - d i r e c t e d  t a r g e t i n g  o f  
ang io s t a t i n ' s  r e c e p t o r  a n n e x i n  II i nh ib i t s  L ew i s  L u n g  C a r c i n o m a  t u m o r  g r o w t h  v ia  b l o c k i n g  o f  
p l a s m i n o g e n  ac t i va t i on :  p o s s ib l e  b io c he m ic a l  m e c h a n i s m  o f  an g io s t a t i n ' s  a c t i on .  L x p  Mo l  
Pa tho l  81:  136 -145 .
S h e e t s  PL.  J a c k s o n  Ii JO .  W a x m a n  SG.  D ib -H a j j  S. C u m m i n s  T R  ( 2 0 0 7 a )  A Nav 1.7 C h a n n e l  
M u t a t i o n  A s s o c i a t e d  w i th  H e red i t a ry  E ry th r o m e l a l g i a  C o n t r i b u t e s  to  N e u r o n a l  
Hvpe re .xc i t abi l i t v  a n d  D i s p l a v s  R e d u c e d  L id o ca i ne  Sens i t i v i t y .  J Phys io l .
S hee t s  PL.  J a c k s o n  Ii JO .  W a x m a n  SG.  D ib -H a j j  S. C u m m i n s  T R  ( 2 0 0 7 b )  A Nav  1.7 C h a n n e l  
Mu ta t i on  A s s o c i a t e d  w i th  H e re d i t a ry  L ry th r o m e l a l g i a  C o n t r i b u t e s  to N e u r o n a l  
Hy pe rex c i t ab i l i t y  a n d  D i s p l a v s  R e d u c e d  L id o c a i n e  Sens i t i v i t y .  J Phvs io l .
S h t i v e l m a n  P.. B i s h o p  .IM ( 1 9 9 3 b )  I he  h u m a n  g e n e  A l l N A k  e n c o d e s  a la rge  p h o s p h o p r o t e i n  
loca t ed  p r i ma r i l y  in t he  nu c l e us .  J Ce l l  Biol  120: 62 5 - 6 3 0 .
S h t i v e lm a n  P.. B i s h o p  .IM ( 1 9 9 3 a )  I he h u m a n  g e n e  A H N A k  e n c o d e s  a la rge  p h o s p h o p r o t e i n  
l oca t ed  p r ima r i l y  in t he  nuc l e us .  J Ce l l  Biol  120: 6 25 -6 3 0 .
228
S h t i v e l m a n  F.  C o h e n  FF .  B i s h o p  J M  ( 1 9 9 2 )  A h u m a n  ge n e  ( A H N A k )  e n c o d i n g  an  un u su a l l y  
la rge  p ro t e in  w i th  a 1 . 2 -m ic ro n s  polv ioni c r od  s t ruc tu r e .  P roc  Nat l  A c a d  Sci  l : S A 89:  5 4 7 2 -  
5476 .
S i m o n e  D A .  k a j a n d e r  k C  ( 1 9 9 7 b )  R e s p o n s e s  o f  c u t a n e o u s  A - t l b e r  n o c i c e p to r s  to  n o x i o u s  
co ld .  J N e u r o p l n  siol  77: 2 0 4 9 - 2 0 6 0 .
S i m o n e  D A .  k a j a n d e r  k C  ( 1 9 9 7 a )  R e s p o n s e s  o f  c u t a n e o u s  A - f i b e r  n o c i c e p to r s  to n o x i o u s  
co ld .  J N e u r o p l n s i o l  77: 2 0 4 9 - 2 0 6 0 .
S i n d r u p  SI 1. J e n s e n  I S ( 1 9 9 9 )  F ff i cacv  o f  p h a r m a c o lo g i c a l  t r e a tm e n t s  o f  n e u r o p a t h i c  pa in:  an 
u p d a t e  a n d  e f f ec t  r e l a t ed  to  m e c h a n i s m  o f  d r u g  ac t i on .  Pain  85: 589 -4 00 .
S l a d e c / e k  F. C a m o n i s  J l l .  B u rn o l  AF .  F e  BF  ( 1 9 9 7 )  T h e  C dk - l i k e  p ro t e in  P C T A I R F - 1  f rom  
m o u s e  b r a i n  a s s oc i a t e s  w i th  p i  1 a nd  14-5-5 p ro t e in s .  Mo l  G en  G e n e t  254:  5 71 -5 7 7 .
S m i t h  G D .  G u n t h o r p e  M l .  k e l s e l l  R F .  H a v e s  PI) .  Re i l ly  P. Fa ce r  P. W r i g h t  .IF. J e r m a n  JC .  
W a l h i n  JP .  Oo i  F.  F g e r t o n  J. C h a r l e s  k. l .  S m a r t  D. Ran da l l  A D .  A n a n d  P. Dav is J B  (2 0 0 2 a )  
I R P C 5 is a t e m p e r a t u r e - s e n s i t i v e  van i l l o id  r e cep to r - l i ke  pro t e in .  N a tu r e  418 :  186-190 .
S m i th  G D .  G u n t h o r p e  MJ .  k e l s e l l  R F .  H a v e s  PD.  Rei l ly  P. F ac e r  P. W r i gh t  J F .  J e r m a n  JC .  
W a lh i n  JP .  O o i  F.  F g e r t o n  J. C h a r l e s  k J .  S m a r t  D. R anda l l  A D .  A n a n d  P. D a v i s  J B  ( 2 0 0 2 b )  
T R P V 5  is a t e m p e r a t u r e - s e n s i t i v e  van i l l o id  r e cep t o r - l i ke  p ro t e in .  N a tu r e  418 :  186-190 .
S m i t h i e s  () .  G r e g g  R G .  B o g g s  SS.  k o r a l e w s k i  M A .  k u c h e r l a p a t i  RS  ( 1 9 8 5 )  I n s e r t i on  o f  D N A  
s e q u e n c e s  into t he  h u m a n  c h r o m o s o m a l  be t a - g lo b in  l ocus  by h o m o l o g o u s  r e c o m b i n a t i o n .  
N a t u r e  517 :  2 5 0 - 2 5 4 .
S o p k o v a - d e  O l i v e i r a  SJ.  O l i n g  F k .  Retv S. B r i s s on  A.  S m i t h  JC .  F e w i t - B e n t l e v  A  ( 2 0 0 0 )  S I 00  
p r o t e in - a n n e x in  i n t e r a c t i on s :  a m o d e l  o f  t he  ( A n x 2 - p  1 1 )(2) h e t e r o t e t r a m e r  c o m p l e x .  B i o c h i m  
B io p h y s  A c t a  1498:  181 -191 .
S ou s l o va  V A .  Fox  M.  W o o d  .IN. A k o p i a n  A N  ( 1 9 9 7 )  C l o n i n g  an d  c h a r a c t e r i z a t i o n  o f  a m o u s e  
sensorv  n e u ro n  t e t r o d o t o x in - r e s i s t a n t  v o l t a ge -g a t ed  s o d i u m  ch a n n e l  ge ne .  Sen  10a. G e n o m i c s  
41:  20 1 -209 .
Sprav DC ( 1 9 8 6 )  C u t a n e o u s  t e m p e r a t u r e  r ecep to r s .  A n n u  Rev Ph vs i o l  48:  6 2 5 - 6 5 8 .
S tavr i  ( i f .  Z a c h a r y  1C. B a s k e r v i l l e  PA .  Mar t i n  JF .  F r u s a l i m s k y  J D  ( 1 9 9 5 )  B as i c  f i brob l a s t  
g r o w th  fac to r  u p re g u l a t e s  t he  e x p r e s s i o n  o f  v a s c u l a r  en do t he l i a l  g r o w t h  f ac t o r  in v a s c u l a r  
s m o o t h  m u s c l e  cel l s .  S y n e rg i s t i c  i n t e r ac t i on  w i th  h y po x i a .  C i r c u l a t i o n  92:  1 1-14.
229
Steen  K H .  I s sb e r ne r  I .  R e e h  PW ( 1 9 9 5 )  Pa in  d u e  to e x p e r i m e n t a l  a c id o s i s  in h u m a n  skin:  
e v i d e n c e  for  n o n - a d a p t i n g  n o c i c e p t o r  exc i t a t i o n .  N e u r o s e i  Let t  199: 29 -32 .
S teen  K H .  R ee h  P W .  A n t o n  P. H a n d w o r k e r  H O  ( 1 9 9 2 )  P ro t ons  s e l ec t i ve ! )  i n d uc e  la s t i ng  
exc i t a t i on  an d  s en s i t i z a t i o n  to m e c h a n i c a l  s t im u la t i on  o f  n o c i c e p to r s  in rat skin,  in vi t ro .  J 
N e u ro s e i  12: 86 -93 .
S t i r l i ng  l .C.  I o r l an i  ( i .  B a k e r  M I ) .  W o o d  .IN. M a t t h e w s  LA.  D i c k e n s o n  A H .  N a s s a r  M A
( 2 0 0 3 )  N o c i c e p t o r - s p e c i f i c  g e n e  de l e t i o n  u s i ng  h e t e r o z y g o u s  N a V 1 .8 -C ' r e  r e c o m b i n a s e  mice .  
Pain  113: 27 -36 .
Storv ( i M .  ( i c r c a u  R W  ( 2 0 0 6 )  N u m b i n g  t he  s ense s :  ro l e  o f  T R P A 1  in m e c h a n i c a l  an d  co ld  
s ensa t i on .  N e u r o n  30: 177 - 18 0 .
Storv ( i M .  Pe i e r  A M .  R e e v e  A.I. Lid  SR .  M o s b a e h e r  J. H r i c ik  T R .  Larlev TJ .  H e r g a r d e n  A C.  
A n d e r s s o n  D A .  H w a n g  S W .  M c l n t v r e  P. J e g l a  I . Be va n  S. Pa t a p ou t i a n  A ( 2 0 0 3 )  A N K T M 1 ,  a 
I R P - l i k e  c h a n n e l  e x p r e s s e d  in n o c i c e p t i v e  n e u r on s ,  is a c t i va t ed  bv co ld  t e m p e r a t u r e s .  Ce l l  1 12: 
8 1 9 -8 2 9 .
S t r o t m a n n  R. H a r t e n e c k  C.  N u n n e n m a c h e r  K.  S ch u l t z  ( i .  P l an t  I D  ( 2 0 0 0 a )  O T R P C 4 .  a 
n o n s e l e c t i v e  ca t i o n  c h a n n e l  t ha t  c o n fe r s  s ens i t i v i t y  to ex t r a ce l l u l a r  o sm o la r i t v .  N a t  Ce l l  Biol  2: 
69 3 - 7 0 2 .
S t r o t m a n n  R. H a r t e n e c k  C.  N u n n e n m a c h e r  K.  Schu l t z  G.  P l an t  T D  ( 2 0 0 0 b )  O I  R P C 4 .  a 
n o n s e l e c t i v e  ca t i o n  c h a n n e l  t ha t  c o n f e r s  s ens i t i v i t y  to e x t r a ce l l u l a r  o sm o la r i t v .  N a t  Ce l l  B iol  2: 
6 9 5 - 7 0 2 .
S t r ye r  L ( 1 9 7 8 )  F lu o r e s c e n c e  e n e rg y  t r an s f e r  as  a s p e c t ro s c o p i c  ruler .  A n n u  Rev B i o c h e m  47:  
819 -8 46 .
Stuckv C L .  Lew in G R  ( 1 9 9 9 )  I so lec t i n  B ( 4 ) -p os i t i v e  a nd  - n e g a t i v e  n o c i c e p t o r s  a r e  f u n c t i o n a l l y  
dis t i nc t .  J N e u r o s e i  19: 6 4 9 7 - 6 5 0 5 .
S t u h m e r  W.  C o n t i  L. Su zu k i  II. W a n g  XI ) .  N o d a  M.  Y a h a g i  N.  K u b o  II. N u m a  S ( 1 9 8 9 )  
St ruc tu ra l  par t s  i n v o l v ed  in act iv a t i on  and  inact iv a t i on  o f  t he  s o d i u m  c h a n n e l .  N a t u r e  339 :  597 -  
603.
Su fka  KJ.  W a t s o n  G S ,  N o t h d u r l t  RL .  M o g i l  JS  ( 1 9 9 8 )  S c o r i n g  t he  m o u s e  f o r m a l in  test:  
v a l i da t i o n  s tudy,  b u r . I  Pain  2: 3 5 1 -3 5 8 .
230
Sun  Y \ 1 .  Lav re I. Sch i Id  L. M o e / y  d lo w s k i  1- (1 9 9 7 )  O n  t he  s t r uctur a l  ba s i s  for  s i / e - s e l e e t i \ e  
p e r m e a t i o n  o f  o rg an i c  c a t i o n s  t h r o u g h  t he  \ o l t a g e - g a t e d  so d i u m  eh an n e l .  I ; f fect  o f  a l a n i n e  
m u t a t i o n s  at  t he  D L K A  lo cu s  on  s e l ec t i v i t y ,  i nh ibi t ion  by C a 2 ^  an d  I G .  an d  m o l e c u l a r  s i e \ i n g .  
J G e n  P hys io l  110: 6 9 3 - 7 1 5 .
S u / u k i  M.  M i / u n o  A.  K o d a i r a  K.  Imai  M ( 2 0 0 3 )  Im p a i r e d  p r e s s u re  s en sa t i o n  in m i c e  l a c k i ng  
T R P V 4 .  .1 Biol  C I tem 278 :  2 2 6 6 4 - 2 2 6 6 8 .
S u / u k i  R. R a h m a n  \V. H u n t  SP.  D i c k e n s o n  A l l  ( 2 0 0 4 )  D e s c e n d i n g  fac i l i ta tory co n t r o l  o f  
m ec ha n i ca l l y  e v o k e d  r e s p o n s e s  is e n h a n c e d  in d e e p  do rsa l  ho rn  n e u r o n e s  fo l l o w in g  p e r i p h e r a l  
n e r \ e  injury.  B ra in  Re s  1019:  68 -7 6 .
S \ e n n i n g s s o n  P. C he r g u i  K.  R a c h l e f f  I. I la jolet  M.  / h a n g  X. 14 Y a e o u b i  M.  V a u g e o i s  J M .  
N o m i k o s  G G .  G r e e n g a r d  P ( 2 0 0 6 )  A l t e r a t i o ns  in 5 - H T 1 B  r e ce p t o r  f unc t i on  by p i  1 in 
d e p r e s s io n - l i k e  s t a t es .  S c i e n c e  311 :  77 -80 .
S \ e n n i n g s s o n  P. G r e e n g a r d  P ( 2 0 0 7 )  p l l  ( S 1 0 0 A 1 0 ) —an induc ib l e  a d a p t o r  p ro t e in  that  
m o d u l a t e s  n e u ro n a l  f u nc t i on s .  C u r r  O p i n  P h a rm a c o l  7: 27 -32 .
1 a b e r  RI ( 1 9 7 3 )  P r e d i c t i v e  v a lu e  o f  an a lg e s i c  a s s a ys  in m ic e  and  rats.  Adv B i o c h e m  
P s y c h o p h a r m a c o l  8: 191-21 1.
I a k a h a s h i  N.  K ik u c h i  S. Dai  Y.  K o b a y a s h i  K.  F u k u o k a  T.  N o g u c h i  K ( 2 0 0 3 )  L x p r e s s i o n  o f  
auxi l i a ry  be t a  su b u n i t s  o f  s o d i u m  c h a n n e l s  in p r imary a f f e r en t  n e u r o n s  an d  t he  e f f ec t  o f  n e r ve  
injury . N e u r o s c i e n c e  121: 4 4 1 - 4 5 0 .
T a k e d a  K. K a i s h o  T.  Y o s h i d a  N .  I ' akeda  J. K i s h i m o t o  I .  A k i r a  S ( 1 9 9 8 )  S ta t3 a c t i va t i o n  is 
r e s p o n s i b l e  f o r  I I , - 6 - d e p e n d e n t  T  cell  p ro l i fe r a t i on  t h r o u g h  p r e v e n t i n g  a p o p to s i s :  g e n e r a t i o n  
an d  c h a r a c t e r i z a t i o n  o f  I c e l l - spe c i f i c  S t a t 3 -de f i c i en t  m ice .  J I m m u n o l  161: 4 6 5 2 - 4 6 6 0 .
T a k e s u e  F4. S c h a e f e r  W .  Jukn i evvi cz  H (1 9 6 9 )  M o d i t l e a t i o n  o f  t he  R a n d a l l -S e l i t t o  a n a lg e s i c  
appa r a t u s .  J P h a r m  P h a r m a c o l  21:  788 -789 .
l a  1 ley F M .  Lei  Q. S i r o i s  JL ,  B a y l i s s  D A  (2 0 0 0 a )  TAS K- 1 ,  a t w o - p o r e  d o m a i n  K +  e h a n n e l .  is 
m o d u l a t e d  by m u l t i p l e  n e u r o t r a n s m i t t e r s  in m o t o n e u r o n s .  N e u r o n  25:  3 9 9 -4 1 0 .
I al ley P.M. Lei  Q .  S i ro i s  JL .  Bay liss D A  (2 0 0 0 b )  I A S K - 1 ,  a tw o - p o r e  d o m a i n  K +  e h a n n e l .  is 
m o d u l a t e d  by m u l t i p l e  n e u r o t r a n s m i t t e r s  in m o t o n e u r o n s .  N e u r o n  25:  3 9 9 - 4 1 0 .
231
I a ru i  I .  M a j u m d a r  M.  M i l e s  L A .  R u f  W.  I a k a d a  Y ( 2 0 0 2 )  P l a s m i n - i n d n c c d  m i g r a t i o n  o f  
en do th e l i a l  ce l l s .  A  po t en t i a l  t a r ge t  for  t h e  a n t i - a n g i o g e n i c  a c t ion  o f  an g io s t a t i n .  J Biol  C’h em  
277:  3 3 5 6 4 - 3 3 5 7 0 .
te RH.  M a a n d a g  F R .  B e rn s  A ( 1 9 9 2 )  H ig h ly  e f f ic i en t  ge n e  t a rg e t i ng  in e m b r y o n i c  s t e m  ce l l s  
t h r o u g h  h o m o l o g o u s  r e c o m b i n a t i o n  w i th  i sog en i c  D N A  con s t ruc t s .  Proc  Nat l  A c a d  Sei  L  S A 
89: 5 1 2 8 - 5 1 3 2 .
T h i a g a r a j a n  P. R i p p o n  A.I. Fa r r e l l  I )H  ( 1 9 9 6 )  A l t e rn a t i ve  a d h es i o n  s i tes  in h u m a n  f i b r i n og en
for  \ a s c u l a r  en d o th e l i a l  ce l l s .  B i o c h e m i s t r y  35:  4169 -41  75.
T h o m a s  K R.  C’a p e c c h i  M R  ( 1 9 8 7 )  S i t e - d i r e c t e d  m u t a g e n e s i s  by g e n e  t a rg e t i n g  in m o u s e  
e m b r v o - d e r i v e d  s t e m  cel l s .  Ce l l  51:  5 0 3 -5 1 2 .
T h o m a s  K R.  D e n g  C .  C ' ap ecc h i  M R  ( 1 9 9 2 )  H igh - f i de l i t y  ge ne  t a rg e t i n g  in e m b r v o n i c  s t e m  
ce l l s  b> u s i ng  s e q u e n c e  r e p l a c e m e n t  vec to r s .  Mo l  Ce l l  Biol  12: 2 9 1 9 - 2 9 2 3 .
T h o m p s o n  W l ) .  S m i th  LB.  St  irk C M .  M ar sh a l l  FI. S tou t  A.I. K o c c h a r  A ( 1 9 9 2 )  A n g i o g e n i c
ac t i vi t v o f  f ibr in d e g r a d a t i o n  p r o d u c t s  is loca t ed  in f ibr in f r ag m e n t  L. J Pa tho l  168: 4 7 - 5 3 .
T h y a g a r a j a n  B. G u i m a r a e s  MJ .  G r o th  A C .  C a lo s  M P  (2 0 0 0 )  M a m m a l i a n  g e n o m e s  c o n t a i n  
ac t i v e  r e c o m b i n a s e  r e c o g n i t i o n  s i tes.  G e n e  244:  47 -54 .
T jo l s en  A.  B e rg e  O G .  H u n s k a a r  S. R o s l a nd  JH .  H o le  K ( 1 9 9 2 )  T h e  fo rm a l in  test :  an  e v a lu a t i o n  
o f  t he  m e t h o d .  Pa in  51:  5 -17 .
I o l e d o - A r a l  JJ. M o s s  BL .  H e  ZJ. Koszovvski  A G .  W h i s e n a n d  I . Lev i n son  SR .  W o l f  JJ. Silo s-  
S a n t i a g o  I. H a l e g o u a  S. M a n d e l  G ( 1 9 9 7 )  I den t i f i c a t i on  o f  P N 1 .  a p r e d o m i n a n t  v o l t a ge -  
d e p e n d e n t  s o d i u m  e h a n n e l  e x p r e s s e d  pr i nc ipa l l y  in pe r i ph e ra l  ne u ro ns .  P roc  Na t l  A c a d  Sei  U S 
A 94:  1 5 27 -1 53 2 .
T o m i n a g a  M.  C a t e r i n a  MJ .  M a l m b e r g  A B .  R os en  I A.  G i lb e r t  H. S k i n n e r  K.  R a u m a n n  BL.  
B a s b a u m  AT J u l i u s  D  ( 1 9 9 8 d )  The c lo ne d  ca ps a i c i n  r e c e p t o r  i n t eg r a t e s  m u l t i p l e  pa in-  
p r o d u c i n g  s t imul i .  N e u r o n  21:  53 1-543.
T o m i n a g a  M.  C a t e r i n a  MJ .  M a l m b e r g  A B .  R os en  I A,  G i lb e r t  H. S k i n n e r  K.  R a u m a n n  BL.  
B a s b a u m  AI.  Ju l i u s  I) ( 1 9 9 8 c )  I h e  c l o n e d  c a ps a i c i n  r e c ep t o r  i n t eg r a t e s  m u l t i p l e  pa in-  
p r o d u c i n g  s t imul i .  N e u r o n  21:  53 1-543.
232
Tominaga M. C aterina Ml. Malmberg AIT Rosen TA. Gilbert H. Skinner k .  Raumann BT. 
Basbaum Al. Julius D (1998c) The cloned capsaicin receptor integrates multiple pain-
producing stimuli. Neuron 21: 531-543.
Tominaga M. C aterina MJ. Malmberg AB. Rosen I A. Gilbert H. Skinner K. Raumann BT.
Basbaum Al. Julius I) (1998b) The cloned capsaicin receptor integrates multiple pain-
producing stimuli. Neuron 21: 531-543.
Tominaga M. C aterina MJ. Malmberg AB. Rosen TA. Gilbert II. Skinner k .  Raumann BT. 
Basbaum Al. Julius I) (1998a) The cloned capsaicin receptor integrates multiple pain-
producing stimuli. Neuron 21: 53 1-543.
Treede RI). Mever RA. Campbell .IN (1998) Mvelinated mechanical!) insensitive afferents 
from monkev hair) skin: heat-response properties. J Neurophysiol 80: 1082-1093.
Tsien J / .  Chen I)b. Gerber I). Tom C . Mercer 141. Anderson DJ. May ford M. kandel TR. 
Tonegavva S (1996) Subregion- and cell tvpe-restricted gene knockout in mouse brain. C ell 87: 
1317-1326.
I 'eda H. Matsunaga S. Inoue M. Yamamoto Y. Ila/ato I (2000) Complete inhibition of 
purinoceptor agonist-induced nociception by spinorphin. but not by morphine. Peptides 21: 
1215-1221.
Upton AT. Moss ST (1994) Molecular cloning of  a nov el N-terminal v ariant of  annexin II from 
rat basophilic leukaemia cells. Biochem J 302 ( Pt 2): 425-428.
Urch CT. Dickenson AH (2003) In v ivo single unit extracellular recordings from spinal cord 
neurones of rats. Brain Res Brain Res Protoc 12: 26-34.
van de CJraaf ST. Hoenderop JG. Gkika D. Tamers D. Prenen J. Reseller U. Gerke V. Staub O. 
Ni 1 ins B. Bindels RJ (2003) Functional expression of the epithelial Ca(2+) channels (TRPV5 
and TRPV6) requires association of  the S 10 0 A 10-anne.xin 2 complex. TMBO J 22: 1478-1487.
Vassilev P. Scheuer I. Catterall WA (1989) Inhibition of  inactivation of  single sodium 
channels by a site-directed antibody. Proc Natl Acad Sci U S A  86: 8147-8151.
Vassilev PM. Scheuer I . Catterall WA (1988) Identification of  an intracellular peptide segment 
involved in sodium ehannel inactivation. Science 2 4 1: 1658-1661.
Verge VM. Richardson PM. Benoit R. Riopelle RJ (1989) I listochemical characterization of  
sensorv neurons with high-affinity receptors for nerve growth factor. J Neurocytol 18: 583-591.
Viana F. de la PF. Belmonte C (2002a) Specified) of cold thermotransduction is determined bv 
differential ionic ehannel expression. Nat Neurosei 5: 254-260.
Viana F. de la PF. Belmonte C (2002b) Specificity of  cold thermotransduction is determined by 
differential ionic ehannel expression. Nat Neurosei 5: 254-260.
Vijavaragavan k .  Boutjdir VI. Chahine M (2004a) Modulation ol Na\1 .7  and Nav 1.8 
peripheral nerve sodium channels bv protein kinase A and protein kinase C. J Neuroplnsiol 01: 
1556-1569.
Vijavaragavan k .  Powell A.I. kinghorn I.l. C'hahine M (2004b) Role ol auxiliary beta 1 -. beta2-. 
and betax-subunits and their interaction with Na(v) 1.8 voltage-gated sodium channel. Biochem 
Biophvs Res Commun 5 10: 55 1-540.
Virginio C. Robertson ( j . Surprenant A. North RA (1008) I rinitrophenv 1-substituted 
nucleotides are potent antagonists selective for P2X1. P2X5. and heteromeric P2X2/3 
receptors. Mol Pharmacol 53: 060-975.
Voillev N (2004a) Acid-sensing ion channels (ASIC's): new targets for the analgesic effects of 
non-steroid anti-inflammatorv drugs (NSAIDs). Curr Drug Targets Inflamm Allergy 3: 71-70.
Voillev N (2004b) Acid-sensing ion channels (ASIC's): new targets for the analgesic effects of 
non-steroid anti-inflammatorv drugs (NSAIDs). Curr Drug Targets Inflamm Allergy 3: 71-70.
Voillev N. de Weille J. Mamet J. Fazdunski M (2001) Nonsteroid anti-inflammatorv drugs 
inhibit both the activity and the inflammation-induced expression of  acid-sensing ion channels 
in nociceptors. J Neurosei 21: 8026-8033.
Vozivanov Y. Pathania S. Jayaram M (1999) A general model for site-specific recombination 
by the integrase family recombinases. Nucleic Acids Res 27: 030-041.
Vukicev ic M. kellenberger S (2004) Modulatory effects of acid-sensing ion channels on action 
potential generation in hippocampal neurons. Am .! Physiol Cell Phvsiol 287: C682-C690.
Wall PI). Melzack R (1000) Textbook of'Pain. Churchill Livingstone.
Wasner Ci. Schattsclmeider J. Binder A. Baron R (2004) Topical menthol—a human model for 
cold pain by activation and sensitization o fC  nociceptors. Brain 127: 1 150-1 171.
Watanabe H, Davis JB. Smart I). Jerman JC. Smith CD. Hayes P. Vriens J. Cairns W. 
Wissenbach 11. Prenen J. f lockerzi V. Droogmans G. Benham CD. Nilius B (2002a) Activation
234
of TRPV4 channels (hVRL-2/m’FRPl 2) bv phorbol derivatives. J Biol Chem 277: 13569- 
13577.
Watanabe H. Vriens J. Sub SH. Benham CD. Droogmans G. Nilius B (2002b) Meat-evoked 
activation of TRPV4 channels in a HTK293 cell expression svstem and in native mouse aorta 
endothelial cells. J Biol Chem 277: 47044-47051.
Waxman SG. Koesis .ID. Black JA (1994) Type 111 sodium channel mRNA is expressed in 
embryonic but not adult spinal sensorv neurons, and is reexpressed following axotomy. J 
Neuroplnsiol 72: 466-470.
W elch JM. Simon SA. Reinhart PH (2000) The activation mechanism of rat vanilloid receptor 
1 by capsaicin involves the pore domain and differs from the activation by either acid or heat. 
Proc Natl Acad Sci I S A 97: 13889-13894.
Wemmie JA. Askvvith CC. Lamani L. Cassell Ml). Freeman JH. Jr.. Welsh MJ (2003) Acid- 
sensing ion channel 1 is localized in brain regions with high synaptic density and contributes to 
fear conditioning. J Neurosei 23: 5496-5502.
Wemmie JA. Chen J. Askvvith CC. Hruska-Hageman AM. Price MP. Nolan BC. Yoder PG. 
Lamani b. Hoshi T. Freeman JH. Jr.. Welsh MJ (2002) The acid-activated ion channel ASIC 
contributes to synaptic plasticity, learning, and memory. Neuron 34: 463-477.
Wemmie JA. Coryell MW'. Askvvith CC. Lamani L, Leonard AS. Sigmund CD. Welsh MJ
(2004) Overexpression o f  acid-sensing ion channel la in transgenic mice increases acquired 
fear-related behav ior. Proc Natl Acad Sci U S A 101: 3621-3626.
W'erb / .  Banda MJ. Jones PA (1980) Degradation of connective tissue matrices by 
macrophages. 1. Proteolysis o f  elastin. glycoproteins, and collagen by proteinases isolated from 
macrophages. J Lxp Med 152: 1340-1357.
West JW'. Patton DL. Scheuer 1. Wang Y. Goldin AL.. Catterall WA (1992) A cluster of 
hydrophobic amino acid residues required for fast Na( + )-channel inactivation. Proc Natl Acad 
Sci IJ S A 89: 10910-10914.
Wetzel C. Hu J, Riethmaeher D. Benekendorff A. Harder L, Tilers A. Moshourab R. 
Kozlenkov A. Labuz D, Caspani (). Lrdmann B. Maehelska 11, Heppenstall PA. Lew in GR 
(2007a) A stomatin-domain protein essential for touch sensation in the mouse. Nature 445: 
206-209.
235
Wet/.el C. Hu J. Riethmacher I). Benckendorff A. Harder L. Idlers A. Moshourab R, 
Ko/.lenkov A. Labuz I). Caspani (). Erdmann B. Maehelska H. Heppenstall PA. Lew in CiR 
(2007b) A stomatin-domain protein essential for touch sensation in the mouse. Nature 445: 
206-200.
Wilson SCi. Mogil JS (2001) Measuring pain in the (knockout) mouse: big challenges in a small 
mammal. Behav Brain Res 125: 65-75.
Wirl (i. Sehwartz-Albiex R (1000) Collagen-binding proteins of mammarv epithelial cells are 
related to Ca2( + )- and phospholipid-binding annexins. J Cell Physiol 144: 51 1-522.
W oo VC’. Park SS. Subieta AR. Brennan TJ (2004) Changes in tissue pH and temperature after 
incision indicate acidosis mav contribute to postoperative pain. Anesthesiologv 101: 468-475.
Wood JN (2000) Molecular Basis of Pain Transduction. W ilev-Liss.
Wood JN. Boorman JP. Okuse K. Baker MI) (2004a) Voltage-gated sodium channels and pain 
pathways. J Neurobiol 61: 55-71.
Wood JN. Boorman JP. Okuse K. Baker MI) (2004c) Voltage-gated sodium channels and pain 
pathways. J Neurobiol 61: 55-71.
Wood JN. Boorman JP. Okuse K. Baker MD (2004b) Voltage-gated sodium channels and pain 
pathways. J Neurobiol 61: 55-71.
Woodbury C.I. Zwick M. Wang S. Lawson JJ. Caterina MJ. Koltzenburg M. Albers KM. 
Koerber HR. Davis BM (2004) Nociceptors lacking TRPV1 and TRPV2 have normal heat 
responses. J Neurosei 24: 6410-6415.
W oolf CJ (1983) Ev idence for a central component of post-injury pain hypersensitivity. Nature 
306: 686-688.
Woolf CJ. Safieh-Garabedian B. Ma QP. Crilly P. W inter J (1994) Nerve growth factor 
contributes to the generation of  inflammatory sensorv hypersensitivity. Neuroscience 62: 327-
-> i1.
W u T. Angus CW, Yao XL. Logun C. Shelhamer JH (1997a) PI 1. a unique member o f  the 
SI 00 family of  calcium-binding proteins, interacts with and inhibits the activity of  the 85-kDa 
cytosolic phospholipase A2. J Biol Chem 272: 17145-17153.
236
Wu I . Angus C\V. Yao XL. Logun C. Shelhamer JH (1997b) PI 1. a unique member of  the 
SI 00 family of  ealeium-binding proteins, internets with and inhibits the actixitx of  the 85-kDa 
ewtosolic phospholipase A2. J Biol Chem 272: 17145-17153.
Wu 1. Angus CW. Yao XL. Logun C. Shelhamer JH (1997c) PI 1. a unique member of the 
SI 00 family of  ealeium-binding proteins, interacts with and inhibits the actixitx of the 85-kDa 
cxtosolic phospholipase A2. J Biol C hem 272: 17145-17153.
Wu T. Angus CW. Yao XL. Logun C. Shelhamer JH (1997d) PI 1. a unique member of the 
SI 00 family of ealeium-binding proteins, interacts with and inhibits the activity of the 85-kI)a 
cxtosolic phospholipase A2. J Biol Chem 272: 17145-17153.
Xie J. Price Y1P. Berger AL. Welsh MJ (2002) DRASIC contributes to pll-gated currents in 
large dorsal root ganglion sensorx neurons b\ forming heteromultimeric channels. J 
Neuroplnsiol 87: 2835-2843.
Xiong Z(i. Zhu XM. Chu XP. Minami M. Hex J. Wei WL. MacDonald JL. Wemmie JA. Price 
MP. Welsh MJ. Simon RP (2004) Neuroprotection in ischemia: blocking calcium-permeable 
acid-sensing ion channels. Cell 1 18: 687-698.
Xu GY. Huang LY. Zhao ZQ (2000) Activation of silent mechanoreeeptive cat C and Adelta 
sensorx neurons and their substance P expression follow ing peripheral inflammation. J Physiol 
528 Pt 2: 339-348.
Xu H. Ramsey IS. Kotecha SA. Moran MM. Chong JA. Lawson D. Ge P. Lilly J. Silos- 
Santiago 1. Xie Y. DiStefano PS. Curtis R. Clapham DL (2002) TRPV3 is a calcium-permeable 
temperature-sensitixe cation channel. Nature 418: 181-186.
Xu H. Zhao H. Tian W . Yoshida K. Roullet JB. Cohen DM (2003) Regulation of  a transient 
receptor potential (TRP) ehannel by tyrosine phosphorylation. SRC family kinase-dependent 
tyrosine phosphorylation of  TRPV4 on TYR-253 mediates its response to hypotonic stress. J 
Biol Chem 278: 1 1520-1 1527.
Yamasaki R. Berri M. W u Y. frombitas K. MeNabb M. Kellermayer MS. W itt C. Labeit D. 
Labeit S. Greaser M. Gran/ier 11 (2001) I itin-aetin interaction in mouse myocardium: passive 
tension modulation and its regulation by calcium/S 100A1. Biophys J 81: 2297-23 13.
Yang N. George AL. Jr.. Horn R (1996) Molecular basis of  charge movement in voltage-gated 
sodium channels. Neuron 16: 1 13-122.
237
Yang N. Horn R (1995) Evidence for voltage-dependent S4 movement in sodium ehannels. 
Neuron 15: 213-218.
Yao XL. Cowan MJ. Gladwin ML. Lawrence MM. Angus CW. Shelhamer JH (1999c) 
Dexamethasone alters arachidonate release from human epithelial cells by induction of  pi 1 
protein synthesis and inhibition of  phospholipase A2 activity. J Biol Chem 274: 17202-17208.
Yao XL. Cowan MJ. Gladwin M l .  Lawrence MM. Angus CW. Shelhamer JH (1999a) 
Dexamethasone alters arachidonate release from human epithelial cells bv induction of  pi 1 
protein synthesis and inhibition of  phospholipase A2 activity. J Biol Chem 274: 17202-17208.
Yao XL. Cowan MJ. Gladwin M l .  Lawrence MM. Angus C'W. Shelhamer JH (1999b) 
Dexamethasone alters arachidonate release from human epithelial cells by induction of  pi 1 
protein synthesis and inhibition of  phos, 1 ’ pase A2 activity. J Biol Chem 274: 17202-17208.
Yeatman 1J. Cpdvke TV. Kaet/el MA. Dedman JR. Nicolson GL (1993a) Expression of 
annexins on the surfaces of  non-metastatie and metastatic human and rodent tumor cells. Clin 
Lxp Metastasis 1 1: 37-44.
Yeatman TJ. I pdyke TV. Kaetzel MA. Dedman JR. Nicolson GL (1993b) Expression of 
annexins on the surfaces of  non-metastatie and metastatic human and rodent tumor cells. Clin 
Lxp Metastasis 1 1: 37-44.
Yeomans DC. Pirec V. Proudfit HK (1996) Nociceptive responses to high and low rates of 
noxious cutaneous heating are mediated bv different nociceptors in the rat: behavioral 
ev idence. Pain 68: 133-140.
Yeomans DC. Proudfit HK (1996) Nociceptive responses to high and low rates of  noxious 
cutaneous heating are mediated by different nociceptors in the rat: electrophysiological 
ev idence. Pain 68: 141-150.
Young KA. Caldwell JH (2005) Modulation of  skeletal and cardiac voltage-gated sodium 
channels by calmodulin. J Phvsiol 565: 349-370.
Yu PH. Catterall WA (2003) Overv iew of the voltage-gated sodium channel family. Genome 
Biol 4: 207.
Yu 1 11. Westenbroek RL. Silos-Santiago I. McCormick KA. Lawson D. Ge P. I erriera II. Lilly 
J. DiStefano PS. Catterall WA. Scheuer I, Curtis R (2003) Sodium channel beta4. a new 
disulfide-linked auxiliarv subunit with similaritv to beta2. J Neurosei 23: 7577-7585.
238
71
Yu W 11. Fraser PI- (2001) SlOObeta interaction with tail is promoted by zinc and inhibited by 
h\perphosphor\  lation in Alzheimer's disease. J Neurosei 21: 2240-2246.
Zhang L. Fogg DK. Waisman DM (2004) RNA interference-mediated silencing of the 
S 100A 10 gene attenuates plasmin generation and invasi\eness of  Colo 222 colorectal cancer 
cells. J Biol Chem 279: 2053-2062.
Zhang Q. Wu WX (2007) Separate and synergistic effect of  progesterone and estradiol on 
induction of annexin 2 and its interaction protein pi 1 in pregnant sheep myometrium. J Mol 
Fndocrinol 38: 441-454.
Zhao J. Seereeram A. Nassar MA. Levato A. Pezet S. Hathawa\ G. Morenilla-Palao C. Stirling 
C. Fitzgerald M. McMahon SB. Rios M. Wood JN (2006) Nociceptor-derived brain-derived 
neurotrophie factor regulates acute and inflammatory but not neuropathic pain. Mol Cell 
Neurosei 31: 539-548.
Zobiaek N. Reseller C. Ludwig C. Zeuschner D. Gerke V (2003) The annexin 2/S 100A 10 
complex controls the distribution of  transferrin receptor-containing recycling endosomes. Mol 
Biol Cell 14: 4896-4908.
Zuber J. Fchernitsa Ol. Hinzmann B. Schmitz AC. Grips M. Hellriegel M. Sers C, Rosenthal 
A. Schafer R (2000) A genome-wide survey of  RAS transformation targets. Nat Genet 24: 144- 
152.
Zurborg S. Yurgionas B. Jira JA. Caspani O. Fleppenstall PA (2007) Direct activation of  the 
ion channel TRPA1 by Ca(2+). Nat Neurosei.
239
